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resumo 
 
 
A fosforilação de proteínas é um dos principais mecanismos reguladores de 
cascatas de transdução de sinais em eucariotas. A fosforilação é catalizada 
por proteínas cinases e é revertida pela acção de proteínas fosfatases. 
Embora as proteínas fosfatases tenham sido descobertas à mais de sessenta 
anos, a sua importância central em múltiplos mecanismos celulares só muito 
recentemente foi reconhecida. 
PP1, uma fosfatase específica para serina/treonina, está envolvida em 
importantes mecanismos celulares, como o ciclo celular, a contracção 
muscular e a apoptose, entre outros. O seu papel em tão variados processos 
celulares depende das suas interacções com subunidades reguladoras. Até à 
data, foram descritas mais de 50 subunidades reguladoras que se ligam à 
subunidade catalítica da PP1, sendo determinantes para a sua função num 
local específico da célula. 
Das três isoformas da PP1 conhecidas, PP1, PP1 e PP1, a isoforma gama 
sofre splicing alternativo, originando a PP11, ubíqua e, a PP12 específica de 
testículo. 
Incubação de espermatozóides imaturos com inibidores de fosfatases induz a 
sua motilidade, sendo a PP12 a fosfatase envolvida. Este facto levou-nos a 
procurar proteínas de testículo humano capazes de interagir especificamente 
com a PP12 que possam ser alvos terapêuticos no tratamento da infertilidade, 
ou na contracepção masculina. Para atingir este objectivo utilizou-se o sistema 
Dois Híbrido de Levedura no rastreio de uma biblioteca de testículo humano, 
na busca de novas proteínas que se ligam à PP1 usando como isco a PP11 
(no YTH1) ou a PP12 (no YTH2). 
Obtivemos 120 clones positivos no YTH1 e 155 no YTH2. Entre eles 
encontravam-se clones que codificam reguladores da PP1 previamente 
descritos, como a Nek2 e a NIPP1, assim como novas proteínas. Efectuámos 
um estudo detalhado de um novo gene, codificando uma nova proteína, que 
denominamos SEARP-T. Esta proteína de 93kDa é expressa maioritariamente 
em testículo e, a sua localização intracelular foi determinada por 
imunocitoquímica de fluorescência. Ambas as proteínas, PP12 e SEARP-T, 
estão presentes na cauda e no segmento equatorial da cabeça do 
espermatozóide. Estes resultados clarificam as funções da PP1 no testículo 
humano e na motilidade do esperma e, indicam que o sistema Dois Híbrido de 
Levedura é um bom método para compreender o papel da PP1 em múltiplos 
eventos de regulação celular.    
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
abstract 
 
Protein phosphorylation is a major regulatory mechanism notably of signal 
transduction cascades in eukaryotic cells. Protein phosphorylation is catalysed 
by protein kinases and can be reversed by the action of protein phosphatases. 
Although phosphatases were discovered more than sixty years ago, their 
importance as central players in multiple cellular mechanisms was only recently 
recognized.  
PP1, a Serine/Threonine specific phosphatase, is involved in important cellular 
mechanisms such as the cell cycle, muscle contraction and apoptosis, among 
others. Its role in such diverse cellular processes depends on its interactions 
with targeting/regulatory subunits. To date, more than 50 regulatory subunits 
have been identified that bind the catalytic subunit of PP1 determining its 
function in a specific cellular location. 
Several isoforms of PP1 are known, termed PP1, PP1 and PP1. The 
gamma isoform undergoes alternative splicing to yield a ubiquitously expressed 
PP11 and a testis-specific PP12 isoform. 
Incubation of non-motile immature sperm with phosphatase inhibitors induces 
sperm motility, and PP12 was implicated in this process. This led us to search 
for PP12-specific interactors in human sperm that could be targeted for 
infertility therapeutics or in male contraception. To achieve this goal the Yeast 
Two Hybrid system was used to screen a human testis library for new PP1 
binding proteins using both PP11 (YTH1) and PP12 (YTH2) as baits. 
We recovered 120 positive clones in YTH1 and 155 positive clones in YTH2. 
Among these were clones encoding “bona fide” PP1 interactors such as Nek2 
and NIPP1, and also previously uncharacterized proteins. We undertook a 
more detailed study of a novel gene encoding a novel protein that we termed 
SEARP-T. This protein of 93KDa is expressed mainly in testis and fluorescence 
immunocytochemistry was used to determine its intra sperm localization. Both 
PP12 and SEARP-T proteins are present in the tail and in the equatorial 
segment of the head.These results provide new insights into PP1 function in 
human testis and sperm motility, and indicates that the Yeast Two Hybrid 
System provides a mean to understand the roles PP1 plays in diverse cellular 
regulatory events.  
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I INTRODUCTION 
 
 
I.1 PROTEIN PHOSPHORYLATION AS A DYNAMIC PROCESS 
 
The reversible phosphorylation of structural and regulatory proteins is a major 
intracellular control mechanism in eukaryotes. It is involved in almost all cellular 
functions, from metabolism to signal transduction, cell division and memory. The 
phosphorylation state of a protein is a dynamic process controlled by both protein kinases 
and protein phosphatases (Fig. I.1).  
 
Figure I.1: The dynamic process of protein phosphorylation. 
 
The protein kinases and protein phosphatases, the key controlling elements, are 
regulated by a myriad of extracellular and intracellular signals. Unlike the protein kinases 
that all belong to a single gene family, the protein phosphatases are divided into several 
distinct and unrelated protein/gene families. The Ser/Thr-specific protein phosphatases 
(Ser/Thr-PPs) comprise two distinct families, the PP1/PP2A/PP2B gene family and the 
PP2C gene family. The Tyr-specific phosphatase family, as well as including the Tyr-
specific phosphatases, also comprises the so-called dual specificity phosphatases (capable 
of dephosphorylating Ser, Thr and Tyr residues). Besides these intracellular phosphatases 
involved in signal transduction, there are also unrelated non-specific alkaline and acid 
phosphatases that are usually found either in specialized intracellular compartments or in 
the extracellular milieu.  
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The sequencing of entire genomes has revealed that approximately 3% of all eukaryotic 
genes encode protein kinases or protein phosphatases (Plowman et al., 1999). Surprisingly, 
there appear to be 2-5 times fewer protein phosphatases than protein kinases. This 
imbalance is even more pronounced when the analysis is limited to Ser/Thr-PP and 
kinases, particularly in vertebrates. The human genome, for instance, encodes 
approximately 20 times fewer Ser/Thr-PP than Ser/Thr-kinases. Thus, whereas the 
diversity of the Ser/Thr-protein kinases has kept pace with the increasing complexity of 
evolving organisms, that of Ser/Thr-PP has not. In the past decade it has became apparent 
that the diversity of Ser/Thr-PP is achieved not only by the evolution of new catalytic 
subunits, but also by the ability of a single catalytic subunit to interact with multiple 
regulatory (R) subunits. 
 
I.2 ABNORMAL PHOSPHORYLATION IN DISEASE 
 
Reversible protein phosphorylation is the major metabolic control mechanism of 
eukaryotic cells. Indeed, cellular health and vitality are dependent on the fine equilibrium 
of protein phosphorylation systems. Not surprisingly many diseases and dysfunctional 
states are associated with the abnormal phosphorylation of key proteins (e.g. cancer, 
diabetes, etc.).  
In neurodegenerative diseases such as Alzheimer’s Disease there is evidence for 
abnormal regulation of protein kinases. Altered activities and protein levels of several 
specific kinases suggest that abnormal phosphorylation contributes to the pathogenesis of 
these diseases. In Alzheimer’s Disease, neurofibrillary degeneration results from the 
aggregation of abnormally phosphorylated Tau protein into paired helical filaments. 
Protein kinase A (PKA) and glycogen synthase kinase 3  (GSK3) are likely to be key 
kinases involved (Delobel et al., 2002), and PP2A is thought to be the main tau 
phosphatase (Planel et al., 2001). Furthermore, activation of protein kinase C (PKC), or 
inactivation of protein phosphatase 1 (PP1) leads to a relative increase in the utilization of 
the non-amyloidogenic pathway for Alzheimer’s amyloid precursor protein (APP) 
processing (Gandy and Greengard, 1994; da Cruz e Silva et al., 1995a).   
Other neurodegenerative diseases that may result from abnormal phosphorylation 
include Parkinson’s Disease (PD) and Huntington’s Disease (HD). Alpha-Synuclein has 
been implicated in the pathogenesis of PD, and is a major component of Lewy bodies (a 
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major anatomical hallmark of PD). Alpha-synuclein was demonstrated to be constitutively 
phosphorylated indicating that its function is regulated by 
phosphorylation/dephosphorylation mechanisms (Okochi et al., 2000). Motor and 
cognitive deficits in HD are likely caused by progressive neuronal dysfunction preceding 
neuronal cell death. Synapsin I is one of the major phosphoproteins regulating 
neurotransmitter release. In mice expressing the HD mutation, synapsin I is abnormally 
phosphorylated suggesting that an early impairment in its phosphorylation may alter 
synaptic vesicle trafficking and lead to defective neurotransmission in HD (Lievens et al., 
2002).  
Altered phosphorylation has also been implicated in the etiology and/or symptoms of 
heart failure (Neumann, 2002) as well as in Diabetes (Sridhar et al., 2000). 
Therefore, protein phosphorylation systems represent attractive targets for 
diagnostics and therapeutics of several neurodegenerative and non-neurodegenerative 
diseases. 
 
I.3 PHOSPHATASES AND THEIR CLASSIFICATION 
 
The Ser/Thr-PPs, based on biochemical parameters, were initially divided into two 
classes: the type-1 phosphatases  (PP1) that were inhibited by two heat-stable proteins, 
inhibitor-1 (I-1) and inhibitor-2 (I-2), and preferentially dephosphorylated the -subunit of 
phosphorylase kinase; and the type-2 phosphatases, insensitive to the heat-stable inhibitors 
and that preferentially dephosphorylated the -subunit of phosphorylase kinase 
(Ingebritsen and Cohen, 1983; Cohen, 1989). Type-2 phosphatases were further subdivided 
into cation independent (PP2A), Ca2+-dependent (PP2B) and Mg2+-dependent (PP2C) 
classes. The use of okadaic acid, a specific phosphatase inhibitor, further facilitated the 
discrimination between different classes (Cohen et al., 1989). Although widely in use, this 
classification does not reflect the actual phylogenetic relationship between the different 
Ser/Thr-PP. Molecular cloning revealed that PP2A was in fact much more related to PP1 
than to PP2C (Berndt et al., 1987; da Cruz e Silva et al., 1987).  From a phylogenetic point 
of view it is more reasonable to group PP1, PP2A and PP2B in family I or PPP [that also 
includes the bacteriophage λ, orf221 phosphatase (Cohen et al., 1988)] and PP2C in family 
II or PPM (Fig. I.2).  
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Figure I.2: Phylogenic tree depicting the degree of similarity between the known phosphatases 
based on their primary amino acid sequence. PP1-PP7 belong to a single gene family (PPP) that is 
structurally distinct from the PP2C family (PPM). The phosphatases above the dashed line are 
highly sensitive to inhibition by the naturally occurring toxins, okadaic acid, mycrocystin and 
calyculin A (Honkanen and Golden, 2002). 
 
I.3.1 The PPP Family 
 
The application of recombinant DNA techniques to the field yielded not only the 
primary structure of all four phosphatase types, but also documented the existence of 
isoforms for each type and revealed the existence of previously undetected phosphatases in 
a variety of eukaryotic cells (Berndt et al., 1987; da Cruz e Silva et al., 1987; da Cruz e 
Silva and Cohen, 1987; Cohen et al., 1988; da Cruz e Silva et al., 1988). Three genes are 
known to encode type 1 phosphatase catalytic subunits, termed PP1α, PP1β and PP1γ. At 
least PP1γ is known to undergo tissue-specific processing to yield an ubiquitously 
expressed PP1γ1 isoform and a testis-specific PP1γ2 isoform (da Cruz e Silva et al., 1995b). 
Two genes are known encoding PP2A catalytic subunits, termed PP2Aα and PP2Aβ, and 
the three known PP2B catalytic subunit genes (Aα, Aβ and Aγ) are also subject to complex 
regulation to yield several alternatively spliced isoforms from each.      
Perhaps more surprising was the discovery, from a variety of tissues and species, of 
other previously unknown phosphatase catalytic subunit isoenzymes, that were termed 
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novel phosphatases (da Cruz e Silva et al., 1988). PP4, PP5 and PP6 (Cohen, 1997) are 
present in all mammalian tissues examined. In contrast, human PP7 (Huang and Honkanen, 
1998), also found in Arabidopsis thaliana by Andreeva et al. (1998) and two Drosophila 
phosphatases are tissue specific (PPY is testis-specific and RdgC is restricted to 
photoreceptor organs and a small region in the brain). PP7 has been detected in the human 
retina and also in specialized sensory cells in plants (Fig. I.3). 
PP1, PPY
PP2A, PP4, PP6
Ppg1
PP2B
PP5
RdgC,PP7
E. Coli diadenosine
tetraphosphatase
ORF221
Ppz, Ppq1
Serine-rich
Phosphatase catalytic domain
CaM binding
TPR motifs
Ca2+-binding
302-334
549-710
303-377
368
502-604
499-520
661-663
221
280
 
Figure I.3: Domain organization of PPP family members. The numbers of amino acids in each are 
indicated on the right. 
 
I.3.1.1 PP1 - Protein Phosphatase 1 
 
Eukaryotic genomes contain between one (Saccharomyces cerevisiae) and eight 
(Arabidopsis thaliana) genes that encode isoforms of PP1 catalytic subunit. These 
isoenzymes typically show an overall sequence identity of approximately 90% and cannot 
be distinguished by either their substrate specificity or their ability to interact with R 
subunits in vitro (Zhang et al., 1993; Schillace and Scott, 1999). The sequence of the 
catalytic core of PP1 (residues 41-269 of the mammalian PP1 isoform) is almost identical 
in all isoforms, showing a high degree of similarity with the corresponding fragment of the 
catalytic subunits of PP2A and PP2B (Egloff et al., 1995; Goldberg et al., 1995). A 
detailed description of PP1, its properties and binding proteins will be given below. 
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I.3.1.2 PP2A - Protein Phosphatase 2A  
 
PP2A has one of the most highly expressed catalytic subunits. It has been detected 
in various cell types and can comprise 0.3-1% of cellular proteins (Ruediger et al., 1991; 
Lin et al., 1998). The first descriptions of PP2A holoenzymes in the late 1970s and early 
1980s demonstrated that the prevalent holoenzymes in rabbit skeletal muscle were 
heterotrimers composed of a catalytic subunit (C), a structural A subunit and a regulatory 
B subunit. cDNAs have been identified for two A subunits (α,β), two C subunits (α,β) and 
over twenty B subunits. For example, PR55 (B subunit), a 54 kDa protein (B’ subunit), 
PR72, a 74 kDa protein (B’’ subunit) and PR130. It has becoming increasingly clear that a 
major function of these regulatory subunits is to target the PP2A holoenzyme to distinct 
intracellular locations, signaling complexes and substrates. The A subunit is composed 
almost entirely of 15 imperfect repeats, each of 39 amino acids. These HEAT repeats (so 
named because they were found in Huntingtin, Elongation factor, PP2A subunit and the 
TOR kinase) are found in a variety of proteins. It seems that the repeats consist of two α 
helices connected by an intra-repeat loop, and that these loops are the binding sites for the 
B and C subunits (Ruediger et al., 1992; Ruediger et al., 1994; Ruediger et al., 1999) (Fig. 
I.4). The crystal structure of the mammalian Aα subunit (PR65α) has been solved: the 
subunit is a hook-shaped protein with the C subunit binding to the inner face of the hook; 
the various B subunits attach to the medial surface of the hook (Fig. I.5) (Cegielska et al., 
1994).  
A
C
B
C subunit regulators and interactors
Natural products (okadaic acid, calyculin, cantharidin, etc.)
Polypeptide inhibitors (I1/pp32, I2/SET, Hox11)
Methylesterase PME-1
Tap42/α4, CK2α, axin, Bcl-2
B subunit and their targets
B/PR55 Vimentin, CamKIV,
E4orf4, others
B’/B56/PR61
B’’/PR72
Cyclin G, APC
P107, CDC6
Polyoma T
antigens
 
Figure I.4: The heterotrimeric form of 
PP2A includes a catalytic C subunit, a 
structural A subunit and a regulatory B 
subunit. Several cellular and viral 
proteins that interact with PP2A 
components are indicated. 
 
 
Other molecular mechanisms that regulate PP2A catalytic subunit function include 
phosphorylation, carboxylmethylation, inhibition by intracellular protein inhibitors 
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I(1)PP2A and I(2)PP2A (Li et al., 1995) and stimulation by ceramide. The C subunit of 
PP2A can be phosphorylated in vitro by the tyrosine kinases p60v-src, p56lck, epidermal 
growth factor receptor and insulin receptor (Chen et al., 1992). Phosphorylation occurs at 
Tyr-307 at the extreme C-terminus of the protein and leads to 90% loss of activity. 
Dephosphorylation reactivates the phosphatase. This reactivation is prevented by okadaic 
acid, suggesting an auto-dephosphorylation reaction. A carboxymethyltransferase  (Lee 
and Stock, 1993; Xie and Clarke, 1994a, b) has PP2A C subunit as the major substrate. The 
methylation of the α-carboxyl group of the C-terminal Leu-309 of PP2A in vitro has only 
moderate stimulatory effects on phosphatase activity and impairs binding of peptide-
specific antibodies to the C-terminus of PP2A C subunit (Favre et al., 1994). Interestingly, 
the C-terminal sequence of PP2A C subunit is conserved from yeast to man suggesting that 
modifications of the C-terminus may be a conserved regulatory mechanism (Zolnierowicz 
et al., 1994). This modification may influence the interaction of the C subunit with its 
regulatory subunits. In vitro ceramide activates the trimeric forms of PP2A that contain 
either the PR55a or the 54kDa (B’) subunit. In contrast, PP2A dimmeric form and the 
isolated  C subunit are insensitive to ceramide (Dobrowsky et al., 1993).   
 
Figure I.5: Crystal structure of the mammalian Aα subunit of PP2A. 
 
PP2A plays a central role in processes as varied as cell cycle regulation, cell 
signaling and neuronal function.  
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Cell Cycle Control and PP2A 
PP2A was first implicated in the control of DNA replication when PP2A C subunit 
was purified as replication protein C on the basis of its ability to stimulate the efficient 
initiation of simian virus 40 (SV40) DNA replication (Virshup and Kelly, 1989). PP2A C 
subunit restored SV40 DNA replication activity to extracts from G1 phase cells suggesting 
that specific PP2A activity was regulated in the cell cycle as well (Virshup et al., 1989). 
More recently, strong evidence has been obtained  for the involvement of PP2A in 
chromosomal DNA replication (Lin et al., 1998). The immunodepletion of A-subunit-
containing forms of PP2A from Xenopus egg extracts inhibit subsequent DNA replication. 
This inhibition was relieved by replenishing the extracts with purified free PP2A C 
subunit. It was shown that PP2A activity was required for initiation of chromosomal 
replication rather than elongation. Immunodepletion of A/C dimers alone did not inhibit 
DNA replication, suggesting that a specific heterotrimeric form of PP2A is required (Lin et 
al., 1998). The finding of a novel PR72-related B subunit that recruits PP2A to the human 
replication initiator protein CDC6 suggests that this family of B subunits (the 
PR72/130/B’’ family) may be involved in initiation of both chromosomal and viral DNA 
replication (Yan et al., 2000). Another novel PR72 family member, PR59, has been 
isolated in a two hybrid screen using p107, the Rb-related cell-cycle regulatory protein 
(Voorhoeve et al., 1999a). PR59 may target PP2A to dephosphorylate p107 in response to 
stimuli such as UV irradiation that causes G1 arrest (Voorhoeve et al., 1999b). So, the 
PR72-related proteins may be the PP2A regulatory subunit family involved in regulation of 
the G1/S transition. 
 Interestingly, a body of data suggests that a subset of PP2A holoenzymes function 
as tumor suppressors. The PP1/PP2A inhibitor okadaic acid can promote tumor formation 
suggesting that phosphatase inhibition can function similarly to kinase activation. The most 
compelling evidence that PP2A is a tumor suppressor remains the finding that DNA tumor 
virus small and middle T antigens replace B subunits in the PP2A heterotrimer and 
modulate substrate specificity (Pallas et al., 1990; Walter et al., 1990). Other potentially 
oncogenic human proteins that inhibit PP2A function have been reported, including 
HOX11 and SET oncogenes (Li et al., 1996b; Kawabe et al., 1997). Set expression and 
hence PP2A inhibition has been shown to induce c-JUN and AP-1 activity, whereas 
increased expression and hence increased activity of PP2A catalytic subunit inhibits ras-
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induced transformation (Al-Murrani et al., 1999; Baharians and Schonthal, 1999). 
Although some studies indicate that PP2A might exert tumor suppressive functions, other 
findings demonstrate the requirement for PP2A in cell growth and survival, which is not a 
characteristic of a tumor suppressor. This discrepancy might be due to the fact that PP2A is 
a multitask enzyme system, rather then a single enzyme. The puzzling observation that 
PP2A exerts inhibitory as well as stimulatory effects on cell growth could be due to the 
activity of different PP2A complexes with distinct subcellular location and diverse 
substrate specificity.  
PP2A and neuronal function 
The roles of PP2A in dephosphorylation of brain proteins are obscure. PP2A is a 
major activity that dephosphorylates voltage-sensitive sodium channels (Chen et al., 1995), 
and is also a major brain phosphatase that dephosphorylates autophosphorylated CaMKII. 
PP2A selectively dephosphorylates soluble CaMKII rather then CaMKII associated with 
postsynaptic density, where it becomes a substrate for PP1 (Strack et al., 1997a). The 
recent demonstrations that PP2A associates with and regulates CaMKIV (Westphal et al., 
1998), p70S6 kinase and p21-activated kinase (Westphal et al., 1999a), support the 
proposal that PP2A might be a general regulator of protein kinases (Barnes et al., 1995). 
PP2A is also known to be associated with neurofilaments, dephosphorylating NF-M and 
NF-L (Saito et al., 1995; Strack et al., 1997b). It probably regulates either the stability of 
neurofilaments or their interactions with other components of the neuronal cytoskeleton. 
Another potential function of PP2A is the regulation of the state of phosphorylation of 
microtubulule-associated proteins (MAPs). Neuronal-specific MAPs, including Tau and 
MAP2, bind to microtubules and regulate their stability. Neural MAPs are phosphorylated 
at multiple sites by a variety of protein kinases. Phosphorylation causes disassociation of 
MAPs from microtubules and their loss of stability. Accumulation of hyperphosphorylated 
Tau in neurofibrillary tangles is a pathological mark of Alzheimer’s disease (T. H. Lee, 
1995; Mandelkow et al., 1996; Billingsley and Kincaid, 1997). Disruption of the 
microtubule cytoskeleton as a result of the loss of Tau-mediated stabilization may be one 
mechanism of neuronal cell death.    
Signaling Cascades and PP2A 
PP2A also plays an important role in the regulation of specific signal transduction 
cascades, as witnessed by its presence in a number of macromolecular signaling modules, 
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where it is often found in association with other phosphatases and kinases. Viral proteins 
target specific PP2A enzymes in order to deregulate chosen cellular pathways in the host 
and promote viral progeny. The observation that a variety of viruses utilize PP2A to 
alienate cellular behavior emphasizes the fundamental importance of PP2A in signal 
transduction. Other examples of the importance of PP2A in signaling cascades include the 
Wnt signaling pathway and the TOR  (Target Of Rapamycin) signaling pathway.  
Wnt signaling regulates vertebrate axis formation in early embryogenesis, and 
deregulation of the Wnt pathway is found in multiple epithelial cancers, including those of 
colon, skin and liver. One major effect of Wnt signaling is increased transcription driven 
by heterodimeric β-catenin/TCF transcription factor (Brown and Moon, 1998). In the 
absence of Wnt signaling β-catenin is maintained at low levels by phosphorylation-
regulated proteolysis. Phosphorylation is mediated by a large multiprotein complex 
containing the adenomatous polyposis coli protein (APC), the serine/threonine kinase 
GSK3β and axin. PP2A has also been placed in this complex. It was shown by a two 
hybrid screen (Seeling et al., 1999) that an amino-terminal domain of APC interacted with 
all members of the B’/B56 family of PP2A regulatory subunits. It was also found (Hsu et 
al., 1999) that the carboxyl terminus of axin binds to PP2A via the catalytic subunit. Thus, 
the role of B56-containing PP2A heterotrimers in Wnt signaling may be to regulate the 
activity of GSK3β, keeping it dephosphorylated and thus active, leading to lower β-catenin 
levels in vivo. It was shown that PP2A C subunit dephosphorylated and activated GSK3β 
in vitro.  
TOR signaling activates a response to nutrients, leading to TOR kinase activation 
with subsequent phosphorylation and activation of the ribosomal S6 kinase and 
phosphorylation and inactivation of eukaryotic initiation factor 4E-BP1, an inhibitor of 
translation initiation factor eIF4E (Gingras et al., 1999). The result is stimulation of mRNA 
translation. Rapamycin inhibits TOR leading to growth arrest. TOR signaling may be due 
largely to its effect on PP2A and related phosphatases (Di Como and Arndt, 1996). TOR 
directly phosphorylates the Tap42 protein of S. cerevisiae, which then binds to either the C 
subunit of PP2A or the related yeast phosphatase Sit4 (Jiang and Broach, 1999). The 
Tap42-PP2A C dimer does not contain PP2A A or B, subunits representing a novel form of 
PP2A. In mammals, mTOR is downstream of phosphatidylinositol 3 kinase (PI3K) and can 
be directly activated by phosphorylation by PKB/Akt. A mammalian protein related to the 
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yeast Tap42, α4, has been shown to bind PP2A C  (Murata et al., 1997) and also the 
related phosphatases PP4 and PP6 (Jiang and Broach, 1999). 
In summary, many proteins have been identified that interact with PP2A. Some of 
them affect PP2A activity [such as I(1)PP2A, I(2)PP2A, PTPA, Tap42/α4, SV40 small t, 
polyoma middle T/small t, HIV-1 NCp-7Vpr, adenovirus E4orf4CKIIα, Hox11 and PKR], 
some are PP2A substrates (such as Bcl2, p70s6 kinase, CaMKIV, vimentin, paxillin and 
SCR), for some PP2A it self is a substrate (such as caspase-3, JAK2, PME-1 and PKR) and 
some act as targeting proteins (such as eRF1, axin, APC and CG-NAP). An overview is 
given in Figure I.6. 
       
 
Figure I.6: PP2A interacts with a variety of proteins (Janssens and Goris, 2001). 
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I.3.1.3 PP2B - Protein Phosphatase 2B 
 
PP2B, or calcineurin, is a Ca2+/calmodulin-dependent protein phosphatase. The 
enzyme consists of two subunits, the catalytic A subunit of 60 kDa (PP2B A) and the 
myristoylated regulatory B subunit of 19 kDa (PP2B B). Calcineurin is present in nearly all 
mammalian cells studied but is highly enriched in neural tissue comprising over 1% of the 
total protein in the brain [a review can be found in (Klee et al., 1998)]. Originally, the term 
calcineurin referred to the neuronal form of PP2B but, more recently, calcineurin refers to 
both neuronal and non-neuronal PP2B. The amino acid sequence of PP2B is highly 
conserved from humans to yeast with over 50% sequence identity (da Cruz e Silva and 
Cohen, 1989; da Cruz e Silva et al., 1991; Stemmer and Klee, 1994). Cloning from rat 
brain indicated an A subunit of 521 amino acids. There are three mammalian genes for the 
A subunit, giving rise to the PP2B Aα, PP2B Aβ and PP2B Aγ isoforms. Aα and Aβ are 
highly expressed in brain, whereas Aγ is testis specific. Differential splicing of PP2B 
Aα generates two transcripts (α1 and α2), whereas PP2B Aβ gene is alternatively spliced to 
give three transcripts β1, β2 and β3. PP2B Aα1 and PP2B Aβ2 are highly expressed in 
neuronal tissue (Ueki et al., 1992). The A subunit shows autoinhibition that is relieved by 
interaction with the B subunit. PP2B, in contrast to PP1 and PP2A, is the only PP directly 
regulated by Ca2+. The inhibition of B on A is relieved if B binds Ca2+. This explains why 
the enzyme is dependent on Ca2+ for activity. Proteolysis of the autoinhibitory COOH 
terminus (residues 467-492) of the PP2B A generates a Ca2+-independent form. The B 
subunit was sequenced at the protein level and found to comprise 168 amino acids, 
exhibiting a high degree of sequence similarity to calmodulin. Both contain four EF-hand 
Ca2+-binding loops, both are needed for full PP2B activity, and both bind to unique regions 
on PP2B A without any cross interference. Two different B subunit genes are known: 
PP2B Bα and PP2B Bβ. PP2B Bα gives rise to one protein isoform expressed in many 
tissues termed PP2B Bα1 (170 amino acids) and, by means of a different promotor, leads 
also to another testis-specific isoform PP2B Bα2 (216 amino acids). PP2B Bβ (179 amino 
acids) is only expressed in the testis (Ueki et al., 1992; Chang et al., 1994). The crystal 
structure of PP2B has been determined (Griffith et al., 1995; Kissinger et al., 1995) and 
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helped to further clarify the various binding domains and interaction sites of PP2B (Fig. 
I.7).  
The best known in vitro and in vivo substrates of PP2B are the PP1 inhibitors I-1 
and DARPP-32. Thus, PP2B controls PP1 activity and the two together form the first 
documented phosphatase cascade (Mulkey et al., 1994). 
COOHNH2
14                                                              342 373 390 414       469 486
Catalytic domain CaN B CaM AID
AID
CaN B
a)
b)
 
Figure I.7: Structure of calcineurin. a) Diagrammatic representation of the calcineurin A subunit 
indicating the catalytic domain, the binding domains for calcineurin B (CaN B), calmodulin 
(CaM), and the auto-inhibitory domain (AID). b), the crystal structure of the human calcineurin 
heterodimer is shown with secondary structural elements. The calcineurin A subunit is shown in 
blue and the B subunit in green. Fe (red) and Zn (yellow) are bound in a cleft of the catalytic 
domain and four Ca (black) are shown binding to the B subunit. 
 
PP2B and neuronal function 
Calcium-stimulated dephosphorylation of target proteins by PP2B modulates 
numerous neuronal activities. Described functions for PP2B in the brain include Ca2+-
dependent dephosphorylation of DARPP-32, inhibition of neurotransmitter release, 
dephosphorylation of dynamin I, and desensitization of postsynaptic NMDA-receptor-
coupled calcium channels (Yakel, 1997; Greengard et al., 1998; Klee et al., 1998). PP2B is 
also thought to regulate the calcium channel activity of the ryanodine and inositol 1,4,5-
Characterization of the PP1 Interactome from Human Testis Chapter I  
 
Centro de Biologia Celular 
Universidade de Aveiro 
28 
triphosphate receptors via an immunophilin-mediated interaction (Snyder et al., 1998), and 
plays a role in the neurotoxicity associated with excessive stimulation of NMDA-type 
glutamate receptors. Immunossuppressants prevent apoptosis and rearrangments of the 
cytoskeleton in response to excitotoxic glutamate (Halpain et al., 1998). Overexpression of 
PP2B in transgenic mice revealed a novel phase of long-term potentiation in the CA1 
region of the hippocampus that may be normally constrained by PP2B (Winder et al., 
1998). These observations provide evidence for a physiological function for PP2B in intact 
animals. The altered regulation of this component of long-term potentiation by PP2B 
correlates with reversible deficits in long-term memory that occur during expression of 
activated PP2B (Mansuy et al., 1998). These observations provide an elegant 
demonstration of the role of PP2B in memory. Along with PP2A, PP2B is one of the major 
tau phosphatases in vitro and can restore the microtubule-binding ability of 
hyperphosphorylated tau (Billingsley and Kincaid, 1997). When nerve terminals in the 
brain are stimulated, a group of phosphoproteins called dephosphins are coordinately 
dephosphorylated by PP2B. Amazingly, the seven presently known dephosphins are not 
structurally related, yet each has been independently shown to be essential for synaptic 
vesicle endocytosis. Nowhere else in biology is there a similar example of the coordinated 
dephosphorylation of such a large group of proteins each sharing roles in the same 
biological response.  
PP2B and T-cell activation 
PP2B plays a crucial role in the Ca2+-signaling cascade of activated T-cells. 
Increases in Ca2+ concentrations in T-cells promoted by antigen presentation to T-cell 
receptor stimulates PP2B to dephosphorylate the cytosolic subunit of the transcription 
factor NFAT, Nuclear Factor of Activated T-cells, (Jain et al., 1993). Dephosphorylated 
NFAT translocates into the nucleus where, in concert with other transcription factors, it 
induces expression of the IL-2 gene, one of the early genes in the T-cell activation 
pathway. Inhibition of this Ca2+-signaling cascade by immunosuppressant drugs (such as 
FK506 and cyclosporin A, when complexed to their intracellular receptors FKBP and 
cyclophilin, respectively) suppresses T-cell activation. 
PP2B and transcription control 
Regulation by PP2B of the nuclear import of NFAT has already been mentioned 
above. It was the first example of the transduction of a signal at the plasma membrane to 
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the nucleus. More recently, it has been shown that this transcription factor is not only 
involved in T-cell activation, but also in several other mechanisms. PP2B has been shown 
to have important roles in axonal guidance (Chang et al., 1995), as well as memory and 
learning (Mansuy et al., 1998; Winder et al., 1998). In general, these functions in neurons 
have been thought to be independent of transcription. However, recent evidence indicates 
that NFAT family members may have critical roles in the development of synaptic 
connections (Graef et al., 1999). It also seems that the NFAT pathway is involved in the 
morphogenesis of heart valves. Additionally, it has been shown that severe cardiac 
hypertrophy can be induced by the overexpression of a truncated constitutively active 
PP2B A subunit (Molkentin et al., 1998). 
 NF-κB and other Rel proteins play critical roles in the development of the liver, 
skin, inflammatory responses and in some aspects of recombinational immune response. 
Unlike NFAT, which absolutely requires a calcium stimulus, NF-κB can be fully activated 
by PKC activators in the absence of calcium (Singh et al., 1986). However, suboptimal 
stimuli can be augmented with a calcium signal (Mattila et al., 1990). This calcium 
facilitation of NF-κB activity can be mimicked by overexpression of a constitutively active 
PP2B and can be partially blocked with FK506 or cyclosporin A, indicating that PP2B is 
required for full induction of NF-κB activity in certain circumstances (Frantz et al., 1994). 
The AP-1 transcription complex consists of Fos and Jun proteins. Transcription controlled 
by most AP-1 sites is not sensitive to inhibition by cyclosporin A or FK506 (Mattila et al., 
1990). However, a site in the IL-2 promoter that binds junD and perhaps c-jun requires the 
action of PP2B for full function (Ullman et al., 1993). In addition, an apparent AP-1 site in 
the collagenase promoter is sensitive to FK506 (Su et al., 1994) and hence likely to be 
PP2B-dependent. 
 PP2B inhibitors 
Several different classes of PP2B inhibitors have been discovered raising questions 
about their various roles in Ca2+/PP2B signaling. The inhibitors bind to PP2B and inhibit 
its ability to dephosphorylate substrates such as NFAT family members, thereby 
preventing their nuclear localization. One of the most interesting is the DSCR1 gene and 
its relatives, DSCR2 and ZAK14 (Fuentes et al., 2000). DSCR1 is located on chromosome 
21 in the so called critical region (hence its designation, Down’s syndrome critical region 1 
gene). Some evidences indicate that overexpression of DSCR1 might underlie the 
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pathogenesis of Down’s Syndrome. First, it was shown that DSCR1 protein is 
overexpressed in the brains of Down’s Syndrome patients. Second, some of the symptoms 
of the Syndrome appear in mice with mutations of the different PP2B-dependent (NFAT) 
subunits of the transcription complex (Fuentes et al., 2000). It is possible that 
overexpression of DSCR1 as a result of trisomy leads to inhibition of PP2B and subsequent 
effects on the development of the brain, immune system, heart and skeleton. However, the 
Down’s Syndrome critical region includes a number of genes and it is possible that the 
syndrome is due to overexpression of several of these. Recently, yeast has been shown to 
have a related protein, Pcn1p that binds and inactivates PP2B (Gorlach et al., 2000). Two 
additional classes of PP2B inhibitors are Cabin/Cain (Lai et al., 1998; Sun et al., 1998), 
which are novel proteins, and the CHP protein that has similarity to PP2B B subunit (Lin 
and Barber, 1996; Lin et al., 1999). The CHP proteins appear to compete with PP2B B for 
binding to the A protein and thereby inhibit the Ca2+-dependent activation of PP2B A. 
Cabin, or Cain (Calcineurin inhibitor), is a non competitive inhibitor of PP2B phosphatase 
activity with a Ki of 440nM. A physiologic role for these proteins is still unclear, but they 
do antagonize NFAT translocation. A fourth class of PP2B inhibitors is found in the 
genome of certain viruses, (e.g. African swine fever virus). The A238L protein encoded by 
the virus binds tightly to PP2B and blocks NFAT translocation and function (Miskin et al., 
1998). AKAP79 (protein kinase A anchoring protein) was the first PP2B protein inhibitor 
to be found (Coghlan et al., 1995) and is also a scaffolding protein. AKAP79 binds both 
calcineurin and protein kinase A, and may anchor PP2B at specific sites that allow the 
protein to engage the proper substrates when activated. Another inhibitor that constitutes a 
useful laboratory tool is the auto-inhibitory peptide. This is a 26-residue peptide that 
interacts with the catalytic core and blocks PP2B activity with an IC50 of 10-15µM 
(Hashimoto et al., 1990). Immunosuppressant drugs such as cyclosporin A and FK506 
(Liu, 1993) belong to a different class of PP2B inhibitors. These are fungal compounds that 
require binding to their cognate intracellular immunophilins (cyclophilin A and FKB12, 
respectively) prior to binding to and inhibiting PP2B activity with nanomolar affinity. 
Being membrane permeable, these compounds have greatly facilitated the in vivo study of 
PP2B function. Yet another class of inhibitors is the type II pyrethroid insecticides, 
including cypermethrin and deltamethrin (Enan and Matsumura, 1992). 
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In conclusion, within the past few years PP2B has been implicated in a wide variety 
of extremely important biological responses including lymphocyte activation, neuronal and 
muscle development, neurite outgrowth, morphogenesis of vertebrate heart valves, learning 
and memory (Fig. I.8). 
 
Figure I.8: Calcineurin as a multifunctional regulator (Shibasaki et al., 2002). 
 
I.3.2 The PPM Family 
 
The PPM protein phosphatases belong to a large and diversified family of protein 
phosphatases expressed in both eukaryotes and prokaryotes that dephosphorylate serine 
and threonine residues, as does the PPP family. PPC relates to the main enzyme subtype of 
the PPM, including Arabidopsis ABI1 (Leung et al., 1994), Arabidopsis KAPP-1 (Stone et 
al., 1994), pyruvate dehydrogenase phosphatase (Lawson et al., 1993) and Bacillus subtilis 
SpoIIE phosphatase (Barak et al., 1996). Within the PPM family, the PP2C domain occurs 
in numerous structural contexts that reflect functional diversity. For example, PP2C 
domain of the Arabidopsis ABI1 gene is fused with EF- hand motifs (Leung et al., 1994; 
Meyer et al., 1994), whereas in KAPP-1, a kinase-interaction domain that associates with a 
phosphorylated receptor precedes the phosphatase domain (Stone et al., 1994). Other 
examples include the Ca2+-stimulated mitochondrial pyruvate dehydrogenase phosphatase, 
which contains a catalytic subunit sharing 22% sequence identity with mammalian PP2C 
(Lawson et al., 1993) and SpoIIE phosphatase, which has ten membrane-spanning regions 
preceding the PP2C-like catalytic domain (Fig. I.9).  
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Figure I.9: The PPM family. 
 
PP2C was originally identified as a Mg2+-dependent protein phosphatase. The 
enzyme is monomeric with a molecular mass of 43-48 kDa (Cohen, 1989) and is resistant 
to okadaic acid. To date the existence of six distinct PP2C genes (PP2Cα, PP2Cβ, PP2Cγ, 
PP2Cδ, Wip1 and FIN13) has been reported in mammalian cells (Tamura et al., 1989; 
Wenk et al., 1992; Fiscella et al., 1997; Guthridge et al., 1997; Travis and Welsh, 1997; 
Tong et al., 1998). In addition, mouse PP2Cβ has been found to have five distinct isoforms 
(β1, β2, β3, β4, β5), which are splice variants from a single pre-mRNA (Terasawa et al., 
1993; Hou et al., 1994; Kato et al., 1995). 
Considerable information on the function of mammalian PP2C has accumulated 
over the last decade. PP2C can be activated by polyunsaturated fatty acids such as 
arachidonic acid. Upon addition of fatty acids PP2C no longer requires unphysiologically 
high Mg2+ concentrations for activity, and Ca2+ ions become inhibitory in the micromolar 
range. The stimulation of PP2C in vitro by fatty acids suggests that this enzyme may be 
regulated by an endogenous lipid messenger in vivo (Klumpp et al., 1998). It was shown 
(Murray et al., 1999) that PP2Cγ is physically associated with the spliceosome in vitro and 
is required during the early stages of spliceosome assembly for efficient formation of the A 
complex. PP2C is also involved in the regulation of AMP-activated protein kinase (Moore 
et al., 1991) and Ca2+/calmodulin–dependent protein kinase II (Fukunaga et al., 1993). 
PP2C may also selectively inhibit the SAPK pathway through suppression of MKK3b, 
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MKK4, MKK6b and MKK7 activities in mammalian cells (Hanada et al., 1998). Recent 
research further revealed that PP2C might be involved in the control of cell apoptosis 
(Wolf et al., 1997), gene expression and other cellular functions (Bohmann, 1990; 
Kurosawa, 1994; Schonthal, 1995). More recently, PP2Cα has been implicated in Wnt 
signaling, being a positive regulator and exerting its effects through the dephosphorylation 
of axin (Strovel et al., 2000), a role that was first attributed to PP2A (Willert et al., 1999). 
PP2C influences the dynamic interactions between the actin cytoskeleton and membrane 
constituents linked to moesin (Hishiya et al., 1999). Members of the moesin protein family 
are localized membrane structures rich in actin filaments that act as linkers between the 
plasma membrane and the actin cytoskeleton. Furthermore, PP2Cα and PP2Cβ2 are 
responsible for the inactivating dephosphorylation of Cdk2/Cdk6 (Cheng et al., 2000b). 
The dephosphorylation of Cdk2 and Cdk6 by PP2C isoforms is inhibited by the binding of 
cyclins. PP2Cβ was recently implicated in the regulation of the TAK1 signaling pathway: 
TAK1 is a stress-activated protein kinase that is activated by interleukin-1, transforming 
growth factor-β or stress. PP2Cβ negatively regulates the TAK1 signaling pathway by 
direct dephosphorylation of TAK1 (Hanada et al., 2001). 
 
I.4 PHOSPHATASE INHIBITORS 
 
One of the most significant advances in the study of Ser/Thr-PPs, and the 
elucidation of the cellular events they control, was the identification of several naturally 
occurring toxins as powerful and specific phosphatase inhibitors. Among these are okadaic 
acid (Fujiki and Suganuma, 1993), cantharidin (Laidley et al., 1997), calyculin A (Ishihara 
et al., 1989), microcystins (Carmichael, 1992; Fujiki and Suganuma, 1993; Carmichael, 
1994) and tautomycin (MacKintosh and Klumpp, 1990; Hori et al., 1991) to name a few 
examples. Another class of phosphatase inhibitors are the protein inhibitors readily 
available inside the cell. The specificity of these inhibitors for a given phosphatase has 
placed the former as key tools in the study of phosphorylation dependent processes. 
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I.4.1 Toxins as natural inhibitors of PPs 
 
I.4.1.1 Okadaic acid and derivatives 
 
Okadaic acid (OA) is a polyether compound with a C-38 structure and was isolated 
from the black sponge Halichondria okadai (Fujiki and Suganuma, 1993) (Fig. I.10).  
 
 
Figure I.10: Structure of okadaic acid (R1=H, R2=H, R3=CH3). 
 
OA is a potent phosphatase inhibitor in smooth muscle preparations (Bialojan et al., 
1988), and was reported to inhibite PP1, PP2A and PP2B with IC50 values of 272, 1.6, and 
3,600nM, respectively (Bialojan and Takai, 1988). PP2C, phosphotyrosyl phosphatase, 
acid phosphatase and alkaline phosphatase were not inhibited by up to 10µM OA. It is 
currently thought that tumor promotion by OA and related compounds like calyculin A and 
microcystin LR is due to inhibition of PP1 and PP2A [a review can be found in (Fujiki and 
Suganuma, 1993)]. OA in concentrations <2nM inhibits also other PP2A related family 
members such as PP4, PP5, and PP6 (Cohen, 1997).  
 
I.4.1.2 Cantharidin and analogs 
 
Cantharidin (CT), cantharidic acid, palasonin and endothall are structural analogs 
(Laidley et al., 1997). CT is the vesicant in blister beetles, palasonin is an anti-helmintic in 
seeds of a medical tree and endothal is a synthetic herbicide. The toxic action of CT is 
thought to be due to phosphatase inhibition. Initially, CT was reported to bind to PP2A in 
mouse liver (Li et al., 1993). However, CT inhibits PP1 and PP2A in vivo with IC50 values 
of 500 and 40nM (Honkanen, 1993; Li et al., 1993; Neumann et al., 1995). Palasonin and 
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cantharidic acid exhibited similar inhibitory activity (Li et al., 1993). Endothal inhibits 
both PP1 and PP2A with IC50 values of 5,000 and 1,000nM (Li et al., 1993). Neither 
compound inhibits PP2B (>30,000nM) or PP2C (>1mM). CT is a terpenoid and is cell 
membrane permeable. It is less potent and selective than OA, but much cheaper. 
Mutational analysis indicates that OA and CA might act on different amino acids on PP1 
(Zhang et al., 1994b) (Fig. I.11). 
 
 
Fig. I.11: Structure of Cantharidin.  
 
I.4.1.3 Calyculin A:  
 
Calyculin A (CA) was isolated from another marine sponge, Discodermia calyx. It 
is an octamethylpolyhydroxylated C-28 fatty acid linked to two γ-amino acids and 
esterified with phosphate. It is cell membrane permeable. CA is equally potent against PP1 
and PP2A (Ishihara et al., 1989; Fujiki and Suganuma, 1993) with IC50 values from 1 to 
14nM. OA and CA seem to compete for the same inhibitory site on PP2A (Takai et al., 
1995). Mutational analysis suggests that CA inhibits the enzyme via interaction with amino 
acid tyrosine-272 on PP1 because its IC50 is changed from 0.5 to 3,000nM in the Y272K 
mutant (J. Zhang et al., 1996) (Fig. I.12). 
 
Figure I.12: Structure of calyculin A (CA A,R=H; CA C, R=Me). 
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I.4.1.4 Microcystins 
 
Whereas OA and CA are fatty acid derivatives, microcystins (Mic) and nodularin 
(Nod) are peptide toxins. Mic are of toxicological and public health relevance. They cause 
death in cattle and humans exposed to water contaminated by certain algae. These include 
colonical and filamentous algae and cyanobacteriae like Microcystis aeruginosa 
(Carmichael, 1992; Fujiki and Suganuma, 1993; Carmichael, 1994). Mic are cyclic 
heptapeptides containing five constant (some of which are unique) and two variable amino 
acids. The variable amino acids in Mic are indicated in the one-letter code. Hence, their 
short-hand notation is microcystin-LR, -YR and –RR. Mic-LR inhibits PP1 and PP2A with 
IC50 values of 0.1nM each (MacKintosh et al., 1990). It inhibits PP2B with an IC50 of 
0.2µM and does not inhibit PP2C up to 4µM (MacKintosh et al., 1990). PP4 and PP5 are 
inhibited by <2nM Mic. Mic is the most potent (and toxic) PP inhibitor, but being a 
peptide it is not cell permeable. The 3D structure of Mic-LR bound to PP1 has been 
determined (Goldberg et al., 1995; Bagu et al., 1997), and mutation of the critical cysteine-
273 in PP1 to alanine impeded covalent binding of Mic to PP1 (Fig I.13).  
 
Figure I.13: Structure of Microcystin. 
 
I.4.1.5 Nodularin  
 
Nodularin (Nod), a cyclic pentapeptide, was isolated from the toxic cyanobacterium 
Nodularia spumigenia (Carmichael, 1992). Like Mic it is toxic to the liver. Nod R and its 
derivative motuporin (nodularin V) potently inhibit PP1, as well as PP2A, with IC50 values 
of 1.6 and 0.03nM, respectively (Honkanen et al., 1991). Hence, it inhibits PP1 and PP2A 
10 times more potently than OA, being is 70 fold selective for PP2A. It inhibits PP2B with 
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an IC50 of 8.7µM but does not affect PP2C (Honkanen et al., 1991). The IC50 values are 
comparable to those of Mic-LR. In contrast to Mic, Nod R or V do not covalently bind to 
PP1 or PP2A (Craig et al., 1996). Mutational analysis suggests that Nod also inhibits PP 
activity via interaction with amino acid Tyr-272 on PP1 because its IC50 changed from 0.5 
to 150nM in the Y272S mutant (J. Zhang et al., 1996). The 3D solution structure of Nod 
closely resembles that of Mic-LR (Annila et al., 1996) (Fig. I.14).          
 
Figure I.14: Structure of Nodularin. 
 
I.4.1.6 Tautomycin 
 
Tautomycin (Tau) was isolated from Streptomyces spiroverticillatus as an antibiotic 
because it is toxic to yeast and fungi. Its structure as a polyketide resembles somewhat that 
of OA (MacKintosh and Klumpp, 1990; Hori et al., 1991). It inhibits PP1 and PP2A with 
IC50 values of 0.2-0.7 and 0.4-0.65nM, respectively (MacKintosh and Klumpp, 1990; 
Fujiki and Suganuma, 1993). Others reported IC50 values of 0.4 and 34nM for PP1 and 
PP2A, respectively (Takai et al., 1995). It does not inhibit PP2C and its IC50 for PP2B is 
100µM. OA prevents the interaction of Tau with the catalytic subunit of PP2A (Fig. I.15). 
 
Figure I.15: Structure of Tautomycin. 
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I.4.1.7 Cyclosporin 
 
Ciclosporin (CsA) or cyclosporin A (a cyclic undecapeptide), and FK506 (a 
macrocyclic lactone) inhibit PP2B (Parsons et al., 1994). This inhibition is not direct as 
was already mentioned. First CsA and FK506 bind to cyclophilin and a FK506-binding 
protein (FKBP), respectively. Then, they interact with the latch region of PP2B B 
(Clipstone et al., 1994; Milan et al., 1994), leading to inhibition of PP2B A. The 3D 
structure of the PP2B-FK506 and FKBP complex supports this notion (Griffith et al., 
1995); (Kissinger et al., 1995). Rapamycin, an immunosupressant fungal metabolite, also 
binds to FKBP but does not inhibit PP2B because it cannot interact with PP2B B for steric 
reasons (Griffith et al., 1995). In contrast, it targets a rapamycin-associated protein (FRAP) 
that leads to inactivation of some specialized protein kinases like p70s6k (Price et al., 1992; 
Alberts et al., 1993).Work with CsA is complicated by its poor aqueous solubility. 
However, it is cell membrane permeant (Fig. I.16). 
 
 
Figure I.16: Structure of Cyclosporin. 
 
I.4.1.8 Cypermethrin  
 
Type 2 pyrethroids like cypermethrin are used as insecticides because they 
modulate ion channel activity, but they also have been reported to inhibit PP2B at sub-
nanomolar concentrations (Enan and Matsumura, 1992), independently of mediator 
proteins like cyclophilin. Subsequent reports that up to 1mM cypermethrin did not affect 
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PP2B, PP1 or PP2A (MacKintosh and MacKintosh, 1994), are thought to be due to 
artifactual reasons. 
 
I.4.1.9 Apomorphine 
 
Apomorphine and SKF-38393 inhibited PP2A from rat brain with IC50 values of 1 
and 50µM, respectively. In contrast, apocodeine was inactive. It has apparently not been 
reported to inhibit other PPs (Kawai, 1991). Apomorphin is cell membrane permeant. 
 
I.4.1.10 Fostriecin 
 
The antitumor antibiotic fostriecin (FT) is a type II DNA topoisomerase-directed 
anticancer drug, like doxorubicin or etoposide (Boritzki et al., 1988). FT is a naturally 
occurring compound from Streptomyces pulveraceus subspecies fostreus, an actinomycete 
found in a Brazilian soil sample. It is a water soluble polyene lacton with a phosphate ester. 
FT inhibited both PP1 and PP2A with IC50 values of 4µM and 40nM, respectively, but it 
did not inhibit tyrosine phosphatases (Roberge et al., 1994). It has been suggested that the 
PP inhibition at least contributes to its efficacy against solid tumors in humans.  
 
I.4.1.11 Heparin 
 
Heparin binds and inhibits to PP1 but not PP2A (Gergely et al., 1984; Erdodi et al., 
1985a, b). Heparin can actually stimulate PP2A. This property led to a procedure to 
separate these phosphatases using a heparin-based affinity column chromatography. 
Spermine inhibits both PP1 and PP2A with similar potency (Shenolikar and Nairn, 1991).   
 
I.4.1.12 Thyrsiferyl 23-acetate 
 
This compound is, like OA, a polyether fatty acid and contains a squalene carbon 
skeleton. It was isolated from the red alga L. obtuse. It is unique because it is a selective 
inhibitor of PP2A. It does not inhibit PP1, PP2B, PP2C or tyrosine phosphatase activity at 
concentrations up to 1mM. Its IC50 for PP2A is 4µM. It is several orders of magnitude less 
potent than OA or CA. It is expected to be cell membrane permeant (Matsuzawa et al., 
1994).  
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I.4.1.12 Oscillamide B and Oscillamide C 
 
Two new phosphatase inhibitors, oscillamide B and C, were isolated from the 
cyanobacteria Planktothrix (Oscillatoria) agardhii and P. rubescens. These inhibitors are 
ureido-containing cyclic peptides and inhibit PP1 and PP2A (Sano et al., 2001). 
 
I.4.2 Protein inhibitors 
 
I.4.2.1 Inhibitor 1 (I-1)  
 
I-1 and I-2 were identified by Huang and Glinsmann (F. L. Huang and W. H. 
Glinsmann, 1976; Huang et al., 1976). They share unusual physical properties: both are 
heat stable and are not precipitated by 1% trichloroacetic acid, in contrast to most other 
proteins. I-1 comprises 171 amino acids (Aitken et al., 1982; Elbrecht et al., 1990; Endo et 
al., 1996). Only in the C-terminal were differences between rabbit, rat and human noted 
(Endo et al., 1996). I-1 from rabbit skeletal muscle and human brain has a calculated 
molecular mass of 18.7 and 19.2kDa, respectively (Aitken et al., 1982; Endo et al., 1996), 
but the apparent molecular mass on SDS-PAGE is 26kDa. This discrepancy has been 
explained by a low degree of order in the protein. I-1 binds to and inhibits PP1 only after 
being phosphorylated on Thr-35 by cAMP-dependent protein kinase or cGMP-dependent 
protein kinase (Hemmings et al., 1984b). It is highly selective for PP1, inhibiting PP1 and 
PP2A with IC50 values of 1.1 and 21,000nM, respectively (Endo et al., 1996). I-1 is a 
cytosolic protein; it has been used as a tool to study whether a process involves PP1. 
Amino acids 9-12 KIQF are conserved in rat, rabbit and human and seem to be crucial for 
binding and inhibition of PP1 (Egloff et al., 1997). 
 
I.4.2.2 Inhibitor 2 (I-2) 
 
I-2 from rabbit skeletal muscle comprises 204 amino acids and has a calculated 
mass of 22.9kDa (Holmes et al., 1986a). Similarly to I-1, its apparent molecular mass on 
SDS-PAGE is much larger (31kDa). It binds to and inhibits PP1 regardless of 
phosphorylation. Mutational analysis suggests that I-2 inhibits via interaction with amino 
acid Tyr-272 on PP1 because its IC50 changed from 13 to 180ng/ml in the Y272K mutant 
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(L. Zhang et al., 1996). I-2 inhibition of PP1 can be reversed by GSK3 phosphorylation of 
I-2. 
 
I.4.2.3 DARPP-32  
 
DARPP-32 (dopamine and cyclic AMP-regulated phosphoproteins, Mr 32,000Da) 
is similar to I-1 in function but derived from a different gene, and is mainly expressed in 
the brain (Hemmings et al., 1984a). It is cytosolic and a predicted molecular mass of 
22.6kDa, but again a higher apparent molecular mass of 32kDa on SDS-PAGE (Williams 
et al., 1986). The same Thr residue on DARPP-32 is phosphorylated by cAMP-dependent 
protein kinase and also by cGMP-dependent protein kinase. Phosphorylation of DARPP-32 
changes its IC50 for PP1 from 1µM to 2nM (Desdouits et al., 1995a; Desdouits et al., 
1995b), underscoring its high selectivity. Under physiological conditions (mM Mn2+ in the 
assay) I-1 and DARPP-32 are dephosphorylated and inactivated by PP2A and even better 
by PP2B (Hemmings et al., 1984a; Hemmings et al., 1990; Desdouits et al., 1995c). The 
dephosphorylation by PP2B is dependent on the presence of calcium. It was suggested that 
this might be a way for Ca2+ levels to control protein phosphorylation (Hubbard and 
Cohen, 1989). Thiophosphorylated I-1 or DARPP-32 is not dephosphorylated and has been 
successfully used to study the physiological role of PP1-mediated phosphorylation in 
muscle contraction. 
 
I.4.2.4 Inhibitor 1 PP2A 
 
Inhibitor 1 PP2A has been isolated from bovine kidney. It is thermostable and not 
inactivated by 1% trichloroacetic acid. Its apparent molecular mass is 30kDa (Li et al., 
1995). Identified as putative class II human histocompatibility leukocyte-associated protein 
(PHAP) I (Li et al., 1996a), it seems to inhibit the catalytic subunit directly. It is not known 
whether its activity is regulated by a posttranslational modification like I-1 of PP1 (Li et 
al., 1995). 
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I.4.2.5 Inhibitor 2 PP2A 
 
This inhibitor has been isolated from bovine kidney. It is also thermostable and not 
inactivated by 1% trichloroacetic acid. Its apparent molecular mass was initially reported 
as 20kDa (Li et al., 1995). Protein sequencing revealed that the protein had been described 
before as SET (Li et al., 1996b), PHAP II (Vaesen et al., 1994) and template activating 
factor-1β (Nagata et al., 1995). These last two inhibitors might be useful tools to study the 
physiological function of PP2A. It has been speculated that I-1 and I-2 of PP2A might be 
involved in signal transduction, particularly to mediate the effects of insulin on PP2A (Li 
et al., 1995). 
 
I.4.2.6 Simian virus 40 small tumor antigen (SV40) 
 
SV40 is a member of the papova family of small DNA tumor viruses. Its lytic cycle 
takes place in permissive monkey cells. SV40 infection leads to the production of proteins 
that are immunogenic and that were called tumor antigens. One such antigen is the SV40 
small tumor antigen. It can inhibit PP2A activity with an IC50 of 10-15nM. SV40 inhibits 
PP2A trimeric complex (Yang et al., 1991). In cells the interaction of small tumor antigen 
with PP2A leads to deinhibition and thus activation of MAP kinase and MEK which 
induces cell proliferation (Sontag et al., 1993).   
 
I.4.2.7 Inhibitor 4 
 
Kikuchi and coworkers isolated a human cDNA for a novel PP1 inhibitory protein, 
named I-4, from a cDNA library of germ cell tumors (Shirato et al., 2000). I-4, composed 
of 202 amino acids, is 44% identical to I-2. I-4 conserves functionally important structure 
of I-2 and exhibited similar biochemical properties. I-4 inhibited activity of the catalytic 
subunit of PP1 with IC50 of 0.2nM, more potently than I-2 with an IC50 of 2nM. Gel 
overlay experiments showed that I-4 binds PP1c directly through a multiple-point 
interaction.  
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I.5 DISTRIBUTION AND EXPRESSION OF PROTEIN 
PHOSPHATASES 
 
I.5.1 PP1 
 
By using specific antibodies raised against the different PP1 isoforms (α, β and γ1) it 
was shown that all the three isoforms were expressed in a variety of mammalian cells 
tested although they localize within these cells in a distinct and characteristic manner. All 
the isoforms were present both in the cytoplasm and nucleus during interphase. Within the 
nucleus PP1α associates with the nuclear matrix, PP1γ1 concentrates in nucleoli in 
association with RNA, and PP1β localizes to non-nucleolar chromatin. During mitosis 
PP1α is localized to the centrosomes, PP1γ1 is associated with microtubules and 
PP1β associates with chromosomes (Andreassen et al., 1998). 
In the brain the mRNAs for PP1α, PP1β and PP1γ1 were found to be particularly 
abundant in hippocampus and cerebellum (da Cruz e Silva et al., 1995b). At the protein 
level  PP1α and PP1γ1 were found to be more highly expressed in brain than in peripheral 
tissues (Table I.1), with the highest levels being measured in the striatum, where they were 
shown to be relatively enriched in the medium-sized spiny neurons (da Cruz e Silva et al., 
1995b). At the electron microscopic level, PP1 immunoreactivity was demonstrated in 
dendritic spine heads and spine necks and possibly also in postsynaptic density (Ouimet et 
al., 1995). PP1 immunoreactivity has also been reported in human hippocampal neuronal 
cytoplasm (Pei et al., 1994). In addition, most neuronal nuclei were not immmunoreactive 
for PP1γ1 but were usually strongly immunoreactive for PP1α (Ouimet et al., 1995). 
 
I.5.2 PP2A 
 
Both PP2A catalytic subunit isoforms α and β are ubiquitously expressed, and very 
high levels are found in brain and heart. However, PP2A α is about 10 times more 
abundant than PP2A β (Khew-Goodall and Hemmings, 1988).  PP2A is mainly 
cytoplasmic (Waelkens et al., 1987), although it has also been found in the nucleus 
(Turowski et al., 1995). Of all tissues tested, its activity was highest in brain extracts 
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(Ingebritsen and Cohen, 1983). The catalytic subunit was found to have a wide regional 
distribution in brain, with the highest immunoreactivity being present in neurons and 
particularly enriched in the cytosolic and synaptosolic subcellular fractions (Saitoh et al., 
1989).  
 
I.5.3 PP2B 
 
PP2B is present in nearly all mammalian cells studied but it is most abundant in the 
brain (Wallace et al., 1980). In brain, 50-70% of PP2B is bound to membrane or 
cytoskeleton elements, and is found in most cells, although its concentration varies from 
one area to another (Yakel, 1997). PP2B Aα1 and PP2B Aβ2 isoforms are highly expressed 
in neuronal tissues whereas PP2B Aγ is testis specific (Ueki et al., 1992). PP2B Bα gives 
rise to an isoform expressed in many tissues named PP2B Bα1 (170 amino acids) and by 
means of a different promoter leads to another testis-specific isoform PP2B Bα2 (216 
amino acids). Similarly, PP2B Bβ (179 amino acids) is only expressed in the testis (Ueki et 
al., 1992; Chang et al., 1994). 
The PP2B Aα isoform is the most abundantly expressed in neurons. PP2B activity has 
been detected in both the soluble and particulate fractions of brain homogenates (Tallant et 
al., 1983). A dual cytoplasmic and membrane distribution was revealed by a series of 
immunohistochemical studies. PP2B has been detected in association with postsynaptic 
densities (Carlin et al., 1981; Grab et al., 1981), enriched at postsynaptic loci, plasma 
membranes and dendritic microtubules, with a more diffuse cytoplasmic distribution 
(Wood et al., 1980), and has also been reported in axons (Kincaid and Coulson, 1985). 
PP2B is either absent or present at very low levels in glia (Goto et al., 1986). Loss of PP2B 
immunoreactivity has been reported in the brains of both Huntington’s disease (Goto et al., 
1989b) and Parkinson’s disease (Goto et al., 1989a) patients.  
Developmentally, PP2B is undetectable in rat brain at a very young age, then PP2B 
expression increases to a peak at around 5 weeks of age, after which it remains at a high 
level throughout adulthood (Takahashi et al., 2000). PP2B levels in rat brain increase in 
parallel with synaptogenesis (Tallant and Cheung, 1984). 
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Table I.1: Tissue distribution of the main protein phosphatases catalytic subunits of the PPP 
family. 
 PP1α PP1γ1 PP1γ2 PP1β PP2Aα,β PP2BAα PP2BAβ PP2BAγ 
Brain ++ 
 
+++ 
 
- 
 
+++ 
 
+ 
 
+++ 
 
+++ 
 
- 
 
Heart + 
 
+ 
 
 + 
 
+ 
 
+ 
 
+ 
 
 
Liver + 
 
+ 
 
 -  
 
+ 
 
+ 
 
+ 
 
 
Intestine + 
 
+ 
 
- 
 
+++ 
 
+ 
 
   
Kidney + 
 
+ 
 
- 
 
+ 
 
+ 
 
+ 
 
+ 
 
 
Spleen + 
 
++ 
 
- 
 
+ 
 
+ 
 
+ 
 
  
Adrenal 
gland 
+ 
 
++ 
 
- 
 
+ 
 
    
Lung ++ 
 
++ 
 
 +++ 
 
+ 
 
+ 
 
++ 
 
 
Skeletal 
muscle 
+ 
 
+ 
 
 - 
 
+ 
 
++ 
 
++ 
 
- 
 
Testis ++ 
 
+ 
 
+++ 
 
++ 
 
 - 
 
- 
 
+++ 
 
 -, below detection limit. 
 
I.6 PP1 STRUCTURE AND FUNCTION 
 
Protein phosphatase 1 (also known as phosphorylase phosphatase) has been studied 
since the 1940s as the enzyme responsible for the conversion of phosphorylase a to 
phosphorylase b (Cori and Green, 1943). The discovery that PP1 was actually a 
phosphatase came at the same time as the discovery of phosphorylase kinase (Keller and 
Cori, 1955; Sutherland and Wosilait, 1955). These findings marked the beginning of an era 
of the study of protein phosphorylation/dephosphorylation as a regulatory mechanism.  
Investigation of PP1 in the following three decades focused on defining its enzymology 
and role in glycogen metabolism [a review can be found in (Shenolikar and Nairn, 1991; 
Bollen and Stalmans, 1992; Brautigan, 1994; Shenolikar, 1994; E. Y. C. Lee, 1995)] and 
the progress in the isolation and characterization of PP1 activity was very slow. The study 
of the enzymology of this enzyme is still incomplete and PP1 continues to bring surprises 
as well as new questions about its cellular functions. 
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I.6.1 Historical background 
 
The key steps that led to the beginning of the understanding of the enzymology of 
PP1 came with the isolation of the catalytic subunits (PP1c) from liver and muscle (Brandt 
et al., 1975a; Gratecos et al., 1977). Underlying this success was the discovery that 
treatment of tissue extracts with denaturants (alcohol or urea) led to the release of a 35kDa 
catalytic subunit which could be readily isolated (Brandt et al., 1974). This 35kDa subunit 
was derived from a 37kDa form by proteolytic cleavage near the C-terminus (Cohen, 1989; 
E. Y. C. Lee, 1995). The denaturant treatment released the catalytic subunit from its 
regulatory subunits, so that the enzyme activity behaved in a monodisperse manner and 
was amenable to isolation by conventional chromatographic methods. Following this 
treatment (ammonium sulfate precipitation followed by 95% ethanol at room temperature) 
the PP1 activity could be extracted from the pellet of denatured proteins. At the time it was 
clear that while phosphorylase a was the best PP1c substrate, both glycogen synthase and 
phosphorylase kinase were also dephosphorylated. Later studies (Cohen, 1989) showed 
that this enzyme was relatively non-specific when compared, for example, to the protein 
kinases. PP1c isolation from rabbit skeletal muscle led to the isolation of another catalytic  
subunit of 35kDa, which differed in its ability to act on p-nitrophenyl phosphate 
(Silberman et al., 1984). This activity turned out to be PP2A catalytic subunit (Cohen, 
1989). Ethanol or trypsin treatment of tissue extracts led to large increases in PP1 activity, 
concomitant with the reduction in apparent size to the free catalytic subunit (Brandt et al., 
1974). These findings led to the discovery of the heat-stable PP1 inhibitor proteins (Brandt 
et al., 1975b).  
The existence of these inhibitors led to two important considerations about the 
enzymology of PP1: the role of the inhibitor proteins in regulating phosphatase activity and 
the existence of holoenzyme forms. Subsequent studies (F. L. Huang and W. H. 
Glinsmann, 1976) identified two such inhibitors: inhibitor-1 (I-1) and inhibitor-2 (I-2) [a 
review can be found in (Cohen, 1989; Shenolikar and Nairn, 1991; Bollen and Stalmans, 
1992)]. I-1 and I-2 are small proteins (165 and 204 amino acids, respectively) with 
estimated molecular mass of 23kDa and 19kDa. I-1 is only inhibitory when phosphorylated 
at a threonine residue by a cAMP-dependent kinase (Cohen, 1989). The concept of a 
holoenzyme complex of the catalytic subunit with regulatory subunits was supported by 
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the findings that PP1 activity was generally associated with high molecular weight 
complexes recovered by gel filtration, but that could be reduced to a low molecular weight 
form by proteolysis, urea or ethanol treatment (Killilea et al., 1979; Mellgren et al., 1979). 
A high molecular weight form of PP was first isolated as a myosin light chain PP (Pato et 
al., 1993). However, studies of an inactive form of PP1 that could be activated by ATP and 
that had been studied by Merlevede and co-workers for many years, led to its isolation and 
the surprising finding that it consisted of a 1:1 complex of the 37kDa PP1c and I-2 (Yang 
et al., 1980; Merlevede et al., 1984). In muscle, early studies had shown the existence of a 
“glycogen particle” in which glycogen sedimented from muscle extracts was shown to be 
associated with phosphorylase phosphatase, PP1 and phosphorylase kinase (Haschke et al., 
1970; Meyer et al., 1970). The purification of the glycogen-bound form of muscle PP1 
revealed it to be a heterodimer of the catalytic subunit and a glycogen binding subunit, GM 
(Stralfors et al., 1985). GM bound both glycogen and PP1, and also modified its substrate 
specificity in that its activity toward glycogen synthase was enhanced. These studies led 
Cohen (Cohen, 1989; Hubbard and Cohen, 1993) to propose that the catalytic subunit 
could associate with different targeting subunits, which serve to direct the enzyme to 
specific subcellular locations in addition to serving regulatory functions. This finding was 
followed by isolation of the myosin bound PP1 which contained two other subunits, one of 
which, M110, binds to myosin (Chen et al., 1994). The targeting hypothesis is 
substantiated by the recent discovery of a large number of PP1 binding proteins, and the 
current view that PP1c exists in many heterodimeric forms provides an understanding of 
some of the original difficulties in the isolation of PP1c.   
   
I.6.2  Recombinant PP1c 
 
I.6.2.1 Molecular cloning and expression of the PP1c  
 
Attempts to express PP1 as a recombinant protein were initially unsuccessful as it 
was readily overexpressed in the pET3a vector, but as an inactive, insoluble protein in 
inclusion bodies (Browner et al., 1991). Attempts to renature the solubilized PP1 protein 
were only partially successful and required the presence of Mn2+, dithiothreitol, high salt 
and high dilution. The renatured enzyme exhibited only 5% of the expected specific 
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activity. So another vector system was tried: the pTACTAC vector, which had been used 
for the expression of rabbit muscle phosphorylase in a soluble form (Browner et al., 1991). 
This vector allowed the expression of PP1 in an active soluble form (Zhang et al., 1992). 
Expression was dependent on induction at a lowered temperature of 26-28ºC, rather than at 
37ºC and was also dependent on the presence of Mn2+ in the culture media, as had been 
used for the expression of phosphorylase (Browner et al., 1991).  
 
I.6.2.2 Enzymatic properties of recombinant PP1 
 
The striking feature of the recombinant protein which marks it as distinct from the 
catalytic subunit isolated from muscle and liver is that its activity is dependent on the 
presence of added Mn2+ (Zhang et al., 1992). Muscle PP1 is normally isolated in the 
presence of buffers containing EDTA, and such preparations are also active in the presence 
of EDTA (Silberman et al., 1984; Bollen and Stalmans, 1992). The exceptions are the 
catalytic subunits released from the PP1-inhibitor-2 complex (Bollen and Stalmans, 1992) 
or from higher molecular weight forms of PP1 by trypsin (Brautigan et al., 1982). In 
addition, a form of cardiac myofibrillar PP1 that requires activation by Co2+ has been 
reported (Chu et al., 1994). It has been suggested by Lee and coworkers (Zhang et al., 
1993) that the recombinant enzyme may be related to the form present in the PP1-inhibitor-
2 complex. The existence of the metal-dependent and –independent activity forms of PP1 
suggests that there exist two stable conformations of PP1 (discuss below in terms of the 
metalloprotein nature of PP1). The specific activities and general enzymatic properties of 
recombinant PP1 toward phosphorylase a are similar to those of the muscle enzyme with 
some exceptions: it is much less sensitive to inhibitor-1 (Alessi et al., 1993; Zhang et al., 
1993) and dephosphorylates phosphotyrosine containing substrates (MacKintosh et al., 
1996). Recombinant PP1 actively dephosphorylates p-nitrophenol phosphate (Zhang et al., 
1992), a property that makes it useful for the assay of toxins (by inhibition of PP1 activity) 
such as microcystin by simple colorimetric methods (Ward et al., 1997). 
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I.6.3 PP1c crystal structure and catalytic mechanism 
 
During the past decade there has been major progress in the elucidation of the 
atomic structures of the Ser/Thr-PPs in general. Crystal structures for PP1-microcystin 
(Goldberg et al., 1995), PP1-tungstate (Egloff et al., 1995), PP1-GM peptide complexes 
(Egloff et al., 1997) and more recently PP1-okadaic acid (Maynes et al., 2001) have been 
determined. Two structures for PP2B have been solved, the auto-inhibited enzyme (Fig. 
I.7) and a ternary complex of a truncated PP2B with FKBP12/ FK506 (Griffith et al., 1995; 
Kissinger et al., 1995). These structures show that the molecular architecture of the 
catalytic cores [a review can be found in (Barford, 1996)] of PP1 and PP2B are conserved, 
and that both contain a bimetal center at the active site which is structurally similar (Strater 
et al., 1995) to that present in the purple acid phosphatase. PP1, like PP2B, is a 
metalloprotein that possess a bimetal center that is bridged by a water molecule at the 
active site. The use of proton induced X-ray emission spectroscopy revealed the presence 
of Mn and Fe in the ratio 1 to 0.5 in PP1 (Egloff et al., 1995). The nature of the metal ions 
in the wild type muscle PP1 is unknown, although it can be speculated that this may be a 
Fe/Zn pair as in PP2B (King and Huang, 1984; Kissinger et al., 1995). The current views 
of the catalytic mechanism (reviewed in Barford, 1996) for PP1 are that the metals serve as 
ligands for the phosphate oxygens and for the generation of a hydroxide ion which serves 
as the nucleophile that is involved in the catalysis, while H125 serves as a proton donor for 
the leaving alcohol group (Fig I.17). Other residues in the active site which serve to 
stabilize the proposed pentacoordinate state of the phosphate intermediate are R96, N124 
and R221. Mutation of the metal ligands (J. Zhang et al., 1996) H66, D64, D92 and H248 
led to severe loss of catalytic function. Mutation of H125 and of H173 did not result in 
readily expressed proteins, although small amounts of the H125S and H125A mutants 
could be isolated. These mutants were inactive. Mutation of D95, which is proposed to 
stabilize the protonation of H125 by a salt bridge in PP1, resulted in significant reduction 
in catalytic activity. Mutations of R96 and N124 have also supported their proposed roles 
in phosphate binding.  
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Figure I.17: Active site of PP1. The active site of PP1 contains a bimetal center (shown as Fe and 
Zn) bridged by a water molecule which is displaced on binding of phosphate (Egloff et al., 1995). 
Ligands for the metal ions are shown in heavy lines. The hydrogen bonds of the phosphate oxygens 
to N124, R96 and R221 are shown in thin lines. The catalytic mechanism, based on studies of PP1 
(Egloff et al., 1995), purple acid phosphatase (Strater et al., 1995) and  PP2B (Griffith et al., 1995) 
is indicated in the diagram. The proposed reaction mechanism involves nucleophilic attack by a 
hydroxide ion, with the H125 providing the proton for the leaving alcohol group, and is supported 
by mutagenesis of the active site residues (J. Zhang et al., 1996). 
 
I.6.3.1 Binding region for toxins 
 
Several mutants of PP1 which exhibit a general loss of sensitivity towards several natural 
toxins show that these toxins have a common binding region on PP1. It was shown that a 
mutated PP2A (Cys269 to Gly) had reduced sensitivity to OA (Shima et al., 1994). By 
comparing the sequences of PP1 and PP2A in this region (Fig. I.18) it was noted that the 
region was well conserved except for a four residue difference, YRCG in PP2A (267-270) 
and GEFD (274-277) in PP1.  
 
Figure I.18: Alignment of C-terminal regions of PP1, PP2A and PP2B. The boxed region shows 
the loop regions that connect beta sheets 12 and 13 in the structures of PP1 and PP2B.  
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The chimeric PP1 mutant in which GEFD was changed to YRCG resulted in 
increased sensitivity to okadaic acid (Zhang et al., 1994a), consistent with the fact that 
PP2A is more sensitive to okadaic acid than PP1. The same occurred when F276 was 
mutated to Cys (J. Zhang et al., 1996). It was also shown that Y272 is important for the 
binding of all of the inhibitors tested, as its conservative mutation to phenylalanine caused 
decreases in PP1 toxin sensitivity. These mutagenesis studies indicate that binding of the 
toxins must all involve some common contacts on PP1, and that Y272 is particularly 
important in this context. Y272 is located close to the active site with its hydroxyl within 
several angstroms from the Fe ion (Egloff et al., 1995); the mutation of Y272 without 
deleterious effects on its catalytic activity suggests that it is not involved in the catalysis. 
This region of PP1 represents the loop region connecting beta strands 12 and 13 in PP1 
structure (Fig I.19).  
 
 
Figure I.19: The β12/β13 loop of 
PP1. The diagram shows a ribbon 
model of the PP1 structure 
(Goldberg et al., 1995). The two 
beta sheets that are the scaffold for 
the active site are shown in yellow 
(beta sheet 1) and magenta (beta 
sheet 2). Beta strands 12 and 13 are 
shown in red. Microcystin is shown 
in wireframe and the two metal ions 
as black spheres. 
 
If the toxins bind to the same site on PP1 this must reflect the possibility that these 
diverse molecules must present topographically similar surfaces at the points of interaction 
with PP1. This idea has been supported by molecular modeling studies (Bagu et al., 1997; 
Gauss et al., 1997; Lindvall et al., 1997). 
 The structure of PP1 bound to okadaic acid (Maynes et al., 2001) is remarkably 
similar to the two structures of PP1 and PP2B determined previously (Fig I.20). Even with 
only the phosphate-mimic tungstate present the architecture of the active site of the 
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tungstate-bound PP1 structure is virtually identical to OA-bound PP1 complex. In contrast, 
the microcystin-bound structure reveals large changes in the conformation of the active 
site. These changes are mainly restricted to the β12/β13 loop. The loop in the microcystin-
bound PP1 structure folds back on itself causing significant shifting of residues 273-278. 
One critical difference between microcystin and OA is the presence of a dehydroalanine 
residue in microcystin that covalently alkylates the Sγ of Cys273 in a time dependent 
reaction (Dawson and Holmes, 1999). This covalent linkage is not the primary cause of 
inhibition of PP1 by microcystin (Goldberg et al., 1995). Given the strong similarity of the 
PP1-interacting domains of OA and microcystin it is likely that the primary mode of 
inhibition of PP1 by microcystin is similar to that of OA and that the movement of the 
β12/β13 loop in the microcystin complex is a secondary event accompanying the covalent 
binding reaction. An important interaction between PP1 and microcystin that is not present 
in the PP1-OA complex is the hydrogen bond that occurs between Arg96 (PP1) and the 
acid of the methyl-aspartate residue (microcystin). This interaction may account for the 
100-fold greater inhibition of PP1 by microcystin over OA (Holmes and Boland, 1993). 
The structure of PP1-OA is very similar to the structure of PP2B despite the fact that OA 
does not strongly inhibit PP2B. 
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Figure I.20: A, stereo representation of the 
backbone carbon alignment of tungstate-bound 
PP1 (gold), PP1-OA complex (blue) and PP1-
microcystin LR complex (red). OA is shown in 
ball and stick representation with carbon atoms 
in gray and oxygen atoms in red. The metals 
are from the PP1-OA structure and are shown 
as spheres. B, stereo representation of the 
backbone carbon alignment of PP1-OA (blue) 
and PP2B (gold). C, stereo representation of 
the backbone carbon alignment between the 
PP1-OA complex (blue) and the PP1-
microcystin LR complex (red). OA is shown as 
ball and stick representation and is colored 
light blue, microcystin LR is shown as ball and 
stick representation and is colored red (adapted 
from (Maynes et al., 2001).  
 
I.6.3.2 Substrate binding 
 
The active site of PP1 lies at the confluence of three shallow grooves, a C-terminal 
groove, an acidic groove and a hydrophobic groove, which are potential binding sites for 
substrates and inhibitors (Egloff et al., 1995; Goldberg et al., 1995). Microcystin binds in a 
manner such that it occupies the active site, while its extended ADDA side chain occupies 
the hydrophobic groove. The hydrophobic groove forms the obvious binding site for 
peptide substrates. The two PP1 inhibitors, I-1 and DARPP-32 both carry four basic 
residues N-terminal to the phosphothreonine residue and its binding to PP1 has been 
hypothesized to be that of a pseudosubstrate (Goldberg et al., 1995). Binding of 
peptide/polypeptide substrates to PP1 can be considered to be composed of three elements: 
interaction of the basic residues N-terminal to the phosphoserine with the acidic residues in 
the acidic groove, binding of the phosphoserine to the active site and an interaction of the 
region C-terminal of the phosphoserine (or phosphothreonine) to the hydrophobic groove. 
In the active site region the structure of the PP1-tungstate complex has shown that R96, 
N124 and R221 are involved in the binding of the phosphate oxygens (Egloff et al., 1995). 
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R221 and R96 are well positioned to form salt bridges with two of the phosphate oxygens 
while the amino group of N124 can be hydrogen bound to the third oxygen. D208 was 
hypothesized to be important for the orientation of R221 via a salt bridge interaction. It 
was also pointed out (Egloff et al., 1995) that W206 and Y134 are well positioned to 
interact with the Ser or Thr carrying the phosphate residue. These interactions and the 
location of the acidic and hydrophobic grooves are shown in Figure I.21. 
 
            
Figure I.21: The C-terminal, acidic and hydrophobic grooves of PP1. The diagram shows a space 
filled model of PP1 with a view of the face of the molecule containing the active site. The dashed 
red oval shows the location of the active site, with the two metal ions as red spheres. Microcystin is 
shown in wireframe. The location of the hydrophobic groove is delineated by the binding of the 
ADDA group of microcystin. The hydrophobic, acidic and C-terminal grooves radiate from the 
active site. Residues which are labeled are those which were analyzed by mutation (Zhang and Lee, 
1997). 
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I.7 PP1 TARGETING/BINDING PROTEINS 
 
During the last decade evidence has accumulated, that the substrate specificity of 
PP1 is achieved by the interaction with other proteins that can act as targeting subunits or 
activity modulators. Targeting, as the requirement for the molecular juxtaposition of 
proteins for the generation of signaling events, is well established as a paradigm in a 
number of growth regulated signaling systems involving tyrosine phosphorylation 
(Lemmon and Schlessinger, 1994; Pawson, 1994; Kuriyan and Cowburn, 1997), as well as 
in the anchoring of Ser/Thr-protein kinases by A-kinase anchoring proteins (AKAPs), one 
of which also binds PP2B (Lemmon and Schlessinger, 1994; Rubin, 1994). The concept of 
targeting as it relates to PP1, however, has a major twist in terms of the large number of 
PP1 binding proteins that have been reported during the past years, as it expands the 
number of PP1 heterodimers that may exist and consequently the repertoire of cellular 
functions that involve PP1.  
Genetic studies of yeast mutations that affect glycogen metabolism and cell cycle 
regulation, and the use of the yeast two hybrid system have revealed over a dozen genes 
that encode putative PP1-binding proteins (reviewed in (Stark, 1996). These include 
GAC1, REG1, REG2, SCD5, GIP1, SHP1, GIP2 and SDS22 in S. cerevisiae. These genes 
are required for the control of glycogen metabolism, protein synthesis, glucose repression, 
meiosis, sporulation and mitotic cell cycle regulation. Rigorous biochemical demonstration 
that these PP1-binding proteins actually interact with PP1 or the nature of the targeting 
function or the substrates have not been shown in all cases. A key element of the targeting 
hypothesis is that the cellular activity of PP1 is only expressed when it is targeted. This 
would explain why the PP1 catalytic subunit exhibits a relatively nonspecific phosphatase 
activity. The strongest experimental support for a targeting function of a PP1 regulator (R) 
has come from genetic and biochemical studies of yeast glycogen metabolism. The 
glycogen-deficient yeast mutant glc7-1 was found to express a PP1 with a R73C point 
mutation (Peng et al., 1990). This did not affect PP1 activity but resulted in loss of its 
ability to bind to the yeast homolog (Gac1p) of the mammalian glycogen binding protein 
(Stuart et al., 1994). The activation of glycogen synthase requires its dephosphorylation by 
PP1 and it has been shown that glycogen synthase in this mutant is largely in the inactive 
phospho-form. Overexpression of Gap1p, on the other hand, led to increased glycogen 
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accumulation. These findings demonstrated that the physiological functioning of PP1 in 
glycogen metabolism was dependent on it being targeted to the appropriate micro-
environment and that other cellular functions were not affected when targeting to glycogen 
was disrupted.           
Several mammalian PP1-binding proteins have also been isolated either by 
biochemical methods or by yeast two hybrid analyses (Table I.2). Based on their effect on 
PP1c the best characterized R subunits can be divided into three groups. The first group is 
represented by activity-modulating proteins, including true inhibitors such as I-1 (Connor 
et al., 1999) and CPI-17 (Koyama et al., 2000) that in their phosphorylated form block the 
activity of PP1c towards all substrates. Other members of this group act instead as 
substrate-specifiers of PP1c. For example, I-1  PP2A/PHAP-I and I-2 PP2A/PHAP-II, 
which are potent inhibitors of PP2A, promote the dephosphorylation of specific substrates 
by PP1c (Katayose et al., 2000). A second group of R subunits contains the targeting 
proteins, which bind both PP1c and one of its substrates. For example, MYPT1 binds PP1c 
as well as specific substrates such as myosin (Fukata et al., 1998; Hartshorne and Hirano, 
1999; Toth et al., 2000a). Other targeting subunits do not bind the substrate directly but 
instead associate with a subcellular structure that contains the substrate. For example, the 
G subunits target PP1 to glycogen particles which also bind the substrate glycogen 
synthase (Liu and Brautigan, 2000). The targeting proteins of PP1 also include scaffolding 
proteins that mediate the formation of protein complexes. Often, these complexes function 
as signaling modules that contain both protein kinases and phosphatases and are localized 
in close proximity to the substrates of these enzymes. The third group of proteins that 
directly and tightly associates with PP1c defines a subset of its substrates. Some of these 
substrates also function as targeting proteins. Thus, the centrosomal protein kinase Nek2 
not only binds its substrate C-Nap1 but also PP1c and both Nek2 and C-Nap1 are proposed 
substrates of the associated PP1c (Helps et al., 2000). Some PP1c-bound substrates also 
function as activity modulators. For example, the retinoblastoma protein interacts with 
PP1c both as a substrate and as a noncompetitive inhibitor (Tamrakar and Ludlow, 2000). 
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Table I.2: Classification of the R subunits of PP1 
Activity  
modulators 
I-1; DARPP-32 
CPI-17; PHI-1; KEPI 
G-substrate; 
I-2; I-4 
I-1 PP2A/PHAP-I; I-2 PP2A/SET/PHAP-II/TAF-1β 
GADD34 
Targeting  
proteins 
AKAPs (AKAP149, AKAP220; Yotiao)  
G subunits (GM/RGL; GL; R5/PTG/U5; R6) 
M subunits (M110/M130/MYPT1; MYPT2/PP-1bp55)  
Neurofilament-L 
Neurabin-I; spinophilin/neurabin-II 
NIPP1 
sds22 
Tau 
Substrates Bad 
Nek2 
Phosphofructokinase 
Retinoblastoma protein 
Ryanodine receptor 
Unclassified BH-protocadherin-c 
HCF (host cell factor) 
HOX11 
Inhibitor-3/HCGV 
p53BP2 
PP-1bp80 
PSF 
R111/p99/PNUTS 
ribosomal proteins (L5, RIPP1) 
GRP-78 
NCLK 
Myr8 
FAK 
Bcl-2 
Herpes virus γ1 34.5 protein 
AKAPs, A-kinase anchoring proteins; G subunits, glycogen-targeting subunits; M subunits, 
myosin-targeting subunits; GRP, glucose related protein; NCLK, nuclear cdc-2 like kinase; FAK, 
focal adhesion kinase. The names of structurally related proteins are on the same line and are 
separated by a semicolon. Synonyms are separated by a slash. 
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I.7.1 “RVxF motif” 
 
Members of all three groups of R subunits have been shown to bind to PP1c via a 
short sequence that is now referred to as the “RVxF motif” (Barford et al., 1988; Egloff et 
al., 1997; Zhao and Lee, 1997a). Although the sequences that correspond to the RVxF 
motif are degenerate (the consensus sequence is [K/R]-X0-1-[V/I/L]-{P}-[F/W] (Wakula et 
al., 2003), the evidence for their role in the binding of PP1c is convincing. First, the co-
crystallization of PP1c with a synthetic fragment of the muscle-type G subunit revealed 
that the RVxF sequence binds tightly in an extended conformation to a hydrophobic 
channel of PP1c that is remote from the catalytic site (Egloff et al., 1997) (Fig. I.22). 
Modelling suggested that the variant RVxF motif of I-2 (KLHY) can be accommodated in 
a similar way in this channel (Yang et al., 2000). Second, it has been demonstrated for 
various R subunits that mutations of the hydrophobic (V/I/L) and/or aromatic (F/W/Y) 
residue in this motif is sufficient to disrupt or weaken their interaction with PP1c (Johnson 
et al., 1996; Egloff et al., 1997; Kwon et al., 1997b; Beullens et al., 1999; Yang et al., 
2000).  
 
 
Figure I.22: Structure of the PP1-GM peptide complex. A ribbon diagram of PP1c indicates the 
position of the peptide-binding channel at the interface of two β-sheets, the GM peptide atoms are 
represented as ball and stick and the position of one of the metal ions at the catalytic site is 
indicated as a green sphere. The Cα of Cys273, whose side chain forms a covalent bond with the 
MDHA side chain of microcystin is shown as a yellow sphere.       
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The residues of PP1c that are necessary for binding to the RVxF motif (in particular 
residues 287-293) are invariant in all isoforms from all species (Barford et al., 1988; Egloff 
et al., 1997). However, they are not conserved in the catalytic subunits of PP2A or PP2B, 
which explains why most regulators of PP1 do not interact with these structurally related 
phosphatases. Conversely, the R subunits of PP1 (HOX11, I-1 PP2A/PHAP-I and I-2 
PP2A/PHAP-II) that are also able to interact with the catalytic subunit of PP2A do not 
contain an RVxF sequence (Kawabe et al., 1997; Katayose et al., 2000).  
The binding of the RVxF sequence does not cause important conformational 
changes in the catalytic subunit (Egloff et al., 1997) and does not have major effects on the 
activity of the phosphatase (Endo et al., 1996; Kwon et al., 1997a; Beullens et al., 1999). 
Studies on MYPT1 and I-2 have indicated that the RVxF motif can function as an anchor 
for PP1c and enables these R subunits to make additional contacts with the phosphatase in 
an ordered and cooperative manner (Toth et al., 2000b; Yang et al., 2000). For example, 
four phosphatase-interaction sites, in addition to the RVxF motif, have been identified for 
MYPT1 and I-2 (Hartshorne and Hirano, 1999; Toth et al., 2000b; Yang et al., 2000). 
Another recurring theme is that the R subunits have common or overlapping binding sites 
on PP1c in addition to the RVxF-binding channel. For example, the inhibition of PP1c by 
phosphorylated I-1 (Endo et al., 1996), DARPP-32 (Kwon et al., 1997a) and MYPT1 
(Hartshorne and Hirano, 1999) have all been attributed to the binding of the 
phosphorylated residue at or near the catalytic site as a pseudo-substrate. The sharing of 
interaction sites is also in accordance with findings that various point mutants of PP1c 
show altered affinity for multiple R subunits (Baker et al., 1997; Ramaswamy et al., 1998). 
As expected from the unusually high conservation of residues on the surface of PP1c, 
mutagenesis studies in yeast have identified many surface residues as being essential for 
the binding of R subunits (Baker et al., 1997; Ramaswamy et al., 1998). A site that lies 
adjacent to the RVxF–binding groove has been identified as a binding pocket for the N-
terminal “IKGI” motif of inhibitor-2 (Connor et al., 2000). 
The picture that emerges shows that the binding of the R subunits to PP1c is 
mediated by multiple, degenerate, short sequence motifs and that the R subunits can share 
interaction sites. It should be pointed out that this combinatorial control (Bollen, 2001) of 
PP1c does not rule out the possibility that some R subunits might have unique binding 
sites. The combinatorial control of PP1 allows the exquisite physiological regulation of 
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PP1 holoenzymes by hormones, growth factors and metabolites at the molecular level. 
Work on the various holoenzymes has demonstrated that their physiological regulation 
involves modulation of subunit interactios, which is mediated by the reversible 
phosphorylation or allosteric regulation of the R subunits. For three unrelated R subunits it 
has been shown that the phosphorylation of Ser residue(s) within or close to the RVxF 
motif disrupts the binding of this motif to PP1c (Beullens et al., 1999; McAvoy et al., 
1999; Liu et al., 2000). This results in altered activity of the holoenzyme or the release of 
the catalytic subunit. In contrast phosphorylation of other subunits strengthens their 
interaction with PP1c. Examples include I-1 and DARPP-32, in which an additional 
binding site for PP1c is created by phosphorylation. A different type of regulation involves 
the binding of allosteric regulators. The allosteric binding of phosphorylase a to the C-
terminal tail of the liver-type G subunit (GL) abolishes the activity of the associated PP1c 
towards glycogen synthase (Armstrong et al., 1998). An additional level of regulation of 
the PP1 holoenzymes is provided by targeting of these enzymes to specific substrates or 
subcellular structures. Bollen and coworkers, by a combination of bioinformatics tools and 
mutagenesis studies have delineated the consensus sequence and function of three PP1 
binding motifs as being [K/R]-X0-1-[V/I/L]-(P)-[F/W], were X denotes any residue and P 
any residue except proline (Wakula et al., 2003). This sequence is very similar to a 
consensus sequence proposed by Zhao and Lee (Zhao and Lee, 1997a), [R/K]-[K/R]-X0-2-
V-[R/H]-[F/W]-X-[DE], by panning of a random peptide display library. The main 
differences are the presence of an N-terminal basic residue and a C-terminal acidic residue 
in the second.  
The RVxF-consensus sequence is present in about one third of all eukaryotic 
proteins but only a small fraction are PP1-binding proteins. It seems that RVxF-consensus 
sequences function as PP1 interaction sites only when they are present in a flexible and 
exposed loop that can be modeled into a -strand. Additionally, other low affinity regions 
on the PP1 regulators strengthen the binding. Thus, the RVxF-consensus sequence 
functions like an anchor and other low affinity interactions have to occur that have 
regulator-specific effects on PP1 activity and specificity (Wakula et al., 2003). 
Recently, another PP1 binding motif has been described, F-X-X-R-X-R, that also 
appears to exist in several PP1 interactors (Ayllon et al., 2002). A combined bioinformatics 
and mutagenesis approach could also be used to study this new consensus motif. 
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The existence of common binding sites for the R subunits explains why a relatively 
small protein such as PP1c can interact with numerous different R subunits and why the 
binding of most R subunits is mutually exclusive. 
 
I.8 PP1 IN TESTES AND SPERM 
 
Post-translational modifications of proteins are essential to the viability of all 
eukaryotic cells, and reversible protein phosphorylation is recognized as the major 
regulatory mechanism. In recent years the serine/threonine-specific protein phosphatases 
have received increasing attention, and the nature of their physiological substrates and 
regulation is the subject of intensive study. As previously mentioned, of the three known 
PP1 genes (alpha, beta and gamma), PP1 undergoes tissue-specific splicing to yield a 
poorly characterized testis-specific isoform, PP12 (Kitagawa et al., 1990; Sasaki et al., 
1990; da Cruz e Silva et al., 1995b).  
Since sperm are terminally differentiated cells essentially devoid of transcriptional 
and translational activity, they are a relatively simple model system to study the regulation 
of PP1 in relation to motility and metabolism. The PP1 driven endogenous regulation of 
protein phosphorylation and sperm motility could represent an important mechanism for 
physiological regulation of a cell that encounters dramatically different environments as it 
journeys through the seminiferous tubules and the female reproductive tract. Previous 
results (Smith et al., 1996; Vijayaraghavan et al., 1996) provide strong support for a novel 
unifying hypothesis based on the observation that PP1 is present in sperm and that 
pharmacological modulation of its activity profoundly affects sperm motility. In other cell 
types PP1 has been implicated in the control of very diverse processes of cell metabolism, 
muscle contraction, mitosis, neurotransmitter release, etc. This regulation is the result of 
complex intracellular pathways, initiated by activation of distinct receptors and second 
messenger systems. However, the precise role played by phosphatases and their regulation 
have only recently started to be elucidated. The available data demonstrate their highly 
regulatable nature, contrary to previous views. One particularly interesting mechanism for 
controlling PP1 activity involves its inhibition by heat-stable protein phosphatase inhibitors 
I-1, and I-2, phosphoproteins whose state of phosphorylation controls their inhibitory 
activity. I-1 is phosphorylated by cAMP-dependent protein kinase and dephosphorylated 
by the phosphatase calcineurin (PP2B). Thus, PP1 is involved in the cross-talk between the 
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intracellular messengers calcium and cAMP. I-2 is also capable of inhibiting the catalytic 
subunit of PP1 leading to the production of a stable PP1-I-2 complex. GSK-3  is capable of 
phosphorylating the I-2 in the PP1-I-2 complex, relieving the inhibition and producing 
active PP1.  
This biochemical scheme is likely to be operative in mammalian sperm since 
preliminary studies have identified an I2-like activity and also GSK-3 in mammalian 
sperm. Immotile bovine caput epididymal sperm contain twofold higher levels of protein 
phosphatase activity, identified as being PP12, and six fold higher GSK-3 activity than do 
mature motile caudal sperm. Thus, the complex PP12/ I2-like is inactive in motile caudal 
sperm and the phosphatase activity is re-established in immotile sperm by the higher GSK-
3 activity (Smith et al., 1996; Vijayaraghavan et al., 1996). In addition, the phosphatase 
inhibitors okadaic acid and calyculin A, were able to induce motility in completely 
immotile bovine caput epididymal sperm and to stimulate the kinetic activity of mature 
caudal sperm.  
 Besides the mechanism of protein phosphatase activity regulation described above 
others may exist. It is now well established that in somatic cells PP1 activity relies on its 
binding to several phosphatase regulators, thus the same is likely to occur in germ cells. 
Other hypothesis will be evaluated in Chapter V. 
 
I.8.1 PP1γ knockout mice 
 
 The PP1 gene was disrupted by targeted insertion in murine embryonic stem cells 
to address the importance of PP11 and PP12 functions. Mice derived from these cells 
were viable and homozygous females were fertile. On the contrary, disruption of the PP1 
gene in mice causes sterility in males due to arrest of spermatogenesis at the spermatid 
stage (Varmuza et al., 1999). Histological examination revealed severe impairment of 
spermiogenesis beginning at the round spermatid stage. Histopathological evidence shows 
that meiosis may be disrupted: the presence of polyploidy spermatids suggests a failure of 
one of the reductional divisions. These observations show that other isoforms of PP1 can 
compensate for the lack of PP11 in somatic cells and for the lack of PP12 in germ cells 
until the final stages of spermatogenesis were PP12 becomes indispensable (Varmuza et 
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al., 1999). PP1γ knockout mice raised very interesting questions about the importance of 
protein phosphatases in spermiogenesis.  
 
I.9 SIGNAL TRANSDUCTION THERAPEUTICS 
 
Cellular health and vitality are dependent on the fine equilibrium of protein 
phosphorylation systems. Not surprisingly many diseases and dysfunctional states are 
associated with the abnormal phosphorylation of key proteins (e.g. cancer, diabetes, etc.). 
Thus, protein phosphorylation systems represent attractive targets for diagnostics and 
therapeutics. However, unlike the myriad of known protein kinases that all belong to a 
single gene superfamily, the protein phosphatases belong to several unrelated families. 
Furthermore, relatively few protein phosphatase catalytic subunits exist, exhibiting broad 
and overlapping substrate specificities in vitro. From a medical perspective, non-selective 
or marginally-selective phosphatase inhibitors have broad biological activity and are highly 
toxic to eukaryotic cells due to the inhibition of a number of critical cellular processes. 
Therefore, the development of non-specific inhibitors (i.e. calyculin A, microcystin and 
cantharidin) into therapeutic agents for systemic use seems unlikely. However, the 
development of type and isoform specific inhibitors seems very promising. Both ISIS 
15534 (Zuo et al., 1998) and ISIS 14435 (Cheng et al., 2000a) have been employed to 
specifically suppress the expression of human PP5 and PP1γ1, respectively.  
More interesting, however, is the data that indicates that in vivo, as phosphatases 
possess exquisite specificities, both in terms of substrates and localization, the key control 
mechanism must reside in the nature of the proteins to which they bind. An increasing 
number of proteins are being identified in diverse cell types that are responsible for 
regulating the catalytic activity of protein phosphatases. Indeed, the diversity of such 
phosphatase regulatory subunits explains not only the need for few catalytic subunit types, 
but also make them attractive targets for pharmacological intervention. The functional 
diversification of PP1 is controlled via its interaction with regulatory proteins. A major 
question remaining is how the regulators exert their discrimination between virtually 
identical mammalian PP1 isoforms. 
The importance of PP1 and its binding proteins as potential targets for signal 
transduction therapeutics is further strengthened by the work of Greengard and co-workers 
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demonstrating the central role played by DARPP-32 in mediating many of the most 
important neuronal signaling pathways (Greengard et al., 1999). To date more than twenty 
primary signaling cascades have been shown to be under the regulation of the 
PP1/DARPP-32 system in the striatum, and the PP1/I-1 system in other brain regions. PP1 
may also have a central role to play in the molecular mechanisms of the actions of drugs of 
abuse.  Furthermore, several lines of evidence also link PP1 to the basic processes thought 
to underlie memory and learning, such as LTP (long term potenciation) and LTD (long 
term depression). In fact, the relevance of PP1 within the context of aging and memory 
loss was recently given a rather intriguing boost. PP1 has been linked to the efficacy of 
learning and memory by limiting the acquisition of new knowledge and favouring memory 
decline (Genoux et al., 2002). PP1 inhibition prolongs memory when induced after 
learning, suggesting that PP1 promotes forgetting. These findings may account for aging-
related cognitive decline and emphasize the physiological importance of PP1 as a 
suppressor of learning and memory. Thus, at least in mice, the molecular machinery is not 
completely deteriorated with aging and the results show that near normal cognitive 
functions can be restored simply by inhibiting PP1. Altered PP1 activity may therefore be 
associated not only with the normal cognitive decline during aging, but may also explain 
the accelerated decline observed in AD patients and in other neurodegenerative diseases. 
 
I.10 AIMS 
 
 
Taking into account all the new roles that have been attributed to PP1 based on its 
binding subunits, it is extremely important to identify novel PP1-binding proteins in order 
to address cellular functions to PP1. Moreover, relatively little is known about isoform-
specific PP1 regulators. Serine/threonine phosphatase PP12 is a testis-specific protein 
phosphatase present in spermatozoa. This enzyme has been shown to play a key role in 
sperm motility. Immotile spermatozoa contain higher activity levels of PP12 compared 
with motile spermatozoa. Inhibition of protein phosphatase activity by okadaic acid and 
calyculin A initiates motility in caput epididymal sperm without requirement for a change 
in cAMP levels (Vijayaraghavan et al., 1996). Based on this data a role for PP12 in sperm 
motility was suggested. 
PP12 is expressed during germ cell differentiation in testis (Kitagawa et al., 1990; 
Sasaki et al., 1990; da Cruz e Silva et al., 1995b). Of the four PP1 isoforms known, PP12 
Characterization of the PP1 Interactome from Human Testis Chapter I  
Centro de Biologia Celular 
Universidade de Aveiro 65 
is the only isoform present in spermatozoa and has been involved in the regulation of all 
mammalian spermatozoa studied so far. It has also been involved in the onset of 
hyperactivated motility and acrosome reaction (Smith et al., 1996; Vijayaraghavan et al., 
1996; Khare et al., 1999; Si, 1999; Si and Okuno, 1999; Smith et al., 1999). The 
evolutionary conservation and the importance of serine/threonine phosphatases in 
regulating flagellar motility is highlighted by the involvement of a PP1 homolog in the 
regulation of rooster sperm motility (Ashizawa et al., 1994; Ashizawa et al., 1995) and by 
the involvement of a serine/threonine phosphatase in the regulation of microtubule sliding 
velocity in Paramecium and Chlamydomonas (Klumpp et al., 1990; Klumpp and Schultz, 
1991; Habermacher and Sale, 1995, 1996, 1997).  
Spermatozoa leave the testis incapable of progressive motility an unable to fertilize 
an egg. Motility is acquired during transit through the epididymis (O'Brien et al., 1994) 
and the ability to fertilize is achieved after incubation within the female reproductive tract, 
a process referred to as capacitation (Yanagimachi, 1994). There, an acrosome reaction 
occurs and the spermatozoa acquire a hyperactivated state. A variety of experimental 
approaches have involved a huge number of proteins in mediating the interaction between 
a spermatozoon and its environment (Wassarman et al., 2001). However, the nature of the 
molecular events behind acquisition of progressive motility, capacitation, hyperactivation 
of motility, directed motility or induction of acrosome reaction remains unresolved.  
A combination of biochemical and molecular approaches will be used, together 
with the unique PP1 tools available in our laboratory to expand the preliminary 
observations (Smith et al., 1996; Vijayaraghavan et al., 1996) that identified PP12 as a 
key component and suggested that PP12 activity may ultimately regulate spermatozoa 
motility and fertility. Thus, the objective of this study is to determine the identity and 
define the properties of the protein regulators of human testis PP12. Therefore, in order to 
identify the sperm proteins that interact with PP1, we performed two separate yeast two-
hybrid screens of a human testis library using the baits PP11 and PP12. These results 
should provide new insights into PP1 function in human testis and sperm motility and point 
to possible targets for pharmacological intervention, particularly regarding infertility and 
contraception. We will undertake an exhaustive characterization of the PP12 interactome 
from human testis.  
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II YEAST TWO HYBRID SCREENS 
 
II.1 INTRODUCTION 
 
Since sperm are terminally differentiated cells essentially devoid of transcriptional 
and translational activity, they are a relatively simple model system to study the regulation 
of PP1 and its relation to motility and metabolism. The PP1 driven endogenous regulation 
of protein phosphorylation and sperm motility could represent an important mechanism for 
physiological regulation of a cell that encounters dramatically different environments as it 
journeys through the seminiferous tubules and the female reproductive tract. Previous 
results (Smith et al., 1996; Vijayaraghavan et al., 1996) provide strong support for a novel 
unifying hypothesis based on the observation that PP1 is present in sperm and that 
pharmacological modulation of its activity profoundly affects sperm motility. On the other 
hand, PP1 activity towards different substrates appears to be mediated via binding to 
specific regulatory proteins.  Such proteins play critical regulatory and targeting roles for 
PP1.  In this context we have undertaken an in-depth survey using the yeast two-hybrid 
approach to identify the proteins expressed in human testis capable of interacting 
specifically with the alternatively spliced isoforms of PP1. 
The yeast two hybrid system (YTH) was originally devised as a simple means to 
probe protein-protein interactions (Fields and Song, 1989). YTH uses the fact that most 
eukaryotic transcription activators have two functionally independent domains, the DNA-
binding domain (BD) that recognizes a specific DNA sequence in the promoters of 
different genes and a DNA-activation domain (AD) that brings the transcriptional 
machinery to the promoter vicinity. This independence was demonstrated by fusing the AD 
of yeast GAL4, a yeast transcription factor involved in galactose metabolism, with the BD 
of E. coli LexA to create a functional transcription factor in yeast (Brent and Ptashne, 
1985). Fields and Song (1989) took advantage of this property of GAL4 to prove the 
interaction between two known proteins. They fused GAL4-AD to a protein X (prey) and 
GAL4-BD [recognizing the UASG sequence, (Weaver, 2002)] to a protein Y (bait). These 
two elements were cointroduced into yeast with one or more reporter genes (the bigger the 
number of reporter genes used the lower the number of false positives obtained) that were 
made to be transcriptionally dependent on activation through a binding site to the BD. 
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Interaction of the BD fusion with the AD fusion positions the AD in the proximity of the 
reporter gene, thus activating its transcription (Fig. II.1). The reporter genes that are most 
commonly used are the MEL1 gene (encoding α-galactosidase that is secreted into the 
culture medium), LacZ gene (encoding -galatosidase) and auxotrophic genes (like HIS3 
and ADE2) that allow the yeast to grow in medium lacking histidine and adenine, 
respectively). This system can also be used to find new interacting proteins by fusing to the 
AD a collection of cDNAs from an expression library. 
 
a) 
UASG Reporter genes
BD
bait
 
 
 
b) 
UASG Reporter genes
AD
prey
 
 
 
c) 
UASG Reporter genes
 
 
 
 
Figure II.1: The yeast two-hybrid system. 
Two chimeric proteins are expressed in 
yeast: a) GAL4 DNA-binding domain (BD) 
fused to a bait protein and GAL4 activation 
domain (AD) fused to a prey protein. The 
BD-bait hybrid protein can bind to upstream 
activation sites (UASG) but cannot activate 
transcription). b) The AD-prey protein 
cannot recognize the UASG, thus, alone is 
not capable of initiating transcription. c) 
When the bait and the prey interact, the BD 
and AD are brought together and can 
activate reporter gene transcription. 
 
 
Larger scale two-hybrid approaches typically rely on interaction mating (Finley and 
Brent, 1994). In this method a yeast strain expressing the bait protein is mated with another 
yeast strain of opposite mating type pretransformed with the cDNA library. Interaction 
between two proteins can then be determined by the activation of one or more reporter 
genes in the diploid strain. The advantages of this approach are the possibility of using 
frozen aliquots of pretransformed yeast cells saving time and resources, and that diploid 
cells are more tolerant to expression of toxic proteins and less false positives will appear 
since the diploids have reporter genes less sensitive to transcription (Kolonin and Finley, 
1998). 
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Over the 14 years since its introduction this system has been modified greatly 
expanding its biological and technological applications. The YTH has been developed first 
as an agent of biological discovery, second as a tool in proteomics and finally as a means 
towards engineering novel pharmaceutical agents. Some YTH alternative systems have 
been developed and in many cases resulted in remarkably elegant hybrid systems (a review 
can be found in (Serebriiskii et al., 2001). 
 
II.2 MATERIALS AND METHODS 
 
For the complete composition of all reagents, media and solutions used, see the 
list presented in Appendix I. All reagents were cell culture grade or ultrapure. 
 
II.2.1 Isolation of plasmids from bacteria 
 
Method 1 – alkaline lysis “mini-prep”   
 A single bacterial colony was transferred into 2ml of LB medium containing 
ampicilin (100µg/ml) and incubated overnight at 37ºC with vigorous shaking. 1.5 ml of 
this culture were transferred into a microtube and centrifuged at 14,000g for 1min at 4ºC. 
The medium was removed by aspiration. The bacterial pellet was resuspended in 100µl of 
ice-cold solution I [50mM glucose/ 25mM Tris.HCl (pH 8.0)/ 10mM EDTA] by vigorous 
vortexing. Then, 200µl of freshly prepared solution II (0.2N NaOH, 1%SDS) were added 
to the microtube that was mixed by inverting several times. Keeping the microtube on ice, 
150µl of ice-cold solution III (3M potassium acetate/ 2M glacial acetic acid) were added 
and the microtube gently vortexed. The microtube was then left on ice for 5min, 
centrifuged at 14,000g for 10min at 4ºC and the supernatant transferred to a clean 
microtube. The DNA was precipitated by adding 2 volumes of ethanol at room temperature 
(RT) and vortexed. The mixture was allowed to stand for 2min at RT. After centrifugation 
at 14,000g for 5min at 4ºC the supernatant was completely removed and the pellet washed 
with 70% ethanol. After further centrifugation, the pellet was allowed to air-dry for 10min. 
The DNA was dissolved in H2O containing DNAase-free pancreatic RNAase (20µg/ml) 
and stored at -20ºC. 
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Method 2 - QIAGEN “miniprep” 
 The bacterial pellet was obtained as described above. The pellet was then 
resuspended in 250µl of buffer P1, 250µl of buffer P2 were added and the microtube was 
mixed by gently inverting until the solution became viscous and slightly clear. Afterwards, 
350µl of buffer N3 were added and the microtube was repeatedly inverted until the 
solution became cloudy. The microtube was centrifuged for 10min and the resulting 
supernatant was applied to a QIAprep spin column placed in a microtube. After a 1min 
centrifugation the flow-through was discarded. The column was washed by adding 0.75ml 
of buffer PE and centrifuging 1min to discard the flow-through. The column was 
centrifuged for an additional 1min to remove residual wash buffer. Finally, the column was 
placed in a clean microtube and 50µl of H2O were added to elute the DNA by centrifuging 
for 1min after letting it stand for 1min. This method gives a cleaner DNA preparation than 
Method 1 with better yields. This method was used when the DNA was subsequently used 
for DNA sequencing. For enzymatic restriction the first method was commonly used.  
  
Method 3 - PROMEGA “Megaprep” 
 1000ml of cell culture were pelleted by centrifugation at 1,500g for 20min at RT. 
The cell pellet was resuspended in 30ml of cell resuspension solution [50mM Tris-HCl 
(pH 7.5)/ 10mM EDTA/ 100µg/ml RNAase A] by manually disrupting the pellet with a 
pipette. 30ml of cell lysis solution (0.2M NaOH/ 1%SDS) were added to the cells and the 
solution mixed gently by inverting until it became clear and viscous. Then, 30ml of 
neutralization solution [1.32M potassium acetate (pH 4.8)] were added and the tube 
immediately mixed by inverting. After centrifugation at 14,000g for 15min at RT the clear 
supernatant was transferred by filtering through gauze swabs to a new tube and the volume 
of supernatant was measured. At this stage 0.5 volumes of RT isopropanol were added and 
the solution mixed by inversion. This solution was centrifuged at 14,000g for 15min at RT, 
the supernatant was discarded and the pellet resuspended in 4ml of TE buffer. 20ml of 
Wizard TM Megapreps DNA purification Resin were added to the DNA and mixed by 
swirling. A Wizard TM Megacolumn was inserted into the vacuum manifold port and the 
DNA/resin mix was transferred into the Megacolumn. Vacuum was applied to pull the mix 
through the Megacolumn. Two washes with 25ml of column wash solution (80mM 
potassium acetate/ 8.3mM Tris-HCl/ 40µM EDTA/ 55% ethanol) were performed and the 
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resin was rinsed with 10ml of 80% ethanol. The Megacolumn was inserted into a 50ml 
screw cap tube and centrifuged at 2,500rpm for 5min using a swinging bucket rotor 
centrifuge. The Megacolumn was placed in a clean tube and 3ml of pre-heated water 
(70ºC) were added to the column. After waiting 1min the DNA was eluted by 
centrifugation at 2,500rpm for 5min. The DNA was stored at –20ºC. This method can yield 
more than 1mg of plasmid DNA from 1,000ml of culture.     
 This procedure was used to prepare large amount of plasmid DNA for storage and 
subsequent cloning, transfection, probe labelling, and other purposes.  
 
II.2.2 DNA digestion with restriction enzymes 
For a typical DNA digestion the manufacturer’s instructions were followed. In a 
microtube the following components were added to the following concentrations: 
- 100µg/ml DNA 
- 1X reaction buffer (specific for each restriction enzyme)  
- 1U/µg DNA of restriction enzyme 
The mixture was incubated at the appropriate temperature for a few hours (or overnight if 
convenient). The restriction enzyme should contribute less than 10% of the final volume. 
When sequential digestions with different enzymes were carried out the DNA was purified 
between the two reactions. 
   
II.2.3 DNA purification 
 
Method 1 - QIAGEN DNA Purification kit 
 This kit was used to purify DNA fragments from PCR and other enzymatic 
reactions. It allowed purification from primers, nucleotides, polymerases and salts by using 
QIAquick spin columns. Briefly, 5 volumes of buffer PB were added to 1 volume of the 
solution to be purified and mixed. The spin column was placed in a collection microtube 
and the sample was applied to the column and centrifuged for 1min at 14,000rpm to bind 
the DNA. The flow-through was discarded and the column was washed with 0.75ml of 
buffer PE, centrifuged for 1min at 14,000rpm and the flow-through discarded. The column 
was placed back in the same microtube and centrifuged again to remove traces of washing 
buffer. Then, the column was placed in a clean microtube, 50µl of H2O were added and 
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allowed to stand for 1min. To elute the DNA the column was centrifuged for 1min at 
14,000rpm. The DNA was stored at –20ºC. 
 
 Method 2: DNA precipitation with ethanol 
 This method is used to concentrate nucleic acids as well as to purify them. 
Approximately 1/10 volume of 3M sodium acetate (pH 5.2) was added to the DNA 
solution to adjust the salt concentration, followed by 2 volumes of ice-cold ethanol. The 
solution was well mixed and stored at –20ºC for 30min to allow the DNA precipitate to 
form DNA was recovered by centrifugation at 4ºC for 15min at 14,000rpm. The 
supernatant was carefully removed without disturbing the pellet. The microtube was half 
filled with ice-cold 70% ethanol and recentrifuged using the same conditions as above for 
5min. The supernatant was again removed and the pellet  allowed to dry before being 
resuspended in sterile water.  
 
 Method 3: DNA purification by extraction with phenol/chloroform 
 This approach can be used to remove proteins from DNA solutions, for instance to 
inactivate and remove enzymes. An equal volume of phenol/chloroform was added to the 
DNA sample. The contents were mixed until an emulsion was formed. The emulsion was 
then centrifuged at 14,000rpm for 1min at RT until the aqueous and organic phases were 
well separated. The aqueous phase was transferred to a clean tube and an equal volume of 
chloroform was added and mixed until an emulsion was formed. Centrifugation was 
performed using the same conditions as above, the aqueous phase was recovered and the 
DNA recovered by precipitation with ethanol (see above).  
 
II.2.4 DNA ligation 
 
Ligation of cohesive termini and blunt ended DNA 
The plasmid and the DNA fragment to be inserted were digested with the 
appropriate restriction enzymes. Digested fragments were separated by gel electrophoresis 
(see below) and purified from low melting temperature agarose. 0.1µg of vector DNA were 
transferred to a microtube with an equimolar amount of insert DNA. H2O was added to 
7.5µl, 1µl of 10X bacteriophage T4 DNA ligase (PROMEGA) buffer and 1µl of 
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bacteriophage T4 DNA ligase were added to the reaction mix and incubated for 4h at 16ºC. 
Two additional control reactions were set up that contained the plasmid vector alone and 
the insert fragment alone. To ligate blunt-ended DNA the protocol followed was exactly 
the same as above. 
 
Alkaline phosphatase treatment 
 In order to prevent self ligation of vector molecules, shrimp alkaline phosphatase 
(SAP) (ROCHE), was used according to the manufacturer’s suggestions. The reaction 
mixture was adjusted with 1/10 volume 10X concentrated dephosphorylation buffer, and 
incubated with 1µl of SAP at 37ºC for 1h. Finally, SAP was inactivated by heating the 
reaction mixture at 65ºC for 15min. 
 
II.2.5 Preparation of competent cells 
 
 A single colony of E. coli XL1-Blue was incubated in 10ml SOB medium at 37ºC 
overnight. Then, 1ml of this culture was used to incubate 50ml SOB until OD550=0.3. The 
culture was incubated on ice for 15min and centrifuged at 4,000rpm at 4ºC for 5min. The 
supernatant was discarded and 15ml of Solution I were added. After allowing to stand on 
ice for 15min the cells were centrifuged at 4,000rpm for 5min at 4ºC and 3ml of Solution II 
were added to the cell pellet. The cells were immediately divided in 0.1ml aliquots and 
stored at –80ºC. 
 
II.2.6 Bacteria transformation with plasmid DNA 
 
Competent cells (100µl) were thawed on ice and 0.1-50ng of DNA were added to 
the cells and gently swirled. The microtube was incubated on ice for 20min and heat 
shocked at 42ºC for 90sec. The microtubes were then incubated on ice for 2min before 
adding 0.9ml of SOC medium. The tubes were incubated at 37ºC for 30min with shaking at 
220rpm. The cells were then plated on the appropriate antibiotic agar medium and 
incubated at 37ºC for 16h until colonies appeared. Control transformations were also 
performed in parallel. These always included a negative control transformation without 
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DNA and a positive control transformation with 0.1ng of a control plasmid, for instance 
pUC19.  
 
II.2.7 Electrophoretic analysis of DNA 
 
 The electrophoresis apparatus was prepared and the electrophoresis tank was filled 
with enough 1X TAE to cover the agarose gel. The appropriate amount of agarose was 
transferred to an Erlenmeyer with 50ml 1X TAE. The slurry was heated until the agarose 
was dissolved and allowed to cool to 60ºC before adding ethidium bromide to a final 
concentration of 0.5µg/ml. The agarose solution was poured into the mold and the comb 
was positioned. After the gel was completely set the comb was carefully removed and the 
gel mounted in the tank. The DNA samples were mixed with the 6X loading buffer (LB) 
(0.25% bromophenol blue/ 30% glycerol in water) and the mixture was loaded into the 
slots of the submerged gel using a micropipette. Marker DNA (-Hind III fragments or 1kb 
ladder) of known size was also loaded into the gel. The lid of the gel tank was closed and 
the electrical leads were attached so that the DNA migrated towards the anode. The gel 
was run until the bromophenol blue had migrated the appropriate distance through the gel. 
At the end, the gel was examined by UV light and photographed or analysed on a 
Molecular Imager (Biorad).   
 
II.2.8 DNA purification from low melting point agarose gels 
 
To purify DNA after restriction digestion, the mixture was ran on a low melting 
temperature agarose gel. The procedure is the same as described in the section above 
except for the use of low melting temperature agarose. In this type of agarose hydroxyethyl 
groups are present in the polysaccharide chain. This substitution causes the agarose to gel 
at around 30ºC and to melt at approximately 65ºC, below the melting point of dsDNA. 
After preparing the gel as described above, the gel was ran in a cold room (4ºC) at 40V for 
4h to ensure that the gel does not melt during the run. After, the desired DNA band was 
localized on the gel with a long-wavelength UV lamp, it was excised using a sharp scalpel 
and transferred to a clean, pre-weighted microtube. To extract the DNA from the agarose 
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slice two methods were used: agarose digestion with agarase (NEB) or purification through 
a QUIAGEN column. 
 
II.2.9 DNA sequencing 
 
 All the DNA samples to be sequenced followed the same protocol. In a microtube 
the following components were added: 
- 500ng dsDNA  
- 4µl of Ready Reaction Mix* 
- 3.2pmol primer 
- H2O to a final volume of 20µl 
* Ready Reaction Mix is composed of: dye terminators, deoxynucleoside triphosphates, 
AmpliTaq DNA polymerase, FS, rTth pyrophosphatase, magnesium chloride and buffer 
(Applied Biosystems). 
This reaction mixture was vortexed and spun down for a few seconds. PCR was then 
performed using the following conditions: 
 96ºC 10sec 
 50ºC 5sec               25 cycles 
 60ºC 4min 
 hold at 4ºC 
Afterwards, the samples were purified by ethanol precipitation (see above). Briefly, 
2.0µl of 3M sodium acetate (pH4.6) and 50µl of 95% ethanol were added to the reaction 
microtube. The microtube was vortexed and incubated at RT for 15min to precipitate the 
extension products. The microtube was then centrifuged at 14,000rpm for 20min at RT. 
After discarding the supernatant 250µl of 70% ethanol were added, the microtube was 
briefly vortexed and recentrifuged for 5min at 14,000rpm at RT. The supernatant was 
discarded and the pellet dried. After this procedure the DNA was ready to be applied in an 
Applied Biosystems Automated DNA Sequencer.    
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II.2.10 Yeast transformation with plasmid DNA  
 
Preparation of competent yeast cells 
The appropriate selection media and agar plates were prepared in advance. One 
colony of yeast strain AH109 was inoculated into 1ml of YPD medium in a 1.5ml 
microtube and vortexed vigorously to disperse cell clumps. The culture was transferred 
into a 250ml flask containing 50ml of YPD and incubated at 30ºC with shaking at 230rpm 
overnight until it reached stationary phase with OD600 > 1. Enough of this culture (20-
40ml) was transferred into 300ml YPD in a 1L flask to produce an OD600 = 0.2-0.3. The 
culture was incubated for 3h at 30ºC with shaking at 230rpm, centrifuged at 2,200rpm for 
5min at RT and the supernatant was discarded and the cells resuspended in 25ml H2O. The 
cells were recentrifuged and the pellet was resuspended in 1.5ml of freshly prepared, 
sterile 1XTE/LiAc.  
 
Yeast transformation- LiAc method 
In a microtube 0.1µg of plasmid DNA were added to 100µg of herring testes carrier 
DNA. Then, 100µl of freshly prepared competent cells were added to the microtube,  
followed by 600µl of sterile PEG/LiAc (40% PEG 4000/ 1X TE/ 1X LiA). The solution 
was incubated at 30ºC for 30min with shaking (200rpm). After adding 70µl of DMSO the 
solution was mixed gently and then heat shocked for 15min in a 42ºC water bath. The cells 
were pelleted after being chilled on ice, centrifuged for 5sec at 14,000rpm and resuspended 
in 0.5ml of 1X TE buffer. 100µl of these cells were then plated in the appropriate selection 
media, and incubated at 30ºC for 2 days.   
 
II.2.11 Expression of proteins in yeast  
 
Preparation of yeast cultures for protein extraction 
For each transformed yeast to be assayed by immunoblotting, 5ml overnight 
cultures in SD (supplement dropout) selection medium were prepared by inoculating a 
colony of the previously transformed yeast (see above). As a negative control an 
untransformed yeast colony (AH109) was inoculated in YPD. The overnight cultures were 
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vortexed and added to 50ml of YPD. These cultures were incubated at 30ºC with shaking 
(220rpm) until OD600 reached 0.4-0.6 (this took 4-8h). The culture was quickly chilled by 
pouring it into a prechilled 50ml centrifuge microtube halfway filled with ice. The 
microtube was immediately centrifuged at 1,000g for 5min at 4ºC. The supernatant was 
discarded and the pellet washed in 50ml of ice-cold water. The pellet was recovered by 
centrifugation at 1,000g for 5min at 4ºC and immediately frozen by placing the microtube 
in liquid nitrogen.  
 
Preparation of protein extracts 
Complete cracking buffer was prepared and pre-warmed to 60ºC. 100µl of cracking 
buffer were used per 7.5 OD600 units of cells. The cell pellets were quickly thawed by 
resuspending in the pre-warmed cracking buffer. The samples were briefly placed at 60ºC 
to hasten melting. An additional aliquot (1µl of 100X PMSF per 100µl of cracking buffer) 
of the 100X PMSF stock solution was added to the samples every 7min during the 
procedure. Each cell suspension was transferred into a 1.5ml microtube containing 80µl of 
glass beads per 7.5 OD600  units of cells. The samples were heated at 70ºC for 10min to 
release the membrane-associated proteins. Then, the microtubes were vortexed vigorously 
for 1 min and the debris pelleted at 14,000rpm for 5min at 4ºC. The supernatants were 
transferred to fresh microtubes and placed on ice. The pellets were boiled for 5min, 
vortexed for 1min and centrifuged again. The supernatants were combined and the samples 
were boiled and stored at –70ºC (or loaded immediately on a SDS-PAGE gel).     
 
II.2.12 SDS-PAGE  
 
 In SDS polyacrylamide gel electrophoresis (SDS-PAGE) separations were carried 
out using well stablished methods (Laemmli, 1970). 
The percentage and size of the gel used depended on the molecular weight of the 
proteins being separated in the gel (Table II.1). For instance, when we wanted to visualize 
PP1 (with molecular weight around 40kDa) 12% gels were used. 
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Table II.1: Composition of the running and stacking gels for SDS-PAGE (mini gels).  
Components 
Running gel 
(7.5%) 
Running gel 
(12%) 
Running gel 
(15%) 
Stacking gel 
(3.5%) 
Water 4.9 ml 3.45 ml 2.45 ml 6.6 ml 
30%Acryl./8%Bisacryl. 2.5 ml 4.0 ml 5.0 ml 1.2 ml 
4X LGB 2.5 ml 2.5 ml 2.5 ml ------- 
5X UGB ------- ------- ------- 2.0 ml 
SDS 10% ------- ------- ------- 100 µl 
10% APS 50 µl 50 µl 50 µl 100 µl 
TEMED 5 µl 5 µl 5 µl 10 µl 
 
The 12% running gel was prepared by sequentially adding the components indicated on 
Table II.1 (APS and TEMED were the last added, as they initiate the polymerising 
process). The solution was then carefully pipetted down the spacer into the gel sandwich, 
leaving some space for the stacking gel. Then, water was carefully added to cover the top 
of the gel and the gel was allowed to polymerise for 1h. The stacking gel was prepared 
according to Table II.1. The water was poured out and the stacking gel was added to the 
sandwich; a comb was inserted and the gel allowed to polymerise for 30min. Then, the 
samples were prepared by adding to the protein sample (when appropriate the amount of 
protein loaded on the gel will be described) ¼ volume of LB (Loading Buffer). The 
microtube was boiled and centrifuged, the combs removed and the wells filled with 
running buffer. The samples were carefully loaded into the wells that were filled with 
running buffer, and the samples were electrophoresed at 90mA until the bromophenol blue 
from the LB reached the bottom of the gel. 
 
II.2.13 Staining gels with Coomassie Blue 
 
Coomassie Blue staining is based on non-specific binding of the Coomassie Blue 
dye to proteins. The separated proteins are simultaneously fixed and stained in the gel, and 
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then destained to remove the background prior to drying and photographing. The proteins 
are detected as blue bands on a clear background. 
The staining was performed at room temperature. Covered plastic trays were used to 
minimize exposure to acetic acid and methanol vapours. The gel was placed in staining 
solution (enough volume was used so that the gel could float) and agitated slowly for 
30min. After, the gel was placed in destaining solution until the bands were visible. The 
gel was then dried using a vacuum gel dryer. To this end the gel was placed on a sheet of 
filter paper of the same size, on top of a larger sheet of filter paper covering the metal 
screen on the dryer. The gel was covered with plastic wrap, then the silicon dryer cover 
flap was lowered and the vacuum applied. Finally, the heat was turned on to 65ºC for 1h. 
Alternatively, gels were scanned wet with a GS-710 calibrated imaging densitometer 
(Biorad) and analyzed with Quantity One software (version 4.2.1).    
 
II.2.14 Immunoblotting 
 
For immunoblotting tank transfer system was used. 3MM blotter paper was cut to 
fit the transfer cassette and a nitrocellulose membrane of the gel size was also cut. The gel 
was removed from the electrophoresis device and the stacking gel removed and discarded. 
The transfer sandwich was assembled under transfer buffer to avoid trapping air bubbles. 
The cassette was placed in the transfer device filled with transfer buffer. Transfer was 
allowed to proceed for 4h at 100mA, for mini gels, or overnight at 200mA for larger gels. 
Afterwords, the transfer cassettes were disassembled, the membrane carefully removed and 
allowed to air dry prior to further manipulations.  
 
II.2.15 Immunodetection by enhanced chemiluminescence (ECL)  
 
ECL TM is a light emitting non-radioactive method for the detection of immobilised 
antigens, conjugated directly or indirectly with horseradish peroxidase-labelled antibodies. 
First, the membrane was soaked in 1X TBS for 10min. Non-specific binding sites were 
blocked by immersing the membrane in 5% low fat milk in TBST for 1h. Then, the 
membrane was incubated with a solution of the appropriate primary antibody diluted in 5% 
low fat milk in TBST for 1h with shaking. After three washes of 10min each in 1X TBST 
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the membrane was incubated with a solution of the appropriate secondary antibody diluted 
in 5% low fat milk in TBST for 1h with shaking. Depending on the origin of the primary 
antibody (mouse, rabbit or sheep), the secondary antibody was anti-rabbit or anti-mouse, 
diluted 1:5000, or anti-sheep, diluted 1:1000, all conjugated to peroxidase. The membrane 
was washed, three times for 10min, and incubated for 1min at RT with the ECL detection 
solution (a mixture of equal volumes of solution 1 and solution 2 from the ECL kit, 
approximately 0.125ml/cm2 membrane). Excess solution was drained by touching the edge 
of the membrane against tissue paper and the membrane was gently wrapped with cling-
film, eliminating all air bubbles. In the dark room, the membrane was placed in a film 
cassette and an autoradiography film (XAR-5 film, KODAK) was placed on the top. The 
cassette was closed and the blot exposed over a certain period of time. The film was then 
removed and developed in a developing solution, washed in water and fixed in fixing 
solution. If needed, a second film was exposed more or less time according to the first 
result.    
To reuse the same membrane with another antibody, the membrane was sometimes 
stripped with stripping solution for 45min at 50ºC, washed with 1X TBST for 15min three 
times and then dried until needed. 
 
II.2.16 cDNA library screening by yeast mating  
 
A concentrated overnight culture of the bait strain (AH109+insert) was prepared by 
inoculating a colony of the bait strain into 50ml of SD/-Trp and incubating it at 30ºC 
overnight with shaking at 250rpm. The next day, the culture was centrifuged at 1,000g for 
5min and the pellet was resuspended in the residual liquid (5ml) by vortexing. The cells 
were counted using a haemocytometer (the concentration was > 1X109 cells/ml). Just prior 
to use, a frozen aliquot (1ml) of the library culture (Pretransformed Human Testis 
MATCHMAKER cDNA Library) was thawed in a room temperature water bath. The 
library was gently mixed and 10µl were set aside for later tittering (see below). The entire 
bait strain culture was combined with the 1ml library culture in a 2L sterile flask, 45ml of 
2X YPDA were added and gently swirled. This culture was incubated at 30ºC for 20-24h 
with shaking at 40rpm. After 20h of mating a drop of the mating culture was checked 
under a phase-contrast microscope to check for the presence of zygotes (Figure II.7). If so, 
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the mating was allowed to proceed for four more hours. The mating mixture was 
transferred to a sterile 50ml tube and the cells spun down at 1,000g for 10min. The mating 
flask was rinsed twice with 2X YPDA (50ml) and the rinses were combined and used to 
resuspend the first pellet. The cells were centrifuged again at 1,000g for 10min, the pellet 
resuspended in 10ml of 0.5X YPDA and the total volume (cells + medium) was measured. 
Half of the library mating mixture was plated on SD/QDO (SD without Leu, Trp, Ade and 
His), and the other half on SD/TDO (SD without Leu, Trp and His), at 200µl per 150mm 
plate. For mating efficiency controls, 100µl of 1:10,000, 1:1,000; 1:100 and 1:10 dilutions 
of the mating mixture were plated in 100mm SD/-Leu, SD/-Trp and SD/-Leu/-Trp plates. 
All plates were incubated at 30ºC until colonies appeared, generally 3-8 days on TDO and 
8-21 days on QDO medium. Then, growth of the control plates was scored and the mating 
efficiency and number of clones screened were calculated. All positive clones were 
replated twice in SD/QDO medium containing X-α-Gal and incubated at 30ºC for 3-8 
days. True positives formed blue colonies. The master plates were sealed with parafilm and 
stored at 4ºC. Glycerol stocks were prepared for all the positive clones.    
 
II.2.17 Library titering 
 
 A library aliquot (10µl) was transferred to 1ml of YPDA in a 1.5ml microtube – 
dilution A (dilution factor 10-2). 10µl from dilution A were added to 1ml of YPDA in 
another microtube and mixed gently – dilution B (dilution factor 10-4). 10µl of dilution A 
were added to 50µl of YPDA in another microtube and mixed gently. This solution was 
spread onto a SD/-Leu plate. From dilution B, 50 and 100µl were spread onto separate 
SD/-Leu plates. All the plates were incubated at 30ºC for 3 days after which the number of 
colonies was counted. The titer of the library was calculated using the following 
expression: [# colonies]  /[ plating volume (ml)x dil factor] = cfu/ml.   
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II.3 RESULTS 
 
Two separate yeast two-hybrid screens were performed to identify proteins from a 
human testis cDNA library capable of interacting with the alternatively spliced isoforms of 
PP1, PP1γ1 (YTH1) and with PP1γ2 (YTH2). These two isoforms are identical, except for 
the C-terminus (Fig. II.2):  
 
PP1gamma1       GGGCGCGAGCCGGCGGCGGCGCCGCTGCGGGAGGGTCGGCGGTGGGAAGGCGATGGCGGA 60 
PP1gamma2       GGGCGCGAGCCGGCGGCGGCGCCGCTGCGGGAGGGTCGGCGGTGGGAAGGCGATGGCGGA 60 
                ************************************************************ 
 
PP1gamma1       TTTAGATAAACTCAACATCGACAGCATTATCCAACGGCTGCTGGAAGTGAGAGGGTCCAA 120 
PP1gamma2       TTTAGATAAACTCAACATCGACAGCATTATCCAACGGCTGCTGGAAGTGAGAGGGTCCAA 120 
                ************************************************************ 
 
PP1gamma1       GCCTGGTAAGAATGTCCAGCTTCAGGAGAATGAAATCAGAGGACTGTGCTTAAAGTCTCG 180 
PP1gamma2       GCCTGGTAAGAATGTCCAGCTTCAGGAGAATGAAATCAGAGGACTGTGCTTAAAGTCTCG 180 
                ************************************************************ 
 
PP1gamma1       TGAAATCTTTCTCAGTCAGCCTATCCTACTAGAACTTGAAGCACCACTCAAAATATGTGG 240 
PP1gamma2       TGAAATCTTTCTCAGTCAGCCTATCCTACTAGAACTTGAAGCACCACTCAAAATATGTGG 240 
                ************************************************************ 
 
PP1gamma1       TGACATCCATGGACAATACTATGATTTGCTGCGACTTTTTGAGTACGGTGGTTTCCCACC 300 
PP1gamma2       TGACATCCATGGACAATACTATGATTTGCTGCGACTTTTTGAGTACGGTGGTTTCCCACC 300 
                ************************************************************ 
 
PP1gamma1       AGAAAGCAACTACCTGTTTCTTGGGGACTATGTGGACAGGGGAAAGCAGTCATTGGAGAC 360 
PP1gamma2       AGAAAGCAACTACCTGTTTCTTGGGGACTATGTGGACAGGGGAAAGCAGTCATTGGAGAC 360 
                ************************************************************ 
 
PP1gamma1       GATCTGCCTCTTACTGGCCTACAAAATAAAATATCCTGAGAATTTTTTTCTTCTCAGAGG 420 
PP1gamma2       GATCTGCCTCTTACTGGCCTACAAAATAAAATATCCTGAGAATTTTTTTCTTCTCAGAGG 420 
                ************************************************************ 
 
PP1gamma1       GAACCATGAATGTGCCAGCATCAACAGAATTTATGGATTTTATGATGAATGTAAAAGAAG 480 
PP1gamma2       GAACCATGAATGTGCCAGCATCAACAGAATTTATGGATTTTATGATGAATGTAAAAGAAG 480 
                ************************************************************ 
 
PP1gamma1       ATACAACATTAAACTATGGAAAACTTTCACAGACTGTTTTAACTGTTTACCGATAGCAGC 540 
PP1gamma2       ATACAACATTAAACTATGGAAAACTTTCACAGACTGTTTTAACTGTTTACCGATAGCAGC 540 
                ************************************************************ 
 
PP1gamma1       CATCGTGGATGAGAAGATATTCTGCTGTCATGGAGGTTTATCACCAGATCTTCAATCTAT 600 
PP1gamma2       CATCGTGGATGAGAAGATATTCTGCTGTCATGGAGGTTTATCACCAGATCTTCAATCTAT 600 
                ************************************************************ 
 
PP1gamma1       GGAGCAGATTCGGCGAATTATGCGACCAACTGATGTACCAGATCAAGGTCTTCTTTGTGA 660 
PP1gamma2       GGAGCAGATTCGGCGAATTATGCGACCAACTGATGTACCAGATCAAGGTCTTCTTTGTGA 660 
                ************************************************************ 
 
PP1gamma1       TCTTTTGTGGTCTGACCCCGATAAAGATGTCTTAGGCTGGGGTGAAAATGACAGAGGAGT 720 
PP1gamma2       TCTTTTGTGGTCTGACCCCGATAAAGATGTCTTAGGCTGGGGTGAAAATGACAGAGGAGT 720 
                ************************************************************ 
 
PP1gamma1       GTCCTTCACATTTGGTGCAGAAGTGGTTGCAAAATTTCTCCATAAGCATGATTTGGATCT 780 
PP1gamma2       GTCCTTCACATTTGGTGCAGAAGTGGTTGCAAAATTTCTCCATAAGCATGATTTGGATCT 780 
                ************************************************************ 
 
PP1gamma1       TATATGTAGAGCCCATCAGGTGGTTGAAGATGGATATGAATTTTTTGCAAAGAGGCAGTT 840 
PP1gamma2       TATATGTAGAGCCCATCAGGTGGTTGAAGATGGATATGAATTTTTTGCAAAGAGGCAGTT 840 
                ************************************************************ 
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PP1gamma1       GGTCACTCTGTTTTCTGCGCCCAATTATTGCGGAGAGTTTGACAATGCAGGTGCCATGAT 900 
PP1gamma2       GGTCACTCTGTTTTCTGCGCCCAATTATTGCGGAGAGTTTGACAATGCAGGTGCCATGAT 900 
                ************************************************************ 
 
PP1gamma1       GGTGGATGAAACACTAATGTGTTCTTTTCAGATTTTAAAGCCTGCAGAGAAAAAGAAGCC 960 
PP1gamma2       GGTGGATGAAACACTAATGTGTTCTTTTCAGATTTTAAAGCCTGCAGAGAAAAAGAAGCC 960 
                ************************************************************ 
 
PP1gamma1       AAATGCCACGAGACCTGTAACGCCTCCAAGGGGTAT----GATCACAAAGCAAGCAAAGA 1016 
                                             R  G  M      I  T  K  Q  A  K   
                                             R  V  G  S  G  L  N  P  S  I  Q  
PP1gamma2       CAATGCCACGAGACCTGTCACACCGCCACGGGTTGGATCAGGCCTGAACCCGTCCATTCA 1020 
                 ***************** ** ** *** *** *      *  *  **  *   **   * 
 
PP1gamma1       AATAG------------------------------------------------------- 1021 
                K  * 
                  K  A  S  N  Y  R  N  N  T  V  L  Y  E  * 
PP1gamma2       GAAAGCTTCAAATTATAGAAACAACACTGTCCTATACGAGTGATCGGGGGTACCGAATTC 1080 
                 * **                                                        
 
PP1gamma1       ------------------------------ 
PP1gamma2       CTCGAGTCTAGGGGATCCGTCGACCTGCAG 1110
Figure II.2: Comparison of the human alternatively spliced PP1γ1 and PP1γ2. The red letters 
mark the splice site, the grey letters mark the stop codon and the green letters represent the PstI 
restriction site. 
 
II.3.1 Construction of the bait plasmids  
 
The vector used to clone the bait cDNAs encoding PP1γ1 and PP1γ2, was 
Clontech’s GAL4 binding domain expression vector pAS2-1 (Appendix IV). pAS2-1 has 
several characteristics that make it suitable for YTH. It has the GAL4-BD, two 
independent yeast and bacteria replication origins, it confers ampicilin and cyclohexamide 
resistance and allows the yeast to grow without tryptophan in the culture media. It also has 
a multiple cloning site used to clone the bait cDNA. 
 
II.3.1.1 Construction of pAS-PP11 
 
The cDNA for human PP1γ1 (da Cruz e Silva, 1995) was removed from pBluescript 
(Appendix IV) by restriction digestion with XmaI/SalI and directionally subcloned into 
XmaI/SalI-digested pAS2-1. The resulting plasmid was sequenced to check the correctness 
of the PP1γ1 sequence and if the fusion protein was in the proper reading frame (Fig. II.3). 
 
atgaagctactgtcttctatcgaacaagcatgcgatatttgccgacttaaaaagctcaag 
 M  K  L  L  S  S  I  E  Q  A  C  D  I  C  R  L  K  K  L  K  
tgctccaaagaaaaaccgaagtgcgccaagtgtctgaagaacaactgggagtgtcgctac 
 C  S  K  E  K  P  K  C  A  K  C  L  K  N  N  W  E  C  R  Y  
tctcccaaaaccaaaaggtctccgctgactagggcacatctgacagaagtggaatcaagg 
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 S  P  K  T  K  R  S  P  L  T  R  A  H  L  T  E  V  E  S  R  
ctagaaagactggaacagctatttctactgatttttcctcgagaagaccttgacatgatt 
 L  E  R  L  E  Q  L  F  L  L  I  F  P  R  E  D  L  D  M  I  
ttgaaaatggattctttacaggatataaaagcattgttaacaggattatttgtacaagat 
 L  K  M  D  S  L  Q  D  I  K  A  L  L  T  G  L  F  V  Q  D  
aatgtgaataaagatgccgtcacagatagattggcttcagtggagactgatatgcctcta 
 N  V  N  K  D  A  V  T  D  R  L  A  S  V  E  T  D  M  P  L  
acattgagacagcatagaataagtgcgacatcatcatcggaagagagtagtaacaaaggt 
 T  L  R  Q  H  R  I  S  A  T  S  S  S  E  E  S  S  N  K  G  
caaagacagttgactgtatcgccggtattgcaatacccagctttgactcatatggccatg 
 Q  R  Q  L  T  V  S  P  V  L  Q  Y  P  A  L  T  H  M  A  M  
gaggccgaattcccgggcgcgagccggcggcggcgccgctgcgggagggtcggcggtggg 
 E  A  E  F  P  G  A  S  R  R  R  R  R  C  G  R  V  G  G  G  
aaggcgatggcggatttagataaactcaacatcgacagcattatccaacggctgctggaa 
 K  A  M  A  D  L  D  K  L  N  I  D  S  I  I  Q  R  L  L  E  
gtgagagggtccaagcctggtaagaatgtccagcttcaggagaatgaaatcagaggactg 
 V  R  G  S  K  P  G  K  N  V  Q  L  Q  E  N  E  I  R  G  L  
tgcttaaagtctcgtgaaatctttctcagtcagcctatcctactagaacttgaagcacca 
 C  L  K  S  R  E  I  F  L  S  Q  P  I  L  L  E  L  E  A  P  
ctcaaaatatgtggtgacatccatggacaatactatgatttgctgcgactttttgagtac 
 L  K  I  C  G  D  I  H  G  Q  Y  Y  D  L  L  R  L  F  E  Y  
ggtggtttcccaccagaaagcaactacctgtttcttggggactatgtggacaggggaaag 
 G  G  F  P  P  E  S  N  Y  L  F  L  G  D  Y  V  D  R  G  K  
cagtcattggagacgatctgcctcttactggcctacaaaataaaatatcctgagaatttt 
 Q  S  L  E  T  I  C  L  L  L  A  Y  K  I  K  Y  P  E  N  F  
tttcttctcagagggaaccatgaatgtgccagcatcaacagaatttatggattttatgat 
 F  L  L  R  G  N  H  E  C  A  S  I  N  R  I  Y  G  F  Y  D  
gaatgtaaaagaagatacaacattaaactatggaaaactttcacagactgttttaactgt 
 E  C  K  R  R  Y  N  I  K  L  W  K  T  F  T  D  C  F  N  C  
ttaccgatagcagccatcgtggatgagaagatattctgctgtcatggaggtttatcacca 
 L  P  I  A  A  I  V  D  E  K  I  F  C  C  H  G  G  L  S  P  
gatcttcaatctatggagcagattcggcgaattatgcgaccaactgatgtaccagatcaa 
 D  L  Q  S  M  E  Q  I  R  R  I  M  R  P  T  D  V  P  D  Q  
ggtcttctttgtgatcttttgtggtctgaccccgataaagatgtcttaggctggggtgaa 
 G  L  L  C  D  L  L  W  S  D  P  D  K  D  V  L  G  W  G  E  
aatgacagaggagtgtccttcacatttggtgcagaagtggttgcaaaatttctccataag 
 N  D  R  G  V  S  F  T  F  G  A  E  V  V  A  K  F  L  H  K  
catgatttggatcttatatgtagagcccatcaggtggttgaagatggatatgaatttttt 
 H  D  L  D  L  I  C  R  A  H  Q  V  V  E  D  G  Y  E  F  F  
gcaaagaggcagttggtcactctgttttctgcgcccaattattgcggagagtttgacaat 
 A  K  R  Q  L  V  T  L  F  S  A  P  N  Y  C  G  E  F  D  N  
gcaggtgccatgatggtggatgaaacactaatgtgttcttttcagattttaaagcctgca 
 A  G  A  M  M  V  D  E  T  L  M  C  S  F  Q  I  L  K  P  A  
gagaaaaagaagccaaatgccacgagacctgtaacgcctccaaggggtatgatcacaaag 
 E  K  K  K  P  N  A  T  R  P  V  T  P  P  R  G  M  I  T  K  
caagcaaagaaatag  
 Q  A  K  K  *   
Figure II.3: Partial sequence of the pAS-PP11 construct. Human PP11 sequence is in green and 
blue; Sequence marked in green is a non-coding sequence in the human PP1γ1; pAS2-1 sequence 
that is fused to PP11 is in black; splice site of PP1 is in red; Pst I restriction site is in orange; 
Initiantion codon is in pink; Stop codon is in grey. 
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II.3.1.2 Construction of pAS-PP1γ2 
 
The cDNA for mouse PP1γ2 was a generous gift from E.Y.C. Lee (Zhang et al., 
1993). This cDNA was inserted into the expression vector pTACTAC. However, the 
mouse PP1γ2 cDNA provided could not be used since sequencing of this plasmid revealed 
that it contained a mutation that resulted in a premature stop, thus yielding a C-terminally 
truncated protein (Fig. II.4). Therefore, the carboxyl terminus of PP1γ2 was taken from this 
vector by digestion with PstI and subcloned into PstI-digested pAS-PP1γ1giving the pAS-
PP1γ2 plasmid (the N-terminal of this cDNA was from human origin and the C-terminus 
from mouse). The resulting plasmid was sequenced to check the sequence of the insert 
cDNA PP1γ2 and also to check if the fusion protein was in the correct reading frame (Fig. 
II.5). 
 
ratPP1gamma2      AGCTCCTCCTCTCGCCACTGGAACCACGAGAAGAGGAGGAAGCCGGGAGCGGGGCGGCTG 60 
LeePP1gamma2      AGCTCCTCCTCTCGCCACTGGAACCACGAGAAGAGGAGGAAGCCGGGAGCGGGGCGGCTG 60 
 
ratPP1gamma2      GGGGGGGGACCCGCCGCGGCTGCTGCTGCCACCGCCGCCGCCACCACCGCTCGTGGGGCT 120 
LeePP1gamma2      GGGGGGGGACCCGCCGCGGCTGCTGCTGCCACCGCCGCCGCCACCACCGCTCGTGGGGCT 120 
 
ratPP1gamma2      CGTGGCGTGAAGAAGGAGGACGAGTGAGACCCGGGCGCGACGGGGCGCGTGCGGGAGGGT 180 
LeePP1gamma2      CGTGGCGTGAAGAAGGAGGACGAGTGAGACCCGGGCGCGACGGGGCGCGTGCGGGAGGGT 180 
 
ratPP1gamma2      CGGCGGCGGGACGGCGATGGCGGATATCGATAAACTCAACATCGACAGTATCATCCAACG 240 
LeePP1gamma2      CGGCGGCGGGACGGCGATGGCGGATATCGATAAACTCAACATCGACAGTATCATCCAACG 240 
 
ratPP1gamma2      GCTGCTGGAAGTGAGAGGGTCCAAGCCAGGCAAGAATGTCCAGCTCCAGGAGAATGAAAT 300 
LeePP1gamma2      GCTGCTGGAAGTGAGAGGGTCCAAGCCAGGCAAGAATGTCCAGCTCCAGGAGAATGAAAT 300 
 
ratPP1gamma2      CCGGGGACTGTGCTTGAAGTCTCGGGAGATCTTCCTCAGTCAGCCTATCCTTTTAGAACT 360 
LeePP1gamma2      CCGGGGACTGTGCTTGAAGTCTCGGGAGATCTTCCTCAGTCAGCCTATCCTTTTAGAACT 360 
 
ratPP1gamma2      TGAAGCACCACTCAAGATATGTGGTGACATCCACGGGCAGTACTATGATTTGCTCCGTCT 420 
LeePP1gamma2      TGAAGCACCACTCAAGATATGTGGTGACATCCACGGGCAGTACTATGATTTGCTCCGTCT 420 
 
ratPP1gamma2      GTTTGAATACGGTGGCTTTCCTCCAGAAAGCAACTATTTGTTTCTCGGGGACTATGTGGA 480 
LeePP1gamma2      GTTTGAATACGGTGGCTTTCCTCCAGAAAGCAACTATTTGTTTCTCGGGGACTATGTGGA 480 
 
ratPP1gamma2      CAGGGGCAAACAGTCACTAGAGACGATCTGCCTCTTGCTGGCCTACAAAATCAAGTATCC 540 
LeePP1gamma2      CAGGGGCAAACAGTCACTAGAGACGATCTGCCTCTTGCTGGCCTACAAAATCAAGTATCC 540 
 
ratPP1gamma2      GGAGAACTTTTTTCTTCTTAGAGGGAACCATGAGTGTGCCAGCATCAATAGAATCTACGG 600 
LeePP1gamma2      GGAGAACTTTTTTCTTCTTAGAGGGAACCATGAGTGTGCCAGCATCAATAGAATCTACGG 600 
 
ratPP1gamma2      ATTTTATGATGAGTGTAAGAGAAGATACAACATTAAGCTGTGGAAAACGTTCACAGACTG 660 
LeePP1gamma2      ATTTTATGATGAGTGTAAGAGAAGATACAACATTAAGCTGTGGAAAACGTTCACAGACTG 660 
 
ratPP1gamma2      TTTTAACTGCTTACCGATAGCAGCCATCGTGGACGAGAAGATATTCTGCTGTCATGGAGG 720 
LeePP1gamma2      TTTTAACTGCTTACCGATAGCAGCCATCGTGGACGAGAAGATATTCTGCTGTCATGGAGG 720 
 
ratPP1gamma2      TTTATCACCAGATCTTCAATCTATGGAGCAGATTCGGCGAATTATGAGACCAACTGATGT 780 
LeePP1gamma2      TTTATCACCAGATCTTCAATCTATGGAGCAGATTCGGCGAATTATGAGACCAACTGATGT 780 
 
ratPP1gamma2   ACCAGATCAAGGTCTTCTTTGTGATCTTTTGTGGTCTGACCCCGATAAAGATGTCTTTGG 840 
                 P  D  Q  G  L  L  C  D  L  L  W  S  D  P  D  K  D  V  F  G  
                 P  D    R  S  S  L  * 
LeePP1gamma2   ACCAGAT--AGGTCTTCTTTGTGATCTTTTGTGGTCTGACCCCGATAAAGATGTCTTAGG 838 
 
ratPP1gamma2      CTGGGGTGAAAATGACAGAGGAGTGTCCTTCACATTTGGTGCAGAAGTGGTTGCAAAATT 900 
LeePP1gamma2      CTGGGGTGAAAATGACAGAGGAGTGTCCTTCACATTTGGTGCAGAAGTGGTTGCAAAATT 898 
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ratPP1gamma2      TCTCCATAAGCATGATTTGGATCTTATATGTAGAGCCCATCAGGTGGTTGAAGATGGATA 960 
LeePP1gamma2      TCTCCATAAGCATGATTTGGATCTTATATGTAGAGCCCATCAGGTGGTTGAAGATGGATA 958 
 
ratPP1gamma2      TGAGTTTTTTGCAAAGAGGCAGTTAGTCACTCTGTTTTCTGCACCCAACTACTGTGGCGA 1020 
LeePP1gamma2      TGAGTTTTTTGCAAAGAGGCAGTTAGTCACTCTGTTTTCTGCACCCAACTACTGTGGCGA 1018 
 
ratPP1gamma2      GTTTGACAATGCGGGCGCCATGATGAGTGTGGATGAGACCCTCATGTGCTCCTTCCAGAT 1080 
LeePP1gamma2      GTTTGACAATGCGGGCGCCATGATGAGTGTGGATGAGACCCTCATGTGCTCCTTCCAGAT 1078 
 
ratPP1gamma2      TTTAAAGCCTGCAGAGAAAAAGAAGCCCAATGCCACGAGACCTGTCACACCGCCACGGGT 1140 
LeePP1gamma2      TTTAAAGCCTGCAGAGAAAAAGAAGCCCAATGCCACGAGACCTGTCACACCGCCACGGGT 1138 
 
ratPP1gamma2      TGGATCAGGCCTGAACCCGTCCATTCAGAAAGCTTCAAATTATAGAAACAACACTGTCCT 1200 
LeePP1gamma2      TGGATCAGGCCTGAACCCGTCCATTCAGAAAGCTTCAAATTATAGAAACAACACTGTCCT 1198 
 
ratPP1gamma2      ATACGAGTGATCGATAATGCTTTCTTTGGCTACATTCTTTATTCTGCGGTGACATTGAGG 1260 
LeePP1gamma2      ATACGAGTGATCGATAATGCTTTCTTTGGCTACATTCTTTATTCTGCGGTGACATTGAGG 1258 
 
ratPP1gamma2      CTTATAAATCAAAAGGAACTAACTTGCCGTCCACCGGTTTATACAGAACTCACAGTATCT 1320 
LeePP1gamma2      CTTATAAATCAAAAGGAACTAACTTGCCGTCCACCGGTTTATACAGAACTCACAGTATCT 1318 
 
ratPP1gamma2      ATGACTTTTTTAAACTACGACCTGTTAAAATGAATCTGTTTCCACAGATGCCGTGTACAA 1380 
LeePP1gamma2      ATGACTTTTTTAAACTACGACCTGTTAAAATGAATCTGTTTCCACAGATGCCGTGTACAA 1378 
 
ratPP1gamma2      TGCCATGTGCTAAGAATGATTTCAGACTTATTAAATGCGAGCTTGTT 1427 
LeePP1gamma2      TGCCATGTGCTAAGAATGATTTCAGACTTATTAAATGCGAGCTTGTT 1425 
Figure II.4: Alignment of the rat PP1γ2 (Gi:3236123) versus the sequence of rat PP1γ2 provided 
by E.Y.C. Lee. The PstI site is marked in green, the splice site is marked in red, the stop codon in 
grey . The cDNA provided by E.Y.C. Lee has a substitution T838-A836 and a two bases deletion 
(C788A789) marked in blue. The last mutation alters the open reading frame leading to a 
premature stop codon (in pink) that originates a 22kDa protein (data not shown). 
 
atgaagctactgtcttctatcgaacaagcatgcgatatttgccgacttaaaaagctcaag 
 M  K  L  L  S  S  I  E  Q  A  C  D  I  C  R  L  K  K  L  K  
tgctccaaagaaaaaccgaagtgcgccaagtgtctgaagaacaactgggagtgtcgctac 
 C  S  K  E  K  P  K  C  A  K  C  L  K  N  N  W  E  C  R  Y  
tctcccaaaaccaaaaggtctccgctgactagggcacatctgacagaagtggaatcaagg 
 S  P  K  T  K  R  S  P  L  T  R  A  H  L  T  E  V  E  S  R  
ctagaaagactggaacagctatttctactgatttttcctcgagaagaccttgacatgatt 
 L  E  R  L  E  Q  L  F  L  L  I  F  P  R  E  D  L  D  M  I  
ttgaaaatggattctttacaggatataaaagcattgttaacaggattatttgtacaagat 
 L  K  M  D  S  L  Q  D  I  K  A  L  L  T  G  L  F  V  Q  D  
aatgtgaataaagatgccgtcacagatagattggcttcagtggagactgatatgcctcta 
 N  V  N  K  D  A  V  T  D  R  L  A  S  V  E  T  D  M  P  L  
acattgagacagcatagaataagtgcgacatcatcatcggaagagagtagtaacaaaggt 
 T  L  R  Q  H  R  I  S  A  T  S  S  S  E  E  S  S  N  K  G  
caaagacagttgactgtatcgccggtattgcaatacccagctttgactcatatggccatg 
 Q  R  Q  L  T  V  S  P  V  L  Q  Y  P  A  L  T  H  M  A  M  
gaggccgaattcccgggcgcgagccggcggcggcgccgctgcgggagggtcggcggtggg 
 E  A  E  F  P  G  A  S  R  R  R  R  R  C  G  R  V  G  G  G   
aaggcgatggcggatttagataaactcaacatcgacagcattatccaacggctgctggaa 
 K  A  M  A  D  L  D  K  L  N  I  D  S  I  I  Q  R  L  L  E  
gtgagagggtccaagcctggtaagaatgtccagcttcaggagaatgaaatcagaggactg 
 V  R  G  S  K  P  G  K  N  V  Q  L  Q  E  N  E  I  R  G  L  
tgcttaaagtctcgtgaaatctttctcagtcagcctatcctactagaacttgaagcacca 
 C  L  K  S  R  E  I  F  L  S  Q  P  I  L  L  E  L  E  A  P  
ctcaaaatatgtggtgacatccatggacaatactatgatttgctgcgactttttgagtac 
 L  K  I  C  G  D  I  H  G  Q  Y  Y  D  L  L  R  L  F  E  Y  
ggtggtttcccaccagaaagcaactacctgtttcttggggactatgtggacaggggaaag 
 G  G  F  P  P  E  S  N  Y  L  F  L  G  D  Y  V  D  R  G  K  
cagtcattggagacgatctgcctcttactggcctacaaaataaaatatcctgagaatttt 
 Q  S  L  E  T  I  C  L  L  L  A  Y  K  I  K  Y  P  E  N  F  
Characterization of the PP1 Interactome from Human Testis Chapter II  
Centro de Biologia Celular 
Universidade de Aveiro 87 
tttcttctcagagggaaccatgaatgtgccagcatcaacagaatttatggattttatgat 
 F  L  L  R  G  N  H  E  C  A  S  I  N  R  I  Y  G  F  Y  D  
gaatgtaaaagaagatacaacattaaactatggaaaactttcacagactgttttaactgt 
 E  C  K  R  R  Y  N  I  K  L  W  K  T  F  T  D  C  F  N  C  
ttaccgatagcagccatcgtggatgagaagatattctgctgtcatggaggtttatcacca 
 L  P  I  A  A  I  V  D  E  K  I  F  C  C  H  G  G  L  S  P  
gatcttcaatctatggagcagattcggcgaattatgcgaccaactgatgtaccagatcaa 
 D  L  Q  S  M  E  Q  I  R  R  I  M  R  P  T  D  V  P  D  Q  
ggtcttctttgtgatcttttgtggtctgaccccgataaagatgtcttaggctggggtgaa 
 G  L  L  C  D  L  L  W  S  D  P  D  K  D  V  L  G  W  G  E  
aatgacagaggagtgtccttcacatttggtgcagaagtggttgcaaaatttctccataag 
 N  D  R  G  V  S  F  T  F  G  A  E  V  V  A  K  F  L  H  K  
catgatttggatcttatatgtagagcccatcaggtggttgaagatggatatgaatttttt 
 H  D  L  D  L  I  C  R  A  H  Q  V  V  E  D  G  Y  E  F  F  
gcaaagaggcagttggtcactctgttttctgcgcccaattattgcggagagtttgacaat 
 A  K  R  Q  L  V  T  L  F  S  A  P  N  Y  C  G  E  F  D  N  
gcaggtgccatgatggtggatgaaacactaatgtgttcttttcagattttaaagcctgca 
 A  G  A  M  M  V  D  E  T  L  M  C  S  F  Q  I  L  K  P  A  
gagaaaaagaagcccaatgccacgagacctgtcacaccgccacgggttggatcaggcctg 
 E  K  K  K  P  N  A  T  R  P  V  T  P  P  R  V  G  S  G  L  
aacccgtccattcagaaagcttcaaattatagaaacaacactgtcctatacgagtgatcg 
 N  P  S  I  Q  K  A  S  N  Y  R  N  N  T  V  L  Y  E  *   
ggggtaccgaattcctcgagtctaggggatccgtcgacctgcag 
Figure II.5: Partial sequence of the pAS-PP12 construct. PP12 sequence is in green and blue; 
Sequence marked in green is a non-coding sequence in the human PP1γ2; pAS2-1 sequence that is 
fused to PP11 is in black; splice site of PP1 is in red; Pst I restriction site is in orange; 
Initiantion codon is in pink; Stop codon is in grey. 
 
II.3.2 Expression of the bait proteins 
 
In order to verify the ability of the recombinant constructs to drive PP1 expression, 
they were transformed into yeast strain AH109, the transformed cells were grown on the 
appropriate media and PP1 expression was confirmed by immunobloting of the 
corresponding protein extracts (Fig. II.6). To detect the fusion protein PP1γ1/GAL4-BD 
the immunoblot was performed using an anti-PP1γ1 antibody (da Cruz e Silva et al., 
1995b), and an anti-rabbit secondary antibody conjugated to peroxidase. A band of the 
expected molecular mass was detected only in protein extracts from yeast cells containing 
the pAS-PP1γ1 plasmid (Fig. II.6A). A non-specific band was detected both in the controls 
(protein extracts from AH109 yeast cells and from AH109 yeast cells transformed with the 
vector pAS2-1 alone) and in the protein extracts from yeast cells containing the pAS-
PP1γ1 plasmid. Detection of the PP1γ2/GAL4-BD protein used an anti-PP1γ2 antibody 
prepared essentially as described in (da Cruz e Silva et al., 1995b; Vijayaraghavan et al., 
1996), that recognizes the C-terminal sequence of PP1γ2. A protein extract from human 
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testis was used as a positive control, and as a negative control the protein extract from 
untransformed AH109 yeast cells was used (Fig. II.6B).  
None of the constructs activated transcription from the UAS (the DNA sequence 
that is recognized by GAL4-BD) as detected by lack of growth of AH109 yeast cells 
containing the different bait plasmids on selective media (data not shown). 
 
Figure II.6: Immunoblot analysis of protein extracts from AH109 yeast transformed with pAS-
PP1γ1 (A) or pAS-PP1γ2 (B). A), The blot was probed with anti-PP1γ1 and X represents a non-
specific immunoreactive yeast protein. Lane 1, untransformed yeast control; Lane 2, pAS2-1 vector 
control; Lanes 3 and 4, two independent pAS-PP1γ1 clones. B), The blot was probed with anti-
PP1γ2. Lane 1, protein extract from rat testis; Lane 2, untransformed yeast control; Lane 3, pAS-
PP1γ2 extract. The calculated molecular masses (in kDa) of the fusion proteins is indicated.   
 
Once yeast cell expression of the fusion proteins GAL4-BD/PP1γ1 and GAL4-
BD/PP1γ2 was confirmed, the yeast two hybrid screens were performed. 
 
II.3.3 Identification of PP1 interacting clones 
 
 After transforming the bait plasmids into the appropriate yeast strain, AH109 (mat 
a), the next step was to obtain the desired library pretransformed in a yeast strain of the 
opposite mating type. In our case we used a pretransformed pACT-2 library in the yeast 
strain Y187 (mat α) containing human testis cDNA sequences fused to the GAL4 
transactivation domain (AD). By using a pretransformed library the most costly and time-
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consuming steps of the library screening are already done. These include, constructing the 
library, amplifying the library in E. coli, isolating the library DNA, performing the library-
scale transformation of yeast strain Y187, plating the transformation mixture and 
harvesting the transformants at high viability and density in freezing medium. 
The YTH screens were performed by yeast mating, instead of the more commun 
cotranformation protocol. By using the yeast mating protocol more unique positive clones 
are obtained due primarily to the “jump-start” that the new diploids receive before being 
plated on selective medium. Besides that, diploid yeast cells are more vigorous than 
haploid cells and can better tolerate the expression of toxic proteins. Also, in diploids, the 
reporters are less sensitive to transcription activation than they are in haploids, reducing the 
incidence of false positives from transactivating baits.  
 The human testis cDNA library was screened to identify new interacting partners 
for PP1γ1 (YTH1) and PP1γ2 (YTH2). Both screens were performed by mating as 
described in the methods section. The mating culture was checked under a phase-contrast 
microscope to check for the occurrence of zygotes (Fig. II.7), indicative that mating was 
occurring as expected. 
 
 
Figure II.7: Zygote formation in the 
mating mixture with its typical three-
lobed shape. The arrow is pointing 
the budding diploid cell. The other 
two lobes are the two haploid 
(parental) cells. This picture was 
taken using an inverted microscope, 
during the mating procedure (40X 
magnification). 
 
 
After plating the mating mixture in the appropriate selective media and waiting 
several days for colonies to appear, the growth on the control plates was scored and the 
mating efficiency and number of clones screened were calculated (Table II.2). 
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Table II.2: Results from the yeast two hybrid screens. 
YTH screen Bait Positive clones 
Mating efficiency 
(% diploids) 
Clones screened 
YTH1 PP1γ1 120 5 9 X 107 
YTH2 PP1γ2 155 5 5 X 107 
To calculate de number of clones screened the following equation was used [# cfu/ml of diploids X 
resuspension volume]. To calculate the mating efficiency the following equation was used [# cfu (in 
SD –Leu/-Trp) X 1000µl/ml/ volume plated (µl) x dilution factor] / [# cfu (in SD -Trp) X 
1000µl/ml/ volume plated (µl) X dilution factor] X 100. 
 
For YTH1 268 clones were colected and for YTH2 333 clones were isolated (Fig. 
II.8) in SD/QDO media. This media tests the expression of the nutritional reporter genes 
HIS3 and ADE2. These clones were further tested for MEL1 expression, another reporter 
gene, by growing these putative primary positive clones in SD/QDO media with X-α-Gal. 
True positive clones turn a blue colour (Fig. II.9). 120 and 155 true positive clones were 
thus identified for the YTH1 and the YTH2, respectively. 
 
1Q 3Q 4Q 5Q 7Q 8Q 9Q 12Q 13Q 17Q 20Q 26Q
27Q 29Q 30Q 31Q 32Q 33Q 34Q 35Q 36Q 37Q 39Q 40Q
41Q 44Q 45Q 46Q 47Q 48Q 49Q 53Q 57Q 55Q 58Q 4T
12T 13T 20T 22T 27T 29T 31T 32T 33T 36T 37T 39T
42T 43T 48T 50T 55T 58T 60T 62 101T 113T 118T 120T
121T 125T 127T 129T 131T 133T 135T 136T 137T 138T 141T 143T
144T 146T 152T 153T 155T 156T 157T 158T 161T 162T 164T 201T
208T 210T 212T 214T 219T 220T 223T 224T 226T 227T 228T 229T
232T 23T 236T 240T 244T 245T 246T 249T 251T 252T 254T 255T
256T 257T 258T 259T 260T 261T 302T 303T 304T 305T 311T 316T
 
A)                                                                 B) 
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C) 
21 22 24 25 26 212 213 214 215 216
217 218 219 220 225 226 229 231 232 239
244 245 247 253 260 261 262 263 264 265
266 268 269 270 271 272 273 275 276 278
279 280 284 285 287 289 291 294 296 298
2100 2101 2104 2109 2110 2123 2124 2133 2138 2140
2141 2142 2143 2144 2145 2146 2147 2149 2150 2151
2152 2153 2155 2158 2159 2160 2161 2162 2163 2164
2165 2168 2174 2175 2176 2178 2179 2183 2186 2187
2188 2189 2192 2194 2198 2202 2204 2205 2209 2210
2211 2215 2216 2217 2218 2220 2223 2224 2226 2227
2229 2231 2232 2234 2235 2236 2237 2238 2239 2240
2247 2248 2250 2252 2254 2255 2257 2258 2259 2261
2263 2264 2267 2268 2269 2271 2272 2275B 2276 2277
2278 2283 2287 2285 2296 2305 2307 2308 2324 2325
2326 2327 2329 2331 2332
 
D) 
 
Figure II.8: Positive clones identified in the yeast two hybrid screens using PP1γ1 as bait (A and 
B) or PP1γ2 (C and D). The numbers in B and D reflect their recovery from the original SD/TDO 
or SD/QDO plates.  
 
 
Figure II.9: MEL-1 expression test 
of the positive clones obtained in the 
YTH1 screen. White colonies 
(arrows) represent false positives 
that grew on SD/QDO medium but 
could not turn blue in the presence 
of X--GAL. 
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II.4 DISCUSSION 
 
As with all detection methods, the YTH system is known to result in the detection of 
some false positives. This was a relatively serious problem in the early days of the YTH 
method but the elimination of such false positive results has been greatly improved 
nowadays. False positive signals result from cells in which the reporter genes are active 
even though the bait and prey do not interact. There are several classes of false positives. 
For example, false positives may arise from preys that interact with DNA upstream of the 
reporter genes or with proteins that interact with promoter sequences. These two classes of 
false positives can be eliminated by the use of more than one reporter gene under the 
control of different promoters, as was the case with the present work. Another inherent 
problem with the system is that not all proteins will be efficiently folded and/or post-
translationaly modified in the yeast nucleus, which may result in the protein not interacting 
with the true partner. In the same way, the protein may adopt a different tertiary structure 
when expressed as fusions with the transcription factor domains. Also, some proteins may 
be toxic when expressed as fusions in yeast, inhibiting growth when expressed at high 
levels. This can be circumvented to some extent by the use of inducible expression 
plasmids. Other false positive results include interactions that occur in the YTH screen but 
not in a physiological context, because the partners are not expressed in the same cellular 
or subcellular environment at the same time. 
By screening 9 X 107 clones from a human testis cDNA library with PP1γ1 as bait 
we obtained 120 positive clones as accessed by their ability to grow on SD/ODO selective 
media and to turn blue in the presence of X--Gal. Similarly, the screening of 5 X 107 
clones with PP1γ2 as bait originated 155 positive clones. We observed multiple colonies 
(268 and 333 for the YTH1 and YTH2, respectively) that were able to induce the 
expression of the nutritional reporters (thus growing on SD/QDO) although they were not 
considered as true positives since they do not induce the expression of another reporter 
gene, MEL-1. 
In conclusion, supplementary data from other sources should be used to evaluate 
the credibility of interactions in an YTH screen. Thereby, the verification of a putative 
interaction can be achieved in a variety of ways. One approach is to mix the recombinant 
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proteins and verify binding in vitro through a variety of biochemical assays. Another 
approach is to express both proteins in cells by transfection and analyse interactions by 
immunoprecipitation studies. However, even if co-immunoprecipitation is successful, there 
is still the possibility that the proteins only interact under the conditions used. So, a crucial 
validation of the two hybrid results is to prove that the two proteins exist in the same 
subcellular environment, by doing immunoprecipitation in the tissue of interest.  
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III CHARACTERIZATION OF THE POSITIVE 
CLONES 
 
III.1 INTRODUCTION  
 
The vast majority of the PP1 binding proteins that have been identified to date were 
discovered using the yeast two hybrid (YTH) method. Often, when performing an YTH 
screen, only a few clones are selected and further characterized. Using such an approach 
many of the rarer positive clones are never analyzed, and some important potential 
interactors may be missed. 
In our screens we obtained 120 positive clones for the interactions with PP11 and 
155 for the interactions with PP12. We decided to analyse all the positive clones in order 
to identify not only the most abundant clones but also the more interesting ones, even 
though they may have been detected only once or twice in the screen. This does not mean 
they are not important but may simply reflect the low abundance of the mRNA in the 
library used or its low abundance in the tissue from which the library was made.  
All positive clones were partially sequenced and some of the clones were further 
analyzed. 
 
III.2 MATERIALS AND METHODS 
 
For the complete composition of all reagents, media and solutions used, see the 
list presented in Appendix I. All reagents were cell culture grade or ultrapure. 
 
III.2.1 Plasmid isolation from yeast and transformation into bacteria 
 
Yeast plasmid DNA was extracted by resuspending cells in 0.2ml of breaking 
buffer [2% Triton X-100/ 1% SDS/ 100mM NaCl/ 10mM Tris-HCl (pH 8.0)], adding 0.3g 
of 0.5mm acid-washed glass beads plus 0.2ml 25:24:1(v/v/v) phenol/chloroform/isoamyl 
alcohol and vortexing for 2min before centrifuging for 5min. DNA was ethanol 
precipitated. 
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An alternative method was also used for isolating yeast plasmid DNA and turned 
out to be more efficient: 3ml of yeast cells were pelleted and the DNA extracted using the 
QUIAGEN kit (Chapter II).  
Both types of DNA were used to transform E. coli XL1-Blue and plasmid DNA 
was isolated from single colonies as described in Chapter II. 
 
III.2.2 Analysis of the positive plasmids by restriction digestion, sequencing 
and database searching  
 
Plasmid DNA was digested with the restriction endonuclease HindIII and fragments 
produced were separated by agarose gel electrophoresis as described in Chapter II.  
 The cloning vector used (pACT-2) produced a characteristic pattern of fragments 
that allowed its differentiation from colonies resulting from transformation by the bait 
vector. Plasmids generating DNA fragments characteristic of the pACT-2+library insert 
digested with Hind III were further analysed. The DNA was purified (500ng) for the 
sequencing PCR (Chapter II) with 3.2 picomole GAL4-AD primer (1µl), 4µl of Term 
Ready Reaction Mix (Applied Byosystems) to a final volume of 20µl with dH2O. PCR 
conditions were as follow:  
96ºC 10sec  
50ºC 5sec         25 cycles 
60ºC 4min 
The PCR products were ethanol precipitated before being sequenced using an 
Applied Byosystems automated DNA sequencer, according to the manufacturer’s 
instructions, using Taq dye terminator cycle sequencing. A search for similar sequences in 
the Genbank database was performed using the BLAST algorithm (Altschul et al., 1997). 
 
III.2.3 Yeast colony hybridization 
 
 A nitrocellulose filter was placed on an agar plate containing the selective media 
(SD/QDO). Isolated yeast colonies were patched onto the filter and incubated overnight at 
30ºC. For each filter to be processed one piece of 3MM Whatman paper was cut, placed in 
a 150mm petri dish and soaked with 6 ml of freshly prepared SCE/DTT/Lyticase solution. 
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The filter was lifted from the growth medium and carefully placed, cell side up, onto the 
saturated paper, removing all air bubbles beneath the filter. The Petri dish containing the 
membrane was closed, placed into a plastic bag and incubated overnight at 30ºC. Then, a 
fresh sheet of plastic wrap was lined on the bench and pieces of 3MM Whatman paper 
were soaked with the solutions described below. 
1) 10% SDS, 5min 
2) 0.5N NaOH, 10min 
3) 200mM Tris(pH 7.5)/ 2X SSC, 5min (repeated 3X) 
The nitrocellulose filters were then placed on a 3 MM Whatman sheet to air dry for 1h and 
baked for 2h in a 80ºC vacuum oven between pieces of Whatman. Finally, they were stored 
between pieces of Whatman 3MM filter paper until being used for hybridization. Filter 
hybridization was performed using specific oligonucleotides.  
 Before use each oligonucleotide was 5’ end-labelled using T4 polynucleotide 
kinase (Roche) and [γ-32P] ATP (3000Ci/mmol, 10mCi/ml) from Amersham Pharmacia as 
follows: 30picomole (90µCi) of [γ-32P] ATP (9µl) were added to 37.5µl 60mM Tris.HCl 
(pH 7.8)/ 10mM MgCl2 / 14mM 2-mercaptoethanol containing 30picomole of 
oligonucleotide (10µl). The reaction was initiated by the addition of 15 units of T4 
polynucleotide kinase (1.5µl) and incubated for 30min at 37ºC. 2µl of 0.5M EDTA (pH 
8.0) were added to stop the reaction and the resulting labelled oligonucleotide was added 
directly to the pre-hybridization solution.  
 The baked nitrocellulose filters were wetted in dH2O and transferred to 3X SSC/ 
0.1% SDS/ 1mM EDTA at 45ºC for 15min. The cellular debris was removed from the 
membrane by gently rubbing with fingertips over a plastic sheet. The membranes were left 
in the same solution for another 15min with shaking. The procedure was repeated and the 
membranes transferred to a glass hybridization bottle containing approximately 0.1ml of 
prehybridization buffer per cm2 of membrane. Prehybridization was carried out 5 degrees 
below the Tm of the oligo for 4h to overnight in a rotary hybridization oven. The 
radiolabelled oligonucleotide was then added to a final concentration of 0.8pmol/ml and 
hybridization was performed at the same temperature for a minimum of 12h with constant 
shaking. At the end of the hybridization period the membrane was transferred to a plastic 
box containing 6X SSC prewarmed to the hybridization temperature. The membrane was 
washed with constant shaking for 15min and the wash solution was replaced and the 
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membrane washed for further 15min. A final wash was performed for 10min. Then, the 
membrane was removed from the solution, sealed in a plastic bag and autoradiographed 
overnight at –70ºC using a Kodak cassette and intensifying screens. Autoradiographs on X-
Omat S film were developed as described in Chapter II.    
 
III.2.4 Isolation of total RNA from mammalian tissues  
  
 The frozen tissues (~500mg) were placed into 9ml of Denaturing Solution 
(Promega kit Z5110), previously chilled on ice, and disrupted with a manual homogenizer. 
Then, 900µl 2M Sodium Acetate (pH 4.0) was added and mixed thoroughly by inverting 
the tube 4-5 times. After, the 9ml of Phenol: Chloroform: Isoamyl Alcohol was added to 
the tube. The tube was capped and the contents mixed by inverting the tube 3-5 times and 
then shaking vigorously for 10sec. The tube was chilled on ice for 15min and then, the 
mixture was transferred to DEPC-treated tube and centrifuged at 10,000g for 20min at 4ºC. 
The top aqueous phase, that contains the RNA, was carefully removed and transferred to a 
fresh DEPC-treated tube. An equal volume of isopropanol was added to the aqueous phase 
and incubated at –20ºC for 20min to precipitate the RNA. The RNA was then pelleted by 
centrifugation at 10,000g for 10min at 4ºC. The RNA pellet was resuspended in 5ml of 
Denaturing Solution and vortexed until the RNA was dissolved. An equal volume of 
isopropanol was added and the RNA was precipitated again by incubating at –20ºC for 
20min and centrifuging at 10,000g for 10min at 4ºC. The resulting pellet was washed by 
adding 10ml of 75% ethanol, resuspended by pipeting with a sterile, RNase-free tip and 
centrifuged at 10,000g for 10min at 4ºC. The pellet was air-dried, resuspended in 
Nuclease-Free Water and stored at –20ºC. 
 
III.2.5 Electrophoretic analysis of RNA 
 
An agarose gel was prepared by melting the appropriate amount of agarose in 
water, cooling it to 60ºC, and adding 5X formaldehyde gel-running buffer and 
formaldehyde to produce a final concentration of 1X and 2.2M, respectively. The gel was 
then cast in a chemical hood and allowed to set for 30min at room temperature. 
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 The RNA samples were prepared by mixing the following components in a sterile 
microtube: 
 - RNA (≈10µg)    4.5µl 
 - 5X formaldehyde gel-running buffer 2.0µl 
 - 17.5% formaldehyde   3.5µl 
 - 50% formamide    10.0µl 
The samples were incubated for 15 min at 65ºC, chilled on ice and centrifuged to 
deposit all of the fluid in the bottom of the tubes. 1µl of ethidium bromide (1mg/ml) and 
2µl of formaldehyde gel-loading buffer were added to the samples before electrophoresis. 
 Before applying the samples the gel was pre-run for 5 min at 5V/cm submerged in 
1X formaldehyde gel-running buffer. After loading the samples the gel was run at 3V/cm 
for 3h. the integrity of the RNA samples was checked by photographing the gel under UV 
illumination. 
 The gels that were transferred to nitrocellulose were not stained with ethidium 
bromide because it can reduce the efficiency of Northern hybridization. 
 
III.2.6 Northern blot analysis  
 
Probe isolation - The DNA to be labelled was cut with the appropriate restriction 
enzymes in order to release the appropriate fragment. Then the fragments were separated 
by electrophoresis on 1% low melting agarose. After staining the gel in ethidium bromide 
(0.2µg/ml) for 30min, the desired band was cut out of the gel and placed in a pre-weighted 
microtube. After, 3ml of dH2O were added per gram of gel slice and placed in a boiling 
water bath for 7 min. The sample was stored at –20ºC. Prior to using the DNA in a 
labelling reaction the DNA was denatured by boiling for 10 min and kept at 37ºC. 
 Labelling reaction - 25 ng of template DNA was dissolved in a final volume of 8µl 
dH2O and denatured in a boiling water bath for 10min. Then, the following components 
were added to the DNA: 4µl of High Prime reaction mixture (Roche) containing random 
primer mixture, Klenow polymerase and reaction buffer followed by 1µl of dATP, 1µl of 
dGTP and 1µl of dTTP and 5µl (50µCi) [α32P]dCTP (3000Ci/mmol). This mixture was 
Characterization of the PP1 Interactome from Human Testis Chapter III  
 
Centro de Biologia Celular 
Universidade de Aveiro 
100 
incubated for 1h at 37ºC. The reaction was stopped by adding 2µl 0.2M EDTA (pH 8.0) 
and heating at 65ºC for 10min. 
 Stratagene’s NucTrap probe purification columns were used to rapidly separate 
unincorporated nucleotides from the radiolabeled DNA, according to the manufacturer’s 
instructions.  
 Membrane hybridization - ExpressHyb Solution Clontech was warmed at 65ºC to 
completely dissolve any precipitate. The membrane, a Clontech rat Multiple Tissue 
Northern (MTN) membrane, was then prehybridized in 10ml of ExpressHyb Solution with 
continuous shaking at 68ºC for 2h. Meanwhile, the radioactively labelled DNA probe was 
denatured at 100ºC for 5min and chilled on ice. After, the probe was added to the 
prehybridized solution and the membrane was incubated overnight. 
 The blot was then rinsed at RT in solution I (2X SSC/ 0.05% SDS), 3 times for 
30min. Then, 2 washes with Solution I at 50ºC for 30min were performed. Finally, the blot 
was covered with plastic wrap and exposed for 1day in a K screen and visualised in a 
Phosphor Imager. 
 To remove the probe the blot was placed in 0.5% SDS at 90-100ºC for 10min with 
shaking. The solution was allowed to cool for 10min before removing the blot. Then the 
blot was slipped into a plastic bag and stored at –20ºC until needed. Complete removal of 
the probe was verified as described above prior to use. 
 
III.2.7 PCR (polymerase chain reaction) 
  
 Amplification reactions were performed according to the manufacturer’s 
instructions. Depending on the experiment, two different polymerases were used: Taq and 
Pfu (Promega). The latter is more accurate due to its proofreading capacity. Standard 
amplification reactions were performed in 0.2ml microtubes by adding10X reaction buffer, 
a mixture of the four dNTPs, two primers and the DNA template. 
The mixtures were heated for 5 min at 94ºC to denature the DNA completely. 
After, the DNA polymerase (1µl) was added to the reaction. Typical conditions used are 
indicated below in Table III.1: 
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Table III.1: Standard PCR conditions. 
Cycle Denaturation Annealing Polymerization 
First cycle 5 min, 94ºC 2 min at 50ºC 3 min at 72ºC 
24 cycles 1 min, 94ºC 2 min at 50ºC 3 min at 72ºC 
Last cycle 1 min, 94ºC 2 min at 50ºC 10 min at 72ºC 
The annealing temperature varied with the primers in the reaction.  
 
To verify the success of the PCR an aliquot was analysed by agarose gel 
electrophoresis. 
 
III.2.8 cDNA synthesis and RT-PCR  
  
cDNA synthesis - The control and experimental reactions were prepared by adding 
the following components to separate microtubes in order: 
5.9µl RNase-free water (not DEPC-treated water) 
1.0µl 10X StrataScript RT buffer (Strategene) 
 0.6µl oligo(dT) primer (100ng/ µl) 
1.0µl dNTP mix (40mM) 
 1.0µl RNA (100ng) or 1.0µl control mRNA 
Reactions were incubated at 65ºC for 5min and then cooled at RT for 5min to allow 
the primers to anneal to the RNA. After, 0.5µl of StrataScript Reverse Transcriptase 
(20U/µl) were added to each reaction. The tubes were incubated for 30min at 42ºC. At the 
end the completed first-strand cDNA synthesis reactions were placed on ice for subsequent 
use in the PCR amplification. The PCR conditions were as follows: 
95ºC, 5 min 
95ºC, 30 sec 
55ºC, 30 sec        25 cycles 
68ºC, 3 min 
All the resulting PCR products were sequenced to confirm the nucleotide sequence. 
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III.2.9 Overlay Blot 
 
The partial cDNAs obtained for Nek2 and Nek2-T were used to express the 
corresponding proteins in bacteria.  The purified protein samples were run on a SDS-
PAGE gel and transferred to a nitrocellulose membrane.  The membrane was then overlaid 
with purified PP12 protein (Watanabe et al., 2003) in TBST/BSA for 1h.  After washing 
with TBST to remove excess protein, the bound PP12 was detected by incubating the 
membrane with anti-PP12 antibody (1:1000 in 5% milk in TBST).  Immunoreactive 
bands were revealed by incubating with horseradish peroxidase conjugated secondary 
antibody (1:5000 in 5% milk in TBST) and developed by ECL (Amersham). 
 
III.3 RESULTS 
 
III.3.1 Preliminary analysis of the positive clones 
 
In order to identify the library insert present in a given positive clone, the plasmid 
DNA must first be isolated from yeast. Thus, a mixture of different plasmidic DNAs can 
be isolated from a single yeast clone: the bait plasmid (Figure III.1, lanes 3 or 4) and one, 
or more, library plasmids (Figure III.1, lane 6), because each yeast cell can incorporate 
more than one library plasmid. So, in order to obtain single plasmids and pure DNA for 
sequence analysis, the plasmid DNA isolated from yeast cells was used to transform E. coli 
XL1-Blue. The plasmid DNA obtained from the resulting transformants was further 
analysed by restriction digestion with endonuclease HindIII. The restriction fragments 
were then separated by agarose gel electrophoresis. Figure III.1 exemplifies a typical result 
obtained after this procedure:  
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Figure III.1: HindIII restriction analysis of yeast 
two hybrid plasmids. Lanes 1and 7, 1Kb ladder 
marker; Lane 2, pAS2-1 vector (4.6+2.2+0.9Kb); 
Lane 3, pASPP11 bait plasmid (4.6+2.2+1.7+0.9 
Kb); Lane 4; pASPP12 bait plasmid 
(4.6+2.2+1.5+0.9+0.3Kb); Lane 5, pACT-2 vector 
(7.4+0.7Kb); Lane 6, pACT-2+library insert 
(7.4+(0.7+ ~1.5 insert)Kb). 
  
 The same strategy was followed for each positive clone. After identifying 
transformants carrying the cDNA library plasmids, their respective inserts were sequenced 
with the GAL4-AD primer (Appendix II). Figure III.2 is a representative example obtained 
with one of the positive clones: 
 
Figure III.2: Nucleotide sequence of the positive clone 48. 
  
The nucleotide sequence of each clone was then converted to FASTA format (Fig. 
III.3). In this format, in the first line the signal > precedes a name or additional information 
on the sequence and the sequence itself starts on the second line.  
 
 
1   2    3   4    5    6   7
3
2
1
kb
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Figure III.3: Sequence of clone 48 in the FASTA format.  
 
Then, the GenBank sequence was copied to the BLAST window (Fig. III.4A) to be 
compared with the GenBank Database of nucleotide sequences. Figure III.4B shows a 
representative example of the results obtained. 
 
 
Figure III.4: A, Blast window to introduce the query sequence; B, Blast results. 
  
The identity of the positive clones identified was thus obtained. After identifying 
around 30 positive clones from both screens, a large number was identified as a known 
PP1 regulator, named Nek2 by Cohen and coworkers (Helps et al., 2000). Therefore, in 
order to reduce the number of clones that needed to be sequenced, all positives resulting 
from both screens (YTH1 and YTH2) were subjected to colony hybridization using 
appropriate oligonucleotides. 
 
 
>48 seq chrom sequence exported from chromatogram file (I2like) 
CTCTGCTGTGCCGACCCTTCTCTTCGCGGACCCCACGCCAAGCAGCGACCCTGAGGCG
ACAGCCGGAGCGCCCGGCAATGGCGGCCTCGACGGCCTCCCACCGGCCCATCAAGGG
GATCTTGAAGAACAAGACCTCTACGACTTCCTCTATGGTGGCGTCGGCNNANCACCCCA
NNCCGANTGTNTANAAAANNCTTNANCAAAAATTCCATAANTGCGNATGAAANTNANNTC
TTGGNCNTCCNAANNTCCANANCAANAAGGCNTTGNGTNANTGANAATANATNACCNAC
CCTTCNTACCATAAAATNNATGGTGANNTTNANATCCNTNTNCGGCCTTGNCNNCCTTGN
AACATGGGNCTNAANTCNANTCATAATTTNNNCTNTTCCGCTTGANACCCANCNNCNNTC
NCNATNNCTCCCTNNNGANTCANNNNNAANNTTNCNTNAANACAAAAAATACGACATNTN
CAAANNGTACNTTACTNNGGNGANNANNNNTNNTNCNAATATATNTTANGCATCANNCCA
NANTNATNGTTTTCCTANGGNANTANCACNNAATTCNCGGTCTNTTNCTCCNAAANACNN
NNTNACAATTNNCACNACTACNAAANNNTNNNTATCGCTCATCACTANAATCACANNNCT
NGCAACGGNATTAATNANCNTGTNATCACGNTNACGGCATTTGGTGNGTAGTTGCAAAT
CNCTNCNNCACTTCNNCNNNACACCNNACTTACTANNG 
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III.3.2 Yeast Colony hybridization analysis 
 
Yeast colony hybridization is an efficient way to screen a large collection of library 
transformants for the presence of an abundant cDNA insert. Transformants carrying the 
same or overlapping library plasmid can be easily identified.  
To quickly identify putative positive Nek2 clones among the large number of 
transformants obtained, a Nek2 specific oligonucleotide (OLIGONEK, Appendix II) was 
radiolabeled with 32P-ATP and hybridised to the full collection of yeast positive colonies 
arrayed in nitrocellulose membranes. The results obtained are shown bellow in Fig. III.5 
and summarized in Table III.2: 
 
 
 
A)          B) 
Figure III.5: Identification of putative Nek2 positives by colony hybridization: A) YTH1, B) YTH2. 
 
Table III.2: Putative positive clones coding for Nek2. 
YTH1 
1Q, 8Q, 33Q, 44Q, 45Q, 49Q, 53Q, 12T, 13T, 60T, 155T, 208T, 210T, 
212T, 226T, 227T, 229T, 233T, 236T, 240T, 246T, 252T, 255T, 260T 
YTH2 
21, 239, 244, 261, 263, 264, 265, 269, 270, 272, 289, 291, 294, 296, 2123, 
2146, 2147, 2159, 2160, 2204, 2220, 2235, 2254, 2263, 2269, 2283 
 
This approach allowed the identification of several different clones in a short period 
of time, not only for Nek2 but also for other abundant positives. Such positives were set 
aside until all the others were sequenced. 
Characterization of the PP1 Interactome from Human Testis Chapter III  
 
Centro de Biologia Celular 
Universidade de Aveiro 
106 
 
III.3.3 Identification of the positive clones 
 
Of the 120 positives identified in YTH1 and 155 positives identified in YTH2, 114 
and 153, respectively, were recovered and definitively identified by partial or full DNA 
sequence analysis. The results obtained are summarized in Table III.3: 
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Table III.3: Complete list of positives. 
Clone ID YTH1 YTH2 PP1 BM chr Data base ID Insert Nº positives
Nek2A
7Q,8Q,30Q,31Q,36Q, 
37Q,44Q,45Q,53Q, 
57Q,4T,13T,60T,113T, 
227T,236T,240TC,246T, 
251T,252T,254TB,254TC, 
257T,259TB,260T,261TB, 
302T,311T,316T
21,24,25,212,225,226,239,244, 
262,263,264,265,270,272,278, 
284,289,291,294,296,2101,2104, 
2109,2123,2140,2141,2142A,2144, 
2146,2147D,2151,2152,2153,2158, 
2159,2160,2163,2165,2168,2174, 
2175,2176,2186,2187,2198,2204, 
2209,2210,2215,2220,2234,2247, 
2248,2252,2254,2258,2261,2263, 
2267,2269,2276,2278,2283,2326 2329
KVHF 1 NM_002497 1170(3Q2) 94
Nek2A-T
3Q,5Q,12Q,13Q,17Q,20Q, 
26Q,27Q,49Q,55QB,12T, 
13TA,155T,208T,229T, 
256T,303T,304TB
26,215,218,232,268,269 KVHF 1 NM_002497 1340(25) 24
PPP1R15B 39Q,48QA
214,229,245,260,266,275,276, 
2110,2138,2142C,2147A,2192, 
2226,2227,2271,2272,2308
KVTF 1 NM_032833 2331(275) 19
PPP1R13B (WRF) 
ASPP1 
47Q,48QB,29T,36T,37T, 
43T,101T,137T,223T 2178,2229 RVRF 14 NM_015316 2500 11
KPI-2 46Q,58Q,39T,201T,254TA VTF 7 NM_014916 1900 5
PPP1R13A (WRF) 
ASPP2 129T,153T 2189 RVKF 1 NM_005426 2500 (2200) 3
PPP1R8-T               
NIPP1-T           273 RVTF 1 NM_138558 710(273) 1
C1QA (WRF) 216,217,287,2155,2223,2231, 2259,2277 RSLGF KGLF 1 NM_015991 540(217) 8
ZAP3 42T,214T,255T KEVEF 14 XM_085151 1700 3
DAPPER 1 2183 KILRF 14 NM_016651 1100 1
RANBP2-like 20T KQLF/RGVIF 10 Gi:30146988 400 1
JAK2 kinase 33T after stop 9 Gi:3068751 1200 1
RANBPM 2232 RMIHF 6 AB055311 2800 1
PPP1R2 -L(WRF)           
I2-L 48T KLHY 5 XM_018216 400 1
AXUD1 261 KRKF/RVAF/ RILSF/RVEF 3 NM_033027 1100 1
FLJ35803
1Q,9Q,41Q,50,55,120T,125T,12
7T,133T,135T,212T,233T,245T,
258T
22,220,247,253,285,2133,2143, 2145,2239 RVRF 9 AK093122 1000 23
DKFZp434D193 
(WRF)
32Q,55QA,31T,58T,62T, 
144T,146T,157T,210T, 244TC
2164,2179,2194A,2202,2205,2216,2218A,2250,2
324,2325,2327 RVSF 2 XM_114297 2500 19
KIAA1949 4Q,29Q,33Q,34Q,35Q,22T,27T,32T,141T 213,2238C KISF 6 XM_166376 1269 (4Q1) 11
FLJ90254 (WRF) 143T,162T,224T,249T KISF 9 RP11-350014 2300 4
MGC22793 131T 2161,2162,2305 RQVRF 7 NM_145030 900 4
MGC35144 152T 2124,2149,2150,2332 KTVRF 5 Gi21595061 300 4
IMAGE5581122 240TB,259TC MIT Gi:22028276 1300 2
FLJ32766                  
(testis clone) 271,2188 absent 2 AK057328 1800 2
LOC51315 (WRF) 2211,2217 after stop 2 NM_016618 117 2
DKFZp434N0650 
(WRF) 280 KVCF 21 NM_032261 900 1
FLJ11904 244TA absent/short peptide 18 AK021966                1300 1
FLJ14069 261TC RVTF 17 AK024131 3000 1
FLJ20373 2257 RVHF 17 BC045694 1100 1
LOC388135         
(WRF) 219T RVRF 15 XM_301534 1200 1
SARP 40Q KVHF 11 AK095193 2416 1
FLJ32771 2307 KVHF 11 NP_659454 1500 1
MGC16664 (WRF) 156T absent 1 NM_173509 2100 1
FLJ39908 (part of) 298 absent 1 NM_144569 3850 1
FLJ32001 279 RVRF 1 NM_152609 3700 1
RP11-114H24 161TA,161TC,220T,228T 2218B,2236,2237,2268,2285,  2287 RVWW 15 Gi27545119 161 10
RP11-383C5 2194B,2235,2255 KVRF 10 Gi:16416159 200 3
RP11-282K6 231,2224,2275B absent 1 Gi21954023 800 3
RP11-13J14 244TB,304TA absent/short peptide 1 AL596217 900 2
CTD-2036P10 121T RVSF 15 Gi:18249987 2400 1
RP11-77G23 20 KVTF 10 Gi:20334535 1
RP11-792D24 2296 RVRF 10 Gi:20177216 800 1
RP13-39P12 2238A 10 Gi:026953 2300 1
RP11-405I21 240TA absent 7 Gi:18042433 800 1
RP1-223E5 305T KFVSF 6 Gi:11830787 1400 1
RP11-294018 2100 absent 3 Gi:22657521 437 1
RP11-84A19 219 absent 1 Gi:28467537 3200 1
 
WRF (wrong reading frame) when shown indicates that the reading frame of the isolated clone 
differs from that of the identified protein. The occurrence of a consensus PP1 binding motif (PP1 
BM) is indicated by the corresponding sequence.The size of the inserts is indicated in base pairs. 
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The identified clones were divided in four groups: proteins already known to be 
PP1 regulators (in purple), proteins known in other contexts (in yellow), proteins of 
unknown function present in the database (in blue) and clones present in the database only 
at the genomic level (in orange). All clones were subject to the same analysis: they were 
partially or completely sequenced, special features of the amino acid sequence were 
searched using Motif search databases and the amino acid sequence was searched for a 
consensus PP1 binding motif ([K/R]-X0-1-[V/I/L]-X-[F/W]). The existence of ESTs 
(expressed sequence tags) was also ascertained by database searching. Inasmuch as several 
positives corresponded to independent hits on the same protein, the PP1 interactomes 
comprised 28 and 29 different proteins for the YTH1 and the YTH2, respectively.  
Interestingly, the most abundant interactions detected for both PP1 isoforms were with the 
same kinase.  Thus, 47 positives out of the 120 detected with PP11 and 71 positives out of 
the 155 detected with PP12 encoded Nek2A (Table III.3).  Another abundant interaction 
detected with PP12 (17 positives) was with a protein identified only as R15B in the 
GenBank database.  It was thus named since it shares a region of homology with R15A 
(also known as GADD34).  Only 2 positives were obtained for R15B with PP11. The next 
known PP1 binder more abundant was PPP1R13B. For the YTH1 9 clones were isolated 
while for the YTH2 only 2 clones were obtained. Also, 3 clones were obtained for a related 
protein, PPP1R13A, 2 with PP11 as bait and 1 with PP12. KPI-2, a recently identified 
PP1 inhibitor, was also isolated in the YTH1 in five independent clones. Finally, 1 positive 
coding for NIPP-1 was isolated as a PP12 binding protein.  
 Some of the positives identified were analyzed more thoroughly: Nek2A-T, NIPP1-
T, R15B, I2-L, KIAA1949, and SEARP. These will be further discussed below (SEARP 
will be addressed in Chapter IV). 
 
III.3.4 Nek2 (NIMA- related kinase 2)  
 
Nek2  is a protein kinase that localizes to the centrosomes throughout the cell cycle 
(Fry et al., 1998b) and regulates their structure during the G2/M transition.  It is known 
that Nek2 interacts with PP1, that dephosphorylates Nek2 itself and other Nek2 substrates 
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(Helps et al., 2000). Surprisingly, Nek2 was the most abundant interacting protein 
identified in both screens (47 and 71 positives respectively). 
By completely sequencing the Nek2 clones with the primers GAL4-AD, 
OLIGONEK, OLIGONEK2, OLIGONEK3 and Amplimer 3’ (Appendix 4), it was 
discovered that two differently spliced isoforms of Nek2 had been identified. One of the 
isoforms was identical to the previously reported sequence (Fig. III.6) (Helps et al., 2000). 
For this isoform several independent clones were obtained (Table III.4) whereas for the 
novel spliced isoform only two independent clones were isolated. 
 
Table III.4: Independent Nek2 and Nek2-N clones in the YTH1 and YTH2. 
5' Sequence First nt YTH1 YTH2
ACGAGTTTTG 642 296
CCTGAACAAA 687 24TC 294
ATGAATCGCA 696 225,226,2158,2159,2163, 2258,2263
GCTTTTAGCC 786 227T,236T 291,2101,2151
ATTCAGGCGA 830 239,2104,2140,2141,2142A,  2144,2147,2152, 2153,2254
TCTGATGAAT 855 289, 2123
GAATTGAATG 861 113T
CCATCGACCT 905 13
CATCGACCTT 906 212,262,2146,2269,2326
GCAGATTTGG 948 265
GAGCAAAGAA 966
44Q,45Q,57Q,4T,246T, 
251T,252T,254T,254TC, 
257T,259TB,260T,261TB, 
302T,311T,316T
21,244,263,272,278,2109, 
2165,2168,2175,2186,2187, 
2198,2204,2209,2210,2215, 
2234,2248,2261,2267,2276, 
2278,2283 
GAGAGAAGAG 984 7Q,8Q,31Q,36Q,37Q
GAAAAATCGC 1014 30Q, 53Q 24,25,270,284,2160,2174, 2176
TTTACAGCTT 780 3Q,5Q,12Q,13Q,20Q,27Q, 55QB,12T,229T,303T, 304TB 26, 215, 218, 232, 268, 269
CAGGATTCCA 1023 17Q,26Q,49Q,136TA,155T, 208T,256T N
ek
2A
-
T
N
ek
2A
 
 
The novel, alternatively spliced isoform was termed Nek2A-T and missed 24 
nucleotides, corresponding to amino acids 371 to 378, that we called phosphorylatable 
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domain (PD) (in red in Fig. III.6 and Fig. III.7). From all clones from the YTH1 and 
YTH2, 47 and 71 coded for Nek2A/Nek2A-T, respectively. By sequencing all the Nek 
clones we could state that 94 were Nek2A and 24 were Nek2A-T (Table III.4).  
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1  ggcacgagtaggggtggcgggtcagtgctgctcgggggcttctccatccaggtccctggagt 
63   tcctggtccctggagctccgcacttggcgcgcaacctgcgtgaggcagcgcgactctggc 
123  gactggccggccatgccttcccgggctgaggactatgaagtgttgtacaccattggcaca 
1                 M  P  S  R  A  E  D  Y  E  V  L  Y  T  I  G  T   
183  ggctcctacggccgctgccagaagatccggaggaagagtgatggcaagatattagtttgg 
17    G  S  Y  G  R  C  Q  K  I  R  R  K  S  D  G  K  I  L  V  W 
243  aaagaacttgactatggctccatgacagaagctgagaaacagatgcttgtttctgaagtg 
37    K  E  L  D  Y  G  S  M  T  E  A  E  K  Q  M  L  V  S  E  V 
303  aatttgcttcgtgaactgaaacatccaaacatcgttcgttactatgatcggattattgac 
57    N  L  L  R  E  L  K  H  P  N  I  V  R  Y  Y  D  R  I  I  D 
363  cggaccaatacaacactgtacattgtaatggaatattgtgaaggaggggatctggctagt 
77    R  T  N  T  T  L  Y  I  V  M  E  Y  C  E  G  G  D  L  A  S 
423  gtaattacaaagggaaccaaggaaaggcaatacttagatgaagagtttgttcttcgagtg 
97    V  I  T  K  G  T  K  E  R  Q  Y  L  D  E  E  F  V  L  R  V 
483  atgactcagttgactctggccctgaaggaatgccacagacgaagtgatggtggtcatacc 
117   M  T  Q  L  T  L  A  L  K  E  C  H  R  R  S  D  G  G  H  T 
543  gtattgcatcgggatcttaaaccagccaatgttttcctggatggcaagcaaaacgtcaag 
137   V  L  H  R  D  L  K  P  A  N  V  F  L  D  G  K  Q  N  V  K 
603  cttggagactttgggctagctagaatattaaaccatgacacgagttttgcaaaaacattt 
157   L  G  D  F  G  L  A  R  I  L  N  H  D  T  S  F  A  K  T  F 
663  gttggcacaccttattacatgtctcctgaacaaatgaatcgcatgtcctacaatgagaaa 
177   V  G  T  P  Y  Y  M  S  P  E  Q  M  N  R  M  S  Y  N  E  K 
723  tcagatatctggtcattgggctgcttgctgtatgagttatgtgcattaatgcctccattt 
197   S  D  I  W  S  L  G  C  L  L  Y  E  L  C  A  L  M  P  P  F 
783  acagcttttagccagaaagaactcgctgggaaaatcagagaaggcaaattcaggcgaatt 
217   T  A  F  S  Q  K  E  L  A  G  K  I  R  E  G  K  F  R  R  I 
843  ccataccgttactctgatgaattgaatgaaattattacgaggatgttaaacttaaaggat 
237   P  Y  R  Y  S  D  E  L  N  E  I  I  T  R  M  L  N  L  K  D 
903  taccatcgaccttctgttgaagaaattcttgagaaccctttaatagcagatttggttgca 
257   Y  H  R  P  S  V  E  E  I  L  E  N  P  L  I  A  D  L  V  A 
963  gacgagcaaagaagaaatcttgagagaagagggcgacaattaggagagccagaaaaatcg 
277   D  E  Q  R  R  N  L  E  R  R  G  R  Q  L  G  E  P  E  K  S 
1023 caggattccagccctgtattgagtgagctgaaactgaaggaaattcagttacaggagcga 
297   Q  D  S  S  P  V  L  S  E  L  K  L  K  E  I  Q  L  Q  E  R 
1083 gagcgagctctcaaagcaagagaagaaagattggagcagaaagaacaggagctttgtgtt 
317   E  R  A  L  K  A  R  E  E  R  L  E  Q  K  E  Q  E  L  C  V 
1143 cgtgagagactagcagaggacaaactggctagagcagaaaatctgttgaagaactacagc 
337   R  E  R  L  A  E  D  K  L  A  R  A  E  N  L  L  K  N  Y  S 
1203 ttgctaaaggaacggaagttcctgtctctggcaagtaatccagaacttcttaatcttcca 
357   L  L  K  E  R  K  F  L  S  L  A  S  N  P  E  L  L  N  L  P 
1263 tcctcagtaattaagaagaaagttcatttcagtggggaaagtaaagagaacatcatgagg 
377   S  S  V  I  K  K  K  V  H  F  S  G  E  S  K  E  N  I  M  R 
1323 agtgagaattctgagagtcagctcacatctaagtccaagtgcaaggacctgaagaaaagg 
397   S  E  N  S  E  S  Q  L  T  S  K  S  K  C  K  D  L  K  K  R 
1383 cttcacgctgcccagctgcgggctcaagccctgtcagatattgagaaaaattaccaactg 
417   L  H  A  A  Q  L  R  A  Q  A  L  S  D  I  E  K  N  Y  Q  L 
1443 aaaagcagacagatcctgggcatgcgctagccaggtagagagacacagagctgtgtacag 
437   K  S  R  Q  I  L  G  M  R  * 
1503 gatgtaatattaccaacctttaaagactgatattcaaatgctgtagtgttgaatacttgg 
1563 ccccatgagccatgcctttctgtatagtacacatgatatttcggaattggttttactgtt 
1623 cttcagcaactattgtacaaaatgttcacatttaatttttctttcttcttttaagaacat 
1683 attataaaaagaatactttcttggttgggcttttaatcctgtgtgtgattactagtagga 
1743 acatgagatgtgacattctaaatcttgggagaaaaaataatattaggaaaaaaatattta 
1803 tgcaggaagagtagcactcactgaatagttttaaatgactgagtggtatgcttacaattg 
1863 tcatgtctagatttaaattttaagtctgagattttaaatgtttttgagcttagaaaaccc 
1923 agttagatgcaatttggtcattaataccatgacatcttgcttataaatattccattgctc 
1983 tgtagttcaaatctgttagctttgtgaaaattcatcactgtgatgtttgtattctttttt 
2043 tttttctgtttaacagaatatgagctgtctgtcatttacctacttctttcccactaaata 
2103 aaagaattcttcagtta(tccctgtt) 
Figure III.6: Sequence of Nek2 (NM_240097). The Nek2A-T clone that we have used for further 
study was the 3Q clone that starts at the nucleotide 780. This clone has an extra 8 nucleotides (in 
blue) after the polyadenylation signal (underlined) and misses the 24 nucleotides that characterize 
this new alternatively spliced isoform (in red, phosphorylatable domain). The PP1 binding motif 
(KVHF) is indicated in green. 
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Another spliced variant of Nek2 exists derived by the use of alternative 
polyadenylation signals (Hames and Fry, 2002). The two isoforms were called Nek2A and 
Nek2B. Although both isoforms localize to centrosomes, only Nek2A can induce 
centrosome splitting upon overexpression. 
Besides the PP1 binding motif, amino acid sequence analysis of Nek2A identified 
the protein kinase domain (residues 8-271) and the protein kinase Serine/Threonine active 
site (residues 137-149), an interesting putative leucine-zipper domain (306-327) and a 
couple of serines whose phosphorylation may be very important for Nek2 function (Fig. 
III.7). Removal of the phosphorylatable domain (PD) leads to the appearance of a new 
nuclear targeting motif (residues 361-377). 
 
DNA
Nek2A-TmRNA
Nek2AmRNA
1 2 4 5 6 7 83
ATG STOP
1 2 4 5 6 73 8a
ELLNLPSS
ATG STOP
1 2 4 5 6 7 83
445BD
383-386
PD
371-378
Kinase domain
8-271
A
B
Nek2Aprotein
 
Figure III.7: (A) Genomic structure of the Nek2 gene, showing the exon-intron organization (not 
to scale).  The 8 amino acid sequence corresponding to the phosphorylatable domain (PD) that is 
specifically spliced out in the testis (exon 8) is shown.  The two phosphorylated serines are shown 
enlarged. (B) Schematic representation of the encoded domain of the Nek2 protein. Amino acids 
missing in Nek2A-T are indicated by the PD box and the PP1 consensus binding motifs by the BD 
box (not drawn to scale).  The numbers denote the exact amino acid localization of the various 
domains. 
 
 The Nek2 gene maps to human chromosome 1 (Hames and Fry, 2002). By aligning 
the Nek2 cDNA with the corresponding genomic sequence the intron-exon boundaries can 
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be identified (Fig. III.7, III.8 and Table III.5). Nek2 is encoded by 8 exons spread over 
13Kb on chromosome 1. The novel alternative splice identified occurs in exon 8. 
 
ggcacgagtaggggtggcgggtcagtgctgctcgggggcttctccatccaggtccctgga 
gttcctggtccctggagctccgcacttggcgcgcaacctgcgtgaggcagcgcgactctg 
gcgactggcc ggcc 
atgccttcccgggctgaggactatgaagtgttgtacaccattggcacaggctcctacggc 
 M  P  S  R  A  E  D  Y  E  V  L  Y  T  I  G  T  G  S  Y  G  
cgctgccagaagatccggaggaagagtgatggcaagatattagtttggaaagaacttgac 
 R  C  Q  K  I  R  R  K  S  D  G  K  I  L  V  W  K  E  L  D  
tatggctccatgacagaagctgagaaacagatgcttgtttctgaagtgaatttgcttcgt 
 Y  G  S  M  T  E  A  E  K  Q  M  L  V  S  E  V  N  L  L  R  
gaactgaaacatccaaacatcgttcgttactatgatcggattattgaccggaccaataca 
 E  L  K  H  P  N  I  V  R  Y  Y  D  R  I  I  D  R  T  N  T  
acactgtacattgtaatggaatattgtgaaggaggggatctggctagtgtaattacaaag 
 T  L  Y  I  V  M  E  Y  C  E  G  G  D  L  A  S  V  I  T  K  
ggaaccaaggaaaggcaatacttagatgaagagtttgttcttcgagtgatgactcagttg 
 G  T  K  E  R  Q  Y  L  D  E  E  F  V  L  R  V  M  T  Q  L  
actctggccctgaaggaatgccacagacgaagtgatggtggtcataccgtattgcatcgg 
 T  L  A  L  K  E  C  H  R  R  S  D  G  G  H  T  V  L  H  R  
gatcttaaaccagccaatgttttcctggatggcaagcaaaacgtcaagcttggagacttt 
 D  L  K  P  A  N  V  F  L  D  G  K  Q  N  V  K  L  G  D  F  
gggctagctagaatattaaaccatgacacgagttttgcaaaaacatttgttggcacacct 
 G  L  A  R  I  L  N  H  D  T  S  F  A  K  T  F  V  G  T  P  
tattacatgtctcctgaacaaatgaatcgcatgtcctacaatgagaaatcagatatctgg 
 Y  Y  M  S  P  E  Q  M  N  R  M  S  Y  N  E  K  S  D  I  W  
tcattgggctgcttgctgtatgagttatgtgcattaatgcctccatttacagcttttagc 
 S  L  G  C  L  L  Y  E  L  C  A  L  M  P  P  F  T  A  F  S  
cagaaagaactcgctgggaaaatcagagaaggcaaattcaggcgaattccataccgttac 
 Q  K  E  L  A  G  K  I  R  E  G  K  F  R  R  I  P  Y  R  Y  
tctgatgaattgaatgaaattattacgaggatgttaaacttaaaggattaccatcgacct 
 S  D  E  L  N  E  I  I  T  R  M  L  N  L  K  D  Y  H  R  P  
tctgttgaagaaattcttgagaaccctttaatagcagatttggttgcagacgagcaaaga 
 S  V  E  E  I  L  E  N  P  L  I  A  D  L  V  A  D  E  Q  R  
agaaatcttgagagaagagggcgacaattaggagagccagaaaaatcgcaggattccagc 
 R  N  L  E  R  R  G  R  Q  L  G  E  P  E  K  S  Q  D  S  S  
cctgtattgagtgagctgaaactgaaggaaattcagttacaggagcgagagcgagctctc 
 P  V  L  S  E  L  K  L  K  E  I  Q  L  Q  E  R  E  R  A  L  
aaagcaagagaagaaagattggagcagaaagaacaggagctttgtgttcgtgagagacta 
 K  A  R  E  E  R  L  E  Q  K  E  Q  E  L  C  V  R  E  R  L  
gcagaggacaaactggctagagcagaaaatctgttgaagaactacagcttgctaaaggaa 
 A  E  D  K  L  A  R  A  E  N  L  L  K  N  Y  S  L  L  K  E  
cggaagttcctgtctctggcaagtaatccagaacttcttaatcttccatcctcagtaatt 
 R  K  F  L  S  L  A  S  N  P  E  L  L  N  L  P  S  S  V  I  
aagaagaaagttcatttcagtggggaaagtaaagagaacatcatgaggagtgagaattct 
 K  K  K  V  H  F  S  G  E  S  K  E  N  I  M  R  S  E  N  S  
gagagtcagctcacatctaagtccaagtgcaaggacctgaagaaaaggcttcacgctgcc 
 E  S  Q  L  T  S  K  S  K  C  K  D  L  K  K  R  L  H  A  A  
cagctgcgggctcaagccctgtcagatattgagaaaaattaccaactgaaaagcagacag 
 Q  L  R  A  Q  A  L  S  D  I  E  K  N  Y  Q  L  K  S  R  Q  
atcctgggcatgcgctagccaggtagagagacacagagctgtgtacaggatgtaatatta 
 I  L  G  M  R  *    
ccaacctttaaagactgatattcaaatgctgtagtgttgaatacttggccccatgagcca    
tgcctttctgtatagtacacatgatatttcggaattggttttactgttcttcagcaacta  
ttgtacaaaatgttcacatttaatttttctttcttcttttaagaacatattataaaaaga 
atactttcttggttgggcttttaatcctgtgtgtgattactagtaggaacatgagatgtg 
acattctaaatcttgggagaaaaaataatattaggaaaaaaatatttatgcaggaagagt  
agcactcactgaatagttttaaatgactgagtggtatgcttacaattgtcatgtctagat  
ttaaattttaagtctgagattttaaatgtttttgagcttagaaaacccagttagatgcaa   
tttggtcattaataccatgacatcttgcttataaatattccattgctctgtagttcaaat  
ctgttagctttgtgaaaattcatcactgtgatgtttgtattctttttttttttctgttta   
acagaatatgagctgtctgtcatttacctacttctttcccactaaataaaagaattcttc 
agtta 
Figure III.8: The exon-intron boundaries of Nek2 are indicated by the different colours in the 
cDNA sequence. The alternatively spliced sequence missing from Nek2A-T is indicated in grey. 
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Table III.5 describes the exon-intron boundaries of Nek2A-T showing in bold the 
canonical 3’ splice acceptor and the 5’ splice donor.   
 
Table III.5: Exon-intron boundaries of Nek2A-T. The canonical exon-intron boundaries sequences 
are in bold. 
INTRON 
3’ splice acceptor 
 EXON 
No. 
 
5’ splice donor 
INTRON 
YNCURACYNNAG G  AG                             GUAAGU
 
GGCACG 1 GGCAAG GTGAGC 
TTCTTATTTCAG ATATTA 2 GGAAAG GTAAGC 
CTTTGGTTTTAG GCAATA 3 TCTCCT GTAAGT 
TTCCCTGTATAG GAACAA 4 ATTAAT GTAAGT 
TTTTAACCCTAG GCCTCC 5 TTAAAG GTAAAG 
TTTTTTCCCCAG GATTAC 6 TGGAGC GTAAGT 
CTCTTTTTAAAG AGAAAG 7 ATCCAG GTATGA 
TTCCTTCTAAAG TAATTA 8A   
 
 The isolation of two independent Nek2A-T cDNAs from the library used indicated 
that this novel isoform was unlikely to be the result of an artifact. However, in order to 
ascertain the occurrence of the corresponding mRNA in human testis, RT-PCR was 
performed using appropriate oligonucleotide primers. Using mRNA from human testis as 
template and two different sets of primers, OLIGONEK/OLIGONEK2 and 
OLIGONEK/OLIGONEK3 (Appendix II), DNA fragments of 224nt (Nek2A-T) and 238nt 
(Nek2A) were obtained (Fig. III.9). DNA sequence analysis of the Nek2A-T product 
confirmed the alternatively spliced sequence (data not shown). 
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
Nek2A
Nek2A-T
A   S   N    P     _   _    _   _    _   _    _    _  V    I    K   K   K
gca agt aat cca gaa ctt ctt aat ctt cca tcc tca gta att aag aag aaa
gca agt aat cca g-- --- --- --- --- --- --- --- ta att aag aag aaa
A   S   N   P    E    L   L  N   L   P   S   S   V   I    K   K K
Nek2ANek2A-T
224 nt 238 nt
A B
 
Figure III.9: RT-PCR analysis of Nek2 expression in human testis using isoform-specific primers. 
A) Alignment of the amino acid and nucleotide sequences of Nek2A and Nek2A-T. The arrows 
indicate the specific oligonucleotide primers used. B) Agarose gel electrophoretic analysis of RT-
PCR products obtained from human testis using the indicated primers.  
 
 The expression of Nek2 in different tissues was analysed by Northern blot 
hybridization using a Rat Multiple Tissue Northern (MTN) Blot and the cDNA from clone 
3Q as probe (Fig. III.10): 
        
He      Br      Sp     Lu     Li      M       Ki Te
Nek2
-Actin
3.2kb
2.1kb
1.6kb
 
Figure III.10: Northern blot analysis of different rat tissues.He, heart; Br, brain; Sp, spleen; Lu, 
lung; Li, liver; M, skeletal muscle; K, kidney; Te, testis.  
 
 Nek2 expression was only detected in testis, where a single transcript of 3.2kb 
hybridized with the probe used (Fig. III.10, top panel). As a control the same blot was also 
hybridized with β-actin probe (Fig. III.10, lower panel). Densitometry analysis of both 
blots allowed for correction of Nek2 expression in terms of the -actin 2.1kb band (muscle 
was excluded from this analysis due to the absence of the -actin species). The results 
obtained are summarized in Table III.6: 
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Table III.6: Relative abundance of Nek2 mRNA. 
Tissue Heart Brain Spleen Lung Liver Kidney Testis 
Nek mRNA 2 0 2 0 0 0 100 
The value for testis was set at 100 and other tissues are expressed in relative terms. 
 
 In order to confirm the interaction of Nek2A and Nek2A-T with PP11 and PP12, 
blot overlay analysis was performed. For this purpose, the cDNAs of clones 25 and 3Q, 
respectively, were used to express the corresponding N-terminally truncated proteins (work 
performed in our laboratory by Wu Wenjuan). The proteins were separated by SDS-PAGE 
gel, transferred to nitrocellulose and the membrane was incubated with PP12 (also 
purified by Wu Wenjuan). Then, the membrane was immunobloted with Anti-PP12 and 
developed by ECL (Fig. III.11). 
                      
Nek2A
(25)
Nek2A-T
(3Q)
31kDa
24kDa
 
Figure III.11: Overlay assay of Nek2 A and Nek2A-T The size of the proteins detected corresponds 
to the calculated molecular weights of the proteins encoded by the partial cDNAs used (25 and 3Q, 
respectively). 
 
Additionally, sequential transformation of yeast with the bait and the prey was 
performed in order to confirm the YTH interaction (Fig. III.12): 
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Nek2A-T
(3Q)
PP11                           PP12                     PP12end
Nek2A
(25)
 
Figure III.12: Sequential transformation of yeast AH109 a bait plasmid (either pAS2PP11,or  
pAS2PP12 or  pAS2PP12end) and the prey plasmid (pACT2-3Q, or pACT2-25). 
 
 The results indicate that both Nek2A and Nek2A-T interact with PP11 and PP12. 
They also appear to interact with the PP12 C-terminal, although the interaction is weaker 
since the blue colour takes longer to develop. This was expected since the C-terminal PP1 
peptide expressed did include the sequence thought to be responsible for binding to the 
consensus binding motifs in other proteins. 
 
III.3.5 NIPP1-T (Nuclear Inhibitor of Protein Phosphatase 1 in Testis) 
 
NIPP1 (Beullens et al., 1992) is a 38.5kDa nuclear inhibitor of PP1 that is 
ubiquitously expressed in multicellular eukaryotes (Ceulemans et al., 2002). Biochemical 
analysis of NIPP1 indicates that it is composed of several functional domains. The basic 
NH2-terminal domain contains a forkhead associated domain (FHA). The acidic central 
third, expressed in bacteria, is a potent inhibitor of PP1 (Van Eynde et al., 1995). This 
domain contains the consensus PP1 binding motif “RVXF”, an additional inhibitory PP1 
binding site (Beullens et al., 1999) and phosphorylation sites for PKA (Ser199) and CK2 
(Ser204). The basic COOH-terminus is identical to the polypeptide Ard-1 (Activator of 
RNA decay) that was shown to be a rare splice variant of NIPP1 (Van Eynde et al., 1999). 
The inhibitory potency of NIPP1 is regulated by multisite phosphorylation and by the 
binding of RNA (Vulsteke et al., 1997; Beullens et al., 2000). NIPP1 is targeted through its 
FHA to the speckles, or splicing-factor compartments, that are storage sites for splicing 
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factors (Trinkle-Mulcahy et al., 1999; Jagiello et al., 2000). This FHA domain interacts 
with the phosphorylated forms of the essential splicing factors CDC5L (Boudrez et al., 
2000) and SAP155 (unpublished observation of Bollen M. and coworkers). Since these 
splicing factors are in vitro substrates for PP1, it has been speculated that NIPP1 might 
target them for dephosphorylation by PP1. This function of PP1 may be very important, 
since toxins that inhibit Ser/Thr-protein phosphatases often inhibit pre-mRNA splicing 
(Mermoud et al., 1992). NIPP1, besides being targeted to the speckles, is a component of 
the spliceosomes and has an essential role in a late step of spliceosome assembly (Beullens 
and Bollen, 2002). Surprisingly, this NIPP1 function seems to be unrelated to its ability to 
bind PP1. So, NIPP1 can be thought of as a bifunctional protein, having a PP1-independent 
function in spliceosome assembly and, after splicing, involved in the regeneration of 
splicing factors by recruiting PP1 to dephosphorylate them. Recently, it was shown that 
PP1 is required for Tat-induced HIV-1 transcription and for viral replication in cultured 
cells (Ammosova et al., 2003). By inhibiting PP1 through overexpression of NIPP1, Tat-
induced HIV-1 transcription was inhibited. By contrast, a mutant of NIPP1 that could not 
bind PP1 did not have this effect. These important results indicate that nuclear PP1 may 
represent a novel target for anti-HIV-1 therapeutics.  
The structure of a human NIPP1 pseudogene and the authentic NIPP1 gene was 
reported by Van Eynde et al. (Van Eynde et al., 1999), who also reported the existence of 
various NIPP1 mRNAs, including the Ard-1 transcript, that are generated by alternative 5’-
splice site selection, exon skipping and/or alternative polyadenylation. By completely 
sequencing the NIPP1 clone 273, with the primers GAL4-AD, OLIGONIPP, 
OLIGONIPP2 and Amplimer 3’ (Appendix 4), we verified that we had isolated a 
previously unknown alternatively spliced isoform of NIPP1. A single clone isolated from 
the YTH2 screen, it started at nucleotide 854 (NM_138558), was 710bp long and differs 
from all the other known NIPP1 isoforms (Fig. III.13): 
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1    cttccagtttcccggcgtgcttagggcgcgccaaatgggagggggagacgcaagatggcg 
61   gcagccgcgaactccggctctagcctcccgctgttcgactgcccaacctggtgagtggcg 
121  gggcggccagggctagagtggcccggccggagctagcctgggctggaagggcggctcttt 
181  ttttacttttctgctgcgagccgaacggctcagaaaccccggaatggttgaggaaaaact 
241  gtttgctgcaccgggccgggcgacgtgttgaagaaccgagagcctggagcccaggcccag 
301  gaactgaagaaacccggggttgggggctcaaaggcgctcacttaggcagcccctttgagc 
361  gattagccagtcgccggagcgcttcgaggccttggcccgaacttacgcccaactcttgac 
421  tgagtgcctggtgctctcgtggagcatcgcatctggccccttcctggcaggtaagccccc 
481  tcccggtttacatctggatgtagtcaaaggagacaaactaattgagaaactgattattga 
541  tgagaagaagtattacttatttgggagaaaccctgatttgtgtgactttaccattgacca 
601  ccagtcttgctctcgggtccatgctgcacttgtctaccacaagcatctgaagagagtttt 
661  cctgatagatctcaacagtacacacggcactttcttgggtcacattcggttggaacctca 
721  caagcctcagcaaattcccatcgattccacggtctcatttggcgcatccacaagggcata 
781  cactctgcgcgagaagcctcagacattgccatcggctgtgaaaggagatgagaagatggg 
1                                                            M  G  
841  tggagaggatgatgaactcaagggcttactggggcttccagaggaggaaactgagcttga 
3      G  E  D  D  E  L  K  G  L  L  G  L  P  E  E  E  T  E  L  D  
901  taacctgacagagttcaacactgcccacaacaagcggatttctacccttaccattgagga 
23     N  L  T  E  F  N  T  A  H  N  K  R  I  S  T  L  T  I  E  E  
961  gggaaatctggacattcaaagaccaaagaggaagaggaagaactcacgggtgacattcag 
43     G  N  L  D  I  Q  R  P  K  R  K  R  K  N  S  R  V  T  F  S  
1021 tgaggatgatgagatcatcaacccagaggatgtggatccctcagttggtcgattcaggaa 
63     E  D  D  E  I  I  N  P  E  D  V  D  P  S  V  G  R  F  R  N  
1081 catggtgcaaactgcagtggtcccagtcaagaagaagcgtgtggagggccctggctccct 
83     M  V  Q  T  A  V  V  P  V  K  K  K  R  V  E  G  P  G  S  L  
1141 gggcctggaggaatcagggagcaggcgcatgcagaactttgccttcagcggaggactcta 
103    G  L  E  E  S  G  S  R  R  M  Q  N  F  A  F  S  G  G  L  Y  
1201 cgggggcctgccccccacacacagtgaagcaggctcccagccacatggcatccatgggac 
123    G  G  L  P  P  T  H  S  E  A  G  S  Q  P  H  G  I  H  G  T  
1261 agcactcatcggtggcttgcccatgccatacccaaaccttgcccctgatgtggacttgac 
143    A  L  I  G  G  L  P  M  P  Y  P  N  L  A  P  D  V  D  L  T  
1321 tcctgttgtgccgtcagcagtgaacatgaaccctgcaccaaaccctgcagtctataaccc 
163    P  V  V  P  S  A  V  N  M  N  P  A  P  N  P  A  V  Y  N  P  
1381 tgaagctgtaaatgaacccaagaagaagaaatatgcaaaagaggcttggccaggcaagaa 
183    E  A  V  N  E  P  K  K  K  K  Y  A  K  E  A  W  P  G  K  K  
1441 gcccacaccttccttgctgatttgatatttttggtcatggagaagggtgggattgggtgg 
203    P  T  P  S  L  L  I  *   
1501 gaatggggtggaagggtgatggggagctaatgaactagggagaaaaactttccatgtgtg 
1561 cggtatcgtctttcagaatgtctcctggcatcctaaccatgtaatatgacaattgggggt 
1621 ggggttgaaatagcccataaagacctgtcttcacaacacttgcattgtagagaaaggctt 
1681 cttatatccttttcaatagactgccctggctctttcctaggccttccactacctcctttc 
1741 tttctcccactttctaggatcatttttatgtaaagtcacatatcccaggccctcaggttg 
1801 aatccagagctgtagaggttacagtagcatcaccagccttgggggtccagagcctaattt 
1861 atattcactatccttccaagtcccgggtagcagaagggttgccatagatctcagtttgat 
1921 caaaaagaaggcttagaattctgcagttaagctgaggtttaaactaaaaaatgtttcctt 
1981 gggtcagtggttttgaggtccagtagctaggcttttctcttttgtccttcctgttggaat 
2041 gaaaacatttcgattttccttcatctgtgactggtgccatagacacaggtttatagtttt 
2101 aacttacagtattgtttgaaatttacctgtttttcttgtcaaacctgagcactcctcctg 
2161 ctgaagtttcttatttaattccagagtactgtcctctactctaaggcattacttttaagt 
2221 gtattatgaaggcagttttcaaaggatatgaccagttggggtaattcaaattaaaaagga 
2281 aaagatttgtttggaagtaactggtgtctctaagaggaatttttagatgtcagtttggag 
2341 gctctttcccccctcaattgagagctcttgttattcagagctccaagactagacctggct 
2401 aacaaacataggagacaaagttaggaaacattgatacaagctttgtacagagatttgtac 
2461 atttgtgtaataggccttttcatgctttatgtgtagctttttacctgtaacctttattac 
2521 attgtaaattaaacgtaacttttgtcatttgggtgcaggctgtgaatttgtctctcagtc 
                                           G  C  E  F  V  S  Q  S 
2581 actgattgccactgccatctggaaatgtttgctaaaggcacagtcactgggcttgggagg 
       L  I  A  T  A  I  W  K  C  L  L  K  A  Q  S  L  G  L  G  G 
2641 caatgctccatccccattatattacaaataaag-atgccctaaatgagtgtg 
       N  A  P  S  P  L  Y  T  K  *   t  
Figure III.13: Nucleotide and corresponding amino acid sequence of NIPP1 (NM_138558). 
Highlighted regions correspond to the sequence of clone 273 (the PP1 binding motif is underlined). 
The dark blue area indicates the C-terminal domain specific for NIPP1-T isoform that is not 
translated in the previously known variants. 
 
This new isoform was named NIPP1-T and uses the same polyadenylation site as 
NIPP1. NIPP1 (NM_138558) is the longer NIPP1 isoform and is encoded over 7 exons. 
Our clone starts at exon 4, and contains exons 5, 6 and 7. Nevertheless, exon 7 in our clone 
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is different from that previously described for NIPP1. Interestingly, in NIPP1-T the 
polyadenylation signal overlays the stop codon. At the protein level, NIPP1-T differs from 
NIPP1 in that it has a longer C-terminal extension (Fig. III.14). It is interesting to note 
that whereas NIPP1 possesses the sequence –KKPTP- in the spliced domain (a proline 
directed kinase consensus acceptor site), a related sequence also occurs in NIPP1-T (-
NAPSP-).  Both motifs are located exactly 4 amino acids from the C-terminus of the two 
proteins.  
STOP
NIPP1-TmRNA
DNA
NIPP1mRNA
GCEFVSQSLIATAIWKCLLKAQSLGLGGNAPSPLYTK
ATG
1 2 3 4 6 7a
1 2 3 54 7
ATG STOP
1 2 3 4 6 7
GKKPTPSLLI
5
6
5
 
Figure III.14: Genomic structure of the NIPP-1 gene (not to scale).  The alternative splicing of 
exon 7 shown produces the different C-terminal amino acid sequences shown.  ATG, location of the 
initiator methionine codon; PP1-BD, PP1 consensus binding domain; STOP, location of the stop 
codon. 
 
Table III.7 summarizes the intron-exon organization of clone 273 encoding NIPP1-T. 
 
 
 
 
 
 
 
 
 
Table III.7: Exon-intron organization of clone 273 (NIPP1-T). 
Exon 
No.  
Nt No.* 
NIPP1-T 
Exon 
size  
(bp) 
Intron 
No. 
Intron Nt No.* Intron 
size  
(Kb) 
Nt No.* 
NIPP1 
4 2777243385-27772433 
(854-901) 
48 4 27772434-27774384 1951 27772213-27772433 
(681-901) 
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5 27774385-27774529 
(902-1046) 
145 5 27774530-27778226 3697 27774385-27774529 
(902-1046) 
6 27778227-27778291 
(1047-1111) 
65 6 27778292-27781291 3000 27778227-27778291 
(1047-1111) 
7 27781292-27781727 
(1112-1548) 
436    27781292-27782871 
(1112-2691) 
Clone 273 starts at exon 4 from NIPP1. Exon 5 and 6 are the same as in NIPP1 but exon 7 is 
different. *, corresponding to sequence from chromosome 1 (NC_000001). In column 2 and 7 
sequences in brakets correspond to sequence NM_138558. 
 
RT-PCR was performed using mRNA from human testis and the primers 
OLIGONIPP and OLIGONIPP2 (Appendix II). These primers are specific for NIPP1-T, 
amplifying a PCR product of 208nt (Fig. III.15). The correct sequence of the PCR product 
was determined by automatic sequence analysis, thus confirming the position of this 
alternative splice (data not shown). 
 
 
Figure III.15: RT-PCR analysis of mRNA from human 
testis using the primers OLIGONIPP/OLIGONIPP2 (lane 
1). A single band of the expected size (208bp) was 
obtained M, molecular weight markers.  
 
 
Interestingly, searching of the EST database identified a single EST (from kidney) 
corresponding to this novel splice variant (gi|3890874|gb|AI271707.1|AI271707). The 
expression of NIPP1 mRNA in different rat tissues was also verified by Northern analysis 
of a Multiple Tissue Northern (MTN) Blot, using the cDNA from clone 273 as probe (Fig. 
III.16).The results from densitometric analysis of the resulting autoradiogram, corrected 
for the actin control, are shown in Table III.8. Muscle was excluded from this analysis 
since it does not express the 2.1kb -actin message. 
 
NIPP-T 
500 
396 
344 
298 
220 
201 
1                M        nt 
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He    Br     Sp     Lu     Li      M     Ki Te
NIPP1-T2.0 kb
-Actin
2.1 kb
1.6 kb
 
Figure III.16: Northern analysis of different rat tissues using the cDNA of clone 273 as probe.The 
same blot was re-probed with -actin as a control (lower panel). He, heart; Br, brain; Sp, spleen; 
Lu, lung; Li, liver; M, skeletal muscle; Ki, kidney; Te, testis. 
 
Table III.8: Densitometric analysis of NIPP1 mRNA considering testis mRNA 100%. 
Tissue Heart Brain Spleen Lung Liver Kidney Testis 
%NIPP1 mRNA 125 93 22 18 86 50 100 
 
 Another Northern blot was also prepared with human testis RNA and several rat 
tissues mRNAs. The results demonstrated the existence of two mRNA bands in the human 
testis lane (Fig. III.17) that might correspond to NIPP1 and the novel NIPP1-T.    
HT     RT     C      Li       M       Ki Lu     Ce
2.4Kb
1.5Kb
NIPP1
NIPP1-T
 
Figure III.17: Northern analysis of human testis and several rat tissues using the cDNA of clone 
273 as probe.HT, human testis; RT, rat testis; C, cortex; Li, liver; M,skeletal muscle; Ki, kidney; 
Lu, lung; Ce, cerebellum. 
  
 These results, together with the RT-PCR analysis (Fig. III.15) and the existence of a 
human EST corresponding to this splice strongly support the existence of a novel NIPP1 
splice variant, that we have named NIPP1-T. 
Additionally, sequential transformation of yeast was performed with the bait 
(PP11 or PP12 or PP12end) and the prey (NIPP1-T) in order to confirm the YTH 
interaction (Fig. III.18). 
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BAIT              PP11                 PP12              PP12end
PREY - NIPP1-T
 
Figure III.18: Sequential transformation of the yeast AH109 first with the bait plasmid 
(pAS2PP11 or pAS2PP12 or pAS2PP12end) and then the prey plasmid (pACT2-273), followed 
by plating in selective medium containing X--Gal. 
 
The results obtained indicate that NIPP1-T interacts more strongly with PP12 than 
with its C-terminal domain or with PP11, since the blue colour due to X--Gal cleavage 
takes longer to develop with the latter two. 
 
III.3.6 PPPR15B (Phosphoprotein Phosphatase Regulatory Subunit 15B) 
 
Data from multiple eukaryotic genomes was used to trace the evolution of well 
established vertebrate PP1 regulators (Ceulemans et al., 2002). That study also identified 
nine poorly characterized proteins as putative PP1 regulators. Among them was a protein 
named PPP1R15B (NM_032833; FLJ14744). This gene is predicted to encode a 
homologue of GADD34 (growth arrest and DNA damage-inducible protein) also known as 
PPP1R15A. GADD34 is a member of a group of genes whose mRNA levels are increased 
following stressful growth arrest conditions and treatment with DNA-damaging agents. 
GADD34 was identified in a yeast two hybrid screen of a human brain cDNA library by its 
interaction with I-1 (inhibitor-1). It was also shown that PP1 bound GADD34 near the C-
terminus, while I-1 bound the central domain of GADD34. Modifications of the I-
1/GADD34/PP1 signaling complex regulate initiation of protein translation in mammalian 
tissues  in response to cell stress, by dephosphorylation of the eukaryotic initiation factor 
eIF-2 (Connor et al., 2001).  Recently, a yeast two hybrid screen using GADD34 as bait 
identified the human cochaperone protein BAG-1 (Hung et al., 2003). Also, Hsp70 and 
PP1 were shown to associate reversibly with the GADD34/BAG-1 complex. It was 
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suggested that BAG-1 might function to suppress the GADD34-mediated cellular stress 
response and have a role in the survival of cells undergoing stress. 
 
In our YTH screens we identified several independent PPP1R15B clones (Table 
III.9):  
 
Table III.9: Independent PPP1R15B clones identified in YTH1 and YTH2. 
Initial Sequence first nt YTH1 YTH2 
CTTGGCTCTTCGC 1004 
 
48QA 
 
229,245,260,266,275,276,2110,2138,2142C, 
2147A, 2192,2226,2271,2272,2308 
GCTTGTAGTAACA 1664  214 
GATGACTGGGAAT 2027 39Q 2227 
 
We chose clone 275 for further studies, starting at nt 1004 and finishing after nt 
2942  relatively to the database sequence NM_032833 (Fig. III.19). We have not get 
sequenced the remaining sequence but we have verified the existence of the poly-A tail. 
The total size of the 275 cDNA insert is approximately 2.8kb. 
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1    attttgggcttcgcttccaccgcaccagccggcctacccagtccttccggtatcgcgttgc 
62    tcaggggcttttcaaccctctgtcagtcggaaaaccatcgccgaggccgtggggggactc 
122   ctatccatggtgttgaagcgtcgagccgactagggaacctccttccccgccaggatggaa 
182   gtcgcatcagtcgccgcctattgcgcgggctgttcttccctgtgttctgccgcccgctgc 
242   cgcattcgctgccctctgtggcttttctgctggctcgaagatcggcctggagcagcgacg 
302   ccaccgctgggcaaggccgagactctgtaggcttcctccgaatcccgtcgacctccagcc 
362   gctgagcgccgcggccctacctgagagactgtcaagaaaaaggagatggagccggggaca 
1                                                    M  E  P  G  T  
422   ggcggatcgcggaaacggcttggccctcgggcgggcttccggttctggccaccctttttc 
6      G  G  S  R  K  R  L  G  P  R  A  G  F  R  F  W  P  P  F  F  
482   cctcggcgatcgcaagcaggctcttctaagttcccgacgcctcttggcccggaaaactcc 
26     P  R  R  S  Q  A  G  S  S  K  F  P  T  P  L  G  P  E  N  S  
542   gggaaccccacactgctttcctctgcccagcccgagactcgggtcagttactggacgaaa 
46     G  N  P  T  L  L  S  S  A  Q  P  E  T  R  V  S  Y  W  T  K  
602   ctgctctcccagctccttgcgccgctccccggattgcttcagaaggtgctaatttggagc 
66     L  L  S  Q  L  L  A  P  L  P  G  L  L  Q  K  V  L  I  W  S  
662   caacttttcggtggaatgtttccgaccagatggctagattttgctggagtctacagcgcc 
86     Q  L  F  G  G  M  F  P  T  R  W  L  D  F  A  G  V  Y  S  A  
722   ctgagagccctgaagggacgggagaaaccagccgcccccacagcgcagaaatctttgagt 
106    L  R  A  L  K  G  R  E  K  P  A  A  P  T  A  Q  K  S  L  S  
782   tcgctgcagctcgactcctcagacccctcggtcaccagtccccttgattggctagaggaa 
126    S  L  Q  L  D  S  S  D  P  S  V  T  S  P  L  D  W  L  E  E  
842   gggatccactggcaatactcgcccccagacctaaaattggagcttaaggccaagggaagt 
146    G  I  H  W  Q  Y  S  P  P  D  L  K  L  E  L  K  A  K  G  S  
902   gctttggaccctgcagcacaggcttttctcttagagcagcagctgtggggagtggagctg 
166    A  L  D  P  A  A  Q  A  F  L  L  E  Q  Q  L  W  G  V  E  L  
962   ttgcccagtagccttcaatcccgtctgtactctaaccgggaacttggctcttcgccctct 
186    L  P  S  S  L  Q  S  R  L  Y  S  N  R  E  L  G  S  S  P  S  
1022  gggcctctaaacattcaacgcatagacgatttcagtgtggtatcctatttgctgaaccct 
206    G  P  L  N  I  Q  R  I  D  D  F  S  V  V  S  Y  L  L  N  P  
1082  tcctacctggactgctttcccaggctagaagtcagctatcagaacagtgatggaaatagc 
226    S  Y  L  D  C  F  P  R  L  E  V  S  Y  Q  N  S  D  G  N  S  
1142  gaggtagtcggcttccagacactaaccccagagagcagctgcctgagagaggaccattgt 
246    E  V  V  G  F  Q  T  L  T  P  E  S  S  C  L  R  E  D  H  C  
1202  catccccagccgctgagtgcagaactcattccggcctcgtggcagggatgtccacctctt 
266    H  P  Q  P  L  S  A  E  L  I  P  A  S  W  Q  G  C  P  P  L  
1262  tctacggaaggcctaccagaaattcaccatcttcgcatgaaacggctggaattccttcaa 
286    S  T  E  G  L  P  E  I  H  H  L  R  M  K  R  L  E  F  L  Q  
1322  caggctagcaaggggcaagatttacccacccctgaccaggataatggctaccacagcctg 
306    Q  A  S  K  G  Q  D  L  P  T  P  D  Q  D  N  G  Y  H  S  L  
1382  gaggaggaacacagccttctccggatggatccaaaacactgcagagataacccaacacag 
326    E  E  E  H  S  L  L  R  M  D  P  K  H  C  R  D  N  P  T  Q  
1442  tttgttcctgctgctggagacattcctggaaacacccaggaatccactgaagaaaaaata 
346    F  V  P  A  A  G  D  I  P  G  N  T  Q  E  S  T  E  E  K  I  
1502  gaattattaactacagaggttccacttgctttggaagaagagagcccttctgagggctgt 
366    E  L  L  T  T  E  V  P  L  A  L  E  E  E  S  P  S  E  G  C  
1562  ccatctagtgagatacctatggaaaaggagcctggagagggccgaataagtgtagttgat 
386    P  S  S  E  I  P  M  E  K  E  P  G  E  G  R  I  S  V  V  D  
1622  tactcatacctagaaggtgaccttcccatttctgccagaccagcttgtagtaacaaactg 
406    Y  S  Y  L  E  G  D  L  P  I  S  A  R  P  A  C  S  N  K  L  
1682  atagattatattttgggaggtgcatccagtgacctggaaacaagttctgatccagaaggt 
426    I  D  Y  I  L  G  G  A  S  S  D  L  E  T  S  S  D  P  E  G  
1742  gaggattgggatgaggaagctgaggatgatggttttgatagtgatagctcactgtcagac 
446    E  D  W  D  E  E  A  E  D  D  G  F  D  S  D  S  S  L  S  D  
1802  tcagaccttgaacaagaccctgaagggcttcacctttggaactctttctgcagtgtagat 
466    S  D  L  E  Q  D  P  E  G  L  H  L  W  N  S  F  C  S  V  D  
1862  ccttataatccccagaactttacagcaacaattcagactgctgccagaattgttcctgaa 
486    P  Y  N  P  Q  N  F  T  A  T  I  Q  T  A  A  R  I  V  P  E  
1922  gagccttctgattcagagaaggatttgtctggcaagtctgatctagagaattcctcccag 
506    E  P  S  D  S  E  K  D  L  S  G  K  S  D  L  E  N  S  S  Q  
1982  tctggaagccttcctgagacccctgagcatagttctggggaggaagatgactgggaatct 
526    S  G  S  L  P  E  T  P  E  H  S  S  G  E  E  D  D  W  E  S  
2042  agtgcagatgaagcagagagtctcaaactgtggaactcattctgtaattctgatgacccc 
546    S  A  D  E  A  E  S  L  K  L  W  N  S  F  C  N  S  D  D  P  
2102  tacaaccctttaaattttaaggctccttttcaaacatcaggggaaaatgagaaaggctgt 
566    Y  N  P  L  N  F  K  A  P  F  Q  T  S  G  E  N  E  K  G  C  
2162  cgtgactcaaagaccccatctgagtccattgtggccatttctgagtgtcacaccttactt 
586    R  D  S  K  T  P  S  E  S  I  V  A  I  S  E  C  H  T  L  L  
2222  tcttgtaaggtgcagctgttggggagccaagaaagtgaatgtccagactcggtacagcgt 
606    S  C  K  V  Q  L  L  G  S  Q  E  S  E  C  P  D  S  V  Q  R  
2282  gacgttctttctggaggaagacacacacatgtcaaaagaaaaaaggtaaccttccttgaa 
626    D  V  L  S  G  G  R  H  T  H  V  K  R  K  K  V  T  F  L  E  
2342  gaagttactgagtattatataagtggtgatgaggatcgcaaaggaccatgggaagaattt 
646    E  V  T  E  Y  Y  I  S  G  D  E  D  R  K  G  P  W  E  E  F  
2402  gcaagggatggatgcaggttccagaaacgaattcaagaaacagaagatgctattggatat 
666    A  R  D  G  C  R  F  Q  K  R  I  Q  E  T  E  D  A  I  G  Y  
2462  tgcttgacatttgaacacagagaaagaatgtttaatagactccagggaacatgcttcaaa 
686    C  L  T  F  E  H  R  E  R  M  F  N  R  L  Q  G  T  C  F  K  
2522  ggacttaatgttctcaagcaatgttgagttggcagcctgtagtcctagctagcatacact 
706    G  L  N  V  L  K  Q  C  *   
2582  acctcttacctgagaggtgtcttttaaaaacaaatcttggcagctgtcctttgacatttt 
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2642  tttttttagaggaaatgtaacttggatctagtttaatttttttttttgcaacatatccca 
2702  ctcagaaacattcaggtttgaagccagccctgataatgaaggatgaactagtgtgatttc 
2762  taatcctcccttttttgatttagttggatgtgcttttaaatgtcctttgcctgcatgagg 
2822  tggaaaggggacctttttgagttgtcattttgcactttcaaaacttattttcttggaaaa 
2882  caatacttatagggcttaaagcccattttcatttctaatctaaattatgtgtgcctatct 
2942  g 
Figure III.19: Sequence of PPP1R15B (NM_032833). Clone 275 starts at nt 1004. The PP1 
binding motif is indicated in green. The pink area corresponds to the small C-terminal module that 
characterizes the GADD34 family. 
 
 Aligning of the PPP1R15B sequence with human genome contig, lead us to map it 
to two exons on chromosome 1 (Fig. III.20). Interestingly, the exon boundaries occur 
within the PP1 binding motif.    
 
               
Figure III.20: Genomic structure of PPP1R15B.  
 
By searching Pfam (Bateman et al., 2002) with the PPP1R15B sequence, some 
special features could be identified. Notably, the existence of a Pfam-B domain 
(Pfam_9893) that characterizes the GADD34 family of proteins (Table III.10 and Fig. 
III.21), and is present in the C-terminus of all members. This family includes members 
from very different organisms like human, mouse, virus and fly. 
1 2326 
2327 2942 
mRNA 
Chr 1     200741516                                                  200739247      200736076      200735457 
aa  637  K  R  K  K  V  T  F  L   644    
Characterization of the PP1 Interactome from Human Testis Chapter III  
 
Centro de Biologia Celular 
Universidade de Aveiro 127 
   
Table III.10: Members of the PPP1R15B family. 
Identification Diagram of the protein domains residues 
MY16_MOUSE   
[Mus musculus (mouse)]  
myeloid differentiation primary  
response protein myd116 
 
657  
Q60465      
[Cricetulus longicaudatus (long 
tailed hamster) (chinese 
hamster)] GADD34 protein 
 
590 
O75807      - GADD34 
[Homo sapiens (human)]  
apoptosis associated protein 
(growth arrest and DNA-damage 
-inducible34) 
 
   
674 
Q9EML3      
[Amsacta moorei entomo 
poxvirus (amepv)] amv193 
  
150 
Q9W1E4       
[Drosophila melanogaster (fruit 
fly)] cg3825 protein (gh11727p) 
 
 
Q91CH8       
[Macropodid herpesvirus 1]  
icp34.5 
 
170 
Q96SN1     - PPP1R15B  
[Homo sapiens (human)]  
hypothetical protein flj14744 
 
713 
Transmembrane:  ; low complexity: ; pfamB:   (different colours indicate different Pfam-B 
families ) ; GADD34 family domain:  .  Pfam B domains are regions of proteins that belong to a 
Pfam-B family; Pfam-B is an automatically generated supplement to Pfam that is generated from 
the PRODOM database. Matches to Pfam-B are likely to indicate true relationships.    
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PPP1R15B
GADD34
 
A 
 
 
 
 
 
 
 
 
 
Figure III.21: A, Diagram of the alignment of the aa sequences of GADD34 and PPP1R15B using 
BLAST algorithm (Altschul et al., 1997). B, Alignment of the boxed aa sequences.* indicates 
identities  and + indicates homologies. 
  
Searching PROSITE (Sigrist et al., 2002) several putative motifs were identified in 
PPP1R15B, including glycosylation sites, sulfation  sites, cAMP and cGMP-dependent 
protein kinase phosphorylations site, PKC phosphorylation sites and CK2 phosphorylation 
sites. 
Sequential transformation of yeast with bait and prey plasmids confirmed the YTH 
interaction (Fig. III.22). 
PREY –R15B
BAIT        PP11             PP12           PP12end
  
Figure III.22: Sequential transformation of yeast AH109 first with, the bait plasmid (pAS2PP11 
or pAS2PP12 or pAS2PP12end) and then the prey plasmid (pACT2-275). 
 
 
PPP1R15B    634 THVKRKKVTFLEEVTEYYIS-----GDEDRKGPWEEFARDGCRFQKRIQETEDAIGYCLT 
                  +  +      +   ++++          +    +         +   + ++ +  
GADD34      549 TPLKARKVRFSEKVTVHFLAVWAGPAQAARQGPWEQLARDRSRFARRIAQAQEELSPCLT 
                *  *  ** * * **              * ****  ***  **  **         *** 
 
PPP1R15B    689 FEHRERMFNRLQGTCFKGLNVLKQ 
                       +   +      + 
GADD34      609 PAARARAWARLRNPPLAPIPALTQ 
                   * *   **          * * 
Score = 53.1 bits (126), Expect = 3e-05 
Identities = 29/84 (34%), Positives = 46/84 (54%), Gaps = 5/84 (5%) 
 
B 
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The results indicated that R15B interacts both with PP11 and PP12. Although it 
also interacts with the PP12 C-terminal domain, the interaction is likely weaker since the 
blue colour takes longer to develop. 
 
III.3.7 KIAA1949  
 
In this section a previously unpublished clone will be described. This cDNA termed 
KIAA1949 (XM_166376) in the database, seemed to be very interesting because it 
encodes for a protein sequence with some special features (Fig. III.23).  
 
1      agacaaagcggtcgccgcccccgcccggccccctggtctctgtctccgtccctcctcctttg 
63       ctgcctctttccctcctcctctccctccctcctcccctccctccagtctccggatctccc 
123      tcggtccctctctcctcctcttcctctctctggacgcccggctcctccgcaccccctccc 
183      ccgggggtcccgcggcctgtgagttgactgaggggctcagacttggggagtgggtgtctc 
243      ctcgcccctgtccttgctcccgtccctggcccggaccttggctgtctcctctttgtgccg 
303      agattgtcagtctgtgcggctacagcggggtggagacggccggctctgtcacggcttcat 
363      gagagcggggacggggcgcaggacttgcaggcgccggggagaagagacatggagccggcc 
423      cttggcactctggggtcgcgtggggcagtcggtgggggaggcaggcggtggtgacaggac 
483      agggtgggggtggacgccagggttctgggaacgcgctggcagccctgacgcccgggttcc 
543      gaaagtctcgggggtgggtatttcccccgacccgcctcgggggcggagtgcggggcagag 
603      gggtgggggctggggagaggcgtggcccgagcggtgctggaagcggagccgggacctttg 
663      gggcccgcgctgagacgcgcccggctgctgccgccgccctcctttcccctcttccctggt 
723      ttcccttctcctctagacctgttcgctctccgcccctccttgcctccccaacaccccctc 
783      aggtcccgttgcctcctggtcctttcagggattcctggtccttccttcccacactagcct 
843      ccctggggtatcgctgaggcagcctggcctgcacccaggttcccctcacccctgccacat 
903      ttctctcttctccctcacgccaactttccttttcgcccttctctctctttctcacatcct 
963      agagacggtctttaatacgcattaaccctgtgctgccacatctggctcctgccctcattg 
1023     cctccaatccggactcttcctctcacatcacccccaccacccccaacttgggctcacaac 
1083     ttctcttcactttttccatttccccagttctctgccttccgtctttccctctgtcctcat 
1143     ccttagcccctctgccctgctttgtgtcccacctctccccctccacttcctctcctccca 
1203     ccctcagtctcacccccgggctgtctcactctctggagcctctccttcctgttctctgtc 
1263     cccagtgctccctaccctcacctcaagacgaccatggccaccatcccagactggaagcta 
1                                          M  A  T  I  P  D  W  K  L  
1323     cagctgctagcccggcgccggcaggaggaggcgtccgttcgaggccgagagaaagcagaa 
10        Q  L  L  A  R  R  R  Q  E  E  A  S  V  R  G  R  E  K  A  E  
1383     cgggagcgcctgtcccagatgccagcctggaaacgagggctcctggagcgccgccgggcc 
30        R  E  R  L  S  Q  M  P  A  W  K  R  G  L  L  E  R  R  R  A  
1443     aagcttgggctgtcccctggggagcctagccctgtgctagggactgtagaggctggacct 
50        K  L  G  L  S  P  G  E  P  S  P  V  L  G  T  V  E  A  G  P  
1503     ccagacccggatgagtctgcggtccttctggaggccatcgggccagtgcaccagaaccga 
70        P  D  P  D  E  S  A  V  L  L  E  A  I  G  P  V  H  Q  N  R  
1563     ttcatccggcaggagcggcagcagcagcagcagcaacaacaacggagtgaagagctgcta 
90        F  I  R  Q  E  R  Q  Q  Q  Q  Q  Q  Q  Q  R  S  E  E  L  L  
1623     gcagagagaaagcctgggcctctggaggcccgggagcggagacccagccctggggagatg 
110       A  E  R  K  P  G  P  L  E  A  R  E  R  R  P  S  P  G  E  M  
1683     cgggatcagagccccaagggaagagagtcaagagaagagagactaagtccgagggagacc 
130       R  D  Q  S  P  K  G  R  E  S  R  E  E  R  L  S  P  R  E  T  
1743     agagagaggaggctggggatagggggagcccaagagttgagcctgaggcctctggaggct 
150       R  E  R  R  L  G  I  G  G  A  Q  E  L  S  L  R  P  L  E  A  
1803     cgggactggaggcaaagcccaggagaggtgggagacaggagctcccgactgtcagaggca 
170       R  D  W  R  Q  S  P  G  E  V  G  D  R  S  S  R  L  S  E  A  
1863     tggaaatggaggctgagtcctggagaaactccagagcggagtctgagactagcagagtct 
190       W  K  W  R  L  S  P  G  E  T  P  E  R  S  L  R  L  A  E  S  
1923     cgagagcaaagccccaggagaaaagaggtggaaagtagactgagcccaggggaatctgcc 
210       R  E  Q  S  P  R  R  K  E  V  E  S  R  L  S  P  G  E  S  A  
1983     taccagaagttgggcctgacagaggcccataaatggagacctgactccagagagtctcag 
230       Y  Q  K  L  G  L  T  E  A  H  K  W  R  P  D  S  R  E  S  Q  
2043     gaacagagtttggtacaactggaggcaacagagtggaggctgaggtcaggagaagaaaga 
250       E  Q  S  L  V  Q  L  E  A  T  E  W  R  L  R  S  G  E  E  R  
2103     caagactactcggaagaatgtgggagaaaagaagagtggccagttccaggggtagctcca 
270       Q  D  Y  S  E  E  C  G  R  K  E  E  W  P  V  P  G  V  A  P  
2163     aaagagactgcagagctgtccgagaccctgacaagggaggcccaaggcaacagttccgca 
290       K  E  T  A  E  L  S  E  T  L  T  R  E  A  Q  G  N  S  S  A  
2223     ggagtggaggcagcagagcagaggcctgtggaagatggcgagaggggcatgaagccaaca 
310       G  V  E  A  A  E  Q  R  P  V  E  D  G  E  R  G  M  K  P  T  
2283     gaagggtggaaatggaccctgaactccgggaaggctcgagaatggacacccagggacata 
330       E  G  W  K  W  T  L  N  S  G  K  A  R  E  W  T  P  R  D  I  
2343     gaggctcaaactcagaaactagaacctccagagtcagcagagaagcttctggaatctccc 
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350       E  A  Q  T  Q  K  L  E  P  P  E  S  A  E  K  L  L  E  S  P  
2403     ggtgtggaggctggagaaggggaggctgagaaggaggaggcgggggctcagggcaggcct 
370       G  V  E  A  G  E  G  E  A  E  K  E  E  A  G  A  Q  G  R  P  
2463     ctgagagccctgcagaactgctgctctgtgccctcccccctcccaccagaggacgctggg 
390       L  R  A  L  Q  N  C  C  S  V  P  S  P  L  P  P  E  D  A  G  
2523     actggaggcctgagacagcaggaagaggaagcagtggagctccagcccccaccaccagcc 
410       T  G  G  L  R  Q  Q  E  E  E  A  V  E  L  Q  P  P  P  P  A  
2583     cctctgtctcccccacccccagccccaactgccccccaacctcctggggatcccctcatg 
430       P  L  S  P  P  P  P  A  P  T  A  P  Q  P  P  G  D  P  L  M  
2643     agccgcctgttctatggggtgaaggcagggccaggggtgggggccccccgccgcagtgga 
450       S  R  L  F  Y  G  V  K  A  G  P  G  V  G  A  P  R  R  S  G  
2703     cacaccttcaccgtcaacccccggcggtctgtgccccctgcgaccccagccaccccaacc 
470       H  T  F  T  V  N  P  R  R  S  V  P  P  A  T  P  A  T  P  T  
2763     tctccagccacagttgatgctgcagtcccgggggctgggaagaagcggtacccaactgcc 
490       S  P  A  T  V  D  A  A  V  P  G  A  G  K  K  R  Y  P  T  A  
2823     gaggagatcttggttctggggggctacctccgtctcagccgcagctgccttgccaagggg 
510       E  E  I  L  V  L  G  G  Y  L  R  L  S  R  S  C  L  A  K  G  
2883     tcccccgaaagacaccacaaacagcttaagatctccttcagcgagacagccctggagacc 
530       S  P  E  R  H  H  K  Q  L  K  I  S  F  S  E  T  A  L  E  T  
2943     acgtaccaatacccctccgagagttcggtactggaggagctgggcccggagcctgaggtc 
550       T  Y  Q  Y  P  S  E  S  S  V  L  E  E  L  G  P  E  P  E  V  
3003     cccagtgcccccaaccctccagcagcccaacccgacgacgaagaggatgaggaagagctg 
570       P  S  A  P  N  P  P  A  A  Q  P  D  D  E  E  D  E  E  E  L  
3063     ctgctgctgcagccagagctccagggcgggctgcgcaccaaggccctgattgtggatgag 
590       L  L  L  Q  P  E  L  Q  G  G  L  R  T  K  A  L  I  V  D  E  
3123     tcctgccggcggtgaccatcttccaacatagggatatacctccctccttcttataactga 
610       S  C  R  R  *   
3183     agatcctggagcccggaagattcagggcagacagaccctgataatgagcctggcagggaa 
3243     gggcaaccaacatcttgtaacttgctttccccaccctgtttctgggggcagagccaattg 
3303     cccaatttctaccctaatccaaagtccctggtgtgggtggggttaaacgtgctggtgcat 
3363     cctaggtcatccaagagtgagcgccaagtcctgagaaggggcacagaactccctggaggg 
3423     tggagatggagcacctgccccccatggcagggtacactctccccacagccttcctcccca 
3483     ccatcccgtggggactctcgggatttaagcactcgtctctctgggaggcccagaccccac 
3543     tccatttataggcacatctccttcatttcctaggtcactgcccctttgtttacagctcct 
3603     gcctcctcccttgaccacagcctggtttacaaattccatcagctcccagccccacctgcc 
3663     aaagtcccaggtttacaagccacgcttacttgctgtgtctgcgtggaattctctcctctg 
3723     tcccctccagtctcctcattggagtgacctgaaggtgtggcttcctccactttttctcag 
3783     tattactttgccttagttttccccaagagggaaggctggaactcttaactctgtacccct 
3843     tgatagttatttaattctgtttctcctagtggttcacaattgaactgaattgagatggtg 
3903     tcgggtggctaaggagacacctcacctctccttccccattgtgccgcctttatcaattgc 
3963     ctgttttgttttgtttgttttttaactttccataataaaatggagttctcttc 
Figure III.23: Nucleotide and deduced amino acid sequence of clone KIAA1949. Clone 4Q starts 
at nt 2763. The PP1 binding motif is indicated in green; A PEST sequence is underlined. 
 
Several KIAA1949 cDNAs were isolated in both YTH screens (Table III.11). 
Clone 4Q was selected for further examination. This clone starts at nt 2763 relatively to the 
XM_166376 sequence in the database.  
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Table III.11: Independent KIAA1949 clones obtained in the YTH1 and YTH2. 
Sequence first nt YTH1 YTH2 
TCTCCAGCCACAG 2763 
 
4Q,29Q,33Q,34Q,35Q, 
22T,27T,32T,141T 
 
 
GAAGCGGTACCC 
 
2804  2238C 
 
The protein encoded by KIAA1949 contains a putative PP1 binding motif, KISF, 
and a putative PEST sequence (responsible for targeting proteins to degradation). Other 
putative domains were also identified by searching Prosite: a N-glycosylation site (aa 306-
309), a Tyr sulfation site (aa 265-279), a cAMP- and cGMP-dependent protein kinase 
phosphorylation site (aa 122-125), and several protein kinase C phosphorylation sites. 
Additionally, it has casein kinase II phosphorylation sites, a Tyr kinase phosphorylation 
site (264-272), several N-myristoylation sites, two amidation sites, a Arg rich region (aa 
120-216), a Gln rich region (aa 87-103), a Glu rich region (aa 247-382) and a Pro rich 
region (aa 425-491). 
 By aligning the XM_166376 database sequence with the human genome, the 
corresponding gene sequence was determined to spread over 3 exons on chromosome 6 
(TableIII.12). 
 
Table III.12: Exon-intron sizes of KIAA1949. 
Exon 
No.  
Nt No.* Exon size  
(bp) 
Intron 
No. 
Nt No.+ Intron size 
(kb) 
1 1-2906 2906    
2 2907-3116 209 1 30712912-30707910 5002 
3 3117-4015 898 2 30707683-30705795 1888 
Clone 4Q starts near the end of exon 1. *, corresponding to sequence XM_166376.+, 
corresponding to the human chromosome 6 sequence (NC_000006). 
 
By searching EST database, several ESTs were found to be present in the database. 
There are ESTs from brain, primary B-cells, spleen, thymus, brain and leukocytes. The 
existence of such ESTs supports the importance of this protein in several tissues. 
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III.3.8 I2-L (Protein Phosphatase 1 Inhibitor 2 Like) 
 
Inhibitor 2 (I2) is a heat stable protein that inhibits PP1 activity in vitro with 
nanomolar affinity and was first  purified from rabbit skeletal muscle (F. L. Huang and W. 
Glinsmann, 1976). It is a 23 KDa phosphoprotein well conserved among eukaryotes. PP1 
is inactivated through binding to I2 and its activity is reestablished when I2 is 
phosphorylated at Thr72 by glycogen synthase kinase III (GSK-3) (Hemmings et al., 
1982; Aitken et al., 1984; DePaoli-Roach, 1984) and Cdk5 (Agarwal-Mawal and Paudel, 
2001). PP1 can then dephosphorylate I2. I2 is also phosphorylated by casein kinase II 
(CK2) at Ser86, Ser120 and Ser121 (Holmes et al., 1986b). Phosphorylation by CK2 does 
not alter the inhibitory activity of I2. Phosphorylation of Ser86 enhances the subsequent 
phosphorylation at Thr72 by GSK-3 (Park and DePaoli-Roach, 1994; Park et al., 1994). 
A recent study showed that Ser120 and Ser121 phosphorylation, of previously unknown 
function, is also important for the binding of GSK-3 (Sakashita et al., 2003). Other 
sequences are thought to be important in the formation of the PP1/I2 complex, such as the 
N-terminal IKGI sequence, Trp46 and the C-terminal FEMKRKLHY sequence (Helps et 
al., 1998; H. B. Huang et al., 1999; Yang et al., 2000).  
To date, two genes have been identified that code for I2, termed I2 and I2 
(Osawa et al., 1996). All the phosphorylation sites were found to be conserved in these I2 
isoforms. Here, we report the finding of a new protein, termed I2-L (Inhibitor 2 Like) that 
is 96% identical at the nucleotide level and 95.6% identical at the aa level to I2 (Fig. III.24 
and 25). Clone 48, shown in red in Figure III.26, starts at nt 57 and ends at nt 901 of the 
sequence XM_018216 in the database.  
  
 
A 
B 
Figure III.24: Diagram of the alignment of the nt sequences of A) I2 (NM_006241) and B) I2-L 
(XM_018216)).  
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I2-L    1 MAASTASHRPIKGILKNKTSTTSSMVASAEQPRRSVDEELSKKSQKWDEINILATYHPAD 
I2      1 MAASTASHRPIKGILKNKTSTTSSMVASAEQPRGNVDEELSKKSQKWDEMNILATYHPAD 
          *********************************  ************** ********** 
 
I2-L   61 KGYGLMKIDEPSPPYHSMMGDDEDACRDTETTEAMAPDILAKKLAAAEGLEPKYRIQEQE 
I2     61 KDYGLMKIDEPSTPYHSMMGDDEDACSDTEATEAMAPDILARKLAAAEGLEPKYRIQEQE 
          * ********** ************* *** ********** ****************** 
 
I2-L  121 SSGEEDSDLSPEEREKKRQFEMRRKLHYNEGLNIKLARQLISKDLHDDDEDEEMLETADG 
I2    121 SSGEEDSDLSPEEREKKRQFEMKRKLHYNEGLNIKLARQLISKDLHDDDEDEEMLETADG 
          ********************** ************************************* 
 
I2-L  181 ESMNTEESNQGSTPSDQQQNKLRSS 
I2    181 ESMNTEESNQGSTPSDQQQNKLRSS 
          ************************* 
95.6% identity in 205 residues overlap; Score: 1006.0; Gap frequency:0.0% 
Figure III.25: Alignment of amino acid sequences of I2-L and I2. Highlighted residues represent 
important regulatory site; underlined region represents the most highly conserved region of the 
protein.  
 
1     gaggcagcaggtgcggccgctttagccctgagcgggctctgcggctgcctgcgagtctctg 
62     ctgtgccgacccttctcttcgcggaccccacgccaagcagcgaccctgaggcgacagccg 
122    gagcgcccggcaatggcggcctcgacggcctcccaccggcccatcaaggggatcttgaag 
1                   M  A  A  S  T  A  S  H  R  P  I  K  G  I  L  K  
182    aacaagacctctacgacttcctctatggtggcgtcggccgaacagccccgcaggagtgtc 
17      N  K  T  S  T  T  S  S  M  V  A  S  A  E  Q  P  R  R  S  V  
242    gacgaggagctgagcaaaaaatcccagaagtgggatgaaattaacatcttggcgacctat 
37      D  E  E  L  S  K  K  S  Q  K  W  D  E  I  N  I  L  A  T  Y  
302    catccagcagacaaaggctatggtttaatgaaaatagatgaaccaagccctccttaccat 
57      H  P  A  D  K  G  Y  G  L  M  K  I  D  E  P  S  P  P  Y  H  
362    agtatgatgggtgatgatgaagatgcgtgtagggacaccgagaccactgaagccatggcg 
77      S  M  M  G  D  D  E  D  A  C  R  D  T  E  T  T  E  A  M  A  
422    ccagacatcctagccaagaaattagctgctgctgaaggcttggagccaaagtaccggatt 
97      P  D  I  L  A  K  K  L  A  A  A  E  G  L  E  P  K  Y  R  I  
482    caggaacaagaaagcagtggagaggaggatagtgacctctcacctgaagaacgagaaaaa 
117     Q  E  Q  E  S  S  G  E  E  D  S  D  L  S  P  E  E  R  E  K  
542    aagcgacaatttgaaatgagaaggaagcttcactacaatgaaggactcaatatcaaacta 
137     K  R  Q  F  E  M  R  R  K  L  H  Y  N  E  G  L  N  I  K  L  
602    gccagacaattaatttcaaaagacctacatgatgatgatgaagatgaagaaatgttagag 
157     A  R  Q  L  I  S  K  D  L  H  D  D  D  E  D  E  E  M  L  E  
662    actgcagatggagaaagcatgaatacggaagaatcaaatcaaggatctactccaagtgac 
177     T  A  D  G  E  S  M  N  T  E  E  S  N  Q  G  S  T  P  S  D  
722    caacagcaaaacaaattacgaagttcatagaagagatttgttcaacactgcaattgtttg 
197     Q  Q  Q  N  K  L  R  S  S  *                                          
782    ttagatataaaccctgtgactataatacattgcttcttgttctccacaattcatgactta 
842    agtaccaaaatgcataccagttattatatattgccaagaattaaatgataaacttagaga 
902    ctaattagactgaaaatgcctaattgatatatatattcttatgcctagtactttaccaca 
962    aatacagtgtaatatcatcagtccaaaactgcattactttcataagaacactggttaatt 
1022   tgtataagatattatagagctttttatgctttagaagttaagcaatatctttggggggga 
1082   actaatttattttcatcactcgaaatgtggtagctcttacaaagtttgttgatttgtttt 
1142   tttaaaaatcaaaagccagttgaacaacaggatatatagacttataaatattcaagctga 
1202   atcgtattttaacacttctcttcaacttgatttgtctgtttaattgaaaagaattgtaag 
1262   agttactgttgcattttctgacctactacctttaaaattcctgttgagtttctttgtgtt 
1322   tacaaggaaaggactgaactttttctcatcaaaactagcttttttccccacaaataaatt 
1382   atcaggttaaactttc 
Figure III.26: Nucleotidic and amino acidic sequences of I2-L (XM_018216). In red is the 
sequence of the clone 48 (it starts at nt 57 and ends at nt 901). Underlined are the important aa 
sequences involved in PP1 binding. The blue adenine is absent in clone 48. 
 
The alignment of I2 and I2-L highlights the differences between the two proteins. 
The main difference is the Thr for Pro substitution at position 72. This Thr72 is the most 
important residue for the regulation of the PP1/I2 complex. Thr72 can be phosphorylated 
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by CDK5/p35, GSK3, MAPK and CDK2/cyclinB. The absence of Thr72 in I2-L raises an 
interesting question. Is I2-L an alternative constitutive inhibitor of PP1, not controlled by 
phosphorylation by GSK-3 but by an alternative mechanism? In Chapter V this question 
will be addressed in more detail. Another difference is the substitution of Ser86 by Arg. 
This fact also alters I2-L regulation by CK2 and subsequently the regulation of PP1 and 
other regulatory proteins, since it was recently shown that the PP1/I2 complex can bind a 
third protein, for instance, Nek2 (Eto et al., 2002). It was shown that  Ser86 
phosphorylation by CK2 does not alter the inhibitory activity of I-2 but accelerates the 
subsequent phosphorylation at Thr72 by GSK-3 (Park and DePaoli-Roach, 1994).    
By searching Prosite for motifs, several CK2 phospho sites (35-38 SvdE, 121-124 
SsgE, 122-125 SgeE, 130-133 SpeE, 193-196 TpsD) were found, as expected. The 35-38 
SvdE is a new putative CK2 phosphorylation site in I2-L that does not exist in I2. There 
are also other possible motifs: protein kinase C phosphorylation sites (7-9 ShR, 41-43 SkK, 
44-46 SqK) and a putative ubiquitin interacting motif (170-189 
EDEEMLETADGESMNTEESN). 
Using the BLAST2 algorithm we aligned the XM_018216 sequence with the 
human genome and concluded that this sequence is present in chromosome 5, while the I2 
gene is located in chromosome 3. The I2-L gene has an unique exon in contrast to the 5 
exons of I2.  
Curiously, in vivo, both negative and positive effects of I2 on PP1 activity were 
observed (Tung et al., 1995; Nigavekar et al., 2002). Overexpression of I2 induces a 
decrease in PP1 activity due to PP1 inhibition (Tung et al., 1995). On the other hand, at 
physiological concentrations, I2 was found to lead to activation of PP1 (Tung et al., 1995; 
Nigavekar et al., 2002). This experiment suggests that I2 may not act simply as a direct 
inhibitor of PP1 activity in vivo. This idea is also supported by the fact that the in vitro 
inactivation of PP1 by I2 is blocked by salt at physiological concentrations (Bollen et al., 
1994). So the current notion is that I2 function may be to promote a PP1 conformational 
change that converts the enzyme to its active form. Supporting this view is the fact that the 
I2 phosphorylation mechanism is conserved: in yeast the major I2 kinase is Pho85, a 
cyclin-dependent kinase, which also phosphorylates glycogen synthase; in mammals I2 is 
phosphorylated, as pointed out above, by GSK-3 (Woodgett and Cohen, 1984) and also 
by Cdk5, the Pho85 orthologue (Agarwal-Mawal and Paudel, 2001).  
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 In what concerns I2-L, the subtle differences in amino acid sequence with respect to 
I2 might induce a different behavior of the sperm PP1 holoenzyme, thus leading to a 
different mode of PP1 activity and sperm function. 
  
III.4 DISCUSSION 
 
PP1 involvement in diverse cellular processes is associated with its binding to a 
diverse set of regulatory subunits. Using the Yeast Two Hybrid System, new PP1 
interactors from human testis were identified in order to gain insight into the various roles 
of PP1 in sperm motility. The results obtained validated the method as a promising 
approach to understand the multiple functions of PP1 catalytic subunit, being a method of 
choice to screen a large number of proteins for putative interactions. We set out to identify 
all the positive clones obtained in our screens. This strategy turned out to be very fruitful 
because we could identify several new very interesting clones that would never be found if 
we decided only to study the more abundant clones. Some bonafide, previously 
characterized, PP1 binding proteins were identified in both screens (YTH1 and YTH2) like 
NIPP1 and Nek2. These findings validated our approach by confirming that expression of 
reporter genes was due to a specific interaction between the bait protein (PP12/ PP11) 
and the identified library protein. 
Nek2 was by far the most frequent interaction in both the YTH1 (47 out of 120) and 
the YTH2 (71 out of 155) screens. There is a panoply of data supporting the involvement 
of PP1 in mitosis. Specifically, PP1 was shown to be targeted to multiple mitotic structures 
such as chromosomes, spindle and centrosomes. Centrosomes duplicate during S-phase 
and remain paired during G2. Before the onset of mitosis the centrosomes split to form the 
poles of the mitotic spindle. Many of the changes that occur during the centrosome cycle 
are due to protein phosphorylation (Nigg, 2001). Two kinases have been shown to be 
involved in centrosome splitting and to be inactivated by PP1, indicating that PP1 prevents 
precocious separation of centrosomes. One of the kinases is Aurora-A, a homologue of 
Aurora-B (Katayama et al., 2001), that interacts with PP1 strongly at mitosis. PP1 
dephosphorylates and inactivates Aurora-A and is also an in vitro substrate for Aurora-A, 
being inactivated by its phosphorylation.  
 The other kinase related to centrosome separation is Nek2. Nek2 is tethered to 
centrioles via binding to a specific substrate called C-Nap1 (Nek-2 associated protein 1) 
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(Fry et al., 1998a). Phosphorylation of C-Nap1 correlates to loss of centrosome cohesion 
and C-Nap1 is likely to be the substrate and effector of Nek2-PP1 complex. It has also 
been shown that I2, a PP1 inhibitor, can enhance the kinase activity of the Nek2-PP1 
complex via inhibition of PP1 to initiate centrosome splitting (Eto et al., 2002). This 
complex is auto-regulated since Nek2 phosporylates PP1 at Thr307 and Thr318. PP1, in 
turn, dephosphorylates Nek2 (Helps et al., 2000). The kinase/phosphatase complex of 
Nek2-PP1 functions as a bistable switch, as first described by Sohaskey and Ferrell (2002). 
Besides the two splice variants Nek2A and Nek2B, identified in primary blood 
lymphocytes and adult transformed cells (Hames and Fry, 2002), no other Nek2 isoforms 
have been described to date. Here we identified a new alternatively spliced isoform of 
Nek2 in human testis called Nek2A-T. Murine Nek2 was shown to be highly expressed in 
adult testis. It was also shown that Nek2 was expressed in a stage specific pattern during 
spermatogenesis and intense signals were also observed in oocytes (Tanaka et al., 1997). 
The new Nek2A-T isoform misses a phosphorylatable domain of 8 amino acids 
(ELLNLPSS) which includes two serines (Fig. III.7.). These serines could be important for 
regulation of PP1 in two ways. First, PP1 may dephosphorylate these serine residues in 
Nek2A but since they are missing from Nek2A-T, the latter would not be subject to such 
regulation, ultimately leading to an increase in centrosome splitting, in agreement with 
testis being a tissue with high levels of cell division. Second, the absence of this 8 amino 
acids stretch could alter Nek2A-T conformation resulting in a different affinity for PP1. In 
conclusion, this may be a very important isoform of Nek2 in testis and further 
experimentation is required to address the significance of this splicing event. Nek2 was 
shown to be phosphorylated on the two serine residues that occur N-terminally to the PP1 
binding domain, thus that are present in the phosphorylatable domain. It is interesting to 
note that it is precisely the phosphorylatable 8 amino acid domain of Nek2A that is missing 
from Nek2A-T. Thus, although Nek2A and Nek2A-T are likely to exhibit distinct 
properties, it may be difficult to specifically target Nek2A-T for therapeutics since it lacks 
the phosphorylatable, regulatory 8 amino acid domain.  However, the effectiveness of 
siRNA directed against Nek2A-T can still be explored.  
Another new alternatively spliced variant found in the YTH2 was designated 
NIPP1-T. While Nek2A-T derives from an alternative 3’splice-site of the pre-mRNA, the 
NIPP1-T results from excision of part of exon 7 (Fig. III.7 and III.14). NIPP1 was 
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originally identified in the particulate fraction of bovine thymus nuclei. Subsequent studies 
showed that the full length NIPP1 cDNA encoded a protein of 38.5 kDa that was extremely 
sensitive to proteolysis. NIPP1 is perhaps the most potent inhibitor of PP1 thus far 
identified, with a Ki in the picomolar range. The protein is largely nuclear in its 
localization and is ubiquitously expressed in mammalian tissues (Van Eynde et al., 1995). 
Although NIPP1, like I-1 and DARPP-32, possesses the consensus PP1-binding motif, it is 
more like I-2 in its action, being a more potent phosphatase inhibitor in the 
dephosphorylated state. Moreover, NIPP-1, like I-2, forms a stable, inactive complex with 
PP1. Following phosphorylation of NIPP1 by PKA on a site within the PP1-binding motif, 
its activity as a PP1 inhibitor is dramatically reduced. NIPP1 is phosphorylated at Ser178 
and Ser199 by PKA and on Thr161 and Ser204 by CK2 (Vulsteke et al., 1997). Both 
kinases reduce the affinity of NIPP1 for PP1 and increase phosphatase activity. The effects 
of the two kinases in activating the NIPP1/PP1 complex are synergistic but do not cause 
dissociation of the complex. NIPP1 phosphorylation may prevent its re-association with 
PP1. NIPP1 contains a RNA-binding motif also found in the bacterial RNA processing 
enzyme, Ard-1. The extensive sequence homology between mammalian Ard-1 and the C-
terminus of NIPP1 suggests that the two proteins are derived from the same gene through 
alternative splicing (Vulsteke et al., 1997). Recombinant NIPP1 was shown to bind to 
RNA and its C-terminal fragment was shown to possess endonuclease activity. While 
RNA-binding was not affected by the presence of PP1, full length NIPP1 did not degrade 
RNA (Jagiello et al., 1997). 
Although several alternatively spliced variants of NIPP1 are known (Van Eynde et 
al., 1999), NIPP1-T appears to be a novel testis-specific variant that uses the same 
polyadenylation site as NIPP1. At the protein level, it differs from the latter in that it has a 
longer C-terminal extension. It is interesting to note that whereas NIPP1 possesses the 
sequence –KKPTP- in the spliced domain (a proline directed kinase consensus acceptor 
site), a related sequence also occurs in NIPP1-T (-NAPSP-). Both motifs are located 
exactly 4 amino acids from the C-terminus of the two proteins. In this case, the distinct C-
terminal sequence of NIPP1-T could constitute a specific therapeutic target. 
The specificity of the interactions between PP11 or PP12 and the identified 
positives was confirmed by sequential transformation of yeast strain AH109 with the 
putative interacting proteins (Fig. III.12 and III.18). To this end the longest cDNAs 
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obtained for Nek2A (clone 25), Nek2A-T (clone 3Q) and NIPP1-T (273) were used. All 
interactions described in this chapter were confirmed by this method. Furthermore, the 
binding of PP12 to Nek2A and Nek2A-T was also verified by the blot overlay technique. 
Both proteins were expressed in E. coli and found to bind purified PP12 (Fig. III.11). 
Thus, both the previously known Nek2A isoform and the novel Nek2A-T and NIPP1-T 
variants appear to bind PP12 in vitro (blot overlays) and in vivo (yeast co-expression).  In 
order to evaluate whether the novel protein variants detected were truly testis-specific and 
produced by alternative splicing, Northern blot and RT-PCR analyses were also performed.  
The results obtained indicate that Nek2A-T expression is largely restricted to the testis 
(Fig. III.10). However, both Nek2A and Nek2A-T appear to be expressed in testis, since 
the RT-PCR performed using the indicated primers detected fragments of the expected 
length for both (Fig. III.9 and III.15). The probe used for NIPP1-T was also expected to 
hybridize with NIPP1. Thus, only a single message was detected in rat tissues, being 
particularly abundant in testis, heart and brain. As expected, two mRNAs were detected in 
human testis, corresponding to NIPP1 and NIPP1-T (Fig. III.16 and III.17). Therefore, it 
appears that both Nek2A-T and NIPP1-T are new and testis-specific alternatively spliced 
variants.  Although Nek2A-T and NIPP1-T were shown to interact with both PP1 
isoforms, the significance of these observations remains to be fully clarified.  Since sperm 
were found to express almost exclusively the PP12 isoform, the possible interaction of 
Nek2A-T and NIPP1-T with PP11 would only be expected to have physiological 
relevance in other testis cell types. 
Some of the positive clones encoded known PP1 binding proteins joined out of 
frame to GAL4-BD (Table III.3, WRF). We would therefore expect a totally different 
reading frame to code for an artificial protein that might not bind PP1. This was the case, 
for example, with well known PP1 binding proteins PPP1R13A and PP1R13B. Thus, the 
fact that several bonafide PP1 regulators were fused to the GAL4-BD in a wrong reading 
frame strongly suggested that the correct protein might still be produced by a well 
established mechanism in yeast, called programmed translational frameshift or 
translational recoding (Shah et al., 2002). Some specific sequences, 7 nucleotides long, are 
known to induce ribosomal frameshifting. This is a directional and reading frame specific 
event. Several programmed frameshift heptanucleotides have been identified: CUU-AGG-
C, CUU-AGU-U and GGU-CAG-A (Shah et al., 2002).We concluded that translational 
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recoding may be a feasible explanation for these observations. Moreover, this mechanism 
could be enhanced because of the use of selective media without some amino acids. So, the 
yeast translation machinery might be using alternative codons favouring the existing amino 
acids. 
The majority of the recovered clones encoded partial cDNA sequences (Table III.3) 
but each shows specific interaction with PP1 in the yeast two hybrid system. The large 
number of totally new putative PP1 binding proteins opens new fields of study. All the 
uncharacterized proteins need to be further analysed in order for their functions to be 
identified, allowing new roles to be attributed to PP1, not only in sperm motility but in 
other cellular functions. In what concerns PP12 and sperm motility, this screen provided a 
large amount of data that will be useful in our search for testis-specific PP1 binding 
proteins that may be used as targets for therapeutic intervention at the level of male 
infertility or contraception. 
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IV SEARP – a novel PP1 interacting protein 
 
IV.1 INTRODUCTION 
 
It is now well estabilished that PP1 occurs in cells in multi-component complexes 
with regulatory/targeting subunits that are responsible for controlling its activity and 
fulfilling its cellular potential. Some PP1 regulatory subunits are known to direct the 
catalytic subunit to specific cellular loci (Ouimet et al., 1995; Allen et al., 1997), 
restricting the action of the catalytic subunit to the substrates expressed there. Thus, such 
regulatory subunits can be highly specific to particular subcellular compartments (Ouimet 
et al., 1995) and control a much more restricted number of cellular events than the 
phosphatase catalytic subunit itself.   
Until now more than 50 different PP1 regulatory subunits have been identified and 
were shown to be responsible for the involvement of PP1 in a number of diverse cellular 
functions from protein synthesis to regulation of the cell cycle, muscle contraction, 
glycogen metabolism, synaptic plasticity, gene transcription, etc (Cohen, 2002). The 
overall picture is summarized in Table IV.1, listing the classification of PP1 R-subunits. 
 
Table IV.1: Classification of the R subunits of PP1. 
Regulatory subunit General Function Reference 
I-1 PPP1R1A (F. L. Huang and W. Glinsmann, 1976) 
DARPP-32 PPP1R1B (Hemmings et al., 1984c) 
I-2 PPP1R2 
PP1 inhibitors 
 
(F. L. Huang and W. Glinsmann, 1976) 
GM (RGL, R3) PPP1R3A (Stralfors et al., 1985) 
GL (R4) PPP1R3B (Doherty et al., 1995; Moorhead et al., 
1995) 
R5(PTG) PPP1R3C (Doherty et al., 1996) 
R6 PPP1R3D 
Glycogen metabolism 
(Armstrong et al., 1997) 
Sds22 PPP1R7 Mitosis/Meiosis (Dinischiotu et al., 1997) 
NIPP-1 (Ard-1) PPP1R8 (Van Eynde et al., 1995) 
SIPP-1  (Llorian et al., 2004) 
PSF1  
RNA splicing 
(Hirano et al., 1996) 
Neurabin I PPP1R9A Neurite outgrowth, synapse morphology (MacMillan et al., 1999) 
Spinophilin (neurabin 
II) 
PPP1R9B 
Glutamatergic synaptic transmission, 
dendritic morphology 
(Allen et al., 1997) 
p99 (R111, PNUTS) PPP1R10 RNA processing or transport? (Allen et al., 1998) 
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Hox11  Cell cycle checkpoint (Kawabe et al., 1997) 
Inhibitor-3 (HCG-V) PPP1R11 Inhibits PP1 (Zhang et al., 1998) 
HCF  Transcription, cell cycle (Ajuh et al., 2000) 
MYPT1 (M110, MBS, 
M130) 
PPP1R12A (Alessi et al., 1992) 
MYPT2 (PP1bp55, 
M20-spliced form) 
PPP1R12B (Moorhead et al., 1998) 
p85 PPP1R12C (Tan et al., 2001) 
Phactr1  
Myosin/actin targeting 
(Allen et al., 2004) 
L5 ribossomal protein  (Hirano et al., 1995) 
RIPP1  
Protein synthesis? 
(Beullens et al., 1996) 
53BP2 (TP53BP2, p53-
binding protein 2) 
PPP1R13A Cell cycle checkpoint? (Helps et al., 1995) 
CPI-17 PPP1R14A Inhibits the myosin bound PP1 complex (Eto et al., 1997) 
PHI-2 PPP1R14B (Eto et al., 1999) 
PHI-1  (Eto et al., 1999) 
KEPI  
Inhibits PP1 
(Liu et al., 2002) 
GBPI-1  
Inhibits PP1 when phosphorylated 
(Brain/Stomach) 
(Liu et al., 2004) 
GBPI-2  
Inhibits PP1 when phosphorylated 
(Testis) 
(Liu et al., 2004) 
I-4   (Shirato et al., 2000) 
GADD34 PPP1R15A Protein synthesis (Connor et al., 2001) 
CReP PPP1R15B Protein synthesis (Jousse et al., 2003) 
AKAP 149  
Nuclear envelope reassembly 
(dephosphorylation of B-type lamins) 
(Steen et al., 2000) 
NF-L  Synaptic transmission? (Terry-Lorenzo et al., 2000) 
AKAP-220  Coordination of PKA/PP1 signaling (Schillace et al., 2001) 
Yotiao  
Synaptic transmission (NMDA receptor 
ion channel activity) 
(Westphal et al., 1999b; Zhao et al., 1999) 
BH-protochaderin c  Neuronal cell-cell interaction (Yoshida et al., 1999) 
Rynanodyne receptor  Calcium ion channel activity? (Zhao et al., 1998) 
NKCCl  Cl transport (Darman et al., 2001) 
AKAP 350 (CG-NAP, 
AKAP450) 
 (Takahashi et al., 1999) 
Nek2  
Centrosomal function 
(Helps et al., 2000) 
Tau  Microtubule stability? (Liao et al., 1998) 
Bcl2  Apoptosis (Ayllon et al., 2001) 
RB  Cell cycle progression (Durfee et al., 1993) 
PRIP-1 (p130, PLC-L1)  Calcium signaling? (Yoshimura et al., 2001) 
PFK  Glycolisis? (Zhao and Lee, 1997b) 
PP1bp80  (Damer et al., 1998) 
MYPT3 PPP1R16A 
Myosin targeting 
(Skinner and Saltiel, 2001) 
I1PP2A(PHAPI)  (Katayose et al., 2000) 
I2PP2A(SET, PHAPII, 
TAF1) 
 
Stimulation of PP1 and Inhibition of PP2A 
(Katayose et al., 2000) 
G-substrate  Inhibition of PP1 (Aitken et al., 1981) 
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Grp78  Unknown (Chun et al., 1994) 
NCLK  Activates PP1 (Agarwal-Mawal and Paudel, 2001) 
Myr8  Brain development (Patel et al., 2001) 
FAK  
PP1 dephosphorylates FAK in cells 
released from mitosis 
(Fresu et al., 2001) 
Herpes vírus 1 34.5 
protein 
 Inhibits protein synthesis (He et al., 1997) 
mGluR7b  Unknown (Enz, 2002) 
Histone H3  Mitosis (Hsu et al., 2000) 
Scapinin  
Associated with the nuclear nonchromatin 
structure 
(Sagara et al., 2003) 
14-3-3  sperm (Huang et al., 2004) 
Abbreviations: PTG, Protein targeting to glycogen; MYPT, myosin phosphatase targeting subunit; 
MBS, myosin binding subunit; NIPP, Nuclear inhibitor of PP1; PSF, polypyrimidine tract-binding 
protein associated splicing factor; PNUTS, phosphatase 1 nuclear targeting subunit; Hox11, 
Homeodomain transcription factor; HCF, host cell factor or human factor C1; RIPP1, ribosomal 
inhibitor of PP1; PHI, phosphatase holoenzyme inhibitor; KEPI, kinase-enhanced protein 
phosphatase type 1 inhibitor; GADD34; growth arrest and DNA damage protein; AKAP, A-kinase 
anchoring protein; NKCCl, Na-K-Cl cotransporter; Nek2; NIMA-related protein kinase; Rb, 
retinoblatoma protein; PRIP-1; phospholipase C-related inactive protein; PFK, 
Phosphofrutokinase; G-substrate, cGMP-dependent protein kinase substrate; Grp-78, glucose-
regulated protein, member of the HSP-70 family; NCLK, neuronal cdc2-like kinase; FAK; Focal 
adhesion kinase. The human genome nomenclature for the regulatory subunits that are only 
classified as PP1 regulators is indicated in column 2. PPP1R4, PPP1R5 and PPP1R6 have 
recently been re-classified as PPP1R3B, PPP1R3C and PPP1R3D.     
 
The cellular functions of several PP1 complexes are now well established although 
there are a number of interactions that have not yet been fully characterized. Most PP1 
regulatory subunits have a consensus binding motif but they do not exhibit any other 
sequence similarities that would allow their identification them by bioinformatic means. 
The methods that are used to identify PP1 regulators include the Yeast Tho Hybrid System, 
immunoprecipitation of PP1 complexes and the screening of expression libraries with PP1 
as probe. The known PP1 regulators can be classified into targeting or modulator subunits. 
Several PP1 targeting subunits can target PP1 to glycogen. These include GM, GL, R5 and 
R6 that possess a glycogen targeting domain (Doherty et al., 1996; Wu et al., 1996; 
Armstrong et al., 1997; Armstrong et al., 1998; Wu et al., 1998). Three novel proteins 
encoded in the human genome also have a similar domain (Ceulemans et al., 2002). GM 
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(124 kDa) is a G subunit that directs PP1 to glycogen particles and membranes of the 
sarcoplasmic reticulum in muscle (Hubbard and Cohen, 1993), GL (33kDa) directs PP1 to 
glycogen in liver (Cohen, 1989) and R5 (36kDa) is related to GL but is ubiquitously 
expressed (Doherty et al., 1995).  
MYPT1, MYPT2, MYPT3, p85 and phactr1 target PP1 to myosin/actin (Hirano et 
al., 1997; Johnson et al., 1997; Skinner and Saltiel, 2001; Tan et al., 2001; Allen et al., 
2004). Smooth muscle myosin phosphatase is composed of three subunits: PP1c and large 
(110kDa) and small (20kDa) noncatalytic subunits. The large subunit binds to myosin and 
to PP1. This subunit was called MYPT1 (myosin phosphatase target subunit 1) because it 
binds to myosin and to PP1c activating it (Tanaka et al., 1998). The N-terminal sequence 
and the ankyrin repeats of MYPT1 are involved in PP1 binding. PKC phosphorylates 
Thr34, the residue that precedes the consensus PP1-binding motif, KVKF, in MYPT1 but 
this did not affect binding of the peptide to PP1c. Another phosphorylation site, within the 
ankyrin repeat, diminished the stimulatory effect of MYPT1 on the phosphorylated 20kDa 
myosin light chain phosphatase activity of PP1c (Toth et al., 2000a). In a yeast two hybrid 
screen using PP1 as bait a new homolog of the MYPT family, MYPT3 (Skinner and 
Saltiel, 2001), was found to interact with PP1. The N-terminal region of MYPT3 consists 
of a consensus PP1-binding motif and multiple ankyrin repeats. MYPT3 is distinguished 
from the other members of the MYPT family by its molecular mass of 58kDa and a unique 
C-terminal region that contains several potential signaling motifs and a CaaX prenylation 
site. Endogenous PP1 from 3T3-L1 lysates specifically interacts with MYPT3. 
Additionally, purified PP1 was inhibited by recombinant GST-MYPT3 using 
phosphorylase a, myosin light chain and myosin substrates in vitro (Skinner and Saltiel, 
2001). 
PP1 can also be targeted to particular subcellular locations by interacting with A-
kinase-anchoring proteins (AKAPs) that keep PKA and PP1 in close proximity (Schillace 
and Scott, 1999). These include AKAP-149, AKAP-220, Yotiao and AKAP-350 
(Takahashi et al., 1999; Westphal et al., 1999b; Steen et al., 2000; Schillace et al., 2001). 
For example, AKAP350 (Takahashi et al., 1999) is a scaffold protein that assembles 
several protein kinases and protein phosphatases, including PP1, at the centrosomes 
throughout the cell cycle and at the Golgi during interphase.  
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There are several PP1 regulators that are involved in RNA processing. L5 (Hirano 
et al., 1995) is part of the 60S ribosomal subunit and localizes in both the cytoplasm and 
the nucleus of eukaryotic cells, accumulating particularly in the nucleoli. L5 is known to 
bind specifically to 5S rRNA and is involved in nucleocytoplasmic transport of this rRNA 
(Rosorius et al., 2000).  L5 was first isolated from rat liver ribosomes and activated 
phosphatase activity of a myosin-bound phosphatase and the isolated type 1 catalytic 
subunit using phosphorylated myosin light chains and phosphorylase a as substrates. In 
addition, it was shown that phosphatase sedimented with ribosomal subunits containing L5 
but did not sedimented with those deficient in L5. These data indicated that L5 binds to 
PP1 and may act as a target molecule for PP1 in ribosomal function or other cell 
mechanisms. PSF (polypirimidine tract-binding protein associated splicing factor) (Hirano 
et al., 1996) was found to interact with and inhibit PP1. PSF contains the consensus PP1-
binding motif and may therefore act as a PP1 target molecule in the spliceosome (Hirano et 
al., 1996). RIPP-1 (ribosomal inhibitor of PP1) (Beullens et al., 1996) is a 23 kDa basic 
polypeptide that is complexed with PP1 in rat liver ribosomes. In vitro, RIPP-1 is a potent 
inhibitor of PP1 (Ki=20nM) with some substrates, (phosphorylase a and myelin basic 
protein) but a much poorer inhibitor (Ki=400nM) with other substrates (histone IIA and 
casein). RIPP-1 inhibits PP1-mediated dephosphorylation of ribosomal S6, a component of 
the 40S ribosomal subunit and suggests a role in the control of protein synthesis (Beullens 
et al., 1996). PNUTS (Kreivi et al., 1997; Allen et al., 1998) was found to bind PP1 in a 
two hybrid assay. PNUTS is widely expressed in human tissues and shows a punctate 
nucleoplasmic staining with additional accumulation within the nucleolus. The C-terminus 
of PNUTS contains seven RGG RNA-binding motifs, and a putative zinc-finger domain. 
Recombinant PNUTS suppresses the phosphorylase phosphatase activity of PP1 and the 
canonical PP1-binding motif (residues 396-401) is unusual in that the phenylalanine is 
replaced by a tryptophan. Recently, PNUTS was shown to inhibit PP1 activity towards the 
retinoblastoma protein (Rb) (Udho et al., 2002). Also NIPP1 targets PP1 to the splicing 
machinery (Jagiello et al., 2000). This regulator was discussed in the previous chapter.  
Some PP1 binding proteins are brain specific. Cyclic GMP and cGMP-dependent 
protein kinase (PKG) mediate several of the actions of nitric oxide in the brain (Wang and 
Robinson, 1997). A specific substrate for PKG, termed G substrate (Hall et al., 1999), is 
highly expressed in Purkinje cells of the cerebellum. Purified recombinant G substrate has 
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recently been shown to be an inhibitor of PP1. The inhibition was dependent on 
phosphorylation by PKG (Hall et al., 1999). Despite its structural similarity to DARPP-32, 
which is highly specific for PP1, recombinant G substrate inhibits PP2A more effectively 
than PP1. Phosphorylation of G substrate may represent a novel pathway for regulation of 
neural PP1 and PP2A in response to nitric oxide production. Myr8 myosins comprise a 
new class of myosins that have been designated class XVI. The head domain contains a 
large N-terminal extension composed of multiple ankyrin repeats implicated in mediating 
an association with PP1α and γ1. The structural features and restricted expression patterns 
suggest that members of this novel class of unconventional myosins comprise a mechanism 
to target selectively the PP1 in developing brain (Patel et al., 2001). Neurofilament-L (NF-
L), a 70kDa membrane-bound protein, was identified as a PP1 binding protein in bovine 
brain cortex plasma membranes. Bovine NF-L, at nanomolar concentration, inhibited the 
phosphorylase phosphatase activity of rabbit skeletal muscle PP1c but not the activity of 
PP2A. PP1 binding to the bovine NF-L was mapped to the head region. NF-L may target 
the functions of PP1 in membranes and cytoskeleton of mammalian neurons (Terry-
Lorenzo et al., 2000). NCLK (neuronal Cdc2-like protein kinase) a heterodimer of Cdk5 
and the regulatory p25 subunit binds PP1 through Cdk5. In brain extracts PP1/I-2 and 
NCLK are associated within a 450kDa complex suggesting that NCLK is one of the PP1/I-
2 activating kinases in mammalian brain. In vitro NCLK phosphorylates I-2 on Thr72 and 
activates PP1/I-2 in an ATP/Mg-dependent manner, just like GSK3 (Agarwal-Mawal and 
Paudel, 2001). Neurabin I is a brain-specific actin-binding protein that binds PP1 and 
inhibits its activity. Phosphorylation of recombinant GST-neurabin I (residues 318-661) by 
PKA significantly reduced its binding to PP1. These findings identify a signaling 
mechanism involving the regulation of PP1 activity and localization mediated by the 
cAMP pathway (McAvoy et al., 1999). Dendritic spines receive the vast majority of 
excitatory synaptic contacts in the mammalian brain and are presumed to contain 
machinery for the integration of various signal transduction pathways. PP1 is greatly 
enriched in dendritic spines and has been implicated in both the regulation of ionic 
conductance and long-term synaptic plasticity. A novel PP1 binding protein, spinophilin 
(neurabin II), was identified by the yeast two hybrid approach that is a potent modulator of 
PP1 enzymatic activity in vitro. Spinophilin has the properties expected of a scaffold 
protein localized to the cell membrane. Spinophilin represents a novel targeting subunit for 
Characterization of the PP1 Interactome from Human Testis Chapter IV  
 
Centro de Biologia Celular 
Universidade de Aveiro 147 
PP1 which directs the enzyme to those substrates in the dendritic spine compartment, e. g., 
neurotransmitter receptors, which mediate the regulation of synaptic function by PP1 
(Allen et al., 1997). PP1 is distributed in many regions of neurons, in addition to dendritic 
spines where it is target by spinophilin, suggesting the existence of multiple targeting 
proteins (Ouimet et al., 1995). PP1 is associated with neurofilaments. As phosphorylation 
of neurofilament proteins is associated with depolymerization, neurofilament-associated 
PP1 may regulate neurofilament stability. PP1c also associates with brain microtubules 
where it appears to be tethered by the microtubule-associated protein tau. Tau acts as 
targeting protein that bridges PP1 to microtubules and can also be a substrate for the 
phosphatase (Liao et al., 1998).  
The protein kinase Nek2 (Fry et al., 1998b) targets PP1 to the centrosomes and it 
was extensively discussed in Chapter III.   Regulatory subunits that do not target PP1 to 
any particular location may instead act on its specificity to certain substrates.  For instance, 
RB (retinoblastoma) interacts with many cellular proteins in complexes potentially 
important for its growth-suppressing function (Durfee et al., 1993). A yeast two hybrid 
screen using RB as bait was performed and PP1α2 was found to interact with it. PP1α2 
differs from the originally defined PP1α isoform by an amino-terminal 11 amino acid 
insert. PP1 isoforms preferentially bind the hyperphosphorylated form of RB. Cell cycle 
synchrony experiments revealed that this association occurs from mitosis to early G1. 
More recent studies have shown that PP1 is associated with the direct dephosphorylation of 
RB while PP2A is involved in pathways regulating G1 cyclin-dependent kinase activity 
(Yan and Mumby, 1999). The p53 binding protein (p53BP2) (Helps et al., 1995) was 
identified as a protein interacting with PP1 also in a yeast two hybrid screen. The p53BP2-
PP1 complex was stable at NaCl concentrations that dissociate the p53-p53BP2 complex, 
and the binding of PP1 and p53 to p53BP2 was found to be mutually exclusive. The region 
required for interaction with PP1 was shown to be contained within amino acids 297-431 
of p53BP2, which includes two ankyrin repeats. The phosphorylase phosphatase activity of 
PP1 was inhibited by p53BP2 at nanomolar concentrations. These results suggest that PP1 
may be involved in dephosphorylation and regulation of p53 through interaction with 
p53BP2 (Helps et al., 1995). Bcl-2 was also found to interact with PP1α and Bad. Bcl-2 
depletion decreased phosphatase activity and association of PP1α and Bad. Bcl-2 contains 
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the PP1-binding motif RIVAF. So Bcl-2 seems to target PP1 to Bad, directly involving 
PP1 in apoptosis (Ayllon et al., 2001). 
Most PP1 inhibitor proteins are thermostable inhibitors of low molecular mass. The 
existence of such a high number of inhibitor proteins (I-1, DARPP-32, I-2, I-3, CPI-17, 
PHI-2, PHI-1, I-4, I1PP2A, I2PP2A) indicates that the activity of free PP1 catalytic subunit 
must be kept under strict control.  
The role of I-1  in regulating PP1 function has been investigated in many different 
physiological settings: hormonal control of glycogen metabolism, synaptic plasticity 
controlled by neurotransmitters, growth of pituitary tumor cells and the control of muscle 
contraction (F. L. Huang and W. H. Glinsmann, 1976). Some but not all hormones that 
elevate intracellular cAMP activate I-1. Hormones that activate I-1 induce much larger and 
more rapid changes in signal transduction pathways transduced by PP1 substrates. 
Hormones, like adrenalin, which activate PKA result in increased phosphorylation and 
inactivation of glycogen synthase in mammalian skeletal muscle. This activation is not due 
to the direct action of PKA on glycogen synthase. Although PKA can phosphorylate and 
inactivate glycogen synthase in vitro, adrenalin promotes the phosphorylation of glycogen 
synthase at serine residues that are not PKA targets (Poulter et al., 1988). Moreover, the 
protein kinase, GSK3, that phosphorylates these serines is itself not activated by PKA. So, 
it was determined that the mechanism for enhanced glycogen synthase phosphorylation 
was the PKA-mediated activation of I-1 and the consequent inhibition of PP1 (Nakielny et 
al., 1991). This revealed a new mechanism for hormone action in that PP1 modulation via 
I-1 mediated cAMP regulation of proteins that are substrates for kinases other than PKA. 
Other hormones, such as insulin, result in the dephosphorylation and activation of 
glycogen synthase. Numerous studies have reported that insulin activates PP1 in insulin-
sensitive cells (Chan et al., 1988). In contrast to GM, some of the G-subunits present in 
other tissues are not subject to regulation by insulin (Brady et al., 1997). This makes the 
role of I-1 in hormonal control of glycogen metabolism even more important in these 
tissues.  
Changes in synaptic transmission elicited by prior neuronal activity have been 
extensively studied in the hippocampus as a potential model for learning and memory. 
Activity-dependent enhancement of synaptic transmission is seen as long term potentiation 
or LTP. Other stimuli depress the functions of hippocampal synapses leading to long term 
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depression or LTD. Several protein kinases, including CaM-kinase II, PKC (Malinow et 
al., 1989) and fyn (Grant et al., 1992), have been implicated in LTP. Recent studies have 
established that two protein phosphatases, PP1 and PP2B, act in tandem to regulate LTD 
(Mulkey et al., 1994). I-1 is highly expressed in the hippocampus and functions as the link 
between PP2B and PP1. LTP and LTD are both activated by the excitatory 
neurotransmitter glutamate, acting via the second messenger calcium. A single second 
messenger mediates such opposing physiological effects because of the different calcium 
sensitivities of PP2B and CaM-kinase II in neurons. Low calcium levels activate PP2B and 
induce LTD, while higher concentrations of calcium activate CaM-kinase II which is 
required to trigger LTP. Thus, the current model is that LTP-generating stimuli result in the 
activation of both CaM-kinase II and calcium/calmodulin-stimulated adenylyl cyclase. The 
role of cAMP in the LTP pathway is to activate I-1 and suppress PP1 activity which 
reverses the actions of CaM-kinase II. Hence, I-1 functions as the gatekeeper which 
determines whether the neuron will transition from early to intermediate or late phases of 
LTP. In contrast to LTP, LTD results from the small influx of calcium which is unable to 
activate either CaMKII or adenyl cyclase, and the predominant signal transducer for LTD 
is PP2B. 
The β-adrenergic agonist isoproterenol has a positive ionotropic effect in the heart. 
Isoproterenol increases I-1 phosphorylation and results in the inhibition of PP1 activity in 
the myocardium (Neumann et al., 1991). This decrease in PP1 activity enhances cardiac 
contractility by preventing the dephosphorylation of proteins such as the Na/K-ATPase, 
phospholamban, troponin I and voltage sensitive calcium channels which are all involved 
in maintaining the contractile state of heart muscle (Lindmann and Watanabe, 1989). On 
the other hand, smooth muscle PP1 is tightly bound to myosin and is the primary myosin 
phosphatase (Chisholm and Cohen, 1988). Dephosphorylation of myosin light chain results 
in the relaxation of smooth muscle. Thus, hormones such as epinephrine that increase 
intracellular cAMP and lead to I-1 phosphorylation promote the relaxation of smooth 
muscle. This paradox was resolved by the finding that smooth muscle myosin light chain 
kinase (MLCK) is phosphorylated at an inhibitory site in response to cAMP. The 
dephosphorylation of MLCK at this site is also mediated by PP1. Thus, it has been 
proposed that hormonal activation of I-1 leads to the predicted inhibition of PP1 that acts 
on MLCK. MLCK is inactivated and smooth muscle relaxation occurs. Unlike CaM-kinase 
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II which is inactivated by PP1, MLCK requires PP1 activity to remain active. So, I-1 
functions in opposing ways to control protein kinases in neurons and smooth muscle. This 
model also predicts that the myosin bound PP1 is not regulated by I-1. This may be 
consistent with the presence of the common PP1-binding motif in I-1 and the 110kDa 
myosin-targeting subunit of PP1 (MYPT1), see below. Alternatively, the interplay between 
I-1, the myosin and the MLCK phosphatases may modulate the rate of protein 
phosphorylation and dephosphorylation that set the contractile tone of the smooth muscle.      
DARPP-32 (dopamine and cAMP-regulated phosphoprotein) (Hemmings et al., 
1984c) although originally identified by its enhanced phosphorylation in response to 
dopamine, is activated by many hormones and neurotransmitters that modulate cAMP 
levels (Snyder et al., 1992). DARPP-32 shows a more complex mode of regulation than I-
1. For instance, DARPP-32 is phosphorylated in vivo by both PKA and casein kinase I. 
Phosphorylation by casein kinase I impairs the turnover of phosphate at the activating Thr-
34 site (Desdouits et al., 1995b). Indeed, two different phosphatases, PP2B acting on 
Thr34 and PP2C dephosphorylating the casein kinase I sites, may regulate DARPP-32 
function. In brain, dopamine and glutamate have antagonic effects on the excitability of 
neurons, possibly mediated by their opposing effects on DARPP-32. Dopamine acting via 
D1 receptors activates adenyl cyclase, and through PKA, activates DARPP-32 (Walaas et 
al., 1983). Glutamate on the other hand, working through NMDA receptors, increases 
intracellular calcium that activates PP2B and reverses DARPP-32 activity. DARPP-32 also 
appears to be a critical component of the control of salt balance in the mammalian kidney. 
Use of DARPP-32 phosphopeptides showed that PP1 inhibition increased the 
phosphorylation of Na/K-ATPase. This resulted in increased sodium excretion as the 
ATPase no longer pumped sodium from the urine back into the blood stream. Vasodilation 
occurs as water flows into the kidney to maintain the ion gradient (Aperia et al., 1991).   
DARPP-32, but not I-1, is present in 3T3-L1 adipocytes and in these cells it is required for 
adipogenesis. Active DARPP-32 maintains low PP1 activity in differentiated fat cells and 
is essential for insulin to stimulate PP1 activity and facilitate triglyceride biosynthesis 
(Brady et al., 1997). cAMP- mediated activation of DARPP-32 may be critical for 
amplifying the phosphorylation events that lead to activation of hormone-sensitive lipase 
and enhanced lipolysis. 
Characterization of the PP1 Interactome from Human Testis Chapter IV  
 
Centro de Biologia Celular 
Universidade de Aveiro 151 
I-2 (F. L. Huang and W. H. Glinsmann, 1976) forms a stable and inactive complex 
with PP1c. This inactive complex was isolated as an ATP-Mg-dependent phosphatase 
activity which remained inactive until incubated with ATP-Mg. Activation of the latent 
complex is accompanied by the phosphorylation of I-2 on Thr-72 by GSK3. I-2 is also 
phosphorylated on three serines by casein kinase II (CK2). Phosphorylation by CK2 does 
not alter I-2 activity but greatly facilitates the subsequent phosphorylation by GSK3 
(DePaoli-Roach, 1984; Holmes et al., 1986b). The activation cycle for the ATP-Mg-
dependent phosphatase is complicated and controversial. The fundamental aspect of this 
cycle is that I-2 phosphorylation by GSK3 promotes a conformational change in the PP1/I-
2 complex which does not by itself activate the enzyme. The slow auto-dephosphorylation 
of I-2 correlates best with the increase in PP1 activity. Throughout this process I-2 remains 
bound to PP1 and in a longer time frame the complex relaxes back to its original inactive 
conformation. Recent studies show that multiple domains mediate the rapid and reversible 
inhibition of PP1 and the slower inactivation to the stable complex that can be reactivated 
by GSK3 (Park and DePaoli-Roach, 1994). The active PP1/I-2 complex can itself be 
inhibited by addition of exogenous I-2. In vitro studies suggest that I-2 interacts with 
denaturated PP1 to promote a rapid and effective refolding of this protein and yield an 
active enzyme. According to this idea recombinant PP1 behaves much more like the native 
enzyme after incubation with I-2 and reactivation by GSK3 (Alessi et al., 1993; Tung et 
al., 1995; MacKintosh et al., 1996). This led to the proposal that I-2 might be acting as a 
chaperone for PP1. This hypothesis may also be consistent with preliminary reports that 
overexpression of I-2 in mammalian cells does not inhibit cellular PP1 activity but in fact 
elevates the cellular content of PP1c. Studies with Glc8, the yeast homologue of I-2, came 
to a more complex conclusion, suggesting that under different circumstances, Glc8 was 
either an inhibitor or an activator of yeast PP1 (Tung et al., 1995). So, despite extensive 
studies, the functions of I-2 remain elusive. Perhaps the most intriguing property of I-2 is 
that its protein and mRNA levels fluctuate during the cell cycle, peaking twice, at S phase 
and mitosis (Brautigan et al., 1990). More recent studies used I-2 fused to the green 
fluorescent protein to show that I-2 was cytosolic during G1 and translocated to the 
nucleus in S phase (Kakinoki et al., 1997). As I-2 localization failed to correlate with PP1 
distribution in cells, this has raised questions about I-2’s role as a PP1 regulator, but no 
other functions have been described for I-2. However, Brautigan and coworkers, 
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discovered that I-2 is concentrated in the nucleus of cells cultured at low densities, while 
cells growing at high density excluded I-2 from the nucleus (Leach et al., 2003). This 
change in I-2 localization may direct I-2 to different forms of PP1 or change the 
localization of PP1 in response to cell-cell contacts at high density. 
In testis and sperm a few PP1 regulators have been identified. Indeed, the only 
physiological role proposed for I-2 is in the control of sperm motility. The testis-specific 
isoform PP1γ2 forms an inactive complex with an I2-like activity. The increased PP1 
activity seen in nonmotile immature sperm was accredited to an elevation in GSK3 activity 
which activates the PP1/I-2 complex. Incubation of immature sperm with phosphatase 
inhibitors, okadaic acid and calyculin A, induced motility (Vijayaraghavan et al., 1996), 
suggesting that I-2 inhibits PP1 activity in mature mammalian sperm to facilitate their 
motility. In this work we may have identified this I2-like activity, the I2-like protein, 
discussed in the previous chapter.     
Sds22 (Dinischiotu et al., 1997) is a regulatory polypeptide of PP1 that is required 
for the completion of mitosis in both fission and budding yeast. Renouf and coworkers 
(Renouf et al., 1995) reported the cDNA cloning of a human polypeptide that is 46% 
identical to yeast sds22. In S. cerevisiae, sds22 is largely a nuclear protein mostly present 
as a stable 1:1 complex with yeast PP1 (Glc7p). It was suggested recently (Peggie et al., 
2002) that sds22 functions positively with Glc7p to promote dephosphorylation of nuclear 
substrates required for faithful transmission of chromosomes during mitosis and that this 
role is at least partly mediated by effects of sds22 on the nuclear distribution of Glc7p. 
Interestingly, a new splice variant of sds22 is associated with PP1γ2 in rat testis (Chun et 
al., 2000). Bovine PP1γ2 was also found to bind sds22 (Huang et al., 2002) and both 
proteins were shown to be present in the spermatozoid tail and head. Therefore, 
mechanisms regulating sds22 binding to PP1γ2 are likely to be important in understanding 
the biochemical basis underlying development and regulation of sperm function. 
Recently,  a new PP1 testis specific regulator, GBPI-2 (gut and brain phosphatase 
inhibitor) was identified (Liu et al., 2004) that belongs to the PKC-potentiated PP1 
inhibitors (such as CPI, KEPI and PHI). A shorter mRNA encodes another isoform, GBPI-
1 that is expressed in brain, stomach, small intestine, colon and kidney. GBPI-1 inhibits 
PP1 only after phosphorylation by PKC. Interestingly when PKC-phosphorylated GBPI-1 
is phosphorylated by PKA it is unable to inhibit PP1. This new protein may be involved in 
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the integration of the PKC and PKA signal transduction mechanisms. It would be 
interesting to study the effect of GBPI-2 on PP12 activity in testis and its relation to 
sperm motility. 
For several targeting subunits there is a strong association with PP1 through the 
canonical PP1 binding motif allowing the formation of a weaker interaction with other 
regulator motifs that enhance binding or modulate PP1 activity and specificity. One of 
these other motifs are the ankyrin repeats that acts as additional contacts for the interaction 
with PP1. PP1 regulators that possess these domains include Myr8, MYPT1, MYPT3 and 
p53BP2. MYPT1 has seven ankyrin repeats and p53BP2 has four of these domains. 
Ankyrin repeats are motifs usually involved in protein/protein interactions. In the PP1 
binding partners this motifs are usually preceded by the RVxF PP1 binding motif.   
Interestingly, in the YTH1 screen a unique clone was identified encoding a 
previously unknown protein that possesses eight ankyrin repeats and other interesting 
features that attracted us for further studies. We named this protein SEARP (Six to Eight 
Ankyrin Repeat Protein). SEARP, although having been identified as a PP11 binding 
protein, also binds to PP12. Several studies were performed in order to describe SEARP’S 
localization, tissue distribution and possible function in the human testis and sperm 
motility. SEARP is present in a variety of tissues, mainly in testis. There are two splice 
variants of SEARP, one in testis and another in other tissues. The levels of SEARP mRNA 
are amazingly high in testis when compared to other tissues. Immunolocalization studies 
revealed that SEARP in present in the cell cytoplasm and is present throughout 
spermatogenesis and spermiogenesis.   
 
IV.2 MATERIALS AND METHODS 
 
For the complete composition of all reagents, media and solutions used, see the 
list presented in Appendix I. All reagents were cell culture grade or ultrapure. 
 
IV.2.1 Tissue preparation 
 
Rat tissues were obtained from sacrificed animals and immediately frozen on dry 
ice. Frozen rat tissues were resuspended in boiling 1%SDS and sonicated for 30sec. 
Human testis samples were obtained via the kind efforts of  Dr. Jorge Oliveira (IPO, Porto) 
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and processed in the same way as rat tissues. Testes from mature bulls with intact tunica 
were obtained from a local slaughter house and spermatozoa were isolated from caput and 
caudal epididymis (Fig. IV.1). Bovine testes were treated as previously described for rat 
testis for immunoblot analysis. Human semen samples were collected from healthy 
volunteer adult men and had an average sperm concentration of 2.2x108cells/ml (range: 12-
440x106), and an average 62% motility (range 31-85%). The average volume was 2.7ml 
(range 1.5-3.5ml). Samples were washed and processed for preparation of sperm sonicates 
(in boiling 1%SDS), immunoprecipitation (see below), immunocytochemistry (see below), 
or directly mounted on glass slides for motility video capture. 
 
 
Figure IV.1: Adult bovine testis (left) and epididymis (right). Corpus (1), caput (2) and caudal (3) 
sections of the epididymis are indicated.  
 
IV.2.2  Immunoprecipitation 
 
Fresh rat testis (1-10mg) were lysed in 100µl of lysis buffer (see Appendix) for 
15min on ice and sonicated for 30sec. The lysates were precleared with 25µl of Protein A 
Sepharose slurry (Pharmacia) for 1h at 4ºC with agitation. After centrifuging the sample 
for 1min at 4ºC at 10,000g, the supernatant was transferred to a new tube and 25µl of 
Protein A Sepharose slurry and the primary antibody were added. The mixture was 
incubated overnight at 4ºC with agitation. For the anti-PP12 antibody 25µl were used for 
10mg of rat testis and 5µl of anti-PP1 or 5µl of anti-PP1 were used for 1mg of rat testis; 
25µl of pre-immune serum were used with 10mg of rat testis homogenate as a negative 
control. The mixture was then centrifuged for 1min at 4ºC at 10,000g and the pellet washed 
4 times for 15min with 500µl of 50mM Tris-HCl (pH8.0), 120mM NaCl. Finally, 2 washes 
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were performed with 50mM Tris-HCl (pH8.0). The pellet was ressuspended in 100µl of 
electrophoresis buffer (loading buffer for SDS-PAGE of the immunoprecipitation with 
1mg of testis or re-hydratation solution for 2D electrophoresis of the immunoprecipitation 
with 10mg of testis). Before loading, the samples for SDS-PAGE were boiled for 3min and 
briefly centrifuged to pellet the Sepharose beads; for the 2D gel analysis, the samples were 
only centrifuged, but not boiled. 
 For the immunoprecipitation of human sperm, the samples were centrifuged at 350g 
for 7min at RT and the pellet resuspended in 1ml of lysis buffer. 250µl of sperm 
homogenate (corresponding to 500mg of protein) were used for immunoprecipitation with 
2µl anti-PP12 or 2µl of anti-PP11 or 2µl of pre-immune serum or 2µl anti-SEARP (gift 
from P. T. Cohen), using the procedure described above. 
 
IV.2.3 2D Gel Electrophoretic Analysis 
 
Two dimensional gel electrophoresis combines protein separation by isoelectric 
focusing (IEF), in the first dimension, with SDS-PAGE in the second dimension. In a pH 
gradient, under the influence of an electric field, proteins migrate to the position in the 
gradient where their net charge is zero; proteins will separate according to their isoelectric 
point. The original method for the first dimension separation depended on carrier 
ampholyte-generated pH gradients in polyacrylamide tube gels. Because of the limitations 
of this method, an alternative technique for pH gradient formation was developed more 
recently: immobilized pH gradients (IPG) (Bjellqvist et al., 1982; Gorg et al., 1988). This 
type of gradient is created by covalently incorporating a gradient of acidic and basic 
buffering groups into a polyacrylamide gel at the time it is cast. 
The pelleted samples from the immunoprecipitation experiments were resuspended 
and properly solubilized in 100µl re-hydration buffer [lysis buffer supplemented with 0.5% 
of IPG buffer (in the 3-10 pH range), 0.7mg of DTT per strip and 0.002% of bromophenol 
blue]. Each sample thus prepared was pipeted into a strip holder and overlaid with dry strip 
cover fluid (Amersham Pharmacia). The strips were placed in the IPGphor electrophoresis 
equipment and the electrophoresis was started. The IEF program used was as follows: 
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Step Voltage (V) Duration (h) 
          Rehydration of the strip under voltage 30 12 
Ionic impurities removal 150 2 
Sample entry into the strip 500 1 
Protein movement 1000 1 
High definition isoelectric focusing 8000 2 
 
For the second dimension (SDS-PAGE), 11% gels were cast using a 14x16cm gel 
apparatus (Hoefer SE 600 system) and the strips from the first dimension were placed on 
top of the casting gel. Electrophoretic separation was performed at 90mA until the tracking 
dye reached the bottom of the gel. Proteins were later visualized by silver staining or 
transferred to nitrocellulose membranes for immunoblot with anti-SEARP and anti-PP12 
antibodies. 
 
IV.2.4  Silver Staining 
 
For increased sensitivity in protein detection the reversible silver staining procedure 
was used. In this technique the gel is impregnated with soluble silver ions and developed 
by treatment with formaldehyde, which reduces silver ions to form an insoluble brown 
precipitate. Proteins promote this reduction. Gels from the 2D electrophoresis were 
incubated overnight in fixing solution and then transferred into sensitizing solution for 30 
min. The gels were washed three times with distilled water and incubated for 20 min in 
silver solution, in the dark. Following two washes with distilled water to remove excess 
silver nitrate, the gels were placed in developing solution until protein bands appeared. The 
reaction was stopped with stop solution. Finally, the gels were washed with distilled water 
and scanned in a GS-710 calibrated imaging densitometer (Amersham-Pharmacia) and 
analyzed with Quantity One software (version 4.2.1). Alternatively, gels were destained 
with 100mM potassium ferricyanide for a few minutes, rinsed several times in water and 
then transferred to nitrocellulose membranes for immunoblot analysis. 
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IV.2.5  Cell Culture 
 
COS-7 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% heat-inactivated fetal calf serum (Invitrogen). Cells were grown in 
10cm plates or 6-well plates in a 5%CO2 humidified incubator at 37ºC and subcultured 
every 2-3 days.  
 
IV.2.6  Cell transfection  
 
For expression in COS-7 cells, the cDNA insert from clone 40Q was PCR-
amplified using high fidelity Pfu polymerase (Stratagene) with two different set of primers 
(40Q3P1/40Q3P2 and 40Q3P2/40Q3P3) and subcloned between the EcoRI and BamHI 
sites of the pEGFP vector, upstream of the enhanced green fluorescent protein (EGFP) 
cassette. The cDNA for PP12 was also subcloned into the EcoRI site of the pcDNA3.1 
expression vector (Invitrogen). Lipofectamine (Invitrogen) was used for transfection of 
COS-7 cells using the pcDNA3.1-PP12 expression vector, the pEGFP expression vectors 
encoding GFP-40Q or GFP-32240Q (starting at amino acid 322, Fig. IV.II), or GFP alone, 
as a control. One day before transfection, the cells were plated in DMEM with 10% fetal 
fetal calf serum so they were 90% confluent at the time of transfection. For each 
transfection sample in 6-well plates the DNA/Lipofectamine complexes were prepared as 
follows: 10µl of Lipofectamine were diluted in 500µl DMEM without serum or antibiotics 
and added to 1µg of plasmid DNA previously diluted in 500µl of the same medium. The 
mixture was allowed to complex for 20min at RT and then the 1ml sample was added to 
each well and gently mixed by rocking the plate back and forth. 20h after transfection, 
cells were harvested and replated in poly-L-ornithine coated cover slips placed in 6-well 
plates. After 4h, cells were washed 3 times with DMEM without serum and fixed for 
25min with 4% paraformaldheyde. After 3 washes with 1XPBS the cover slips were 
mounted on a slide with one drop of Fluoroguard. Cells were then visualized in an 
epifluorescence Olympus microscope.   
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IV.2.7  Immunocytochemistry  
 
COS-7 cells were fixed with 4% paraformaldehyde and washed with PBS as 
described above. Then were permeabilized with methanol for 2min and immediately 
washed with 1XPBS. After, cells were incubated with primary antibody diluted in 3%BSA 
in PBS (50µl) for 1h at RT (diluted 1:1000 for anti-PP12, or 1:250 for anti-SEARP). The 
primary antibody was removed by washing 3 times with 1XPBS and the secondary 
antibody placed over the cells for 1h at RT (the secondary antibody, Texas Red conjugated 
Goat Anti-Rabbit was diluted 1:300 according to the manufacturer’s instructions). After 
washing 3 times with 1XPBS the cover slips were mounted in one drop of Fluoroguard in a 
glass slide. Cells were visualized in an Olympus epifluorescence microscope.   
 The immunocytochemistry protocol used for spermatozoa was very similar to that 
described above. Briefly, bovine or human spermatozoa were resuspended in 1XPBS after 
centrifugation at 350g for 7min. Samples (500µl) were then plated in poly-L-ornithine 
coated cover slips placed in 6-well plates for 15min. The spermatozoa were then fixed with 
500µl of 4% paraformaldehyde, washed with 1XPBS and permeabilized with methanol for 
2min or 0.2%Triton for 7min. The spermatozoa were then treated for 
immunocytochemistry as described above.  
 
IV.2.8 Immunohistochemistry 
 
Adult mice were perfused with formaldehyde to fix all tissues. Testis were removed 
and submersed in formaldehyde overnight with agitation. The fixed testes were cut in 
slices and put in minicassettes. The tissue was then washed 6 times for 15min with 
30%ethanol and left overnight in 30%ethanol. Afterwards, the samples were processed 
according to the manufacturer’s instructions in a sample processor (Table IV.2). 
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Table IV.2: Paraffin embedding of fixed rat testes. 
Step Solution Time/h 
1 70%ethanol 1 
2 70%ethanol 1 
3 90%ethanol 1 
4 96%ethanol 1 
5 96%ethanol 1 
6 Toluene 1 
7 Toluene 1 
8 Toluene 1 
9 Paraffin 10 
10 Paraffin 4 
 
 The processed tissue was mounted on paraffin and stored at -20ºC. The tissue was 
sliced into 3µm sections using a microtome (Leica). Sections were then stretched on a 
histological water bath with gelatine (Sigma) at 37ºC, put on a glass slide and dried for 
30min in a 60ºC incubator. To check tissue integrity, samples were stained with 
haematoxylin and eosin as illustrated in Table IV.3. 
 
Table IV.3: Haematoxylin and eosin staining procedure. 
Step Solution Time/min 
1 Xylene 15 
2 Xylene 10 
3 96%ethanol 10 
4 96%ethanol 10 
5 70%ethanol 10 
6 H2O 10 
7 Haematoxylin 2-10 
8 H2O 5 
9 Ethanol-HCl 5-30sec 
10 96%ethanol 10 
11 H2O 10 
12 Eosin 2-6 
13 70%ethanol 5 
14 90%ethanol 5 
15 96%ethanol 10 
16 96%ethanol 10 
17 Xylene 5 
18 Xylene 5 
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 After this procedure the tissue was mounted in DPX and visualized in a phase 
contrast microscope. After verification of tissue integrity, immunohistochemistry was 
performed (Table IV.4): 
 
Table IV.4: Immunohistochemistry method. 
Step Solution Time/min 
1 Xylene 10 
2 Xylene 10 
3 96%ethanol 5 
4 90%ethanol 5 
5 70%ethanol 5 
6 H2O 5 
7 0.04%pepsine in 0.1M HCl pH2.0, 37ºC 30 
8 1XPBS 5 
 
 The samples were then treated for 5min with a solution to block endogenous 
peroxidase activity (160ml 1XPBS, 20ml methanol, 20µl 30%H2O2). This step was 
omitted for immunofluorescence. After three 5min washes with 1XPBS, samples were 
incubated for 1h with serum of the animal of the secondary antibody diluted 1:30 in 
1XPBS, to block non-specific background. Afterwards, the samples were incubated with 
the primary antibody diluted in 1XPBS for 1h at RT, or overnight at 4ºC. The primary 
antibodies used and their working dilutions are summarized below (Table IV.5). 
 
Table IV.5: Primary antibody dilution. 
Antibody Dilution 
Preimmune serum 1:1000 
Anti-PP12 1:500 
Anti-PP1 1:500 
Anti-SEARP 1:250 
 
 Following three 5min washes with 1XPBS, the samples were incubated for 1h with 
secondary antibody diluted in 1XPBS, and washed again as before. If the secondary 
antibody was conjugated with peroxidase, a developing solution [198ml 1XPBS, 2ml DAB 
(diaminobenzine), 200ml 30%H2O2 solution, previously filtered with a 0.22µm filter], was 
left over the sample until a brown colour appeared (~10min). Samples were finally stained 
with haematoxylin (as described above) and mounted in DPX. If the secondary antibody 
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was conjugated with a fluorocrome (Cy3, cyanide dye), the sample was directly mounted 
with Fluoroguard and kept in the dark until visualization in the microscope. 
 
IV.3 RESULTS 
 
IV.3.1  SEARP sequence analysis 
 
Clone number 40Q, identified in YTH1, encoded a protein displaying interesting 
characteristics that warranted its further study. First, the clone was completely sequenced 
with the primers GAL4-AD, OLIGO40Q3, OLIGO40Q3/2, OLIGO40Q3/3 and 
OLIGO40Q3/4 (see Appendix). After complete insert sequencing and database searching it 
was concluded that the encoded protein was a completely new protein. When we first 
identified this clone it only existed in the database at the genomic level, mapping to 
chromosome 11. After a few months, a putative coding sequence (Gi: 21754395) was 
submitted containing part of our clone. This cDNA starts at position 964 below (Fig. IV.2), 
whereas the 40Q sequence starts at position 169 and is 2415 nt long: 
 
1 
1 
61 
21 
121 
41 
181 
61 
241 
81 
301 
101 
361 
121 
421 
141 
481 
161 
541 
181 
601 
201 
661 
221 
721 
241 
781 
261 
841 
281 
901 
301 
961 
321 
1021 
atgcccctggagggcaggcgacggccctgctgcctctccagccaagtggctggagtcggg 
 M  P  L  E  G  R  R  R  P  C  C  L  S  S  Q  V  A  G  V  G  
aggctggaaagagactccgagaaagtaccagcggaaggcggccgccgctacggcgattcg 
 R  L  E  R  D  S  E  K  V  P  A  E  G  G  R  R  Y  G  D  S  
cagggagtagcagacgaagacggtggccgccgcactagccaccacgtgtggaggataaac 
 Q  G  V  A  D  E  D  G  G  R  R  T  S  H  H  V  W  R  I  N  
ggtctacacggccattccggcgccgagtctagggaaagagttagcgacgacggggaaaga 
 G  L  H  G  H  S  G  A  E  S  R  E  R  V  S  D  D  G  E  R  
aaatgtgaagagagcgaccgccgctccagggtcgctgcaggaagcctaagtgcagacgcc 
 K  C  E  E  S  D  R  R  S  R  V  A  A  G  S  L  S  A  D  A  
ggcttctcccgcagtgacttgagaagggtcagtgaaaacctcggccactgccgcagcgtc 
 G  F  S  R  S  D  L  R  R  V  S  E  N  L  G  H  C  R  S  V  
tctagggagagagttaggggagatagtggccacagtcacagctgctcttgggagagagtt 
 S  R  E  R  V  R  G  D  S  G  H  S  H  S  C  S  W  E  R  V  
aggggagacagcaccttctgcagcagcgacgtgaattttagtgaagttggaggccaccaa 
 R  G  D  S  T  F  C  S  S  D  V  N  F  S  E  V  G  G  H  Q  
actaccgactccaggggaacagccagagaagaccgaggcctccgcctcagtggtccttgg 
 T  T  D  S  R  G  T  A  R  E  D  R  G  L  R  L  S  G  P  W  
gagggagtcagtgacattcgggacccgcgaactagtgacttcggggatagagtcagtgac 
 E  G  V  S  D  I  R  D  P  R  T  S  D  F  G  D  R  V  S  D  
gatcgcagtcgccgcttcagtggctcctgggagggagggagtgtcgaaggcggccacagc 
 D  R  S  R  R  F  S  G  S  W  E  G  G  S  V  E  G  G  H  S  
gttggtagttcttgggaggaagtaagtggagaccgcggctacgcagccagcgactcctct 
 V  G  S  S  W  E  E  V  S  G  D  R  G  Y  A  A  S  D  S  S  
ggtgtgagcggcagtgaagacgccagctaccgcttcagtggcttttgggagagagaaagt 
 G  V  S  G  S  E  D  A  S  Y  R  F  S  G  F  W  E  R  E  S  
gaagacgaaggtttccgctgcagcttctgggagagagcaagagaggaccttgggccccgt 
 E  D  E  G  F  R  C  S  F  W  E  R  A  R  E  D  L  G  P  R  
cctagtgacgacggagaagagggccgctgccgctgcagtggctcgtgggtgagagcaagt 
 P  S  D  D  G  E  E  G  R  C  R  C  S  G  S  W  V  R  A  S  
gaagaccgccgcagcatcaggggcctggactcaactcctccccagagtcggaggtgttgc 
 E  D  R  R  S  I  R  G  L  D  S  T  P  P  Q  S  R  R  C  C  
gccatgcccggggtggccaattcaggcccctccacttcctctagggagactgcaaacccc 
 A  M  P  G  V  A  N  S  G  P  S  T  S  S  R  E  T  A  N  P  
tgttccaggaagaaggtgcattttggcagcatacatgatgcagtacgagctggagatgta 
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341 
1081 
361 
1141 
381 
1201 
401 
1261 
421 
1321 
441 
1381 
461 
1441 
481 
1501 
501 
1561 
521 
1621 
541 
1681 
561 
1741 
581 
1801 
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1861 
621 
1921 
641 
1981 
661 
2041 
681 
2101 
701 
2161 
721 
2221 
741 
2281 
761 
2341 
781 
2401 
801 
2461 
821 
2521 
841 
2581 
 C  S  R  K  K  V  H  F  G  S  I  H  D  A  V  R  A  G  D  V  
aagcagctttcagaaatagtggtacgtggagccagcattaatgaacttgatgttctccat 
 K  Q  L  S  E  I  V  V  R  G  A  S  I  N  E  L  D  V  L  H  
aagtttacccctttacattgggcagcacattctggaagtttggagtgtcttcattggctg 
 K  F  T  P  L  H  W  A  A  H  S  G  S  L  E  C  L  H  W  L  
ctctggcatggagctgatatcacacacgtaacaacgagaggttggacagcatctcacata 
 L  W  H  G  A  D  I  T  H  V  T  T  R  G  W  T  A  S  H  I  
gctgcaatcaggggtcaggatgcttgtgtacaggctcttataatgaatggagcaaatctg 
 A  A  I  R  G  Q  D  A  C  V  Q  A  L  I  M  N  G  A  N  L  
acagcccaggatgaccggggatgcactcctttacatcttgctgcaactcatggacattct 
 T  A  Q  D  D  R  G  C  T  P  L  H  L  A  A  T  H  G  H  S  
ttcactttacaaataatgctccgaagtggagatcccagtgtgactgataagagagaatgg 
 F  T  L  Q  I  M  L  R  S  G  D  P  S  V  T  D  K  R  E  W  
agacctgtgcattatgcagcttttcatgggcggcttggctgcttgcaacttcttgttaaa 
 R  P  V  H  Y  A  A  F  H  G  R  L  G  C  L  Q  L  L  V  K  
tggggttgtagcatagaagatgtggactacaatggaaaccttccagttcacttagcagcc 
 W  G  C  S  I  E  D  V  D  Y  N  G  N  L  P  V  H  L  A  A  
atggaaggccaccttcactgtttcaaattcctagtcagtagaatgagcagtgcgacgcaa 
 M  E  G  H  L  H  C  F  K  F  L  V  S  R  M  S  S  A  T  Q  
gttttaaaagctttcaatgataatggagaaaatgtactggatttggcccagaggttcttc 
 V  L  K  A  F  N  D  N  G  E  N  V  L  D  L  A  Q  R  F  F  
aagcagaacattttacagtttatccagggggctgagtatgaaggaaaagacctagaggat 
 K  Q  N  I  L  Q  F  I  Q  G  A  E  Y  E  G  K  D  L  E  D  
caggaaactttagcatttccaggtcatgtggctgcctttaagggtgatttggggatgctt 
 Q  E  T  L  A  F  P  G  H  V  A  A  F  K  G  D  L  G  M  L  
aagaaattagtggaagatggagtaatcaatattaatgagcgtgctgataatggatcaact 
 K  K  L  V  E  D  G  V  I  N  I  N  E  R  A  D  N  G  S  T  
cctatgcataaagctgctggacaaggccacatagagtgtttgcagtggttaattaaaatg 
 P  M  H  K  A  A  G  Q  G  H  I  E  C  L  Q  W  L  I  K  M  
ggagcagacagtaatattaccaacaaagcaggggagagacccagtgatgtggcaaagagg 
 G  A  D  S  N  I  T  N  K  A  G  E  R  P  S  D  V  A  K  R  
tttgcccatttggcagcagtgaagctgttagaggagctacagaaatatgatatagatgac 
 F  A  H  L  A  A  V  K  L  L  E  E  L  Q  K  Y  D  I  D  D  
gaaaatgaaattgatgaaaatgatgtgaaatattttataagacatggtgttgagggaagc 
 E  N  E  I  D  E  N  D  V  K  Y  F  I  R  H  G  V  E  G  S  
actgatgccaaggatgatttatgtctgagtgacttggataaaacagatgccagaatgaga 
 T  D  A  K  D  D  L  C  L  S  D  L  D  K  T  D  A  R  M  R  
gcttacaagaaaattgtagaattgagacacctcctggaaattgccgagagcaactataaa 
 A  Y  K  K  I  V  E  L  R  H  L  L  E  I  A  E  S  N  Y  K  
cacttgggaggcataacagaagaagatttaaagcagaagaaagaacagcttgagtctgaa 
 H  L  G  G  I  T  E  E  D  L  K  Q  K  K  E  Q  L  E  S  E  
aagaccatcaaagaactgcagggccagctggagtatgaacgactacgtagagaaaaatta 
 K  T  I  K  E  L  Q  G  Q  L  E  Y  E  R  L  R  R  E  K  L  
gaatgtcagcttgatgaatatcgagcagaagttgatcaactcagggaaacactggaaaaa 
 E  C  Q  L  D  E  Y  R  A  E  V  D  Q  L  R  E  T  L  E  K  
attcaagtcccaaactttgtggctatggaagacagcgcttcttgtgagtcaaacaaagag 
 I  Q  V  P  N  F  V  A  M  E  D  S  A  S  C  E  S  N  K  E  
aagaggcgagtaaaaaaaaaaggtttcttctggaggggtgtttgtgagaaggtactaatc 
 K  R  R  V  K  K  K  G  F  F  W  R  G  V  C  E  K  V  L  I  
agtgaaataactaaattgacctgctagatttttctctttcattaaaaaaattgatataaa 
 S  E  I  T  K  L  T  C  * 
tgtg 
Figure IV.2: Nucleotide and amino acid sequence of SEARP. Clone 40Q starts at nt 169 while the 
database clone (Gi: 21754395) starts at nt 964 and exhibits a different splicing pattern. The PP1 
binding motif is in green. The red and blue colours identify different exons. 
 
Examination of the amino acid sequence for signaling motif (Sigrist et al., 2002) identified 
the existence of eight ankyrin repeats. Arround the same time, a lymphocyte specific 
isoform was also reported (Cohen P. T., personal communication), but with a different C-
terminal sequence (Fig. IV.3). The protein encoded by the 40Q cDNA was termed SEARP-
T, whereas the lymphocyte protein was termed SEARP-L. 
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SEARP-L           MPLEGRRRPCCLSSQVAGVGRLERDSEKVPAEGGRRYGDSQGVADEDGGRRTSHHVWRIN 
SEARP-T           --------------------------------------------------------WRIN 
                                                                          **** 
 
SEARP-L           GLHGHSGAESRERVSDDGERKCEESDRRSRVAAGSLSADAGFSRSDLRRVSENLGHCRSV 
SEARP-T           GLHGHSGAESRERVSDDGERKCEESDRRSRVAAGSLSADAGFSRSDLRRVSENLGHCRSV 
                  ************************************************************ 
 
 
SEARP-L           SRERVRGDSGHSHSCSWERVRGDSTFCSSDVNFSEVGGHQTTDSRGTAREDRGLHLSGPW 
SEARP-T           SRERVRGDSGHSHSCSWERVRGDSTFCSSDVNFSEVGGHQTTDSRGTAREDRGLRLSGPW 
                  ******************************************************:***** 
 
SEARP-L           EGVSDIRDPRTSDFGDRVSDDRSRRFSGSWEGGSVEGGHSVGSSWEEVSGDRGYAASDSS 
SEARP-T           EGVSDIRDPRTSDFGDRVSDDRSRRFSGSWEGGSVEGGHSVGSSWEEVSGDRGYAASDSS 
                  ************************************************************ 
 
SEARP-L           GVSGSEDASYRFSGFWERESEDEGFRCSFWERAREDLGPRPSDDGEEGRCRCSGSWVRAS 
SEARP-T           GVSGSEDASYRFSGFWERESEDEGFRCSFWERAREDLGPRPSDDGEEGRCRCSGSWVRAS 
                  ************************************************************ 
 
SEARP-L           EDRRSIRGLDSTPPQSRRCCAMPGVANSGPSTSSRETANPCSRKKVHFGSIHDAVRAGDV 
SEARP-T           EDRRSIRGLDSTPPQSRRCCAMPGVANSGPSTSSRETANPCSRKKVHFGSIHDAVRAGDV 
                  ************************************************************ 
 
SEARP-L           KQLSEIVVRGASINELDVLHKFTPLHWAAHSGSLECLHWLLWHGADITHVTTRGWTASHI 
SEARP-T           KQLSEIVVRGASINELDVLHKFTPLHWAAHSGSLECLHWLLWHGADITHVTTRGWTASHI 
                  ************************************************************ 
 
SEARP-L           AAIRGQDACVQALIMNGANLTAQDDRGCTPLHLAATHGHSFTLQIMLRSGVDPSVTDKRE 
SEARP-T           AAIRGQDACVQALIMNGANLTAQDDRGCTPLHLAATHGHSFTLQIMLRSG-DPSVTDKRE 
                  ************************************************** ********* 
 
SEARP-L           WRPVHYAAFHGRLGCLQLLVKWGCSIEDVDYNGNLPVHLAAMEGHLHCFKFLVSRMSSAT 
SEARP-T           WRPVHYAAFHGRLGCLQLLVKWGCSIEDVDYNGNLPVHLAAMEGHLHCFKFLVSRMSSAT 
                  ************************************************************ 
 
SEARP-L           QVLKAFNDNGENVLDLAQRFFKQNILQFIQGAEYEGKDLEDQETLAFPGHVAAFKGDLGM 
SEARP-T           QVLKAFNDNGENVLDLAQRFFKQNILQFIQGAEYEGKDLEDQETLAFPGHVAAFKGDLGM 
                  ************************************************************ 
 
SEARP-L           LKKLVEDGVININERADNGSTPMHKAAGQGHIECLQWLIKMGADSNITNKAGERPSDVAK 
SEARP-T           LKKLVEDGVININERADNGSTPMHKAAGQGHIECLQWLIKMGADSNITNKAGERPSDVAK 
                  ************************************************************ 
 
SEARP-L           RFAHLAAVKLLEELQKYDIDDENEIDENDVKYFIRHGVEGSTDAKDDLCLSDLDKTDARM 
SEARP-T           RFAHLAAVKLLEELQKYDIDDENEIDENDVKYFIRHGVEGSTDAKDDLCLSDLDKTDARM 
                  ************************************************************ 
 
SEARP-L           RAYKKIVELRHLLEIAESNYKHLGGITEEDLKQKKEQLESEKTIKELQGQLEYERLRREK 
SEARP-T           RAYKKIVELRHLLEIAESNYKHLGGITEEDLKQKKEQLESEKTIKELQGQLEYERLRREK 
                  ************************************************************ 
 
SEARP-L           LECQLDEYRAEVDQLRETLEKIQVPNFVAMTALLVSQTKRRGE----------------- 
SEARP-T           LECQLDEYRAEVDQLRETLEKIQVPNFVAMEDSASCESNKEKRRVKKKGFFWRGVCEKVL 
                  ******************************     .::::. .                  
 
SEARP-L           --------- 
SEARP-T           ISEITKLTC 
Figure IV.3: Comparison of the amino acid sequences of SEARP-L and SEARP-T. 
 
Other motifs present include a EF-calcium binding domain (aa 677-689), a BZip-
Maf transcription factor domain (aa 721-618) and the PP1 binding domain (aa 345-348) 
upstream of the eight ankyrin repeats (aa 346-375, 380-409, 413-442, 446-476, 478-507, 
511-540, 583-613, 617-646). The ankyrin repeats mediate interaction between a wide 
spectrum of proteins. Ankyrin repeats are tandemly repeated modules of about 33 amino 
acids that occur in a large number of functionally diverse proteins. This domain has been 
described as an L-shaped structure consisting of a beta-hairpin and two alpha helices 
(Gorina and Pavletich, 1996). The appearance of the PP1 binding motif just before the 
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eight ankyrin repeats also occurs in another well known PP1 binding protein, the p53BP2 
or PPP1R13A (Helps et al., 1995). SEARP also possesses consensus sites for 
phosphorylation by Protein kinase C, Casein kinase II, cAMP- and cGMP-dependent 
protein kinases and tyrosine kinases. Thus, SEARP itself may be regulated by 
phosphorylation. 
The exon-intron organization of SEARP was determined by aligning SEARP 
cDNA sequence with the nucleotide sequence of chromosome 11 (Table IV.6). The 
SEARP-T transcript spreads over 63Kb on chromosome 11 and is 2604bp long. 
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Table IV.6: Exon-intron organization of SEARP-T. 
Exon 
nº 
Exon seq Intron sequence Exon seq 
Exon 
nº 
1 gagggcag17 63058gtaattct….tttccaag63812 18gcgacggc 2 
2 aaacccct1041 64817gtgagtca….ttcaatag68566 1042gttccagg 3 
3 gtttggag1206 68731gtaagaaa….tttcttag76145 1207tgtcttca 4 
4 gtgtacag1314 76254gtaataat….atttttag80387 1315gctcttat 5 
5 gaagtgga1431 80505gtggtgag….acctctag81382 1432gatcccag 6 
6 ccttccag1567 81519gtatttta….tcctctag94942 1568ttcactta 7 
7 tcaggaaa1767 95144gtaagtaa….attcatag97834 1768ctttagca 8 
8 gcataaag1893 97961gtgagtta….ttgaacag106491 1894ctgctgga 9 
9 gcaaagag1999 106598gtataaat…ttctacag110846 2000gtttgccc 10 
10 tgccagaa2175 111023gtaagtat….tcttgcag115585 2176tgagagct 11 
11 tctgaaaa2302 115613gtaatgtc….tttgatag118030 2303gaccatca 12 
12 tggctatg2448 118176gttggtgt….gcttatag125932 2449gaagacag 13 
Nucleotide sequences around the identified splice junctions of the human testis specific SEARP-T 
transcript. The conserved gt-ag of splice donor and acceptor sites are shown in bold. The exon 
nucleotide numbers related to Figure IV.2 and the introns nucleotides correspond to the sequence 
of chromosome 11 (Gi:13094222). 
 
IV.3.2  Tissue distribution of SEARP 
 
Table IV.7 compares the general properties of SEARP-T and SEARP-L. The two 
proteins arise by alternative splicing but are very similar, as already pointed out above 
(Fig. IV.3).  
 
Table IV.7: Features of SEARP-testis specific and SEARP-lymphocyte specific. 
Characteristic SEARP-T SEARP-L 
No. of amino acids 848 823 
Molecular weight (KDa) 94.5 91.5 
pI 5.99 5.89 
 
The tissue distribution of SEARP was evaluated by immunoblot analysis of 
different rat tissues, human testis (Fig. IV.4), bovine testis (Fig IV.5) and human sperm 
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(Fig. IV.5). From Figure IV.4 it is evident that SEARP is present in human and rat testis 
and also in ovary. Besides these reproductive tissues, SEARP is also expressed in lung and 
liver, and is apparently also present in the other tissues examined but in much lower 
abundance. The observed slight difference in mobility in rat testis (RT) and ovary (Ov) is 
in agreement with the predicted higher molecular mass of SEARP-T (TableIV.7). In the 
brain, SEARP was only detected in cerebellum and olfactory bulb although at much lower 
levels. Since high levels of PP1 activity were co-immunoprecipitated with SEARP from 
brain (P. T. Cohen, personal communication), the possibility exists that another, different 
796alternatively spliced SEARP isoform may occur in brain. The tissue distribution of 
PP12 is also shown in Fig. IV.4 for comparison. PP12 is most abundant in testis as 
reported before (Vijayaraghavan et al., 1996) but is also found in other tissues. As for 
SEARP, high levels of PP12 were also detected in testis, ovary and lung. Additionally, 
PP12 seems to be also highly expressed in striatum, olfactory bulb and hippocampus. 
 
         
39KDa PP12
90KDa SEARP
HT   RT  Ov Ki M   Lu  He   Li    Co   St    MB  BS   Ce OB   Th Ht   Hc
 
Figure IV.4: Immunoblot analysis using anti-SEARP and anti-PP12 antibodies with different rat 
tissues and human testis (100µg). HT, human testis; RT, rat testis; Ov, rat ovary; Ki, rat kidney; M, 
rat skeletal muscle; Lu, rat  lung; He, rat heart; Li, rat liver; Co, rat cortex; St, rat striatum; MB, 
rat mid brain; BS, rat brain stem; Ce, rat cerebellum; OB, rat olfactory bulb; Th, rat thalamus; Ht, 
rat hypothalamus; Hc, rat hippocampus. 
 
 It is also apparent by analyzing Fig. IV.4 that there is a huge difference in the 
amount of PP12 in rat testis compared with human testis. For that reason, the abundance of 
PP12 in bovine testis was also verified (Fig. IV.5). 
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Figure IV.5: Immunoblot analysis of PP12 in human (100µg), rat (10µg) and bovine (10µg) 
testis. 
 
Whereas bovine and rat testis express approximately the same amounts of PP12, 
human testis contains more than 10-fold less PP12, as can be seen in Fig. IV.5. However, both 
SEARP-T and PP12 appear to be relatively enriched in sperm (Fig. IV.6), in contrast to 
PP1, which is equally expressed in both samples. Using an anti-PP1 antibody 
recognizing both PP11 (37kDa) and PP12 (39kDa), it is apparent that while human testes 
express both PP11 and PP12, human sperm has only PP12 (Fig. IV.6B). In comparison, 
very little PP12 is detected in rat cortex.  
Human 
Testis
Human 
Sperm
94KDa SEARP
PP1239KDa
PP137KDa
Human 
Testis
Human 
Sperm
Rat 
Cortex
94KDa SEARP
37KDa
39KDa
PP1
 
A)                                                                     B) 
Figure IV.6: A) Immunoblot analysis of SEARP, PP12 and PP1 expression in human testis 
and human sperm (50µg). B)  Immunoblot comparison of SEARP (100µg each tissue), and PP1 
(25µg of rat cortex, 200µg human testis and 100µg human sperm) expression in rat cortex and 
human testis and sperm.  
 
 In order to verify the expression of 40Q mRNA in different tissues, Northern blot 
analysis was performed using a Rat Multiple Tissue Northern (MTN) Blot. Using the 40Q 
cDNA as probe, SEARP transcript of 3.6kb was detected (Fig. IV.7). The expression of 
SEARP in testis is amazingly high when compared to the expression of SEARP in the 
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other tissues analyzed. Brain and liver also expressed detectable levels of SEARP mRNA. 
As control we used a -actin probe that detected a transcript of 2.1kb in non-muscle tissues 
and another transcript of 1.6kb in both cardiac and skeletal muscle. 
He      Br      Sp     Lu     Li      M       Ki Te
SEARP
-Actin
3.6 kb
1.6 kb
2.1 kb
 
Figure IV.7: MTN blot analysis of different rat tissues using the cDNA of clone 40Q as probe.He, 
heart; Br, brain; Sp, spleen; Lu, lung; Li, liver; M, muscle; Ki, kidney; Te, testis. 
 
Densitometric analysis of the SEARP mRNA band, corrected against the 2.1kb 
actin control yielded the results shown in Table IV.8. Skeletal muscle was excluded from 
this analysis since it expresses little or none of this actin transcript. Clearly, SEARP 
mRNA is more abundant in testis than in all the other tissues analysed. 
 
Table IV.8: Relative abundance of SEARP mRNA. 
Tissue Heart Brain Spleen Lung Liver Kidney Testis 
%SEARP mRNA 2.3 5.6 0.24 2.4 3.9 1.9 100 
The value for testis was set at 100% and all other tissues were expressed as a percentage of this 
value. 
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IV.3.3  Confirmation of SEARP/PP12 interaction 
 
Sequential transformation of yeast with the bait and the prey vectors performed in 
order to confirm the YTH interaction (Fig. IV.8). 
PREY –SEARP-T
BAIT         PP11              PP12            PP12end
 
Figure IV.8: Sequential transformation of yeast AH109 (see Appendix) first with the bait plasmid 
(pAS2PP11 or pAS2PP12 or pAS2PP12end) and then the prey plasmid (pACT-2-40Q). 
 
 The results obtained (Fig. IV.8) indicate that SEARP-T interacts with PP11 and 
PP12 but not with the unique C-terminal domain of PP12. The interaction of SEARP-T 
with PP12 appear to be stronger than with PP11, since with the latter the colony grew 
white and only turned blue after several days. 
Since it was developed, 2D gel electrophoresis has been the technique of choice to 
study the protein content of a certain tissue or to compare protein expression profiles of 
sample pairs, for instance, healthy versus disease conditions.  2-D technology can provide 
a huge amount of putative protein targets for drug development strategies. Protein spots 
can be further analyzed by mass spectrometry, peptide sequencing and 2D 
immunoblotting. Information taken from 2-D gel analysis can be stored in databases like 
http://biobase.dk/cgi-bin/celis and http://expasy.hcuge.ch/ch2d/2d-index.html.  
Here, we made use of this technique to further characterize the PP12 interactome 
from rat testis and human sperm. Thus, to obtain a global picture of the proteins from rat 
testis or human sperm that interact with PP12 we performed immunoprecipitation of 
protein extracts from these tissues with the highly specific anti-PP12 antibody. 
Furthermore, this experiment was also important to provide biochemical evidence of the 
interaction of SEARP with PP12. After immunoprecipitation, the samples were subjected 
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to 2D gel electrophoresis and the gel was silver stained to visualize the protein spots (Fig. 
IV.9). Many protein spots were obtained, consistent with the multiple interactions 
postulated for PP1 isoforms. The pattern obtained from the immunoprecipitation of human 
sperm was very similar (data not shown). To confirm the interaction of PP12 with 
SEARP, the destained 2D gel from human sperm was transferred to a nitrocellulose 
membrane and immunoblotted with anti-SEARP antibody (Fig. IV.10A). A similar 
analysis was performed with the rat testis immunoprecipitated sample (Fig. IV.10B). In 
both cases a single immunoreactive spot was detected with the anti-SEARP antibody. 
Afterwards both blots were stripped and immunoblotted with anti-PP12 antibody.  
 
Figure IV.9: Silver stained 2D gel of the immunoprecipitation of 10mg of rat testis homogenate 
with anti-PP12. The arrow points to the anti-SEARP immunoreactive spot (see Fig. IV.10).  
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Figure IV.10: Anti-SEARP immunoblot of the anti-PP12 immunoprecipitates from human sperm 
(A) and rat testis (B). 
 
By analyzing Figure IV.10 it is clear that SEARP co-immunoprecipitates with 
PP12 from human sperm and rat testis. Although the predicted molecular mass for 
SEARP was 94.5kDa (Table IV.7) the spot detected was approximately 63kDa. Since 
proteolysis is an unlikely explanation, given the use of protease inhibitors, this observation 
leads us to believe that the complete protein may be cleaved before it interacts with PP12. 
Alternatively, the detected protein may result from translation initiation from an internal 
initiation codon. Indeed, if Met322 is used as the initiator codon, then a protein of 
approximately 60kDa would be expected. Further experimentation will be required in order 
to clarify this point.  
This experiment clearly shows that SEARP interacts with PP12 in rat testis and 
human sperm. Appropriate negative controls, including immunoprecipitating rat testis or 
human sperm with rabbit pre-immune serum, as expected, failed to produce protein spots, 
as visualized by silver staining (data not shown). 
 Immunoprecipitations of rat testis with anti-PP1 and anti-PP1 were also 
performed. Samples were run on a SDS-PAGE gel and immunoprecipitated proteins 
detected by silver staining (Fig. IV.11) to compare with the anti-PP12 immunoprecipitate. 
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kb  Marker       A           B           C
1
2
3
4
5
6
7
8
9
56.2
101
125
210
35.8
 
 
Arrow 
No. 
MW 
(kDa) 
1 282 
2 211 
3 164 
4 130 
5 110 
6 87 
7 50 
8 45 
9 40 
 
I II 
Figure IV.11: I, SDS-PAGE gel showing rat testis immunoprecipitates with anti-PP12 (A), anti-
PP1 (B) and anti-PP1 (C). II, Corresponding table of the molecular masses of the protein bands 
indicated with arrows. 
 
From the analysis of the results obtained (Fig. IV.11) it was concluded that several 
proteins co-immunoprecipitated with PP12, when compared with the proteins that are 
immunoprecipitated with the other two antibodies (anti-PP1 and anti-PP1). The strongest 
bands in the gel of approximately equal molecular mass correspond to the antibodies used 
to immunoprecipitate the proteins. 
In the future, we will subject the SEARP immunoreactive spot to mass 
spectrometry analysis to confirm its identity, and other spots will also be analysed to obtain 
their identification. Thus, a comparative picture will be obtained of the PP12 interactome 
from human sperm, in relation to the interactome defined by the YTH analysis. The 2D 
electrophoresis turned out to be a valuable complementary technique to the Yeast Two 
Hybrid System since it confirmed the SEARP/PP12 interaction in vivo. Without an 
antibody against the putative interactor, the only way to confirm an interaction would be 
by mass spectrometry analysis of the spots in the gel. Further analysis of the 
immunoprecipitated protein spots will continue in the future. 
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IV.3.4  Intracellular localization of SEARP and PP12 in COS-7 cells 
 
The cDNA corresponding to clone 40Q was subcloned into the pEGFP vector in 
frame with the GFP (Green Fluorescent Protein) protein. GFP was first described by 
Davenport and Nicol (1955) who reported that the jellyfish Aequorea victoria fluoresced 
green when irradiated with UV light. However, interest on this protein has grown 
enormously since its cloning (Prasher et al., 1992; Chalfie et al., 1994). The usefulness of 
GFP derives from the finding that the protein’s fluorescence is due to the cyclization of the 
peptide backbone, and no other cofactor is needed in order to have fluorescence. Another 
advantage of GFP is that it can be examined in living cells without fixation and 
permeabilization. In our study, GFP was used as a biological marker, overcoming the need 
to have an antibody against SEARP. It allowed us to evaluate the subcellular localization 
of SEARP in cultured cells by expressing a SEARP-GFP fusion protein and monitoring the 
green fluorescence within the cells. COS-7 cells were transfected with the recombinant 
construct (pEGFP-SEARP) and the cells were immunostained with the anti-PP12 
antibody (Fig. IV.12 and Fig. IV.13). The results demonstrate that PP12 is present 
throughout the cell (Fig. IV.12, C and IV.13, C), but may be particularly enriched in the 
nucleus. In contrast, SEARP is mostly absent from the nucleus, but in some cells it was 
observed in cytoplasmic structures surrounding the nuclear membrane (Fig. IV.12, D). 
This unusual distribution warrants further studies. In other cells, SEARP appears to be 
enriched in the Golgi apparatus (Fig. IV.13, D) and may also be associated with the 
cytoskeleton. In this case, SEARP co-localizes with PP12 in some regions (Fig. IV.13, E 
and F). 
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SEARP-GFP SEARP/PP12/Ph C SEARP/PP12
PP12GFP Ph C
 
Figure IV.12: Intracellular localization of SEARP-GFP and PP12 in COS-7 cells (60X 
magnification). A, Control COS-7 cells transfected with the pEGFP vector; B, phase contrast; C, 
COS-7 cells immunostained with anti-PP12 antibody; D, COS-7 cells transfected with pEGFP-
SEARP; E, composite image of the immunostaining with anti-PP12 antibody and GFP-SEARP 
fluorescence overlaid onto the phase contrast image; F, same as E, but without phase contrast. 
B C
D E F
SEARP-GFP SARP/PP12/Ph C SEARP/PP12
PP12GFP Ph C
A
 
Figure IV.13: Intracellular localization of SEARP-GFP and PP12 in COS-7 cells (60X 
magnification). A, Control COS-7 cells transfected with the pEGFP vector; B, phase contrast of 
COS-7 cell ; C, COS-7 cells immunostained with anti-PP12 antibody; D, COS-7 cells transfected 
with pEGFP-SEARP; E, composite image of the immunostaining with anti-PP12 antibody and 
GFP-SEARP fluorescence overlaid onto the phase contrat image; F, same as E, but without phase 
contrast. 
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 Nevertheless, some interesting differences were observed in the distribution of 
COS-7 cells endogenous SEARP using specific antibodies to detect endogenous SEARP 
and PP1 (Fig. IV.14). 
  
1 
 
2 
     
B
C D
A
 
 
Figure IV.14: Co-localization 
of SEARP and PP12 in COS-
7 cells by 
immunocytochemistry using 
anti-SEARP and anti-PP12 
antibodies, and specific 
secondary antibodies 
conjugated with FITC and 
Texas Red, respectively. 1: A, 
phase contrast micrograph of 
high density COS-7 cells; B, 
immunostaining for SEARP; 
C, immunostaining for PP12; 
D; combined phase contrast 
and fluorescent micrograph of 
the co-localization of SEARP 
and PP12; E, overlay of the 
co-localization of SEARP and 
PP12 (20X magnification). 2: 
A, phase contrast micrograph 
of a low density COS-7 cell; 
B, immunostaining for 
SEARP; C, immunostaining 
for PP12; D; overlay of the 
co-localization of SEARP and 
PP12 (60X magnification). 
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PP12 is present mainly in the nucleus, although it is also found all over the 
cytoplasm. Some regions in the nucleus are not stained, indicating that there may be 
selective PP12 enrichement in specific nuclear loci. In what concerns SEARP, it is also 
found in the nucleus and albeit with lower intensity, in some areas of the cytoplasm. The 
different distributions of SEARP fused to GFP compared to endogenous SEARP, may be 
due to the absence of the complete N-terminal sequence from the former. This N-terminal 
sequence might be essential to target SEARP to the nucleus, or for its interaction with 
some other protein responsible for taking SEARP into the nucleus. 
 Recent studies point to the importance of PP1 regulators as targeting subunits in 
response to cell-cell contact. For instance, I-2 is concentrated in the nucleus of cells 
cultured at low densities, whereas high densities cells excluded I-2 from the nucleus. The 
change in I-2 localization may direct I-2 to different forms of PP1 or directly change PP1 
localization in response to different cell confluency signals (Leach et al., 2002). Similar 
results were observed with SEARP. At low density, in the absence of intercellular contacts, 
SEARP is found throughout the cell but mainly in the cytoplasm (Fig. IV.14-2). However, 
when cells become confluent, SEARP becomes more highly enriched in the nucleus (Fig. 
IV.14-1) but can also be detected in the Golgi apparatus. Probably, the putative nuclear 
targeting sequence present in the N-terminal of full length SEARP is absent from the 
truncated SEARP-GFP fusion protein, (Fig. IV.12 and IV.13) leading to the retention of 
expressed recombinant SEARP in the cytoplasm. PP1 localizes mostly to the nucleus of 
low-density cells. Interestingly, in Fig. IV.14-1D a dividing cell is visible in the lower left 
corner and exhibits an interesting distribution of PP12 and SEARP, suggesting their 
possible involvement in mitotic mechanisms. There is intense PP12 staining around the 
nucleus, forming a ring structure, and SEARP staining is clearly visible in the nuclei of the 
daughter cells. 
 
IV.3.5  Sperm maturation and SEARP expression 
 
Immunohistochemistry was performed on rat testes sections in order to evaluate the 
presence of SEARP and its relationship with PP12 and PP1. First, rat testes sections 
were analyzed to verify the integrity of cellular structures by haematoxylin/eosin staining 
Characterization of the PP1 Interactome from Human Testis Chapter IV  
 
Centro de Biologia Celular 
Universidade de Aveiro 177 
(Fig. IV.15). Haematoxylin is a natural dye that after oxidation gives haematin, a basic dye 
that stains the nucleic acids in the nuclei blue. Eosin is an acidic dye that stains red the 
components of the cytoplasm.    
 
Figure IV.15: Haematoxylin/eosin staining to confirm testes integrity. A, Several seminiferous 
tubules (10X magnification); B, Seminiferous tubule where the arrows mark meiotic figures (40X 
magnification). 
 
 The seminiferous tubule is the structural unit of the testis, being approximately 180-
300µm in diameter and 80cm long in men. The total length of all tubules in each human 
testis has been calculated to be around 300-900m. In a sexually mature adult, each 
seminiferous tubule has a central lumen surrounded by an actively replicating epithelium, 
mixed with supporting cells, the Sertoli cells (Fig. IV.16). Blood vessels and Leydig cells, 
that synthesize the hormone testosterone, are localized in the interstitials space between 
seminiferous tubules. The replicating epithelium (or germinal epithelium) lining the 
seminiferous tubules produces the haploid male gametes (spermatozoa), by a series of 
steps called spermatogenesis and spermiogenesis. Spermatogenesis begins with the 
development of spermatogonia, of which three types are recognized according to their 
nuclear appearance: A1, dark nuclei, A2, pale nuclei and B, coarsely clumped chromatin 
and pale central nucleolus. Spermatogonia type A1 undergo mitosis to give more 
spermatogonia type A1 or type A2. Type A2 mature giving rise to type B. Types A2 and B 
can still undergo mitosis to give more daughter cells. Diploid type B matures into primary 
spermatocytes, which duplicate their DNA in order to undergo the first meiotic division 
(lasting about 22 days). Primary spermatocytes are similar to type B spermatogonia but 
located further away from the basal lamina, and often the different stages of meiosis can be 
identified. Meiosis ends with the formation of diploid secondary spermatocytes which 
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rapidly (within a few hours) undergo the second meiotic division to produce haploid 
spermatids. The spermatids will subsequently undergo maturation, producing mature but 
immotile spermatozoa. 
 
 
Figure IV.16: Diagram of spermatogenesis and spermiogenesis stages in the seminiferous tubules 
(adapted from www.erin.utoronto.ca/~w3bio380/Lectsked/Lect06/Sperm.2htm). 
 
 Only after going through the epididymis do the spermatozoa become motile (this 
process will be addressed later in this chapter). 
In order to determine in which cell types SEARP, PP12 and PP1 were expressed, 
immunohistochemistry analysis was performed on sections prepared from the testes of 8-
week-old adult mice. These were incubated with the appropriate primary antibody and with 
peroxidase-conjugated secondary antibody (Fig. IV.17) or, for PP12 and PP1 with a 
Cy3-conjugated secondary antibody, a red fluorescent dye (Fig. IV.18). As can be seen 
from the brown peroxidase staining in Fig. IV.17, all three proteins are present in rat testes. 
PP12, PP1 and SEARP are found in the spermatozoa tails and possibly in the acrosome 
region of the head. Other cells present in the seminiferous tubule exhibit immunoreactive 
staining indicating the presence of PP12, PP1 and SEARP mainly in the cytoplasm of 
those cells and in the basal lamina. 
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PP12 PP1 SEARP
 
Figure IV.17: Immunolocalization of SEARP, PP12 and PP1 in the mouse testis using a 
peroxidase- conjugated secondary antibody (100X magnification).  
 
 Using the Cys3-conjugated secondary antibody, red fluorescence was clearly 
detected in the spermatozoa tails (Fig. IV.18, 1). Especially for PP12 red fluorescence 
was also detected in the basal lamina (Fig. IV.18, 3), in other cells (Fig. IV.18, 2), and in 
Leydig cells (Fig. IV.18, 4).  
PP12 PP1
1 1
2
34
Seminiferous tubule
12
3
 
Figure IV.18: Localization of PP12 and PP1 in the mouse testis using a fluorescent secondary 
antibody (Cy3- conjugate Goat anti-rabbit). Arrow 1, spermatozoa tails; Arrow 2, other cells; 
arrow 3, basal lamina; Arrow 4, Leydig cells (40X magnification). 
 
Spermatogenesis occurs in waves along the seminiferous tubules and thus adjacent 
areas of the same tubule show different stages of spermatogenesis and spermiogenesis 
(Fig. IV.19). Each stage is characterized by a combination of certain cell types. The most 
frequently encountered is stage XIV, since it lasts approximately 22h.       
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Figure IV.19: Diagram of the different stages of the cycle of the seminiferous epithelium. Notice 
the different cell types present in each stage (adapted from 
www.users.von.uc.edu/hnaskor/plasmalemma_vesicle_protein.htm). 
 
SEARP, PP12 and PP1 are all present during stage XIV in the tails of 
spermatozoa and in the cytoplasm of the different types of cells involved in 
spermatogenesis and spermiogenesis (Fig. IV.20). SEARP is present in spermatozoa tails, 
in the basal lamina and in Leydig cells. Also the cytoplasms of spermatids and the meiotic 
or mitotic fuse seem to be immunoreactive for SEARP. Clearly, PP12 is present in the 
cytoplasm of secondary spermatocytes, in the basal membrane, in Leydig cells and in 
spermatids. Spermatozoa tails are also immunoreactive for PP12. PP1 detected in 
spermatozoa flagella, basal membrane and in the cytoplasm of spermatids. The feature that 
is more relevant in Fig. IV.20, for PP1, is the existence of very distinguishable meiotic 
figures that are likely to have PP1 somewhere around the condensed chromosomes, 
consistent with the postulated central role of PP1 in the control of cell division in other 
cell types. 
Thus, it is obvious that all three proteins (SEARP, PP12 and PP1) are present in a 
variety of cells from the events of spermatogenesis and spermiogenesis. Their exact co-
localization within the same subcellular structure still needs to be investigated.  
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Figure IV.20: Stage XIV of the cycle of 
the rat seminiferous tubules. Top panel: 
section of a rat seminiferuos tubule 
immunostained with anti-SEARP 
antibody; Middle panel:seminiferous 
tubule section immunostained with anti-
PP12 antibody; Lower panel: 
seminiferous tubule immunostained with 
Anti-PP1 antibody. All three 
micrographs were taken after incubation 
of the sections with a peroxidase-
conjugated secondary antibody. 
Magnification used: 40X (top) and 100X 
(middle and lower oanels). 1, 
spermatogonia type A1; 2, Primary 
spermatocyte; 3, Meiotic secondary 
spermatocyte; 4, Spermatid; 5, 
Spermatozoa; 6; Basal membrane; 7; 
Leydig cell. 
 
Images obtained by immunohistochemistry with the fluorescent secondary 
antibodies were also analysed by confocal microscopy (Figure IV.21). The presence of 
PP12 and PP1 in the rat spermatozoa tails was thus further confirmed. An interesting 
observation was that PP1 staining seemed to be restricted to the tail periphery. That is, the 
inner part of the tails is devoid of PP1 immunoreactive material. This raises interesting 
questions in relation to the structure of the spermatozoa tail (Fig. IV.22). Spermatozoa are 
among the smallest cells in the human body. They can be divided in head (5µm) and tail, 
and the tail comprises the neck, middle piece (7µm), principal piece (40µm) and end piece 
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(5-10µm). Along the tail is the axoneme that is responsible for spermatozoa motility. 
Essentially, it is a long, specialized cilium with nine outer doublet tubules organized 
around a central tubule pair. The proximal part of the tail is the neck, containing a pair of 
centrioles and a connecting piece which forms the nine fibrous rings surrounding the 
axoneme. The axoneme runs through the centre of the middle piece, and is surrounded by 
nine longitudinal fibers and elongated mitochondria. The principal piece is the longest part 
of the tail and comprises the axoneme, the nine longitudinal fibers surrounded by external 
fibers oriented circumferentially. The end piece is composed of axoneme only. So, it seems 
that PP1 is not present in the axoneme but might be in the fibrous sheath or, what might 
be more important, in the mitochondria that surround the fibrous sheath and the axoneme 
and are responsible for generating energy for sperm movement.  
 
A B
 
Figure IV.21: Confocal microscopy of rat testis sections immunostained with Anti-PP12 A) and 
Anti-PP1 B). The arrow marks a tail in a transverse section (100X magnification). 
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Figure IV.22: Schematic representation of a mammalian spermatozoon. This is a phase contrast 
micrograph of a bovine caudal spermatozoon with a 60X magnification. A transverse section 
through the end piece is shown to illustrate the axonemal 9+2 structure.   
 
IV.3.6  Colocalization of SEARP and PP12 in human spermatozoa 
 
Human sperm has a corpuscular and a liquid component (Fig. IV.23). The 
corpuscular components are spermatozoa, immature germ cells, sloughed-off epithelial 
cells from the seminiferous tubules, spermatophages, cytoplasmic droplets and leukocytes. 
Cells of the testes, epididymis and accessory glands secrete the liquid components of the 
seminal plasma. The seminal plasma also contains proteolytic enzymes produced by the 
prostate gland. Normally, the volume of the human sperm ejaculate is approximately 3ml 
and contains 50-150 million spermatozoa per ml. In fertile men 25% of the spermatozoa 
are abnormal or degenerated. Ejaculated spermatozoa are motile but they need to undergo 
capacitation in the female genital tract before they can fertilize an oocyte. 
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Figure IV.23: Phase contrast micrograph of Human sperm (20X amplification). 
 
Immunofluorescence was used to localize PP12 and SEARP within human 
spermatozoa. As seen in Fig. IV.24, PP12 is present along the entire length of the 
flagellum including the middle piece. In the head staining is intense in the equatorial 
segment (because of the different flourescence intensities observed in the tail and in the 
equatorial region it is not possible to visualize both patterns in the same image). SEARP 
immunoreactivity was detected in the principal piece of the flagellum and the head-neck 
junction. Staining is relatively weak in the middle piece. In the head region, staining 
appears also in the equatorial region. Thus, there are regions within spermatozoa where 
PP12 and SEARP co-localize (Fig. IV.25). The staining appears to be specific since there 
was no fluorescence observed when the primary antibodies were omitted (data not shown).   
PP12
PP12
SEARP
Ph C IF
 
Figure IV.24: Immunolocalization of PP12 and SEARP in human spermatozoa. Human 
spermatozoa were labeled with anti-PP12 and anti-SEARP antibodies.Ph C, phase contrast; IF, 
immunofluorescence (60X magnification). 
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Figure IV.25: Co-Immunolocalization of PP12 and SEARP in human spermatozoa. A, phase 
contrast micrograph of human spermatozoa; B, immunolocalization of SEARP; C, 
immunolocalization of PP12; D , overlay of PP12 and SEARP immunoreactivity. 
 
IV.4  DISCUSSION 
 
SEARP (Six to Eight Ankyrin Repeat Protein) was identified in a Yeast Two Hybrid 
screen using PP11 as bait with a human testis cDNA library. Subsequently, it was shown 
by sequential transformation with the bait plasmid (pASPP12) and the prey plasmid 
(pACT-2SEARP), that SEARP also interacts with PP12. 
This new protein was characterized in several ways. First, the complete nucleotide 
sequence was analyzed in what concerns, for instance, its genomic or exon-intron 
boundaries. Afterwards, bioinformatic analysis of the encoded protein revealed several 
interesting features of the protein. Eight ankyrin repeats were identified, as well as a PP1 
consensus binding motif just upstream of these ankyrin repeats. Several putative 
phosphorylation sites were also identified, strongly suggesting that SEARP may be 
regulated itself by phosphorylation mechanisms. 
Immunoblot analysis of several rat tissues, and bovine and human testis and sperm, 
showed that SEARP is present in residual amounts in most of the analyzed tissues (such as 
brain) but is expressed in testis, sperm, ovary, lung and liver in relatively large amounts. 
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The relatively slower electrophoretic mobility of testis SEARP compared to other tissues is 
in agreement with the existence of an alternatively spliced SEARP isoform, detected in a 
Yeast Two Hybrid screen of a human lymphocyte library (P. T. Cohen, personal 
communication). Thus, SEARP-L has a shorter C-terminus compared to SEARP-T. 
Northern blot analysis revealed that SEARP mRNA is strongly enriched in testis, 
compared with other tissues, and that the transcript is 3.6kb. 
Analysis with anti-SEARP antibody of a 2D-gel immunoblot of immunoprecipitated 
samples of rat testis and human sperm with anti-PP12 antibody clearly demonstrated the 
in vivo biochemical interaction between PP12 and SEARP in both testis and sperm. 
SEARP co-localizes with PP12 in some regions of COS-7 cells and, more 
importantly, in some areas of spermatozoa, specially in the principal piece of the tail and 
the equatorial segment of the head (involved in the acrosome reaction). In COS-7 cells 
SEARP is mainly nuclear in confluent cells but is enriched in the cytoplasm in low density 
cells. However, when COS-7 are transfected with our truncated SEARP sequence 
(corresponding to clone 40Q) fused to GFP, the immunofluorescence is detected almost 
exclusively in the cytoplasm. This may be explained by the absence of the N-terminus. 
This region might be responsible for targeting SEARP to the nucleus or may interact with 
another protein that targets it to the nucleus.  
Considering the above data, it seems reasonable to hypothesise two possible roles for 
SEARP in sperm function. First, being associated with PP12 in the sperm tail, it might be 
involved in the control of sperm motility. Secondly, the COS7 confluency experiments 
might indicate that in sperm, SEARP is present in the cytoplasm (as confirmed by its 
localization in the equatorial head region) being thus essential for the acrossome reaction. 
After sperm-egg interaction, SEARP might translocate to the nucleus where it may alter 
gene expression. This hypothesis is supported by the presence, on the C-terminal domain 
of SEARP, of a putative transcription factor motif. Finally, SEARP is also present in cells 
involved in spermatogenesis and spermiogenesis. The mechanism by which SEARP may 
be involved in these events still needs to be investigated.  
Sds22 (suppressor of the dis2-mutant) was originally identified in yeast as a PP1 
regulatory subunit essential for the completion of mitosis (MacKelvie et al., 1995). The 
mammalian counterpart, PPP1R7, was cloned by Renouf et al. (1995) and inhibits PP1 in 
rat liver nuclei (Dinischiotu et al., 1997). Sds22 consists of a poorly conserved N-terminus 
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which appears to be essential for protein stability and a well conserved C-terminus that is 
probably involved in the nuclear localization of sds22. The central domain of sds22 has 
highly conserved tandem array of 11 leucine–rich repeats of 22 residues that mediate the 
binding to PP1. Sds22 is ubiquitously expressed in human tissues and up to six transcripts 
can be generated from PPP1R7 gene by alternative polyadenylation and skipping of exon 2 
(Ceulemans et al., 1999). It was shown that sds22 functions positively with GLC7 (yeast 
PP1) to promote dephosphorylation of nuclear substrates required for faithful transmission 
of chromosomes during mitosis (Peggie et al., 2002), primarily by keeping PP1 in the 
nucleus. A sds22 homolog was identified in rat testis that associates with PP12 (Chun et 
al., 2000). The expression pattern of the rat sds22 homolog matches with that of PP12, 
suggesting that it is involved in spermatogenesis by controlling PP12 activity. Using 
immunoaffinity choromatography, sds22 was identified in motile caudal spermatozoa as a 
regulator of  PP12 catalytic activity (Huang et al., 2002). In contrast, PP12 and sds22 do 
not interact in caput bovine sperm (Mishra et al., 2003). This same study showed that caput 
sds22 is bound to a p17kDa protein suggesting that binding to PP12 requires sds22 
dissociation of p17 or some other post-translational modification. This protein, like 
SEARP, is present in the principal piece of the spermatozoa flagellum and in the head-neck 
junction although in somatic cells they are mainly nuclear. Possibly, SEARP may also 
need to be cleaved to interact with PP12, as seen in the 2D-gel immunoblot with anti-
SEARP antibody (Fig. IV.10).  
SEARP also has a putative calcium binding domain, indicating that SEARP could 
act as an intermediary between calcium signaling and PP12 regulation of sperm motility. 
Mechanisms regulating binding of SEARP to PP12 should be important in 
understanding the biochemical events that underline sperm maturation and movement. 
Studies are underway to use recombinant PP12 and recombinant SEARP to further 
analyze the nature of the interaction between these proteins. The complex set off signaling 
motifs detected in SEARP, its restricted expression in specific tissues, and its subcellular 
localization, coupled with the intriguing cell contact-dependent expression pattern, make 
SEARP an ideal target for signal transduction therapeutics. Future work will evaluate its 
usefulness as a target for the development of a male contraceptive or a target for the 
treatment of male infertility. 
Characterization of the PP1 Interactome from Human Testis Chapter IV  
 
Centro de Biologia Celular 
Universidade de Aveiro 
188 
 
 
Characterization of the PP1 Interactome from Human Testis Chapter V  
 
Centro de Biologia Celular 
Universidade de Aveiro 189 
V DISCUSSION AND CONCLUSION 
 
In somatic cells, PP1 isoforms are regulated by a large number of ubiquitous and cell-
specific regulatory and targeting proteins (Oliver and Shenolikar, 1998). Germ cell-specific 
phosphatase PP12 is the predominant serine/threonine phosphatase in spermatozoa (Smith 
et al., 1996; Vijayaraghavan et al., 1996). PP12 activity is inversely correlated with sperm 
motility. Enzyme inhibition with okadaic acid or calyculin A induces motility initiation 
and stimulation. Thus, our goal was to understand how PP12 activity is regulated during 
sperm maturation and to identify the sperm-specific partners in this event. Therefore, in 
order to identify the sperm proteins that interact with PP1, we performed 2 separate yeast 
two-hybrid screens of a human testis cDNA library using the baits PP11 and PP12. The 
validity of the results obtained was confirmed by a variety of criteria, including the 
isolation of bona fide PP1 binding proteins and the occurrence of a PP1 consensus binding 
motif in the newly identified proteins. We recovered 120 positive clones in the YTH1 and 
155 positive clones in the YTH2. Among these were clones encoding previously known 
PP1 interactors, such as Nek2 and NIPP1, and also previously uncharacterized proteins. 
We performed a detailed study of one such novel protein of 93kDa that is expressed 
mainly in testis. We named this protein SEARP-T (Six to Eight Ankyrin Repeat Protein 
from Testis). Fluorescence immunocytochemistry was used to compare the intra sperm 
localization of PP12 and SEARP-T. Both proteins co-localize in the tail and in the 
equatorial segment of the head. 
These results provide new insights into PP1 function in human testis and sperm 
motility and validate the Yeast Two Hybrid System as a mean to understand the roles 
played by PP1 in diverse cellular regulatory events, thereby allowing possible targets to be 
investigated for pharmacological intervention, particularly regarding infertility and 
contraception. 
 
V.1 THE YEAST TWO HYBRID SYSTEM 
 
The availability of complete genome sequences from a variety of organisms initiated 
the development of new approaches to deal with a huge amount of genomic information 
(Table V.1). Thus, high-throughoutput methods for detecting protein interactions were 
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developed. Among them, the most used are the Yeast Two Hybrid System, Affinity 
Purification coupled to Mass Spectrometry and, on a smaller scale, proteome chips 
(Auerbach et al., 2002), which have yielded vast amounts of data that can be exploited to 
infer protein function and regulation. These methods together with the availability of 
sophisticated databases help to decode complex interactions among proteins and to 
integrate interacting proteins in complex cellular pathways. 
 
Table V.1: Genome sequences of some organisms. 
Organism 
Sequence 
published (year) 
No. of Predicted 
ORFs 
Reference 
Haemophilus influenzae 
(bacteria) 1995 1720 
(Fleischmann et 
al., 1995) 
Saccharomyces cerevisiae 
(Yeast) 1996 6234 
(Goffeau et al., 
1996) 
Caenorhabditis elegans 
(Worm) 1998 19099 
(consortium, 
1998) 
Drosophila melanogaster 
(Fruit fly) 2000 13061 
(Adams et al., 
2000) 
Arabidopsis thaliana 
(Plant) 2000 ~25000 (Initiative, 2000) 
Homo sapiens  
(Human) 2001 ~35000 
(Lander et al., 
2001; Venter et 
al., 2001) 
Plasmodiumfalciparum 
(Parasite) 2002 5279 
(Lander et al., 
2001; Hall et al., 
2002; Hyman et 
al., 2002) 
Mus musculus 
(Mouse) 
 
2002 ~30000 (Waterston et al., 2002) 
ORFs: open reading frames.   
 However, sequencing the genome of an organism does not mean decoding the 
functions of the proteins it encodes. Thus, the more challenging issue is to clarify the 
proteome of a given organism, and even more importantly, to characterize the interactions 
between its constituent proteins. Additionally, the goal of proteomics is also to determine 
when and where the proteome of an organism is expressed and to identify post-
translational modifications that regulate protein function, ultimately elucidating how an 
organism or cell in that organism behaves. Proteomics tries to identify the interactions 
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between proteins in a normal versus a disease state, being of great biomedical value in 
order to identify putative protein targets to cure a certain disease and disease markers.   
The Yeast Two Hybrid System has been rapidly adopted since it was first developed 
by Fields and Song (1989) with the number of papers citing “Two-Hybrid” growing 
markedly since its original introduction (Fig. V.1). 
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Figure V.1: Number of publications obtained by searching PubMed (www.ncbi.nlm.nih.gov) with 
the words “Two-Hybrid” from 1989 to 2003. 
 
Only the Yeast Two Hybrid System will be discussed in detail here. The main 
advantages of this method are that the interactions are detected in vivo, there are no 
artificial lyses or washing steps and it has the potential to detect weak or transient 
interactions. Its drawbacks are that it mostly detects binary interactions and the forced 
nuclear localization of the interacting proteins can create false positives or false negatives. 
Also, artificial fusion may inhibit certain interactions and some interactions are preferred 
with regard to cellular compartments. The Yeast Two Hybrid System is a genetic method 
in which an interaction between a bait protein and its library expressed partner is detected 
via reconstitution of a transcription factor and subsequent activation of a set of reporter 
genes. Large scale two hybrid approaches have used the complementary methods called 
“matrix approach” and the “library screening approach” for screening large sets of 
proteins. In the matrix approach a yeast strain expressing the bait protein is mated with an 
array of yeast strains expressing many different prey proteins. The interactions are detected 
by growth on selective media. Here, a library screening method was used to screen our bait 
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proteins (PP11 and PP12) against a human testis cDNA library. Colonies expressing the 
interacting proteins are selected and the library plasmids are isolated and sequenced to 
determine the identity of the interacting prey proteins. 
Overall, our results were very satisfying (Table III.3). Several previously known PP1 
binding proteins were identified in our screens, thus validating the method used. Among 
them are Nek2 and NIPP1 (discussed in Chapter III). Additionally, proteins known in other 
contexts were also identified as putative PP1 regulators, for example, RANBPM 
(Nakamura et al., 1998) and DAPPER1 (Katoh, 2003). Even more interesting was the fact 
that the vast majority of the proteins identified were completely new proteins. Chapter IV 
describes the characterization of a new protein that we named SEARP-T.  
 
V.2 MECHANISMS INVOLVED IN SPERM MOTILITY 
 
Several studies demonstrate the involvement of cyclic nucleotides, bicarbonate, 
cholesterol and protein phosphorylation in acquisition of progressive motility, capacitation, 
hyperactivation of motility, directed motility or induction of acrosome reaction (Garbers 
and Kopf, 1980; Smith et al., 1996; Vijayaraghavan et al., 1996; Vijayaraghavan et al., 
1997; Cross, 1998; Visconti and Kopf, 1998; Smith et al., 1999; Huang et al., 2002; 
Mishra et al., 2003). Calcium ions are also primary determinants of sperm cell behavior 
being absolutely required for the processes described above. Immunostaining studies and 
transcript analysis revealed that spermatozoa possess several calcium channels.  
Ren et al. (2001) discovered a new protein, crucial to sperm swimming in mice that 
could be a target for male contraceptives or fertility treatments. The protein forms a 
channel through the membrane of sperm tail and controls the inflow of calcium ions that 
triggers swimming. This protein was named CatSper and is located mainly in the principal 
piece of the sperm tail. This channel contains 6 transmembrane segments and maps to 
chromosome 15q13 in humans. This explains, at least in part, the role of calcium in sperm 
function, that despite having been known for a long time, the details have been always 
elusive. Mutant mice lacking this channel are sterile. Sperm motility is markedly decreased 
and sperm are unable to fertilize intact eggs.  All humans have the gene that encodes the 
channel, but it is switched on only is sperm cells.  
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Another putative ion channel, CatSper2, was also found to contain 6 
transmembrane segments and also mapped to human chromosome 15q13 (Quill et al., 
2001). CatSper represents a target for non-hormonal male contraceptives.  
Worldwide, the market for oral contraceptives is worth billions of euros and the 
demand for a non-hormonal oral male contraceptive is likely to be phenomenal.  
In our group we are especially interested in the involvement of protein 
phosphorylation on sperm motility. There are several evidences demonstrating that protein 
phosphatases are direct players in the acquisition of sperm movement. Indeed, PP1 
inhibition of immotile caput sperm with specific inhibitors, results in them acquiring 
normal motility parameters. Intriguingly, these effects are completely independent of 
calcium. 
 
V.2.1 PP12/I2-L/GSK-3 
 
Sperm contains a specific PP1 isoform (PP12) as well as the kinase glycogen 
synthase kinase-3 (GSK-3) (Smith et al., 1996; Vijayaraghavan et al., 1996). PP12 and 
GSK-3 activities are two- and six-fold higher, respectively, in immotile caput compared to 
motile caudal epididymal sperm. The PP12 catalytic activity is regulated by its interaction 
with an inhibitor similar to somatic cells I-2. This inhibitor may correspond to a clone we 
identified in our screen, that we named I2-L (Inhibitor 2 Like, XM_018216). The inactive 
PP12-inhibitor complex is activated by phosphorylation of this I2-L inhibitor by GSK-3 
(Fig V.2). Interestingly, the I2-L protein has a Thr/Pro substitution at position 72. The 
absence of the most important regulatory residue of I-2 in I2-L must have consequences on 
the regulation of PP1 and ultimately on the acquisition of sperm motility. Apparently, I2-L 
represents a constitutive inhibitor of PP1 that is independent of GSK-3 phosphorylation.  
One hypothesis might be that I2-L is only expressed in caudal motile sperm, leading to 
constitutive inactivation of PP12. Another hypothesis is that I2-L is bound to a protein 
that keeps it from binding PP12 in immotile caput sperm, paralleling what happens with 
sds22. To test these hypotheses, two parallel sperm immunoprecipitation experiments need 
to be performed with caudal and caput epididymal sperm, followed by a 2D analysis, 
allowing the differences in the I2-L and I-2 spots to be detected. I2-L has a theoretical 
molecular mass of 23.1kDa and a pI of 4.77, whereas I-2 has a molecular mass of 23kDa 
and a pI of 4.64, although it migrates with an apparent molecular mass of 31kDa in SDS-
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PAGE gels. The study of I2-L is difficult, since it is very similar to I-2. They are 96% 
similar at the nucleotide level and 96.5% similar at the protein level. It is therefore very 
difficult to produce I2 or I2-L specific molecular tools (antibodies, probes, etc) for further 
analysis. The protein complex PP12/I2-L/GSK-3 may explain the observed sperm 
motility changes during epidydimal transit. 
I2-L PP12 PP12
GSK-3
I2 P
Inactive Active
Epidydimal
Transit
Caudal 
motile 
sperm
Caput 
immotile 
sperm
 
Figure V.2: Possible mechanism of regulation of PP12 by I2-L and GSK-3 in sperm. 
 
V.2.2 PP12/sds22 
 
 A sds22 homologue was recently identified in sperm (Mishra et al., 2003). The 
mammalian counterpart, PPP1R7 inhibits PP1 catalytic subunit in rat liver nuclei 
(Dinischiotu et al., 1997). A sds22 homolog was identified in rat testis that associates with 
PP12 (Chun et al., 2000). The expression pattern of the rat sds22 homolog matches that of 
PP12, suggesting that its involvement in spermatogenesis relates to the control of PP12 
activity. Sds22 was identified in motile caudal spermatozoa as a regulator of PP12 
catalytic activity (Huang et al., 2002). In contrast, PP12 and sds22 do not interact in caput 
bovine sperm (Mishra et al., 2003). This same study showed that caput sds22 is bound to a 
17kDa protein, suggesting that binding to PP12 requires sds22 dissociation from p17 or 
some other post-translational modification. This protein is present in the principal piece of 
the spermatozoa flagellum and in the head-neck junction although in somatic cells it is 
mainly nuclear. Sds22 has consensus sites for phosphorylation by GSK3, PKA and CDKII 
(calmodulin dependent kinase II), all present in sperm (Fig. V.3). 
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Figure V.3: Possible mechanism of regulation of PP12 by sds22 in sperm. 
 
V.2.3 PP12/AKAP220/PKARII 
 
The cyclic AMP (cAMP)-dependent protein kinase (PKA) and PP1 are broad 
specificity signaling enzymes with opposing actions that catalyse changes in the 
phosphorylation state of cellular proteins. PKA is a ubiquitous, multifunctional enzyme 
involved in the regulation of several cellular events. PKA holoenzyme consists of four 
subunits, two catalytic and two regulatory (RI and RII). Subcellular targeting to the 
vicinity of preferred substrates is a means of restricting the specificity of these enzymes 
(Hubbard and Cohen, 1993; Faux and Scott, 1996). Several PP1 targeting subunits direct 
PP1 to specific locations (Egloff et al., 1997), while compartmentalization of PKA is 
mediated through association of the its regulatory subunits with A-kinase anchoring 
proteins (AKAPs) (Faux and Scott, 1996). Over 40 AKAPs have been identified to date, 
targeting PKA to the plasma membrane, cytoskeleton, endoplasmic reticulum, Golgi, 
mitochondria and nuclear matrix (Schillace et al., 2001). This high level of molecular 
organization ensures selectivity in cAMP-responses. Several anchoring proteins have been 
identified that can simultaneously associate with kinases and phosphatases (Faux and 
Scott, 1996). Neuronal AKAP79 binds to PKA, PKC and PP2B, and AKAP149 recruits 
PKA and PP1 to the lamina of nuclear membranes (Steen et al., 2000). Similarly, the 
NMDA receptor-associated protein Yotiao maintains an anchored PKA constitutively 
active PP1 to regulate the phosphorylation state of the NMDA receptor ion channel 
(Westphal et al., 1999b). Another example is AKAP220 that binds PKA and PP1, being a 
competitive inhibitor of PP1 (Schillace et al., 2001). AKAP220 also associates with PKA 
in testis, where it may target the kinase to peroxisomes. AKAP220 mRNA is expressed at 
high levels in human testis and in isolated human pachytene spermatocytes and round 
spermatids. AKAP220 is present in human male germ cells and mature sperm. In sperm, 
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AKAP220, as well as RII, is located in the middle-piece and is probably associated with 
cytoskeletal structures (Reinton et al., 2000). AKAP220 binds the RI, RII and RII 
subunits of PKA in human testis. The centrosomal AKAP220/PKA complex may regulate 
spindle formation during meiosis. The middle-piece associated AKAP220 could serve to 
anchor PKA and /or PP12, directly regulating the contractile machinery in the sperm 
axoneme (Fig. V.4). Furthermore, it has been shown that disruption of RII interaction with 
AKAPs, by membrane-permeable peptides, causes the arrest of sperm motility 
(Vijayaraghavan et al., 1997). Together, this data suggest that the AKAP/PKA/PP1 
complex is important for regulation of sperm motility.  
 
AKAP220
RII
PP12
 
Figure V.4: Putative AKAP220/PP12/PKARII complex involved in the regulation of sperm 
motility. 
   
V.2.4 PP12/AKAP110/PKA 
 
Several AKAPs have been shown to be present in germ cells. Among them is S-
AKAP84 that localizes in the middle-piece of mouse elongating spermatids (Lin et al., 
1995); its splice variants D-AKAP-1 (L. J. Huang et al., 1999) and AKAP121 (Feliciello et 
al., 1998) are also present in condensing spermatid middle-piece. AKAP82 (Turner et al., 
1998) and TAKAP80 (Mei et al., 1997) are found in the sperm fibrous sheath. Finally, 
AKAP110, recently identified by Vijayaraghavan et al. (1999), is localized to the fibrous 
sheath and acrosomal region. There seems to be an abundance of dual specificity AKAPs, 
which bind RI and RII PKA regulatory subunits. RI subunit localizes primarily in the 
acrosomal region and RII exclusively to the tail.  
 Northern analysis and in situ hybridization detected AKAP110 only in testis, more 
specifically in round spermatids. In the spermatozoon AKAP110 localizes to the acrosome 
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and tail (Smith et al., 1999). In sperm AKAP110 apparently binds RII on the mitochondria 
membrane. AKAP110 may also bind PP12 that, as we demonstrated in Chapter IV, is also 
present in the tail (Fig. V.5). 
 
AKAP110
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RII
Mitochondrial
membrane
 
Figure V.5: Putative AKAP110/PP12/PKARII complex involved in the regulation of sperm 
motility. 
 
Sperm specific AKAPs seem to be a very directional target for the development of a 
male contraceptives or for infertility therapeutics. Although none of these AKAP proteins 
has been identified in the YTH screens performed, they might be present in the 
immunoprecipitate samples from human sperm and rat testis. Several putative spots 
corresponding to these proteins can be seen in the 2D-gel (Fig. IV.9). Mass spectrometric 
analysis of the identified spots should resolve this question. 
 
V.3 SPLICING AS A FEASIBLE THERAPEUTICAL TARGET 
 
Mammalian genes are organized on chromosomes in an exon-intron structure, with 
an average of 8.7 exons per gene (Waterston et al., 2002). After transcription, the pre-
mRNA undergoes splicing, the process of intron excision, performed by a huge RNA-
protein complex, the spliceosome (Will and Luhrmann, 2001). This complex recognizes 
conserved sequences on exon-intron boundaries (the splice sites) and joins exons together 
removing the intermediate introns. Alternative splicing occurs when the introns from a pre-
mRNA are spliced in more than one way resulting in more than one mature mRNA per 
gene. Therefore, one gene can yield several, sometimes functionally different, proteins 
(Graveley, 2001). 
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As was evident from the results of the YTH screens presented, a large number of the 
proteins identified as putative PP1 binding partners derive from an alternative splice of the 
pre-mRNA (Fardilha et al., 2004a; Fardilha et al., 2004b). For instance, Nek2A-T derives 
from an alternative 3’splice-site of the pre-mRNA; NIPP1-T mRNA suffers an excision of 
part of exon 7; SEARP-T and SEARP1 differ by alternative 3’ splice-site (Browne et al., 
2004) (Fig. V.6).  
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Figure V.6: Spliced variants of Nek2A-T, NIPP1-T and SEARP-T. Pink cilinders are the 
alternative spliced  parts of the respective exon. Exons and introns are not drawn to scale. 
 
Interestingly, for unknown reasons, several testis mRNAs are alternatively spliced. 
This is also true for PP1 (da Cruz e Silva et al., 1995b). The alternatively spliced PP12 
(Fig. V.7) protein appears to be the major PP1 isoform expressed in mammalian sperm 
(Vijayaraghavan et al., 1996), although other PP1 isoforms can be detected in other cell 
types in testis. 
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STOP
mRNA1 2 4 5 63 7
GMITKQAKK
STOP
21 4 5 63 7
VGSGLNPSIQKASNYRNNTVLYE
 
Figure V.7: PP11 and PP12 splice variants. Exons and introns are not drawn to scale. 
 
Alternative splicing is a mechanism strictly regulated, being specific to a tissue, to a 
development stage, to a condition or to a pathological stage. Different splice variants of the 
same gene may also exist in the same place (cell or tissue), and act as regulators of each 
other. Errors that occur during splicing can lead to a pathological situation, and splice 
variants can be good diagnostic markers for disease conditions. In addition, different splice 
variants, being tissue specific, can function as ideal targets for the development of new 
drugs that will not affect similar mechanisms occurring in other tissues. For instance, if a 
drug is designed against the C-terminus of testis-enriched PP12, it is unlikely to affect 
other organs except testis. However, an even more specific scenario would be to target a 
PP12 binding protein that, presumably, would be involved in a much more restricted 
number of cellular events than the phosphatase catalytic subunit (Amador et al., 2004). Our 
results indicate the existence of a large number of putative PP12 binding proteins, some 
of which may ultimately be used as targets to develop new drugs to modulate sperm 
motility and other testis specific processes (Fardilha et al., 2004a). The possibility of 
precise and specific modulation of sperm motility should prove inestimable for the 
treatment of male infertility and for developing efficient male contraceptives. Male 
infertility is a growing concern in the industrialized nations and defects in sperm motility 
appear to be one of the main underlying causes. In fact, this approach may also be used to 
identify novel therapeutic targets for other conditions, including neurodegenerative 
diseases (da Cruz e Silva and da Cruz e Silva, 2003; da Cruz e Silva et al., 2004). 
In conclusion, alternative splicing appears to have a significant dimension in 
functional genomics, possibly explaining the much lower number of human protein coding 
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genes that were revealed when the human genome was published than was previously 
estimated. Alternative splicing has thus acquired renewed importance as a mechanism for 
generating biological diversity, probably accounting for the observed discrepancy between 
the sizes of mammalian genome and proteome. For reasons that still need to be fully 
elucidated, alternatively spliced proteins predominate in mammalian testis. The 
identification of testis-specific variants of PP1 regulatory proteins may therefore constitute 
excellent candidates to develop new drugs to control testis-specific processes (including 
infertility/contraception), without affecting other PP1-dependent signal transduction 
pathways in other organs (Fig. V.8). This approach should be useful for designing rational 
intervention strategies both for the development of male contraceptives and for the 
treatment of male infertility.  
  
TESTIS OTHER TISSUES
PP1c
DRUG
PP1cRT
ROT
DRUG
 
Figure V.8: Signal transduction therapeutics for testis-specific processes based on the targeting of 
alternatively spliced protein domains expressed specifically in testis.  RT, testis-specific, 
alternatively spliced PP1 regulatory subunit; ROT, alternative splice variant(s) of the regulatory 
protein expressed in other tissues. 
 
V.4  CONCLUDING REMARKS 
 
Reversible protein phosphorylation is the major control mechanism of eukaryotic 
cells. Many diseases and dysfunctional states are associated with abnormal 
phosphorylation of key proteins (e.g. cancer, diabetes, Alzheimer’s disease, etc.) (da Cruz 
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e Silva et al., 2004).  As a result, protein phosphorylation systems represent attractive 
targets for diagnostics and therapeutics.  An increasing number of proteins have been 
identified in diverse cell types that regulate the catalytic activity of PP1.  Indeed, the 
diversity of such PP1 regulatory subunits makes them attractive pharmacological targets.  
Besides, PP1 isoforms are highly mobile in cells and can dynamically relocalize through 
the direct interaction with targeting subunits (Trinkle-Mulcahy et al., 2001). Clearly, a full 
understanding of the regulation of different cellular processes by PP1 requires the 
identification and characterization of the various PP1 regulatory proteins and holoenzyme 
complexes. The PP1 gene is known to undergo alternative splicing to yield the ubiquitous 
PP11 and the testis-specific PP12 isoforms.  Previous work has also shown that PP12 is 
specifically expressed in sperm and that PP1 plays a key role in the control of sperm 
motility.  Therefore, in order to identify the sperm proteins that interact with PP1 two 
separate yeast two-hybrid screens of a human testis library were performed using PP11 
and PP12 as bait. Several new proteins were identified as PP1 regulatory subunits in 
human testis. These proteins represent potential specific targets to treat infertility and to 
develop new non-hormonal contraceptives. SEARP-T, is a new protein that interacts both 
with PP11 and PP12, and is a good candidate target to interfere with sperm motility. 
Mechanisms regulating binding of SEARP-T to PP12 should be important in 
understanding the biochemical events that underlie sperm maturation and movement. 
PP11 and PP12 interactomes described here constitute important tools for future 
studies, and represent a significant advance in our understanding of PP1 mediated signal 
transduction mechanisms.  
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Appendix I - Culture media and solutions 
 
- LB (Luria-Bertani) Medium 
To 950ml of deionised H2O add: 
Bacto-tryptone 10g 
Bacto-yeast extract 5g 
 NaCl 10g  
Shake until the solutes have dissolved. Adjust the pH to 7.0 with 5N NaOH. Adjust 
the volume of the solution to 1 liter with deionised H2O. Sterilize by autoclaving. 
 
- SOB Medium 
To 950ml of deionised H2O add: 
Bacto-tryptone 20g 
Bacto-yeast extract 5g 
NaCl 0.5g 
Shake until the solutes have dissolved. Add 10ml of a 250mM KCl (prepared by 
dissolving 1.86g of KCl in 100ml of deionised H2O). Adjust the pH to 7.0 with 5N NaOH. 
Adjust the volume of the solution to 1 liter with deionised H2O. Sterilize by autoclaving. 
Just prior to use add 5ml of a sterile solution of 2M MgCl2 (prepared by dissolving 19g of 
MgCl2 in 90ml of deionised H2O; adjust the volume of the solution to 100ml with 
deionised H2O and sterilize by autoclaving). 
 
- SOC Medium 
SOC is identical to SOB except that it contains 20mM glucose. After the SOB 
medium has been autoclaved, allow it to cool to 60ºC and add 20ml of a sterile 1M glucose 
(this solution is made by dissolving 18g of glucose in 90ml of deionised H2O; after the 
sugar has dissolved, adjust the volume of the solution to 100ml with deionised H2O and 
sterilize by filtration through a 0.22-micron filter). 
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- 50X TAE Buffer 
 242g Tris base 
 57.1ml glacial acetic acid 
 100ml 0.5M EDTA (pH 8.0) 
 
- TE buffer (pH 7.5) 
10mM Tris-HCl (pH 7.5) 
1mM EDTA, pH 8.0 
 
- Competent cell solutions: 
Solution I (1L): 9.9g MnCl2.4H2O, 1.5g CaCl2.2H2O, 150g glycerol, 30ml KHAc 
1M; adjust pH to 5.8 with HAc, filter through a 0.2m filter and store at 4ºC. 
Solution II (1L): 20ml 0.5M MOPS (pH 6.8), 1.2g RbCl, 11g CaCl2.2H2O, 150g 
glycerol; filter through a 0.2m filter and store at 4ºC.   
- RNAase stock solution  
10mg/ml (ddH2O) 
 
SDS-PAGE Solutions  
 
- Loading Gel Buffer 
250mM Tris-HCl (pH 6.8) 
8% SDS 
40% Glycerol 
2% 2-mercaptoethanol 
0.01% Bromophenol blue 
 
- LGB (Low Gel Buffer) 
 To 900ml of deionised H2O add:  
181.65g Tris  
 4g SDS  
 Shake until the solutes have dissolved. Adjust the pH to 8.9 and adjust the volume 
to 1L with deionised H2O. 
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- UGB (Upper Gel Buffer) 
 To 900ml of deionised H2O add:  
75.69g Tris  
 Shake until the solute has dissolved. Adjust the pH to 6.8 and adjust the volume to 
1L with deionised H2O. 
 
- 30%Acrylamide/0.8% Bisacrylamide 
 To 70ml of deionised H2O add: 
 29.2g Acrylamide  
 0.8g Bisacrylamide  
 Shake until the solutes have dissolved. Adjust the volume to 100ml with deionised 
H2O. Store at 4ºC. 
 
- Coomassie blue staining solutions: 
Staining solution 
0.1% Coomassie Brilliant Blue R250 
25% Methanol 
10% Acetic Acid 
Fixing solution  
25% Methanol 
10% Acetic Acid 
 
-1X Running Buffer 
25mM Tris-HCl (pH8.3) 
250mM Glycine 
0.1% SDS 
 
-1X Transfer buffer 
25mM Tris-HCl (pH8.3) 
192mM Glycine 
20% Methanol 
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-10X TBS  
10mM Tris-HCl (pH 8.0) 
150mM NaCl 
 
-10X TBST 
10mM Tris-HCl (pH 8.0) 
150mM NaCl 
0.05% Tween 
 
- Stripping solution 
 100mM -mercaptoethanol 
 2% SDS 
 62.5mM Tris-HCl (pH 6.7) 
 
Yeast Two-Hybrid Solutions 
 
- YPD medium 
 To 950ml of deionised H2O add:  
20g Difco peptone  
 10g Yeast extract  
 20g Agar (for plates only) 
 Shake until the solutes have dissolved. Adjust the volume to 1L with deionised H2O 
and sterilize by autoclaving. Allow medium to cool to 60ºC and add glucose to 2% (50ml 
of a sterile 40% stock solution).  
 
- SD synthetic medium 
 To 800ml of deionised H2O add:  
6.7g Yeast nitrogen base without amino acids (DIFCO)  
 20g Agar (for plates only) 
 Shake until the solutes have dissolved. Adjust the volume to 850ml with deionised 
H2O and sterilize by autoclaving. Allow medium to cool to 60ºC and add glucose to 2% 
(50 ml of a sterile 40% stock solution) and 100ml of the appropriate 10X dropout solution . 
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- 10X dropout solution (DO) 
 This solution contains all but one or more of the following components: 
             10X concentration (mg/L) SIGMA # 
L-Isoleucine     300       I-7383 
L-Valine     1500      V-0500 
L-Adenine hemisulfate salt   200      A-9126 
L-Arginine HCl    200      A-5131 
L-Histidine HCl monohydrate  200      H-9511 
L-Leucine     1000      L-1512 
L-Lysine HCl     300      L-1262 
L-Methionine     200      M-9625 
L-Phenylalanine    500                 P-5030 
L-Threonine     2000      T-8625 
L-Tryptophan     200      T-0254 
L-Tyrosine     300      T-3754 
L-Uracil     200      U-0750 
 
10X dropout supplements may be autoclaved and stored for up to 1 year. 
 
- 2X YPDA 
 Prepare YPD as above. After the autoclaved medium has cooled to 55ºC add 15ml 
of a 0.2% adenine hemisulfate solution per liter of medium (final concentration is 0.003%). 
 
- Solutions for preparation of yeast protein extracts 
a) Protease inhibitor solution 
Always prepare solution fresh just before using. Place on ice to prechill. To prepare 
688µl add in a microfuge tube: 
66µl Pepstatin A (1mg/ml stock solution in DMSO) 
2µl Leupeptin (10.5mM stock solution) 
500µl Benzamidine (200mM stock solution) 
120µl Aprotinin (2.1mg/ml stock solution) 
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b) PMSF (phenylmethyl-sulfonyl fluoride) stock solution (100X) 
Dissolve 0.1742g of PMSF (SIGMA) in 10ml isopropanol. Wrap tube in foil and 
store at RT. 
c) Cracking buffer stock solution 
 To 80ml of deionised H2O add:  
 48g Urea  
 5g SDS 
 4ml 1M Tris-HCl (pH6.8) 
 20µl 0.5M EDTA  
 40mg Bromophenol blue  
Shake until the solutes have dissolved. Adjust the volume to 100ml with deionised 
H2O. 
d) Cracking buffer 
To prepare 1.13ml add in a microfuge tube: 
1ml Cracking buffer stock solution (recipe above) 
10µl -mercaptoethanol  
70µl Protease inhibitor solution (recipe above) 
50µl 100X PMSF stock solution 
 
Solutions for yeast colony hybridization experiments 
 
a) SCE solution 
1M sorbitol     
100mM sodium citrate   
60mM EDTA   
b) SCE/DTT/Lyticase 
40ml SCE 
300µl 2M DTT 
5600 units Lyticase 
 
c) 20X SSC 
87.65g NaCl  
44.1g Sodium citrate  
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Dissolve in 400ml dH2O, adjust pH to 7.0 with NaOH, adjust the volume to 500ml 
and sterilize by autoclaving 
d) 200mM Tris/2X SSC 
200ml 1M Tris-HCl (pH7.5) 
100ml 20X SSC 
700ml dH2O 
e) 3X SSC/ 0.1%SDS/ 1mM EDTA 
7.5ml 20XSSC 
0.5g SDS 
1ml EDTA 0.5M 
Adjust the volume to 50ml with dH2O 
f) 60mM Tris-HCl (pH 7.8)/ 10mM MgCl2 / 14mM 2-mercaptoethanol 
3ml 1M Tris-HCl (pH7.8) 
0.5ml 1M MgCl2 
48.5µl 2-mercaptoethanol  
Adjust the volume to 50ml with dH2O 
 g) Hybridization solution 
 0.009M Tris-HCl (pH7.4)                   
 0.9M NaCl   
 6mM EDTA     
 0.5% Nonidet P40    
 2X Denhart’s solution    
 0.2%SDS      
0.05% sodium pyrophosphate  
 (70µg/ml) E. coli tRNA  
 (100µg/ml) E. coli DNA  
h) 50X Denhart’s solution 
1% Ficoll 400 
1% polyvinylpyrrolidone 
1% BSA (Pentax fraction V) 
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 Solutions for Northern Analysis 
 
a) 5X formaldehyde gel-running buffer 
0.1M MOPS (pH7.0) 
40mM sodium acetate 
5mM EDTA (pH8.0) 
b) Formaldehyde gel-loading buffer 
 50% glycerol 
 1mM EDTA (pH8.0) 
 0.25% bromophenol blue 
 0.25% xylene cyanol FF 
 
 Solutions for the 2D gel electrophoresis 
 
a) Lysis buffer 
9M Urea 
4% CHAPS 
b) Equilibration buffer 
50mM Tris-HCl (pH8.8) 
6M Urea 
30% Glycerol 
2% SDS 
0.002% Bromophenol blue 
 
-Silver Staining 
a) Fixing solution 
40%Methanol 
10%Acetic Acid 
b) Sensitizing solution 
30% Methanol 
0.2% Sodium Thiossulfate 
6.8% Sodium Acetate 
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c) Silver solution 
2.5% AgNO3 
d) Developing solution 
2.5% Sodium carbonate 
0.04% Formalin 
e) Stop solution 
1.46% EDTA 
 
 Immnunoprecipitation Solutions 
 
-Lysis buffer  
 50mM Tris-HCl (pH8.0) 
 120mM NaCl 
 4% CHAPS 
0.1mg/ml Pepstatin A 
0.03mM Leupeptin 
145mM Benzamidine 
0.37mg/ml Aprotinin 
4.4mM PMSF in isopropanol 
 
- 1X PBS 
 8mM Sodium Phosphate  
 2mM Potassium Phosphate 
140mM NaCl 
10mM KCl 
Characterization of the PP1 Interactome from Human Testis                                                               Appendix                                                                                                 
 
Centro de Biologia Celular 
Universidade de Aveiro 
242 
 
Appendix II - Primers  
 
PRIMER SEQUENCE (5’:::: 3’) Nt  
No. 
MT
(ºC) 
GAL4 AD TACCACTACAATGGATG  17  48 
GAL4 BD  TCATCGGAAGAGAGTAG  17 50 
OLIGONEK CAGCCCTGTATTGAGTGAGC  20 62 
OLIGONEK2 TCTTCTTAATTACTGGATTACTTG  24 62 
OLIGONEK3 CTGAGGATGGAAGATTAAGAAG 22 62 
OLIGONEK4 GAATACTTTCTTGGTTGGGC 20 58 
OLIGONEK5 GGCTTCACGCTGCCCAGCTG 20 68 
OLIGONIPP GACTCCTGTTGTGCCGTCAG 20 64 
OLIGONIPP2 TGGAGCATTGCCTCCCAAGC 20 64 
OLIGO40Q3 GAGTCAGTGACATTCGGGAC 20 62 
OLIGO40Q3/2 TCTGGCATGGAGCTGATATC 20 60 
OLIGO40Q3/3 CCAGGTCATGTGGCTGCCTT 20 64 
OLIGO40Q3/4 GTAGAATTGAGACACCTCCTG 21 62 
40Q3P1 CGGAATTCGCCATGTGGAGGATAAACGG 28 86 
40Q3P2 CGGAATTCGCCATGCCCGGGGTG 23 78 
40Q3P3 
(reverse) 
CGGGATCCGCAGGTCAATTTAGTTA 25 74 
Amplimer 3’ 
(reverse)  
ATCGTAGATACTGAAAAACCCCGCAAGTTCAC                                                                                                                                                                                                                    32 84
Amplimer 5’ CTATTCGATGATGAAGATACCCCACCAAACCC 32 94 
OLIGO4Q1 CTGAAGATCCTGGAGCCCGG 20 58 
OLIGO4Q1/2 TTGACCACAGCCTGGTTTAC 20 60 
OLIGO4Q1/3 GCACTCGTCTCTCTGGGAGG 20 66 
OLIGO275.2 CCTGGAGAGGGCCGAATAA 19 60 
OLIGO275.2/2 GACGTTCTTTCTGGAGGAAG 20 60 
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Appendix III - Bacteria and yeast strains 
 
- E. coli XL1- blue: recA endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac[F’ proAB 
lacZ∆M15 Tn10(Tetr)] 
 
- S. cerevisiae AH109: MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4∆, gal 80∆, 
LYS2:: GAL1UAS-GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-
MEL1TATA-lacZ, MEL1 
 
- S. cerevisiae Y187: MATα, ura3-52, his3-200, ade2-101, trp1-901, leu2-3, 112, gal4∆, 
met-, gal 80∆, URA3:: GAL1UAS-GAL1TATA-lacZ, MEL1 
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Appendix IV - Plasmids 
 
 
 
       
       
 
 
 
Figure 1: pACT2 (CLONTECH) map and MCS. Unique sites are coloured blue. pACT2 is 
used to generate a hybrid containing the GAL4 AD, an epitope tag and a protein encoded 
by a cDNA in a fusion library. The hybrid protein is expressed at medium levels in yeast 
host cells from an enhanced, truncated ADH1 promoter and is target to the nucleus by the 
SV40 T-antigen nuclear localization sequence. pACT2 contains the LEU gene for selection 
in Leu- auxotrophic yeast strains. 
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Figure 2: pAS2-1 (CLONTECH) map and MCS. Unique sites are coloured blue. pAS2-1 is a 
cloning vector used to generate fusions of a bait protein with the GAL4 DNA-BD. The hybrid 
protein is expressed at high levels in yeast host cells from the full-length ADH1 promoter. The 
hybrid protein is target to the yeast nucleus by nuclear localization sequences. pAS2-1 contains the 
TRP1 gene for selection in Trp- auxotrophic yeast strains.   
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Figure 3: pBluescript II SK map and MCS. This vector is a 2961 bp phagemid derived from 
pUC19. The SK designation indicates that the polylinker is oriented such that lacZ transcription 
proceeds from SacI to KpnI. 
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Figure 4: pEGFP vector map (Clontech). This eukaryotic exppression vector was used to produce 
GFP fusion proteins 
 
 
 
 
 
 
 
 
 
